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Abstract 
 
Abstract 
This thesis details investigations into organocatalytic reactions promoted by 
N-Heterocyclic Carbenes (NHCs) that proceed via an assumed azolium enolate 
intermediate. 
Initial research focused on the catalytic asymmetric synthesis of β-lactones via an 
NHC-catalysed formal [2+2] cycloaddition of alkylarylketenes and chloral. This 
process operated in good yield (typically >70%) and moderate diastereoselectivity 
(typically ~75:25 dr, anti:syn) for a range of alkylarylketenes. The enantioselectivity 
was consistently high for the major anti diastereomer (typically >80% ee) and minor 
syn diastereomer (typically >70% ee). Interestingly, when a ketene bearing a 
2-substituent on the aryl ring, or one that included an α-branched alkyl group was 
used, an exclusive asymmetric chlorination pathway was accessed. This is, to the best 
of our knowledge, the first use of chloral as an electrophilic chlorination agent. This 
methodology was found to be applicable to a range of 2-arylsubstituted 
alkylarylketenes in good yield and enantioselectivity (typically >70% yield and up to 
92% ee).  
The scope of this reaction with respect to the aldehyde moiety was then analysed with 
2-nitrobenzaldehyde providing β-lactone products in excellent dr (up to 94:6 syn:anti) 
and with good yield and enantioselectivity (typically >60% yield and >80% ee). 
Importantly these β-lactone products were amenable to further derivatisation with 
transformation to β-amino- and β-hydroxy acids. 
Following the identification of an NHC-catalysed chlorination reaction using chloral, 
the development of a general procedure was undertaken. Following a wide screen of 
electrophilic chlorination sources, 2,3,4,5,6,6-hexachlorocyclohexa-2,4-dienone was 
identified as optimal, operating in excellent yield (up to 97%) but in moderate to poor 
levels of enantioselectivity (21−61% ee).  
Efforts to expand the practicality of azolium enolate processes focused on the use of 
α-aroyloxyaldehydes as bench stable mono-substituted ketene surrogates. A range of 
differentially substituted α-aroyloxyaldehydes allowed access to δ-lactones via the 
NHC-catalysed [4+2] cycloaddition between azolium enolates and β,γ-unsaturated 
α-ketoesters. Following initial optimisation the reaction proceeded in exquisite 
diastereo- and enantiocontrol (typically >95:5 dr and >99% ee). 
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1.0 Organocatalysis 
The term “organocatalysis” describes the promotion or acceleration of a chemical 
reaction through the addition of a substoichiometric quantity of an organic compound 
that does not contain a metal atom.1 This definition represents a synthetic paradigm 
that was conceived in the late 1990’s and has arguably become one of the most 
desired synthetic methods for the creation of enantiomerically enriched products. The 
last 100 years has seen sporadic reports of reactions catalysed by small organic 
molecules; it was not until the landmark publication from the group of MacMillan in 
2000 that the advent of iminium ion catalysis as a general reaction platform for 
organocatalysis was formally conceptualised.2 In this historic paper3 MacMillan 
clearly defines the field in three important ways: (i) the term organocatalysis was 
introduced for the first time allowing future publications to be placed within a 
chemical descriptor; (ii) the potential benefits of organocatalysis to both academia and 
industry were highlighted, for example potential reductions in cost and greater 
synthetic practicality; (iii) most importantly it introduced the concept of a generic 
mode of activation that allows multiple reaction types from a single catalytic concept. 
Arguably this allowed organocatalysis to be considered a viable synthetic strategy for 
the construction of molecular complexity. Following this publication, the field 
underwent a rapid expansion and led to organocatalysis becoming recognised as a 
major branch of catalysis in its own right. Much recent development has focused 
around five main modes of activation: (i) iminium ion catalysis;4 (ii) enamine 
catalysis;5 (iii) phase transfer catalysis;6 (iv) H-bonding catalysis;7 (v) Lewis base 
catalysis.8 Representative modern asymmetric examples will be discussed below. 
1.1 Iminium ion catalysis 
Iminium ion catalysis (a subclass of Lewis base catalysis) was the first mode of 
activation to be fully explored. It was initially rapidly expanded by MacMillan and 
co-workers with the development of various imidazolidinone catalysts9 and more 
recently through the diaryl prolinol derivatives introduced by Jørgensen et al.10 
Iminium ion catalysis has provided some of the most diverse reactions types including 
asymmetric Diels-Alder,11 Friedel-Crafts12 and dihydroxylation13 reactions. These all 
operate via the common mode of reversible iminium ion formation leading to a 
lowering of the α,β-unsaturated aldehyde LUMO. In a strikingly simple approach the 
group of MacMillan utilised catalyst 3 in the asymmetric hydride reduction of enals.14 
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This proceeds via iminium ion formation followed by stereoselective reduction by 
Hantzsch ester 2. The reaction tolerates a range of saturated aldehydes in good yield 
(typically >70%) and excellent levels of enantioselectivity (typically >90% ee) 
(Scheme 1). 
3 (20 mol%),
CHCl3, !30 °C
(4)
typically >70% yield,
 >90% ee
OR1
R2 N
H
Me Me
CO2EtEtO2C
N
N
H
OMe
Me
Me
Me
•TFA
OR1
R2
(1)
R1 = aryl, alkyl, CO2R
R2 = Me, Et
(2)
N
N
OMe
Me
Me
Me
R1R2
(5)
iminiun ion
 intermediate  
Scheme 1: Iminium catalysed asymmetric hydride reduction of enals. 
1.2 Enamine catalysis 
The benefits of enamines were reported as early as 1954 by Stork et al.,15 with a later 
proline catalysed intramolecular aldol reaction published in 1971 independently by 
Weichert, Sauer and Eder16 as well as Hajos and Parrish.17 Despite these foundations, 
this mode of catalysis lay dormant until the landmark publication of Barbas, Lerner 
and List in 2000.18 Following this a wide range of publications focusing on 
asymmetric enamine catalysis were disclosed, commonly employing either proline,19 
its derivatives, or the imidazolidinones introduced by MacMillan. The stereoselective 
α-functionalisation of aldehydes and ketones has been an especially active area of 
enamine catalysis,20 with the asymmetric fluorination of aldehydes reported in 2005 
by the group of MacMillan.21 Catalyst 8 was found to be efficient for a range of 
aldehydes producing the valuable α-fluoroaldehyde motif (which were subsequently 
reduced to the corresponding alcohol 9) in good yields and excellent 
enantioselectivities (typically >70% yield and 90% ee) (Scheme 2).  
(i) 8 (20 mol%),
THF, i-PrOH, !30 °C
(ii) NaBH4, CH2Cl2
(9)
typically >70% yield,
 >90% ee
N
N
H
O Me
•DCA
(6)
R = aryl, alkyl
(7)
H
O
R N
F
SS
O O
Ph
O
Ph
O
HO
R
F
Me
Me
Ph N
N
O Me
Me
Me
Ph
R
(10)
enamine 
intermediate  
 Scheme 2: Asymmetric fluorination of aldehydes via enmine catalysis. 
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1.3 Phase transfer catalysis 
Perhaps more than any other mode of activation, phase transfer catalysis, as defined 
by Starks,22 has recieved appreciable interest within an industrial chemistry setting. 
This growth began with the pioneering work of Merck in the 1980’s23 and later spread 
to the wider academic community with a range of asymmetric organocatalytic 
strategies. Recent pioneering structure-activity/selectivity relationship studies by the 
group of Denmark have also sought to quantify the area.24 One of the major 
contributors to this area is the group of Maruoka who developed a range of BINOL 
derived chiral quaternary ammonium salts such as 13.25 In a 2005 benchmark 
publication,26 catalyst 13 is employed in the benzylation of glycine derived imine 11 
(a proving ground for phase transfer catalysts).27 At the extremely low catalyst 
loadings of 0.05 mol% and with co-catalytic 18-crown-6, the benzylated product 12 is 
obtained in an excellent 90% yield and 98% ee (Scheme 3). 
13 (0.05 mol%),
18-crown-6, (0.05 mol %),
toluene/50% aq KOH, 0 °C, 3 h
(12)
90% yield,
 98% ee
O
Ot-Bu
N
Ph
Ph
(11)
O
Ot-Bu
N
Ph
Ph
Ph
N
Ar
Ar
(13)
Ar = 3,5-Ph2C6H3
Br
 
Scheme 3: Asymmetric phase transfer benzylation. 
1.4 Hydrogen bonding catalysis 
There has been an array of discrete catalyst architectures reported in the last 10 years 
that can be classified as hydrogen bond donors. These range in the pKa spectrum from 
the phosphoric acids initially defined by Terada28 and Akiyama29 to the urea30 and 
thiourea31 derivatives of the Jacobsen group. In a recent representative example of the 
power of hydrogen bonding catalysis, Jacobsen and co-workers report an asymmetric, 
scalable Strecker synthesis for the preparation of a wide variety of unnatural α-amino 
acids (Scheme 4).32 Mechanistically, the thiourea 16 is postulated to facilitate the 
formation of a catalyst-bound iminium/cyanide ion pair through hydrogen bond 
interactions.33 Collapse of this ion pair in the rate determining C–C bond forming 
event releases the α-aminonitrile 15 and the thiourea catalyst 16. 
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16 (2 mol%),
TMSCN (2.0 equiv), 
MeOH (2.0 equiv),
 toluene, 
! 30 °C, 20 h
R
NBn
R
NHBn
CN
(16)(15)
typically >90% yield,
 >95% ee
(14) 
R = alkyl, aryl
N
H
t-Bu
N
H
S
CF3
CF3
O
N
Me
Ph
PhH
 
Scheme 4: Asymmetric Strecker reaction via H-bonding catalysis. 
1.5 Lewis base catalysis 
Lewis base catalysis (that includes the previously summarised iminium and enamine 
catalytic modes) has been the area of greatest appreciable research since the birth of 
organocatalysis. Defined in its simplest terms by the donation of a pair of electrons,34 
Lewis bases span a broad catalysis landscape8 from iminium and enamine to 
ammonium enolate35 and acyl ammonium manifolds36 (Fig 1). NHC catalysis is also 
contained within this mode of activation and will be the basis for the forthcoming 
review of the literature.  
 
O
R
R
N
R
R
R R
NHR2
(±) H2O
O
H
R
N
R
R
R R
NHR2
(±) H2O
O
LG
R
LB O
LB
R
O
LG
R
LB O
LB
R
O
RH
or
iminium ion catalysis
enamine catalysis
C1 ammonium enolate 
catalysis
acyl ammonium catalysis  
Fig 1: Modes of Lewis base activation. 
2.0 N-Heterocyclic Carbenes 
Carbenes are neutral compounds featuring a divalent carbon atom with only six 
valence electrons in two possible ground state spin multiplicities.37 Singlet carbenes 
possess a filled and a vacant orbital and show ambiphilic character whereas triplet 
carbenes contain two singly occupied orbitals and behave as diradicals. NHCs are a 
specific class of carbene that typically contain two adjacent nitrogen atoms. NHCs 
typically exhibit greater stability when compared to other classes of carbene which 
can be simplistically attributed to a “push-pull” stabilisation (Fig 2). This mechanism 
operates via the mesomeric donation of a nitrogen lone pair into the vacant p orbital, 
with a concurrent electron withdrawing effect from the doubly occupied σ orbital to 
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the electronegative nitrogen substituent. NHCs can also be kinetically stabilised by 
sterically bulky N-substituents that provide shielding of the carbene centre, through 
which their lifetime, with respect to dimerisation, is extended. 
N NR R C
NR2
NR2
C
NR2
NR2
!-electron 
donation
"-electron 
withdrawal  
Fig 2: Stabilisation of NHCs. 
These factors contributed to the isolation of the first stable crystalline form of an 
NHC in 1991 by Arduengo et al.38 who employed an imidazolinylidene framework 
with sterically bulky N-adamantyl substituents (Scheme 5). This publication followed 
the previous 1988 report of Bertrand who isolated the first stable phosphinocarbene.39 
The early pioneering work of Wanzlick and co-workers in the field must also be 
recognised, as although the isolation of a free NHC was never reported they were 
actively involved in the preparation of imidazolidin-2-ylidenes as early as the 
1960’s.40  
N
N
H
Cl
NaH
N
N
(17) (18)  
Scheme 5: Preparation of the first stable NHC. 
One of the earliest reports of carbene Lewis base catalysis was the 1943 account of 
Ukai et al.41 where the ability of thiazolium salts to promote the benzoin reaction was 
demonstrated. These transformations are postulated to occur via the catalytic effect of 
a carbene type intermediate, first proposed by Breslow42 and based on the initial ideas 
of Lapworth’s similar system43 that was used to explain the thiamine catalysed 
benzoin condensation (Fig 3). This function, by which an electron deficient moiety is 
converted into a nucleophilic ‘Umpolung’ (reversed polarity)44 species, is the basis of 
the reaction pathway induced by the action of an NHC.  
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Fig 3: Proposed mechanism for the thiamine catalysed benzoin condensation. 
While NHC mediated organocatalysis was founded via this ‘Umpolung’ mode of 
reaction45 centred upon thiazolium derivied NHCs, recent research has moved away 
from employing thiazolinylidenes to other catalyst architectures such as 
imidazolidinylidenes, imidazolinylidenes and triazolinylidines. The acyl anion mode 
of reactivity, more specifically the benzoin reaction, was the first to be studied in 
detail. This reaction and the corresponding intramolecular α,β-unsaturated aldehyde 
variant (Stetter reaction)46 represent the most heavily investigated use of acyl anion 
synthons. More recently, other modes of reactivity have been demonstrated that have 
widened the scope of NHC reactions, allowing access to d2 (enolate), d3 
(homoenolate) and eletrophilic a1 synthons (Fig 4).  
SNR1
R2 R3
NNR1
R2 R3
NNR1
R2 R3
N
NNR1
R2
R4 R4R4
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Fig 4: Representative NHC scaffolds and modes of reactivity. 
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3.0 Modes of NHC induced reactivity 
3.1 Generation and reactivity of acyl anion equivalents in asymmetric catalysis 
The first reported asymmetric benzoin reaction was by Sheehan and Hunneman47 in 
1966 who employed thiazolium precatalyst 25 to achieve an ee of 22%. Although 
wide ranges of thiazolium architectures were later developed, the levels of 
enantioselectivity remained low, with the axially chiral precatalyst 26 proving optimal 
to date.48 It was not until the introduction of triazolium precatalyst 27–29 by the 
groups of Enders49 and Leeper50 in the later 1990’s that the obtained level of 
enantioinduction reached practical levels (up to 90% ee) (Scheme 6). 
The current state of the art in the benzoin condensation is the 2009 report from the 
group of Connon.51 Crucial is the employment of precatalyst 30, bearing both a 
N-C6F5 substituent and a free hydroxyl group, the former being vital for good 
reactivity and the latter for high enantioselectivity. These two important catalyst 
features combine to provide both the broadest scope of tolerable aldehydes and the 
highest enantioselectivities to date.   
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Leeper 1998
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Enders 2002
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BF4
"
OH
Ph
Ph
(30) 90% yield, >99% ee
Connon 2009
OH
Ph
(20) (24)
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Scheme 6: Development of NHCs in the asymmetric benzoin reaction. 
Since the original report by Stetter and co-workers in 197652 the application of acyl 
anion chemistry to the asymmetric Stetter reaction has received much attention.53 In 
this reaction process the acyl anion equivalent adds to a Michael acceptor to furnish a 
new C–C bond. Due to the inherent problem with competing benzoin reaction 
research initially focussed on the more facile intramolecular Stetter reaction. Enders 
and co-workers were the first to report the asymmetric Stetter reaction on substrate 31 
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utilising precatalyst 33,54 with subsequent work detailing a diverse set of NHC 
precatalysts that have been developed and evaluated on substrate 31. The group of 
Miller demonstrated the structurally interesting peptidic thiazolium precatalyst 3455 
with the current state of the art represented by precatalyst 35 developed within the 
group of Rovis (Scheme 7).56  
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R = t-Bu, 94% yield,
 97% ee
Rovis 2003
(31)
Precatalyst (33!35)
(32)
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Scheme 7: Development of NHCs for the asymmetric intramolecular Stetter reaction. 
The asymmetric intermolecular Stetter reaction, in comparison to the intramolecular 
variant, has only recently been investigated. Only sporadic reports from the group of 
Enders57 were known prior to the recent studies of Rovis et al. who, in the current 
state of the art, generate Stetter products 38 from heteroaryl aldehydes 36 and 
nitroalkenes 37 in excellent yield and enantioselectivity (up to 98% yield and 90% 
ee).58 Although this report is a clear advancement in the field, the problems of 
competing benzoin condensation continue to severely restrict the reaction scope and 
utility (Scheme 8).    
Precatalyst 39 (10 mol%),
i-Pr2NEt (1.0 equiv)
 MeOH, 0 °C
(37)
N N
N
C6F5
Cl
(38)
typically >90% yield,
 >99% ee
(39)
Ar
O
R
NO2
(36)
i-Pr
F
Ar NO2
R
O
H
 
Scheme 8: Current state of the art in asymmetric intermolecular Stetter reaction. 
3.2 Generation and reactivity of homoenolate equivalents in asymmetric catalysis 
Under specific conditions homoenolates59 can be generated from the action of a NHC 
with an enal. Following NHC addition and proton transfer to form the Breslow 
intermediate 42, tautomerisation of this species can lead to homoenolate 43 (Fig 5).    
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Fig 5: Generation of homoenolates form enals. 
The generation and reactivity of homoenolates from enals was independently 
investigated by the groups of Glorius60 and Bode61 in the synthesis of 
γ-butyrolactones 46. The former also reported the use of chiral NHC precatalyst 47, 
however only low levels of enantioselectivity were obtained (25% ee) (Scheme 9). 
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 47 (5 mol%),
DBU, THF, rt
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74:24 dr, 70% yield,
12 and 25% ee
H
 
Scheme 9: Synthesis of γ-butyrolactones via formal [3+2] cycloadditions of homoenolates with 
trifluoromethylketones. 
In a recent study the group of Scheidt has shown the ability of homoenolates to 
participate in asymmetric formal [3+2] cycloadditions with nitrones.62 The reaction 
employing precatalyst 51 proceeds with excellent levels of diastereo- and 
enantioselectivity (typically >70% yield and 90% ee) for a range of aryl nitrones 49 
and alkyl or aryl substituted enals 48 (Scheme 10).  
 
 
 
 
 
Scheme 10: Asymmetric formal [3+2] cycloadditions of homoenolates with nitrones. 
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4.0 Generation and reactivity of azolium enolates in asymmetric catalysis 
Following extensive investigation into the benzoin and Stetter reactions attention 
turned to extending the reactive centre from a d1 to a d2 synthon, thus formally 
inducing enolate type reactivity. This mode of reactivity has allowed access to novel 
structural motifs and has become an especially efficient route to a range of important 
heterocyclic scaffolds via formal [2+2], [4+2] and, to a lesser extent, [3+2] type 
cycloadditions. Synthetically interesting enantioenriched esters and α-chloroesters 
have been furnished along with other reaction modes such as intramolecular 
cyclisations and desymmetrisations, often leading to high levels of molecular 
complexity. There are three distinct modes of generation for azolium enolates: via 
ketenes, α-functionalised aldehydes and enals that will serve as valid subclasses for 
the forthcoming section (Fig 6). 
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Fig 6: Generation of azolium enolates. 
4.1 Generation of azolium enolates via ketenes 
4.1.1 Ketenes  
Ketenes are a class of highly reactive carbonyl containing molecules.63 A ketene was 
probably first prepared by Wedekind in 1901 when he treated diphenylacetyl chloride 
with n-Pr3N and noted the formation of the n-Pr3N.HCl salt.64 He did not however, 
isolate the ketene and thus allowed the first characterisation to be reported by 
Staudinger.65 In 1905, inspired by the formation of the stable triphenylmethyl radical 
by Gomberg,63 Staudinger was successfully able to isolate diphenylketene 51 via the 
dehalogenation of 2-chlorodiphenylacetyl chloride 52 with zinc. Diphenylketene 
represents one of the most stable compounds of this class whose behaviours are 
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typified by the highly electrophilic C1 carbon. The highest occupied molecular orbital 
(HOMO) 54 lies perpendicular to the ketene plane, showing substantial electron 
density on oxygen and C2. The lowest occupied molecular orbital (LUMO) 55 shows 
significant positive charge character at C1 explaining the observed trend for 
nucleophilic addition to this carbon (Fig 7).66 
 
Cl
O
Cl
Ph
Ph Ph
C2
Ph
C1 O
Zn R
R
O RR O
(52) (53) (54)
HOMO
(55)
LUMO  
Fig 7: Formation of diphenylketene and HOMO and LUMO representations for diphenylketene. 
Although diphenylketene represents one of the most stable disubstituted ketenes, 
owing to the steric shielding of the C1 carbon that hinders its dimerisation, a wide 
range of other more reactive ketenes can be prepared and utilised in synthesis. There 
are many methods for the formation of ketenes67 other than that first used by 
Stuadinger, for example pyrolysis of the parent dimer or acid anhydride. A route to 
form other less reactive ketenes is via the dehydrohalogenation of acyl chlorides, 
reported by Staudinger in 1911.68 This method, although generally limited to 
alkylarylketenes, benefits from the preparative ease of the parent acyl halides and 
easy removal of the base hydrochloride salt via filtration.  
Since their discovery ketenes have shown a vast array of different reactivities.69 The 
[2+2] cycloaddition however, remains the most characteristic and most investigated 
reaction type. Staudinger’s original 1907 report of the formation of β-lactams from 
ketenes and imines70 continues to receive attention and serve as a inspiration for more 
modern synthetic approaches to these biologically important motifs. A variant of the 
Staudinger β-lactam synthesis by Fu and co-workers involves the use of electrophilic 
imines 57, with Umpolung ketene reactivity generated from addition of a Lewis basic 
catalyst71 to form an enolate. In this reversal of reactivity, excellent enantiomeric 
induction (typically >90% ee) can be achieved via the use of PPY derivative 59 as a 
chiral Lewis basic catalyst (Scheme 11). 
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Scheme 11: Asymmetric β-lactam synthesis from ketenes and imines. 
Interestingly, in a stereo-complementary report from Fu and co-workers the use of 
N-Tf imines resulted in a switch of diastereoselectivity.72 In this instance the anti 
β-lactams 62 were formed as the major product with equally high levels of 
enantioselectivity observed (Scheme 12). 
Ph i-Bu
O
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NSO2R
Ph NSO2R
Oi-Bu
Ph
Ph
59 (10 mol%), 
 toluene/CH2Cl2, rt
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SO2R = Tf: 97:3 dr; anti major (63% ee)
SO2R = Ts: 11:89 dr; syn major (98% ee)
(62)
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H
 
Scheme 12: Switch in diastereoselectivity for the use of N-Tf imines when compared to N-Ts 
imines in the asymmetric β-lactam synthesis. 
This mode of ketene activation has been heavily investigated in the last ten years, 
especially in formal [2+2], [4+2] and α-functionalisation reactions.73 In a series of 
other excellent reports Fu expands the scope of this reaction mode to encompass a 
range of formal cycloadditions allowing, amongst others, the synthesis of aza 
β-lactams,74 β-lactones75 and nitroso derived α-hydroxycarboxylic acids.76 These 
pioneering studies of Fu employing ketenes as precursors to ammonium enolates 
functioned as invaluable inspiration for the development of the first studies into the 
action of ketenes and NHCs. 
 
4.1.2 NHC-catalysed formal [2+2] cycloadditions employing ketenes 
There have been many recent publications on formal [2+2] cycloaddion reactions 
(concurrent with this thesis) and an appropriate selection of which will be discussed in 
the following section.77  
The groups of Smith and Ye independently discovered the field of NHC-mediated 
ketene derived azolium enolate chemistry in 2007. Ye78 employed (R)-pyroglutamic 
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acid derived precatalyst 66 in the formal [2+2] cycloaddition of unsymmetrical 
alkylarylketenes and N-Boc imines 64 with excellent levels of diastereo- and 
enantioselectivities (up to 99:1 dr and 99% ee). The work of Smith79 employed a 
similar reaction protocol with diphenylketene and N-tosyl imines 68, the optimum 
precatalyst being either triazolium 70 or imidazolium precatalyst 71 providing up to 
75% ee that could be further increased to 99% with recrystallisation (Scheme 13). 
The enantiocontrol in the reaction employing precatalyst 71 was shown to be relayed 
from the cyclohexane backbone to the reactive centre via the intimacy of the N-benzyl 
substituent.80 This effect was later fully investigated with a variety of catalyst 
skeletons and N-substituents examined.81 
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Scheme 13: NHC-catalysed formal [2+2] cycloaddition between ketenes and imines. 
A common mechanistic rationale for formal [2+2] cycloaddition is shown in (Fig 8). 
Attack of NHC 72 on the ketene α-carbon, anti to the aryl unit,82 yields enolate 73 
with subsequent addition to imine 64 to produce zwitterionic intermediate 74. 
Collapse of this species generates β-lactam 65 and releases NHC 72 back into the 
catalytic cycle. The origin of enantio-and diasterstereo selectivity was not rationalised 
in the original work of Ye however it has been recently investigated computationally 
by Tang and co-workers.83 
Chapter 1: Introduction 
 15 
R
Ar
O
N
N N Ar
O
Ar R
N
N N Ar
R
Ar
O
N
N N Ar
N
H
Ar1
NBoc
OR
Ar
Ar1
(73)(74)
TBSO
PhPh
TBSO
PhPh
TBSO
PhPh
HAr1
NBoc
Boc
(65) (72) (63)
(64)  
                     Fig 8: Postulated catalytic cycle for the NHC-catalysed β-lactone synthesis. 
 The β-lactone functionality can be generated by either the use of 2-oxoaldehydes84 or 
trifluoromethylketones.85 For the synthesis of β-lactones 76 from 2-oxoaldehydes 75, 
alkylarylketenes incorporating a 2-substituent on the aryl portion, or an i-pr alkyl 
moiety, were vital for high diastereoselectivity. In this series the anti lactones are 
obtained in good yield (typically >70%) in excellent diastereo- and 
enantioselectivities (up to >20:1 dr and 99% ee) (Scheme 14).  
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Scheme 14: NHC-catalysed asymmetric β-lactone synthesis from ketenes and oxoaldehydes. 
Trifluoromethyl lactones 78 were generated in equally impressive yields and 
selectivities, (typically >80% yield and up to 23:1 dr and 99% ee). In this instance the 
use of an alkylarylketene substituted in the two position, or an i-pr alkyl substituent 
provided no reaction. This is a structural feature consistent with a range of formal 
[2+2] and [4+2] ketene cycloadditions employing NHCs, where either 2-substitution 
of the aryl unit, or α-branching on the alkyl substituent, generally results in reduced 
yields or in some specific cases, a reversal of enantioselectivity (vide infra). 
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Scheme 15: NHC-catalysed asymmetric β-lactone synthesis from ketenes and trifluoromethyl 
ketones. 
Biologically important spirocyclic oxindoles 81 were generated via the formal [2+2] 
cycloaddition between disubstituted ketenes and isatins 80 (Scheme 15).86 Although 
the reaction only proceeded in moderate diastereoselectivity (typically 3:1 dr, 
anti:syn) the levels of enantioselectivity for the major diastereomer were uniformly 
outstanding (13 examples of 99% ee). A range of alkylarylketenes were tolerated in 
the process, however 2-substitution on the aryl portion resulted in significantly lower 
yield. The scope of the isatin N-substituent was briefly explored with N-Me, N-Bn and 
N-Cbz substituents all providing similarly high yields and enantioselectivities, with 
the moderate diastereoselectivity for the anti isomer also retained. The reaction utility 
was also demonstrated via ring opening of the oxindole-β-lactone 81 to generate the 
corresponding hydroxy ketone 82 with no erosion of enantiointegrity.  
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Scheme 16: NHC-catalysed asymmetric spiro-β-lactone synthesis from ketenes and isatins. 
Nitrogen electrophiles are also well suited to similar cycloaddition processes, with 
diazenedicarboxylates 83 and disubstituted ketenes providing access to aza β-lactams 
84 with excellent enantioselectivity (Scheme 17).87 The nature of the N-carbonyl 
group is crucial for control of formal [2+2] vs [4+2] reaction processes, with the 
carboxylates providing [2+2] cycloaddition products with various alkylarylketenes in 
excellent yields (typically 80–90%) and good to excellent enantioselectivities 
(typically 80–90% ee). Interestingly, employment of a ketene bearing a 2-substituted 
aryl moiety or one including an α-branch on the alkyl portion resulted in a switch in 
enantioselectivity to the opposite enantiomer (2-chlorophenylethyl ketene provided 
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52% yield and 57% ee). A limited range of other dialkyl diazenedicarboxylates 
(dimethyl, di(i-propyl), and di(t-butyl)) were also shown to be valid coupling partners 
with the cycloaddition reaction producing similar results.   
N
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R CO2Et
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Scheme 17: NHC-catalysed asymmetric aza-β-lactam synthesis from ketenes and 
diazenedicarboxylates. 
Alkylarylketenes have also been employed in dimerisation reactions promoted by 
precatalyst 87, forming the unsymmetrical dimer 86 in exclusive regioselectivity and 
with good to excellent levels of enantiocontrol (46–99% yield and typically >90% ee) 
(Scheme 18).88 The lactone products served as viable synthetic precursors with 
reductive ring-opening providing β-keto alcohols in high dr (typically >99:1) and 
with no erosion of enantiointegrity. The enantioselectivity of the reaction was shown 
to be dependent on the use of precatalysts with a free hydroxyl group (such as 87) 
and, as such, a stereochemical model featuring a key hydrogen-bond between the 
NHC and the ketene was postulated. 
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Scheme 18: NHC-catalysed asymmetric ketene dimerisation with postulated stereochemical 
model. 
4.1.3 Formal [4+2] cycloadditions employing ketenes 
Prior to the reported formal [2+2] cycloaddition of ketenes and diazenes (Scheme 17) 
the corresponding formal [4+2] cycloaddition was realised via the use of 
N-benzoyldiazenes 89 (Scheme 19).89 This reaction proceeds in good yield and 
excellent enantioselectivity for a wide range of alkylarylketenes (up to 97% yield and 
97% ee). Control of this dibenzoyldiazene reaction is highly dependent on the catalyst 
substructure, with the N-substituent playing a pivotal role in the level and absolute 
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sense of configuration at the newly formed stereocentre. Precatalyst 66 and 91 bearing 
the N-phenyl group provided product 88 with the (S) absolute configuration at the 
quaternary centre, whereas N-mesityl substituted precatalyst 92 supplied the 
(R)-enantiomer of 90.  
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Scheme 19: NHC-catalysed asymmetric  [4+2[ cycloaddition between ketenes and diazenes. 
To account for this difference in selectivity the authors proposed two possible 
transition states (TS) based on the orientation of the enolate to the triazole framework.  
Following addition of the NHC to the ketene, the enolate can adopt a conformation 
whereby maximum orbital overlap can be achieved, with the enolate and triazole 
portions adopting a coplanar conformation (TS A). This conformation, however, is 
not available with the mesityl substituted precatalyst 92 due to the larger steric 
demand or the N-aryl substituent, favouring a perpendicular orientation (TS B) that 
leads to the opposite absolute configuration (Fig 9). This provides access to both 
enantiomers of the product, which was shown to undergo ring opening by 
MeOH/NaOMe to afford  α,α−disubstituted-α−amino acid derivatives. 
 
Fig 9: Proposed rationale for the switch in absolute configuration. One methyl group of the 
mesityl group has been omitted for clarity. 
In an interesting extension of the formal [4+2] cycloadditions of ketene derived 
enolates to a 4π component, unsaturated acyl chlorides 97 were employed as 
vinylogous dienolate precursors in a [4+2] cycloaddition reaction with ketones 
(Scheme 20).90 Reactions with trifluoromethyl ketones 77 provided dihydropyranones 
96 in excellent yield (up to 94%) and good enantioselectivity (typically >70% ee). 
Isatins 79 were also effective coupling partners in this methodology leading to 
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spirocyclic oxindole-dihydropyranones 93 in equally impressive yield (typically 
>75%) and enantiocontrol (71–95% ee). The dihydropyranone products proved 
amenable to further derivatisation including epoxidation, leading to products with 
enantioenriched trifluoromethyl bearing stereogenic centres.  
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Scheme 20: Asymmetric formal [4+2] cycloaddition reaction employing vinylogous dienolate. 
4.2 Generation of azolium enolates from α-functionalised aldehydes 
Whilst the addition of an NHC to a ketene allows direct and rapid access to a reactive 
enolate equivalent, the high sensitivity and limited diversity of the ketene component 
has led to the development of alternative protocols that allow the in situ generation of 
an azolium enol or enolate intermediate. This mode of generation has been widely 
utilised as a means to access an acylazolium species 162 from α-functionalised 
aldehydes 98 (Fig 10) via sequential elimination of a suitable leaving group from the 
Breslow intermediate 101 to form the azolium enol or enolate species 99. This can 
then undergo protonation to form an acylazolium 102 and undergo further redox 
esterification and amidation processes.91 There has also been appreciable research into 
the direct use of the enol or azolium intermediate in a number of different reactions, 
especially those that asymmetrically forge carbon-carbon bonds. For those reactions 
that employ the enol or azolium intermediate in catalysis the use of a catalyst bearing 
a N-mesityl substituent is crucial to obtain good reactivity. In a recent and insightful 
study by the group of Bode92 the N-mesityl substituent is rationalised to increase the 
rate of formation of Breslow intermediate 101 and accelerate the likely irreversible 
and rate determining displacement of leaving group to generate azolium enolate 99. 
The N-mesityl substituent is also postulated to enhance the electron density of the 
enolate 99 and reduce the unwanted tautomerisation to the acylazolium 102.  
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Fig 10: Generation of azolium enolates from α-Functionalised aldehydes. 
In 2005 Rovis and co-workers developed a novel strategy to access α-chloroesters via 
the enantioselective protonation of an in situ generated α-chloroenolate 107 (Scheme 
21).93 The use of a bulky acidic phenol 104 as a buffer negated the problem of 
background epimerisation of the product and in combination with an excess of an 
alternative phenolic compound provided access to a range of α-chloroesters 105 in 
good yields (typically 60–70%) and excellent enantioselectivity (84–93% ee). This 
methodology was later extended to the direct synthesis of α-halo carboxylic acids via 
the use of water as a nucleophile in a biphasic reaction medium.94 Both asymmetric 
protonation and deuteration could be achieved in excellent yields and 
enantioselectivites (up to 95% yield and 95% ee).  Further pharmaceutical importance 
was demonstrated by the generation of α-fluoro carboxylic acids with excellent 
enantiocontrol  (up to 96% ee) from the redox hydration of α-fluoroenals.  
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Scheme 21: NHC-catalysed asymmetric synthesis of α-chloro esters. 
The use of α-halo aldehydes was extended to racemic α-chloroaldehydes 109 by the 
group of Bode who showed them to be effective enolate precursors in the [4+2] 
oxodiene Diels-Alder reaction with enones 110 (Scheme 22).95 Very low catalyst 
loadings of 0.5 mol% of 122 were used to prepare a range of 3,4,6-trisubstituted 
dihydropyran-2-ones 111 in excellent yield (up to 98%) and with high diastereo- and 
enantioselectivity (up to >20:1 dr and typically 99% ee, respectively). The absolute 
configuration of the α-chloro stereocentre was not important in the success of the 
reaction, as identical results were observed using both enantiomers of the aldehyde. 
During the reaction, complete epimerisation of the starting α-chloroaldehyde occurred 
after 1.5 h, accounting for this observation.   
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Scheme 22: Synthesis of dihdropyran-2-ones from α-chloro aldehydes. 
4.3 Generation of azolium enolates from enals 
A second synthetic route for obtaining azolium enolates from aldehydes is the 
addition of an NHC 41 to an enal 40. Under specific conditions β-protonation of the 
homoenolate species 43 leads to the azolium enolate 99 (Fig 11).  As with those 
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enolates generated from α-halo aldehydes, the use of an NHC bearing an N-mesityl 
substituent is crucial for control of the reaction mode, in this instance increasing the 
propensity of tautomerisation of the acyl anion species 42 to access either 
homoenolate 43 or the desired enolate 99. 
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Fig 11: Generation of azolium enolates from from enals. 
Recently Bode et al. has fully explored and expanded the scope of enal derived 
enolate equivalents in the formation of a range of substituted dihydropyran-2-ones 
115 (Scheme 23).96 Crucial to the control of undesired homoenolate pathways and 
promotion of the enolate mode of reactivity is the use of a weak amine base such as 
N-methylmorpholine (NMM) or 4-dimethylaminopyridine (DMAP). This facilitates 
the protonation of the homoenolate from the conjugate acid of the amine base at a 
faster rate than direct homoenolate C–C bond formation, minimising this potential 
side reaction. A wide range of electron deficient enones 114 were demonstrated to be 
good coupling partners with the catalytically formed enolate equivalent, with 
outstanding levels of diastereo- and enantioselectivity uniformly observed (typically 
>20:1 dr and 99% ee) in the formation of heterocyclic products 116–120. The [4+2] 
reactivity of enolates derived from enals could also be extended to the use of 
α,β-unsaturated imines, generating dihydropyridinone products in high diastereo- and 
enantioselectivity (>20:1 dr and typically 99% ee).97 
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Scheme 23: Synthesis of a range of dihydropyran-2-ones via enals. 
Scheidt and co-workers have developed an expedient synthesis of β-lactone 
frameworks and successfully applied it to the synthesis of Bakkenolides I, J and S 123 
(Scheme 24).98 The key NHC step in this process is a desymmetrisation of 121 to 
produce the 6,5-carbocyclic core 122 in 69% yield with the key ring junction set with 
the required cis-fused stereochemistry in an exquisite 20:1 dr and 98% ee from 
aldehyde. Importantly this reaction could be performed on 5 g scale allowing rapid 
access to a large quantity of stereochemically pure intermediate that formed the main 
framework of Bakkenolide I, J and S natural products.   
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Scheme 24: Synthesis of Bakkenolides I, J and S featuring a key NHC-catalysed 
desymmetrisation 
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5.0 Previous work within the Smith group 
As previously summarised, the Smith group, independently to the group of Ye, have 
disclosed some of the first interactions between ketenes and NHCs. Following 
multiple reports of the NHC-catalysed Staudinger reaction efforts were directed 
towards other NHC-catalysed processes. The asymmetric esterification of ketenes has 
been demonstrated, again independently by the groups of Smith99 and Ye.100 The 
methodology developed in the Smith group uses 2-phenylphenol 124 to access esters 
125 under the catalytic influence of precatalyst 126. This process operates in similar 
yields (65–91%) and enantioselectivities (up to 84% ee) to that obtained by Ye and 
co-workers. (Scheme 25).  
 
 
 
 
 
Scheme 25: NHC-catalysed asymmetric esterification. 
6.0 Aims and objectives 
This thesis will explore the scope of NHC-mediated catalysis, specifically the 
generation and reactivity of azolium enolates. Studies will be initiated to expand the 
successful methodology for β-lactam formation to an analogous β-lactone protocol. 
Research will focus on obtaining good reactivity via the identification and 
optimisation of a reaction procedure. Following this, the development of an 
enantioselective protocol will be undertaken via the synthesis and evaluation of a 
broad range of different NHC catalyst architectures. 
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1.0 Synthesis of alkylarylketenes 
To enable detailed investigation into reactions employing azolium enolates generated 
from NHCs and ketenes, it was imperative from the outset to employ a reliable 
protocol for the formation of alkylarylketenes. It was found that dehydrohalogenation 
of the requisite acid chloride could adequately supply a variety of alkylarylketenes in 
good purity and acceptable yields (Scheme 26, Table 1).  
 
 
Scheme 26: Synthesis of alkylarylketenes. 
Entry R Aryl Yield (%) 
1 Me Ph 45 
2 Et Ph 60 
3 i-Pr Ph 50 
4 n-Bu Ph 51 
5 Et 4-FPh 55 
6 Et 4-MePh 52 
7 Et 4-MeOPh 48 
8 Et 2-MePh 35 
9 Et 2-ClPh 52 
10 i-Pr Thiophene 59 
Table 1: The synthesis of a representative range of alkylarylketenes. 
Key to the success of this process is the filtration under inert atmosphere of the 
Et3N.HCl generated during the course of the reaction (Fig 13, picture 2). Following 
this, concentration of the reaction solution and transfer via cannula to a Kugelrohr 
flask, allowed purification by distillation while maintaining the inert atmosphere 
throughout the procedure (Fig 13, picture 3). 
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Figure 13: Synthetic procedure for the synthesis of alkylarylketenes. 
Importantly, once experienced with the synthetic procedure it could be reliably 
carried out on multiple occasions resulting in near identical results in terms of yield 
and purity. Generally, the ketenes can be stored for periods of up to one month when 
stored at -20 ºC under an argon atmosphere. After this period, however, impurities as 
a result of hydrolysis can be observed. The limitation of this procedure was the scale, 
with approximately 2.5 g of ketene typically representing the maximum quantity of a 
single reaction, irrespective of the quantity of acid chloride used. With a reliable 
procedure for the synthesis of alkylarylketenes, attention turned to the synthesis of a 
frequently employed NHC precatalyst. 
 
2.0 Synthesis of NHC precatalyst 66 
2.1 Analysis of current synthetic route 
A variety of NHC precatalyst architectures have been developed1 however due to the 
limited availability and/or expense of purchasing such NHC precatalysts for 
asymmetric transformations, the synthetic community has yet to fully embrace their 
use. This is compared to other organocatalytic platforms such as enamine catalysis 
where the most common catalyst structures, proline and its derivatives, are widely 
available or readily prepared. This lack of commercial availability is one of the 
fundamentally limiting aspects to the wider use and uptake of NHC-mediated 
processes in the chemical community.  
NHC precatalyst 35, 66 and 112 (Fig 14) represent some of the most widely 
employed NHC scaffolds, with 66, and its structural analogues, finding particularly 
prevalent use in formal cycloadditions employing ketenes. Although a scalable 
synthetic procedure for the highly effective precatalysts 35 and 112 has been 
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reported,2 the synthesis of precatalyst 66 within our group has only been reliably 
carried out to provide ~1 g of material.   
N
N
N Ph
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OTBSPh
(66)
N N
N
Mes
O
(112)
N N
N
C6F5
O
(35)
BF4BF4
 
Figure 14: Frequently employed NHC precatalysts. 
The synthetic procedure to give 66 was initially carried out according to the 
literature.3 Pyroglutamic acid is first converted to the methyl ester 130 by treatment 
with thionyl chloride in methanol followed by double phenylmagnesium bromide 
addition to form the tertiary alcohol 131. TBS protection of the alcohol moiety is 
carried out to obtain 132 then the lactam is converted to the triazolium scaffold in a 
one-pot, three-stage process yielding precatalyst 66. This is achieved through 
activation of the carbonyl by methylation using trimethyloxonium tetrafluoroborate to 
form an acetimidate in situ, with subsequent phenylhydrazine displacement to afford 
the amide-derived hydrazone hydrotetrafluoroborate salt. Concentration of the 
reaction mixture followed by reflux in triethyl orthoformate and methanol precipitates 
the final NHC precatalyst as the tetrafluoroborate salt (Scheme 27). 
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Scheme 27: Previous synthetic route to precatalyst 66. 
In our hands there are a number of problems associated with this reported route, 
especially when applied to large scale synthesis:  
• Firstly the methyl ester preparation typically provided a very viscous oil and 
therefore no direct purification of this material by distillation was normally 
attempted. The purity of methyl ester 130 was only crudely established by 1H 
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NMR spectroscopy and typical mass return exceeded 100% implying 
significant residual impurities such as SOCl2 or dimethyl sulfite. 
• The quality of the methyl ester was found to effect directly the subsequent 
Grignard addition step, with yields for this stage showing considerable 
variation.4 A second factor for the variable yields for the Grignard step was a 
particularly difficult work up and isolation procedure, particular on scale. This 
is postulated to be due to the large quantities of magnesium salts formed 
during the reaction process.  
• The TBS protection step, although quoted as high yielding in the literature, 
provided erratic yields in our hands. This is likely due to difficulties associated 
with the chromatography of 132; ideally, no chromatographic purification 
would be necessary. 
• The final three-step procedure is inherently difficult. Typically, if the 
precatalyst salt 66 does not precipitate from the reaction solution following 
reflux with triethyl orthoformate, an arduous and often low-yielding isolation 
procedure had to be undertaken. Although not reported in this course of 
research, other work in the Smith group has recently found that the hydrazone 
intermediate can be isolated and partially purified prior to the cyclisation 
step.5 
 
With these problems defined, an improved procedure that allowed the facile synthesis 
of 66 on large (>10 g) scale was developed. This portion of research was undertaken 
at the AstraZeneca Process Research and Development department in Macclesfield as 
part of the CASE award programme. 
2.2 Large scale synthesis of methyl ester 130 
The first stage of this project was to ascertain the purity of the material obtained from 
the current methanol and thionyl chloride method for preparation of methyl ester 130. 
Following the literature procedure on a 50 g scale of (S)-pyroglutamic acid, treatment 
with 1.1 equivalents of thionyl chloride provided >120% mass return of a thick pale 
yellow oil. 1H NMR spectroscopic analysis in a variety of solvents indicated the 
presence of significant residual solvent but also other unidentified organic impurities. 
At this point it was found that the crude methyl ester could be purified by washing 
with saturated aqueous NaHCO3. Significant material, however, is lost due to 
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hydrolysis, giving only an isolated yield of 40%. Other methods such as the use of  
catalytic quantities of concentrated hydrochloric acid6 or thionyl chloride7 were 
attempted according to the literature. These procedures incorporated the aqueous 
NaHCO3 wash and again, yields of 40% and 44% were obtained, respectively. 
Purification by distillation of the crude methyl ester product was found to be effective 
on small scale; however due to the viscosity of the material at this stage, Kugelrohr 
distillation of large quantities (>50 g) was not envisaged as a long term practical 
solution (Scheme 28).  
N
H
O
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HO
N
H
O
O
MeOi. MeOH, H+ 
ii. NaHCO3
(129) (130)
typically <50% yield  
Scheme 28: Low yielding routes to methyl ester 130 
A practical and scalable solution to this problem was found by the use of solid 
AmberlystTM 15 acidic resin. An approximate 40% weight/weight quantity in 400 mL 
of methanol at reflux for 24 h delivered analytically pure methyl ester as a highly 
mobile colourless oil in 97% yield. Importantly, this reaction was readily conducted 
on a 100 g scale with >100 g of the methyl ester returned with no requirement for 
purification. This reaction was carried out in a 1 L jacketed CLR (Controlled 
Laboratory Reactor) that allowed increased ease of procedure; in practice, however, 
this reaction could also be conducted in standard laboratory glassware (Scheme 29). 
 
Scheme 29: Successfully developed synthesis of methyl ester 130 
2.3 Large scale synthesis of alcohol 131 
Although it was predicted that the use of purified methyl ester 130 in the subsequent 
Grignard addition reaction would improve the yield of this step, the problems 
associated with the work up remained. To this end the use of phenyllithium was 
explored and found to be an effective substitute with an improved work up on a 
laboratory scale.8 On a large scale (typically 50 g of methyl ester) it was found that 
the use of commercial phenyllithium, (1.8 M in dibutyl ether) generated an effective 
solvent composition to allow direct precipitation of the alcohol product from the 
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reaction medium, following NH4Cl (aq) quench. The alcohol product 131 could then 
be directly obtained via filtration and typically proceeded in up to 61% yield 
following a recrystallisation. 
N
H
O
O
MeO
N
H
O
Ph
OH
Ph
PhLi (3.5 equiv)
 1.8 M solution in Bu2O,
THF, !78 °C to rt
(130)
40 g scale
(131)
enantiopure 41 g, 57% yield
racemic 44 g, 61% yield  
Scheme 30: Successfully developed synthesis of alcohol 131 
2.4 Large scale TBS protection of alcohol 131 
The TBS protection of alcohol 131 was attempted on large scale following the typical 
reaction conditions employing TBSOTf and Et3N. In this instance, reaction on a 40 g 
scale failed to provide any conversion to the TBS protected alcohol. Significant 
problems were encountered with the solubility of alcohol 131 in the CH2Cl2 reaction 
solvent, with this only becoming apparent when >1 L of reaction solvent are required. 
The reaction mixture could be made homogeneous upon addition of additional TBS 
triflate, however this had no apparent effect on the reaction course and alcohol 131 
was recovered in near quantitative yield (Scheme 31). 
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Scheme 31: Unsuccessful TBS protection of alcohol 131 
The TBS protection could be carried out effectively by using the reaction conditions 
employed by Enders et al.3b employing the combination of TBS triflate and 
2,6-lutidine. This gave the product in 59% yield without the need for silica 
chromatography.9 This is lower than the typically reported yields for this procedure, 
which are generally quoted as >90%, however the use of standard silica 
chromatography on >100g of crude product greatly inhibits the synthetic practicality 
of this approach. 
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Scheme 32: Successfully developed TBS protection of alcohol 131 
2.5 Large scale three-step triazolium heterocycle construction 
The final three stages were conducted in keeping with the literature and as previously 
carried out within our own research group. On a 20 g scale for both the racemic and 
enantiopure TBS protected alcohol 132, triazolium precatalyst 66 was obtained in an 
average 60% yield following recrystallisation from methanol (Scheme 33).10  
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CH2Cl2
ii. PhNHNH2 (1.1 equiv)
iii. CH(OEt)3, MeOH
N
H
O
Ph
TBSO
Ph
(132)
20 g scale
(66)
enantiopure 18 g, 61% yield
racemic 17 g, 58% yield  
Scheme 33: Final three step synthesis of NHC precatalyst 66. 
3.0 Summary 
Overall, the developed precatalyst synthesis provided ~20 g of both the racemic and 
the enantiopure (S)-precatalyst 66. Importantly, this scaled-up procedure provided 
solutions to a number of the practical issues associated with the literature and 
moreover it is very unlikely that the previously employed route (Scheme 27) could 
have provided comparable quantities of material.  
With both racemic and enantiopure precatalysts 66 synthesised on such large scale, 
the standard quantities employed in future organocatalytic processes could be 
increased. This allowed both an increase in reaction practicality and accuracy, while 
allowing access to a greater quantity of material upon which derivatisation studies 
could be conducted. 
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1.0 Introduction 
Previous work within the Smith group had shown that NHCs are efficient Lewis base 
catalysts for the formal [2+2] cycloaddition reaction between disubstituted ketenes 
and imines, enabling access to a range of enantioenriched β-lactams.1 Following this 
proof of concept, the expansion of this methodology to the analogous formal [2+2] 
cycloaddition between disubstituted ketenes and aldehydes, generating β-lactones, 
was investigated. 
The β-lactone moiety has a long and distinguished history in synthetic chemistry, 
serving as a versatile starting material in both complex2 and small molecule 
synthesis.2b,3 Although less biologically prevalent than the analogous β-lactam motif, 
the β-lactone moiety features in the core structure of a range of natural products with 
notable pharmacological properties.4 A number of synthetic methods have been used 
to prepare these versatile scaffolds in enantioenriched form, ranging from substrate5 
and chiral auxiliary6 controlled processes to catalytic asymmetric methods.7 The 
Lewis base catalysed formal [2+2] cycloaddition between aldehydes and ketenes to 
generate β-lactones is well documented.8 As early as 1982 Wynberg and Staring 
reported the efficient synthesis of β-lactone 135 from parent ketene and chloral, 
elegantly demonstrating the synthetic utility of this approach by the derivatisation of 
135 to (S)-acid 136 (Scheme 34).9  
 
Scheme 34: Wynberg’s pioneering Lewis base catalysed formal [2+2] cycloaddition. 
Romo et al. have expanded the scope and practicality of the Wynberg approach by the 
use of mono-substituted ketenes, generated in situ.10 The use of less reactive 
dichlorinated aldehydes 139 was also demonstrated, with the utility of the β-lactone 
products 140 showcased via a range of derivatisation strategies, including conversion 
to the β-hydroxy ester 141 (Scheme 35). 
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Scheme 35: Development of the original Wynberg process by Romo et al. 
Further utility of the parent Wynberg lactone 135 was demonstrated by the group of 
Romo. In this report the use of trichloromethyl-β-lactone 135 as an amino acid 
synthon is outlined.11 This strategy proceeds via ring opening to provide an 
enantioenriched trichloromethylcarbinol, followed by conversion to the α-azido acid 
as developed by Corey.12 This procedure is known to proceed with inversion of 
configuration at the carbinol centre, thus providing the masked amino acid motif in 
enantiomerically pure form from either enantiomer of the commercially available 
lactone 135. Romo and co-workers later exemplified this efficient methodology in the 
synthesis of Schulzeines B and C 145.13  
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Scheme 36: The use of trichloromethyl-β-lactone 135 as an amino acid synthon. 
Although Wynberg’s original synthesis stands as an elegant early example of 
organocatalysis where the utility of the parent trichloromethyl-β-lactone has been 
demonstrated, extension to the α,α-disubstituted lactone motif via the use of 
disubstituted ketenes has not been realised.  
  
2.0 Project aim 
This project will seek to expand the original report of Wynberg to reactions of 
disubstituted ketenes and chloral, via the development of an NHC-catalysed formal 
[2+2] cycloaddition process. The amenity of the β-lactone products to derivatisation, 
most importantly to the amino acid motif, will be investigated.  
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3.0 NHC-catalysed asymmetric β-lactone synthesis 
3.1 Preliminary investigations 
Initial investigations into the feasibility of this approach began by employing 
precatalyst 66, whose general structure had proved effective in a wide range of similar 
processes (Chapter 1: 4.1.2). Employing triazolium salt 66 at a prototypical 
precatalyst loading of 10 mol% in combination with 9 mol% KHMDS as the base,14 
the formal [2+2] cycloaddition process was investigated with ketene 146 (1.0 equiv) 
and chloral (1.0 equiv) at 0 °C. Pleasingly, the desired separable β-lactone products 
were obtained in 89% combined yield as a 72:28 (anti:syn) diastereoisomeric ratio of 
products 147 and 148. The enantiomeric excess of both products was determined by 
chiral HPLC by comparison with genuine racemic standards prepared in analogous 
fashion from racemic precatalyst 66. The major anti lactone 147 was formed in an 
excellent 92% ee with the minor syn product 148 formed in slightly lower 84% ee 
(Scheme 37). 
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Scheme 37: Initial reaction screen. 
The relative configurations within 147 and 148 were established by X-ray 
crystallography, with the anti configured product found to be the major diastereomer 
(vide infra). Following this unambiguous assignment the relative configurations could 
also be assigned via the characteristic 1H NMR resonances for the lactone C(4) and 
ethyl protons (Fig 15 and 16). Specifically, the lactone C(4) proton for the anti 
diastereomer 147 has a resonance at higher chemical shift (ppm) than the 
corresponding syn 148 C(4) lactone proton. Typically he two diastereotopic CH2 ethyl 
protons for the anti lactones are observed at distinct chemical shift, whereas the 
corresponding ethyl protons for the syn diastereomer are not typically resolved.  
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Figure 15: Characteristic anti 1H NMR proton resonances. 
 
Figure 16: Characteristic syn 1H NMR proton resonances. 
 
In all further examples, the diastereoselectivity was defined via analysis of the 
characteristic C(4) proton shift by 1H NMR spectroscopy and comparison with the 
authenticated diastereomers of 147 and 148. 
3.2 Optimisation of NHC catalyst architecture 
Following this promising initial result a representative range of both chiral triazolium 
and imidazolinium NHC precatalysts was screened under identical conditions 
(Scheme 38, Table 2). Precatalyst 7015 provided slightly reduced yield (76%), but 
improved dr (83:17), and almost identical enantiomeric excess 16 (anti 91% ee, syn 
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84% ee) (Table 2, Entry 2). To investigate the effects of the N-aryl moiety of the 
triazolium-derived NHC, other differentially N-substituted aminoindanol derived 
precatalysts, 11215 and 35,17 were then screened. N-Mesityl substituted precatalyst 
112, know to function effectively for other NHC modes of action,18 was considerably 
less effective than the N-phenyl substituted precatalyst, proceeding in lower yield 
(43%), diastereomeric ratio (70:30 dr), and  low (≤10% ee) enantioselectivities 
(Table 2, Entry 3). The N-pentafluorophenyl substituted precatalyst 35, known to 
favour acyl anion processes,18 failed to provide any lactone product, possibly due to 
preferential addition to chloral (Table 2, Entry 4). Triazolium precatalyst 126 
proceeded to give the desired product in similar dr to 70 but with substantially lower 
yields (12% and 22%) and enantioselectivities (10% and 39% ee) (Table 2, Entry 5). 
Imidazolinium precatalyst 71, effective in the β-lactam methodology, provided 
reduced dr (63:37) and yield (54%) while providing only slightly enantioenriched anti 
product (17% ee) and essentially racemic syn product (<5% ee) (Table 2, Entry 6). 
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Scheme 38: Initial precatalyst screen. 
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Entry Precatalyst dr[a] 
(anti:syn) 
Yield (%)[b] 
(anti:syn) 
ee (%)[c] 
(anti:syn) 
1 66 72:28 61, 28 92, 88 
2 70 83:17 59, 17 91 (ent), 84 (ent) 
3 112 70:30 31, 12 10, 7 
4 35 −,− NR −,− 
5 126 77:23 12, 22 10, 39 (ent) 
6 71 63:37 34, 20 17, <5 
[a] Calculated by inspection of the crude reaction mixture using 1H NMR spectroscopy [b] Combined 
isolated yield of single diastereomer. [c] % ee determined by HLPC analysis on a chiral stationary 
phase. 
Table 2: Initial precatalyst screen. 
3.3 Optimisation of reaction conditions 
Precatalyst 66 was chosen for further optimisation due to its comparable results to 70, 
the most effective precatalyst screened, combined with its availability in gram 
quantities in both enantiopure and racemic form.19 The effects of base and 
temperature were then analysed (Scheme 39 Table 3). Cs2CO3, a frequently 
employed alternative to KHMDS, was tested under the reaction conditions and found 
to provide incomplete conversion on multiple attempts, even at elevated reaction 
temperatures (Table 3, Entry 1). At rt only 50% conversion was obtained in 69:31 dr, 
providing low isolated yield (16% anti) but in excellent enantiomeric excess (94% 
ee). Lowering of the reaction temperature when employing KHMDS as the base  
provided incomplete lactone formation with considerable ketene dimerisation at either 
−25 °C or −78 °C (Table 3, Entry 2 & 3). In the absence of precatalyst 66, it was 
found that KHMDS proved proficient in promoting the (racemic) background 
reaction, proceeding in good conversion but low dr (53:46) (Table 3 Entry 4). 
Similar such observations have been reported by Wilhelm, where KHMDS has been 
shown to promote formal [2+2] cycloadditions of ketenes with imines or carbonyls.20 
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Scheme 39: Temperature screen employing optimal precatalyst 66. 
Entry Temp (°C) Conversion (%)[a] dr[a] 
(syn:anti) 
Yield (%)[b] 
(syn:anti) 
ee (%)[c] 
(syn:anti) 
1[d] rt 50 69:31 16, − 94 , − 
2 −25 50 74:26 −,− −,− 
3 −78 to rt 50 85:15 −,− −,− 
4[e] rt >75 53:46   
[a] Calculated by inspection of the crude reaction mixture using 1H NMR spectroscopy [b] Isolated 
yield of single diastereomer. [c] % ee determined by HLPC analysis on a chiral stationary phase. [d] 9 
mol% Cs2CO3 used as the base. [e] Reaction performed in the absence of precatalyst 66. 
Table 3: Temperature screen employing optimal precatalyst 66. 
3.4 Substrate scope 
Following the identification of optimum conditions for this methodology, a range of 
disubstituted ketenes were tested to establish the reaction scope. Firstly, a range of 
alkylphenyl ketenes bearing different alkyl substitution were prepared and evaluated 
in this protocol (Scheme 40).  Reducing the length of the alkyl side chain, from ethyl 
to methyl, resulted in a excellent isolated yield, an increase in dr to 88:12 (anti:syn), 
and with a slight decrease in enantiomeric excess (82% and 78% ee, respectively). 
Conversely, an increase in the alkyl chain length (to n-butyl) decreased the dr to 
69:31, giving the combined lactones in 75% yield, with an ee of 88% for the major 
anti diastereomer 154. The enantiomeric excess for the minor syn diastereomer could 
not be determined via chiral HPLC analysis or derivatisation methods.21 Finally, a 
further increase in the steric demand of the alkyl portion to an i-butyl group reduced 
the dr to a lower level (42:58 dr), in this case, slightly in favour of the syn 
diastereomer. The yield for this example was good (85%), as was the ee for the major 
syn diastereomer 155 (84% ee). Unfortunately the enantiomeric excess for the minor 
anti diastereomer could not be determined by chiral HPLC or derivatisation 
methods.21  
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O
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KHMDS (9 mol%),
toluene, 0 °C,  3 h
R1
O
O
Cl3C
H O
O
Cl3C
H O
O
Cl3C
H O
O
Cl3C
H
(152)
95% yielda
88:12 drb
anti 82% eec
syn 78% eec
(153)
89% yieldd
72:28 drb
anti 92% eec
syn 88% eec
(154)
75% yielda
69:31drb
anti 88% eec
syn % ee ND
(155)
85% yielda
42:58 drb
anti % ee ND
syn 84% eec
(149) (134) (150)
anti
(151)
syn
 
[a] Combined isolated yield of combined diastereomers [b] Calculated by inspection of the crude 
reaction mixture using 1H NMR [c] % ee determined by HLPC analysis on a chiral stationary phase. 
[d] Isolated yield of single diastereomers. 
Scheme 40: Scope of the reaction with respect to the alkyl substituent. 
Substitution on the aryl portion of the ketene was next evaluated by screening a range 
of electron rich substituted alkylarylketenes (Scheme 41). Employment of a 4-tolyl 
group as the aryl substituent was well tolerated with results consistent with those 
observed for the parent ethylphenylketene (159: 69% yield, 73:27 dr, 88% ee anti, 
76% ee syn). Reducing the alkyl chain to a methyl group whilst maintaining the 
4-tolyl group gave the expected increase in dr to 88:12, and proceeded in good yield 
and enantioselectivities (160: 69% yield, 82% ee anti, 76% ee syn). Finally, 
4-methoxyphenylethylketene provided equally good results as those previously 
obtained for the tolyl substituted ketenes (161: 70% yield, 75:25 dr, 88% ee anti, 84% 
ee syn). 
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H
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toluene, 0 °C,  3 h
(160)
69% yielda
88:12 drb
anti 82% eec
syn 76% eec
(159)
69% yielda
73:27 drb
anti 88% eec
syn 76% eec
(161)
70% yielda
75:25 drb
anti 88% eec
syn 84% eec
X
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O
H
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O
O
Cl3C
H
R1X X
(156) (134) (157)
anti
(158)
syn
 
[a] Combined isolated yield of single diastereomers [b] Calculated by inspection of the crude reaction 
mixture using 1H NMR spectroscopy [c] % ee determined by HLPC analysis on a chiral stationary 
phase.   
Scheme 41: Scope of the reaction with respect electron donating groups on the aryl substituent. 
Electron deficient aryl substituted ketenes were then selected to test further the 
substrate scope (Scheme 42). Initially, 4-fluorophenylketene was examined with the 
reaction proceeding in only moderate conversion. In this case, ketene dimerisation 
functioned as the predominant pathway under standard reactions conditions. It was 
found that dropwise addition of the ketene to the reaction over 0.5 h, to minimise the 
potential for the competing ketene dimerisation process, was sufficiently effective to 
allow good conversions to β-lactone products 165. The 4-fluorophenyl moiety led to 
improved enantioselectivities (94% and 97% ee respectively) while maintaining the 
good yield and diastereoselectivity (73% yield, 69:31 dr). Changing to a 4-chloro or 
4-bromophenyl substituent had minimal effect, with both well tolerated in the reaction 
process, providing results similar to those with the parent ethylphenylketene.   
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X
(166)
88% yielda
74:26 drb
anti 92% eec
syn 84% eec
(165)
73% yielda
69:31 drb
anti 94% eec
syn 97% eec
(167)
79% yielda
75:25 drb
anti 90% eec
syn 82% eec
O
(162) (134) (163)
anti
(164)
syn
X X
 
Ketenes added dropwise as a solution over 0.5 h [a] Combined isolated yield of single diastereomers 
[b] Calculated by inspection of the crude reaction mixture using 1H NMR spectroscopy [c] % ee 
determined by HLPC analysis on a chiral stationary phase.   
Scheme 42: Scope of the reaction with respect electron withdrawing groups on the aryl 
substituent. 
3.5 Preparative scale synthesis of lactones 147 and 148 
To demonstrate the synthetic utility of this process, a multi-gram scale reaction of 
ethylphenylketene and chloral was carried out with a reduced catalyst loading of 
2.5 mol% of 66 (Scheme 43). As with the use of the electron deficient aryl substituted 
ketenes, the ketene was added dropwise to prevent any competing dimerisation. The 
reaction proceeded with improved results compared to the standard scale with over 
3 g of separable lactone product isolated (80% combined yield). The 
enantioselectivity was increased to 94% ee for the anti diastereomer 147 and 92% ee 
for the syn 148, which could each be further increased to enantiopurity with a single 
recrystallisation.  
Ph Et
O 66 (2.5 mol%),
KHMDS (2.0 mol%),
toluene,  0 °C,  3 hCl3C
O
H O
O
H
Cl3C
Ph
Et
O
O
Cl3C
H
Ph
(147)
anti
(148)
syn
Et
2.4 g
94% ee
0.96 g
92% ee
80% combined yield
>99% ee
recrystallisation
74:26 dr
(146) (134)
 
Scheme 43: Preparative scale β-lactone formation. 
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3.6 Absolute configurations of lactone products 
With material of >99% ee obtained, the absolute configurations of the lactone 
products were unambiguously identified by X-ray crystallographic analysis. The anti 
lactone 147 was found to have the (3S,4R) configuration, while the syn 148 was 
proven to be (3S,4S) (Fig 17). 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: X-ray crystallographic representations of anti and syn lactones showing relative and 
absolute configuration. 
3.7 Derivatisation studies 
Following the initial choice of chloral as the aldehyde component, it was envisaged 
that facile derivatisation could provide acess to amino acid-type motifs. To this end, a 
range of ring-opening strategies was undertaken, initially using simple alcohols 
(MeOH, EtOH and BnOH) under acidic or basic reaction conditions. On all occasions 
this failed to provide any ring-opened product with the starting material returned in all 
cases. Next, a more proficient nucleophile, azide, was employed as it had previously 
been shown to open effectively benzaldehyde derived β-lactones by the group of Fu.22 
Under both open flask and sealed tube conditions at 65 °C for 24 h, no ring opening 
was observed using sodium azide, returning the lactone in all cases. It is postulated 
that addition of nucleophiles to the C(4) carbon is severely hindered by both the 
trichloromethyl group and the adjacent quaternary centre, thus preventing ring 
opening. Addition to the carbonyl was next investigated with attempted tandem ring 
opening and trichloromethyl group hydrolysis by aqueous KOH. Accordingly, lactone 
147 was heated to 65 °C in a sealed tube for 12h in a mixture of KOH/THF, resulting 
in a complex mixture of products. More mild KOH ring opening conditions were also 
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screened but resulted in inefficient ring opening. In a solitary example of lactone 
utility, it was found that lactone 147 could be reduced with 3.5 equivalents of DIBAL 
to afford the diol 168 in 42% yield. However, a reduction in enantiomeric excess to 
84% ee (from 92% ee for the lactone) was observed, this is attributed to the potential 
error in chiral HPLC analysis. Given the difficulties in lactone ring opening, 
especially with azide (to allow access the desired amino acid motif), no further 
strategies were investigated.  
 
Scheme 44: DIBAL reduction of lactone 147 to furnish diol 168. 
3.8 Mechanistic proposal 
We postulate this NHC-mediated process is initiated through NHC addition of in situ 
generated NHC 169 to ketene 146, preferentially anti to the aryl unit,23 to generate 
azolium enolate intermediate 170. Subsequent concerted, but asynchronous,24 formal 
[2+2] cycloaddition with chloral provides zwitterionic intermediate 171. Collapse of 
this intermediate results in concurrent catalyst regeneration and lactone formation 
(Fig 18).  
 
Figure 18: Postulated catalytic cycle. 
This mechanism is in accordance with the mechanism postulated by Ye for the 
corresponding synthesis of β-lactones from 2-oxoaldehydes.25 We assume that as no 
benzoin products have been detected in these reactions that this possible competitive 
mechanistic pathway is not in operation. Although NHC addition to the reactive 
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chloral aldehyde is likely, it is assumed that this is reversible. Any subsequent 
benzoin step originating from a Breslow type intermediate is also presumed to be 
either slow or reversible under the reaction conditions. Basic mechanistic 
investigations such as addition of stoichiometric amounts of the NHC to either chloral 
or ketene, then in situ analysis by 1H NMR spectroscopy, were undertaken. Under no 
conditions did these studies show any conclusive evidence for either an NHC-chloral 
adduct, or the anticipated enolate from NHC addition to the ketene, and no further 
analysis was attempted. In a rudimentary reaction to probe whether the reaction may 
be proceeding via an initial but reversible ketene dimerisation, ketene dimer 172 was 
prepared according to the literature7h and employed as a ketene surrogate in the 
standard protocol (Scheme 45). No lactone product was isolated with the ketene 
dimer starting material recovered unchanged from the reaction mixture.  
 
Scheme 45: Use of the ketene dimer 172 as a potential ketene surrogate. 
3.9 Stereochemical considerations 
For a full rationale of the observed diastereo- and enantioselectivity of this reaction a 
series of factors must be taken into consideration. First is the selective formation of an 
(E)-enolate following NHC addition to the ketene. Following this, an explanation of 
the facial reactivity of this enolate, either Re or Si, must be accounted for in order to 
explain the configuration at the C(3) centre. Finally, a model that rationalises the 
diastereoselectivity and is able to account for the observed trends (higher dr for 
methyl substituted ketenes, lower for butyl) is required.  
Our stereochemical model begins with the assumed addition of the NHC anti to the 
more sterically demanding aryl unit of the ketene. This reasoning is based on the 
location of the ketene LUMO (Chapter 1: 4.1.1), which lies in the plane of the 
ketene. Nucleophilic attack must proceed directly past either the alkyl or more 
sterically demanding aryl substituent, with the former being the more dominant 
pathway (Fig 19). This is supported by computational calculations on the addition of 
chiral alcohols to ketenes from the group of Houk, as well as enolate trapping studies 
by Tidwell and co-workers.23 
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Fig 19: Proposed geometry of azolium enolate. 
Following the formation of the azolium enolate 170, we postulate that the enolate is 
orientated approximately perpendicular to the triazolium ring, to minimise any steric 
interactions with the N-substituent (Fig 20). A co-planar orientation has been 
proposed by Ye and co-workers for a similar system87 (Fig 9), however we suggest 
that the steric interactions between the enolate and the N-Ph group favor a more 
perpendicular orientation. This conformation has previously been proposed by 
research from Smith and co-workers,26 and is supported by computational calculations 
from the group of Bode,27 who investigated the orientation of the azolium enolate 
generated from the addition of an NHC to an enal. We, in agreement with Bode, 
postulate the enolate to orientate with the oxy-anion directed towards the large 
stereodirecting group to minimise steric interactions between the enolate and the large 
stereodirecting unit. Assuming this is the most favourable orientation of the azolium 
enolate, two clear approaches to different faces of the ketene are available. One 
approach is past the N-substituent, with reaction from the Re face of the enolate. The 
alternative, passing the stereodirecting group, would render reaction to the opposing 
Si face of the enolate (Fig 20).  
 
Fig 20: Differing approaches defining the facial selectivity of azolium enolate 170. 
Due to the considerable size of the stereodirecting group we propose the approach of 
chloral past the N-phenyl substituent (Fig 21). In this regard approach past the 
N-substituent, and subsequent reactivity from the Re face of the enolate, would 
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provide the observed (S)-configuration at the lactone C(3) position. The 
diastereoselectivity from this selective approach would be defined by the facial 
addition to either the Re or Si face of chloral. Addition to the Re face of chloral would 
provide the anti diastereomer with the observed (3S,4R) configuration (Fig 21). 
Et
Ph
O
NHC
Cl3C O
H
(173)
addition to the Re face 
of chloral
(S)
(R)
O
O
H
Cl3C
Ph
Et
(147)
anti (3S,4R)
Cl3C O
H
N
N
NPh
TMSO
Ph Ph
O
Et
Ph
approach past the N-Ph 
substituent to the Re face 
of the enolate(170)
 
Fig 21: Rationale for the observed configuration at C(3). 
The preference for addition to the Re face of chloral over the Si face in a ratio of 
72:28 for the use of ethylphenylketene may be explained by a combination of steric 
and electrostatic arguments. Firstly it is assumed that arrangement is staggered about 
the two prochiral faces to minimise steric interactions, with the bulky CCl3 group 
orientated away from the NHC skeleton on steric grounds. This is also in agreement 
with a concerted but asynchronous [2+2] cycloaddition process, with the build up of 
electron density on the forming chloral oxy-anion orientated towards the forming 
acylazolium in the transition state (Fig 22). With the CCl3 group placed opposite the 
NHC skeleton there are two possible orientations for the approaching carbonyl, one 
with the C=O dipole aligned with the azolium enolate oxy-anion or one with dipoles 
opposed. We propose that in order to reduce the overall dipole moment of the pre-
transition state assembly the C=O bond preferentially directs away from the azolium 
enolate oxygen, thus favouring addition to the Re face, generating the anti β-lactone 
(Fig 22).  
 
 
 
 
 
 
 
 
 
Fig 22: Rationale for the observed diastereoselectivity. 
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The observed increase in diastereoselctivity with the use of methylphenylketene 
(88:12, anti, syn) and the corresponding decrease for the use of butylphenylketene 
(69:31, anti, syn) may be explained via the steric interactions between the alkyl 
substituent on the azolium enolate and the CCl3 group (Fig 23). A decrease in the 
steric size of the alkyl substituent will decrease any steric interaction with the CCl3 
group and favour the pre-transition state assembly shown above where the dipoles are 
opposed (Fig 22). Increasing the steric demand of the alkyl substituent will result in 
greater steric clash with the CCl3 group. To minimise this clash it is proposed that 
chloral now approaches from the Si face, positioning the CCl3 group opposite the 
alkyl substituent while maintaining the proximity requirements of a concerted but 
asynchronous cycloaddition. This pre-transition state assembly would lead to the syn 
β-lactone, as predicted, this assembly is an increasingly favored as the size of the 
alkyl group increases (Fig 23).  
 
Fig 23: Rationale for the observed trend in diastereoselectivity. 
 
4.0 Unexpected chlorination pathway  
4.1 Initial reaction discovery 
It is known that the use of ketenes substituted in the two position, or containing 
α-branching on the alkyl portion, normally leads to no reaction in NHC-catalysed 
formal cycloadditions of ketenes.7h,28 In certain rare cases, partial reactivity is 
retained,29 or a change in absolute configuration for the product is observed.30 For 
example in the formal [2+2] cycloaddition between ketenes and 
diazenedicarboxylates 83 by the group of Ye,30b the use of 2-chlorophenylketene 
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resulted in a proposed switch in product configuration. The reaction also proceeds 
with reduced yield and enantioselectivity (52% yield, 57% ee) when compared to 
other ketenes (typically >90% yield and >90% ee) (Scheme 46). 
ent-(84)
Ar = 2-ClC6H4  
52% yield, 57% ee
N
N
O
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R CO2Et
CO2Et
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N N
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N N
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BF485 (10 mol%),Cs2CO3 (10 mol%),
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O
RAr
(63)
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N
N
O
Ar
R CO2Et
CO2Et
(85)
 
Scheme 46: Switch in absolute configuration for the NHC-catalysed synthesis of aza-β-lactams. 
In an isolated case also reported by Ye et al, 2-chlorophenyl substitution,25 or 
α-branching on the alkyl portion of the ketene, is vital to achieve good selectivity for 
the formal [2+2] cycloaddition between ketenes and oxoaldehydes with no reported 
examples employing other alkylarylketenes (Scheme 47). No reasoning for this was 
postulated and in all the reports to date no specific reasoning for the effect of the 
2-substituent or α-branching has been proposed. 
O
RAr
O
O
OAr
H
R
Ar1OC
(76) 
 80:20 to >95:5 dr
94-99% ee
O
Ar1
66 (12 mol%),
Cs2CO3 (10 mol%),
THF, rt
(63)
Ar = 2-ClC6H4 or
R = i-Pr
(75)
 
Scheme 47: Synthesis of β-lactones requiring of 2-aryl substitution or α-branching on the ketene. 
With such a large quantity of literature detailing the effects of 2-substitution on the 
aryl group of the ketene, we were intrigued to discover what effect this would have in 
our developed methodology. To this end, 2-chlorophenylethylketene was prepared 
and tested under the optimised reaction conditions (Scheme 48). No lactone product 
was observed by 1H NMR spectroscopic analysis, instead the reaction proceeded 
cleanly to give α-chloroester 180 as the sole product in 73% yield and 62% ee. α-
Chloroester 180 is believed to be the result of formal chlorination of the ketene by 
means of chloral acting as a electrophilic chlorinating agent.  
O
Cl3C
O
H
66 (10 mol%),
KHMDS (9 mol%),
Toluene, 0 °C,  12 h
Cl Cl
O
O
H
Cl
Cl
Cl
(179) (134) (180)
73% yield, 62% ee  
Scheme 48: Unexpected chlorination product from 2-chlorophenylethylketene. 
Chapter 3: Chemo- and Enantiodivergent NHC-Catalysed Reactions of Alkylarylketenes and 
Chloral 
 56 
4.2 Mechanistic proposal  
This surprising result is, to the best of our knowledge, the first example of chloral 
acting as an electrophilic chlorinating reagent. We postulate this unexpected reaction 
mechanism to proceed to through an analogous initial process to the lactonisation 
cycle, by addition of the NHC 169 to the ketene 179 to generate azolium enolate 170. 
This enolate may then abstract a chlorine atom from chloral 134,31 forming a new 
α-chloro stereocentre and a second enolate species 183. These species may combine 
to displace the NHC catalyst, generating α-chloroester 180, and complete the catalytic 
cycle (Fig 24).  
 
Fig 24: Postulated catalytic cycle for the formation of chlorinated product 180. 
4.3 Substrate scope 
To probe whether this was a general reaction, a further range of 2-tolyl substituted 
ketenes were prepared (Scheme 49). Three 2-tolylalkyl ketenes with methyl, ethyl 
and butyl groups were screened under the developed reaction conditions. In all cases, 
moderate to good reactivity was observed, forming exclusively the chlorinated 
product. Methyl-2-tolylketene proceeded in 52% yield and 80% ee, a significant 
improvement on the initial 62% ee achieved with 2-chlorophenylethylketene. 
Ethyl-2-tolylketene also proceeded in high ee (82%) and in increased yield (71% 
yield) compared to the methyl analogue 186. Finally, butyl-2-tolylketene provided a 
good isolated yield of the chlorinated product 188, however the enantioselectivity 
could not be determined via HPLC analysis.  
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 [a] % ee determined by HLPC analysis on a chiral stationary phase.   
Scheme 49: Scope of the reaction with respect alkyl chain length on 2-tolylalkyl substituted 
ketenes. 
Maintaining this range of alkyl groups, switching the aryl substituent to 1-naphthyl 
also provided good isolated yields of exclusively chlorinated products (Scheme 50). 
Methyl-1-naphthylketene proceeded in 63% yield and 84% ee (191), similar to the 
levels of enantioselectivity observed with the 2-tolyl substituent. Employing 
ethyl-1-naphthylketene, however, provided an excellent level of enantioselectivity 
(92% ee) with good isolated yield (80%) (192). Finally butyl-1-naphthylketene was 
screened with similar yield (84%) and in excellent enantiomeric excess (90% ee) 
(193). 
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[a] % ee determined by HLPC analysis on a chiral stationary phase.   
Scheme 50: Scope of the reaction with respect alkyl chain length on 1-naphthylalkyl substituted 
ketenes. 
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At this stage it was clear that a 2-substituent on the phenyl ring was effectively 
switching the reaction course to provide exclusively the chlorinated product. As 
α-branching on the ketene substituent has previously been shown to effect NHC-
catalysed formal cycloadditions in a similar manner to 2-substitution, 
i-propylphenylketene was prepared and evaluated in this reaction (Scheme 51). In 
accordance with the use of 2-substitution on the aryl substituent, the use of an i-propyl 
alkyl group also provided exclusively chlorinated ester 195, in 86% yield and 88% ee.  
 
Scheme 51: Chlorination reaction employing isopropylphenylketene 194. 
4.4 Preparative scale synthesis of chlorinated product 196 
Following the demonstration of substrate scope, the utility of the chlorination process 
was demonstrated by preparative scale formation of chlorinated product 192. The 
formation of chlorinated product 192 proceeded in 86% yield and with 94% ee to 
provide 1.1 g of the chloroester. Importantly, at this increased scale only 2.5 mol% of 
precatalyst 66 was employed (Scheme 52).   
 
 
 
 
 
 
Scheme 52: Preparative scale chlorination reaction. 
4.5 Determination of the absolute configuration  
X-ray crystallographic methods could not be directly utilised to provide details of the 
absolute configuration of the products as all α-chloroester products were liquids. To 
determine conclusively the absolute configuration of the chlorination reaction, a 
two-step procedure to form the amide 197 was undertaken. Following the precedent 
of Fu,32 the ester 192 (92% ee) was initially treated with bromine then subjected to 
(S)-α-methylbenzylamine in THF to provide the amide product 197 in 90% yield as a 
O
Cl3C
O
H
66 (2.5 mol%),
KHMDS (2.4 mol%),
toluene, 0 °C,  12 h
(196) (134) (192)
1.1 g, 86% yield, 94% ee
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O
O
H
Cl
Cl
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single diastereomer after purification. This compound was sufficiently crystalline to 
allow unambiguous X-ray crystallographic determination of the absolute 
configuration, giving the (S,S)-configured product.    
Cl
O
O
H
Cl
Cl
(192)
92% ee
i. Br2, CH2Cl2, 
0 °C to rt, 1.5 h
ii. (S)-(!)-"-methylbenzylamine
THF, 60 °C, 16 h
(S)
Cl
O
N
H
(S)
(197)
90% yield  
Scheme 53: Derivatisation of chlorinated product 192 to allow X-ray crystallographic analysis. 
  
Figure 25: X-ray crystallographic representations 197-(S,S). 
 
The determination of the absolute configuration for the chlorination pathway as (S) 
implies reaction from the opposite Si face of an assumed (E)-enolate to that observed 
for the β-lactone process. The configuration of (S) at the ketene derived stereocentre 
for both products is the result of a change in Cahn-Ingold-Prelog priority33 caused by 
the presence of a chlorine atom in the latter ester product. In the lactone formation the 
absolute configuration was explained via reaction from the Re face of the enolate, 
with chloral approach past the N-phenyl substituent. Therefore any rationale for the 
absolute configuration employing a similar azolium enolate orientation would be 
required to explain reaction of the azolium enolate, for the opposite Si face, with 
chloral approach past the stereodirecting group. 
4.6 Chemoselectivity and stereochemical considerations 
Two important questions are raised by the identification that the chlorination reaction 
is both chemo- and enantiodivergent. Firstly, an explanation for the switch in 
reactivity to provide exclusively the chlorination product is required. Secondly, this 
proposal must also account for the observed switch in facial reactivity of the azolium 
enolate from Re to Si.   
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The rationale for both these questions begins by assuming an (E)-geometry for the 
azolium enolate 198 generated from NHC addition to a ketene bearing a 2-substituted 
aryl group. With this initial geometry fixed we next assume that the azolium enolate 
orientates with the oxy-anion approximately directed towards the stereodirecting 
group, as proposed previously (Fig 26).  
 
Fig 26: Azolium enolate geometry consistent with the previous model. 
At this point the model for the chlorination reaction deviates from that proposed for 
the formation of β-lactone products. We propose that the presence of a 2-substituent 
on the aryl group of the azolium enolate forces the aryl group to adopt a non-planar 
orientation with respect to the enolate. This twisted orientation would necessitate 
directing the 2-substituent either towards the N-phenyl group or the large 
stereodirecting group (Fig 27). 
 
Fig 27: Rationale for a twisted enolate geometry when 2-substitued aryl groups are employed. 
Using this model, we proposed that the 2-substituent will orient towards the N-phenyl 
substituent as to avoid the large stereodirecting group. With the 2-substituent directed 
towards the N-phenyl substituent, the previously favoured approach to the Re face of 
the enolate is now effectively blocked. This rationale explains the reaction of the 
azolium enolate from the Si face, with approach of chloral past the stereodirecting 
group accounting for the enantiodivergent nature of this process (Fig 28). It is also 
proposed that to allow reaction from the Si face a twist in enolate geometry from the 
approximately perpendicular orientation (Fig 20) is required to eleviate some of the 
steric interactions with chloral approaching past the stereodirecting unit. A similar 
argument is employed for the use of a α-branched group. In this case, either its own 
steric effect, or a steric clash induced via a twisting of the accompanying phenyl 
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group, results in approach past the N-phenyl substituent to the Re face of the azolium 
enolate being disfavoured.34  
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Fig 28: Rationale for the change in facial reactivity of the azolium enolate when 2-substituted 
aryl groups are used. 
The switch in chemoselectivity observed for the reaction with chloral is rationalised 
by the consideration of the hybridisation of the electrophile in both mechanistic 
pathways. For the lactonisation to occur the azolium enolate must add to the π* 
orbital of the sp2 hybridised carbonyl at approximately 107° (206).35 In comparison, 
addition in the chlorination pathway must occur to the C−Cl σ* orbital, with an 
antiperiplanar orientation of the C−Cl σ* orbital and the C=O π* orbital (205) (Fig 
29).  
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Fig 29: Rationale for the change in chemoselectivity 
It is this difference in hybridisation of the electrophile that is proposed to account for 
the difference in reactivity. Specifically the geometrical requirements for the addition 
to the carbonyl of chloral, followed by lactonisation in a concerted but asynchronous 
manner, cannot be met with this orientation of the azolium enolate. Thus reactivity 
from the Si face of the enolate proceeds with addition to the sp3 hybridised CCl3 
centre to furnish the (S)-configuration at the chlorinated-centre.  
The proposed twist of aryl substituent, and subsequent disfavoured approach, may be 
employed to account for the consistently low reactivity observed for ketenes bearing 
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2-substituted aryl groups in most cycloaddition processes. In our case it is the 
unexpected dual reactivity of chloral that is postulated to allow reactivity from the Si 
face of the azolium enolate, past the large stereodirecting group.  
 
5.0 Further 2-substituted examples 
5.1 The use of 2-anisylethylketene 
To test further the limits of this methodology, particularly with respect to where the 
crossover may lie between the lactonisation and chlorination pathways, 2-
anisylethylketene was prepared (Scheme 54). This ketene has not previously been 
reported in NHC-catalysed formal cycloaddition reactions.36 We predict that it may 
provide a different reactivity profile when compared to other 2-substituted ketenes, 
due to a more conformationally flexible 2-methoxy group. This proposal was verified 
by the use of 2-anisylethylketene under standard reaction conditions, which produced 
an approximate 66:33 ratio of lactonisation 209 to chlorination products. The 
chlorinated product 210 was isolated in 11% yield, however the enantiomeric excess 
could not be determined via HPLC analysis. Analysis of the crude 1H NMR spectrum 
indicated the lactone 209 had been formed as a single diastereomer and was 
subsequently isolated in 48% yield and with >99% ee.  
Et
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Scheme 54: Use of 2-anisylethylketene in the reaction procedure. 
This lactone 209 product was confirmed as the syn diastereomer via X-ray 
crystallographic analysis which also identified the absolute configuration to be 
(3S,4S) (Fig 30). 
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Figure 30: X-ray crystollgraphic representation showing the absolute configuration of the 
β-lactone 209. 
The competitive formation of both the β-lactone and the chlorination product 
validates the proposal that a 2-substituent with increased flexibility could alter the 
product ratio. The formation of the β-lactone could be rationalised by the increased 
flexibility of the 2-methoxy substituent allowing approach past the N-phenyl 
substituent to the Re face of the enolate. Approach to the Re face accounts for the 
configuration obtained at the C(3) centre, while the opposite diastereoselectivity 
(preferentially syn) compared to the preferentially anti diastereomer is not instantly 
apprent. To account for the high diastereoselectivity (preferentially syn), addition to 
the Si face of chloral 211 must be preferred over addition to the Re face 210, 
assuming the same orienentation of the enolate with respect to the NHC (Fig 31). At 
this time, a full rationale for the preference cannot be provided. 
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Fig 31: Proposed rationale for the observed configuration of the lactone product obtained from 
2-anisylethylketene. 
 
Chapter 3: Chemo- and Enantiodivergent NHC-Catalysed Reactions of Alkylarylketenes and 
Chloral 
 64 
5.2 The use i-propyl-3-thiophenylketene 
A second ketene that could potentially provide dual reactivity was 
i-propyl-3-thiophenylketene.35 As with 2-anisylethylketene,this ketene has not 
previously been reported in NHC-catalysed formal cycloaddition reactions. It could 
provide a different reactivity profile when compared to other α-branched alkyl 
substituted ketenes due to a less sterically demanding aryl unit. In this case the use of 
i-propyl-3-thoipheneketene in the reaction protocol proceeded to give predominantly 
chlorination, with an approximate 75:25 ratio of chlorination to lactonisation (16:84 
anti:syn ratio of lactone diastereomers).  The chlorinated product 215 was isolated in 
32% yield and in 78% ee; however, due to difficulties associated with the purification 
of the two lactone diastereomers 214 the enantioselectivities could not be determined 
(Fig 55).37  
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Scheme 55: The use of i-propyl-3-thiophenylketene in the reaction protocol. 
It is inferred by the increased ratio of chlorination to lactonisation that the 
combination of a thiophene and an i-propyl substituent disfavour the lactonisation 
process to a greater degree than a 2-anisyl group. Although, as predicted, the 
thiophene substituent still results in a greater proportion of lactonisation than a phenyl 
and an i-propyl substituent, presumably due to the reduced steric demand of thiophene 
compared to the phenyl moiety.   
The preferentially syn diastereoselectivity can be explained via the proposal to 
account for reduced dr obtained with butylphenylketene. In this rationale the 
increased steric demand of the i-propyl substituent results in addition to the Si face of 
chloral as to minimise steric interactions between the bulky CCl3 group and the 
i-propyl substituent of the azolium enolate (Fig 32).  
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Fig 32: Rationale for the observed diastereoselectivity with i-propyl-3-thiophenyl ketene 
6.0 Summary  
This chapter has reported the identification and development of a novel chemo- and 
enantiodivergent reaction manifold. The first strategy to be developed was the NHC-
catalysed formal [2+2] cycloaddition between disubstituted ketenes and chloral. This 
proceeded for a range of alkylarylketenes in good yield (55-95%), with moderate to 
good diastereoselectivities (up to 88:12 dr) and in good to excellent levels of 
enantioselectivity (up to 97% ee). This reaction was highly amenable to scale with 
>3 g prepared from a single reaction using the low precatalyst loading of 2.5 mol%. 
The synthetic utility remained limited, with the desired derivatisation to amino acid-
type motifs were not realised due to the difficulties encountered with various lactone 
ring opening strategies. Reduction methods with DIBAL, however, delivered the 
alcohol products, which could potentially be derivatised to the desired amino acid 
targets if desired.  
A second and intriguing novel chlorination reaction pathway was also discovered 
when 2-chlorophenylethylketene was used. This reaction was found to be general, and 
provide exclusively chlorination products for a range of ketenes either substituted in 
the two position of the aryl ring, or bearing an α-branched alkyl chain. In most cases 
no lactone products could be detected spectroscopically with only chlorinated esters 
isolated in good to excellent yield (52-86%), and moderate to excellent 
enantioselectivity (up to 94% ee). This novel chlorination methodology was also 
amenable to preparative scale with >1 g isolated using the low precatalyst loading of 
2.5 mol%. This methodology still has significant scope for improvement, especially 
with regard to the following: 
• Further study is needed into the scope of the reaction with respect to the 
aldehyde component. Further work will aim to develop a NHC promoted 
lactonisation methodology suitable for less reactive aldehydes other than 
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chloral, that may allow significant improvements in utility via ring opening 
derivatisation strategies. 
• Investigation into the possibility of developing a more general asymmetric 
halogenation methodology in order to extend the scope of the reaction beyond 
the necessity for either a 2-substituted aryl group or α-branching on the alkyl 
substituent.  
• Whilst the use of isolable ketenes allows efficient access to highly reactive 
azolium enolates, they are limited with respect to the available substitution 
pattern, as well as  reaction scale and practicality. The use of a suitable ketene 
surrogate, such as an α-functionalised aldehyde, could address some of these 
problems. 
 
These highlighted limitations will be addressed in the subsequent chapters of this 
thesis. 
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1.0 Project aim 
(Chapter 3) demonstrated the efficient NHC-catalysed synthesis of β-lactones from 
disubstituted ketenes and chloral. Although proceeding in excellent yield and 
enantioselectivity, the diastereoselectivities obtained were modest, typically ∼75:25 
anti:syn, and thus represented significant scope for improvement. Equally, the use of 
anhydrous chloral as a highly reactive aldehyde substrate limited both the scope and 
the practicality of the procedure. To overcome these limitations expansion of the 
NHC-catalysed formal [2+2] cycloaddition to less reactive benzaldehyde derivatives 
was investigated. 
2.0 Introduction 
Following the seminal publication of Wynberg and Staring,1 the use of cinchona type 
derivatives as Lewis bases in asymmetric β-lactone synthesis has been expanded 
through the reports of Romo,2 Nelson3 and Calter.4 Crucially Romo and co-workers 
improved the utility of the original Wynberg process via the replacement of the parent 
dimeric ketene gas with in situ generation of parent ketene by dehydrohalogention of 
acetyl chloride. This work also expanded the scope of the aldehyde component to 
other activated aldehydes and functions in good yield and excellent enantioselectivity 
(93-98% ee) (Scheme 56). 
 
Scheme 56: Use of in-situ generated ketene in the Wynberg β-lactone process. 
In an elegant extension to the Wynberg procedure catalysed by either silylated 
quinine or quinidine 221, the group of Nelson utilised a wide range of aldehydes in 
partnership with in situ generated unsubstituted and monomethylketene. Unactivated 
aryl and alkyl (both linear and branched) aldehydes provide good yield (typically 
>75%) and excellent diastereo- and enantioselectivity (typically >20:1 dr and ≥99% 
ee). Importantly this extension to the previous reports allows the preparation of 
3,4-disubstituted β-lactones (Scheme 57).  
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Scheme 57: Extension of the Wynberg β-lactone synthesis to mono-substituted ketenes. 
Calter and co-workers have employed the same cinchona alkaloid derivative 221 but 
achieved the synthesis of anti β-lactones by the use of a scandium(III) 
trifluoromethanesulfonate Lewis acid co-catalyst. This switch in diastereoselectivity 
is explained via an antiperiplanar open transition state compared to the closed 
transition state proposed by Nelson to rationalise the syn selectivity in their process 
(Scheme 58. 
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Scheme 58: Synthesis of anti β-lactones with proposed transition states. 
These methods provide efficient and rapid access to a range of β-lactones with 
mono-substitution in the α-position, owing to the use of mono-substituted ketenes. 
Reactions employing disubstituted ketenes are more limited, with recent reports from 
the group of Fu,5 Ye6 and Kerrigan.7 Fu reports the efficient synthesis of β-lactones 
from dialkyl ketenes and benzaldehydes under the catalytic influence of the well 
documented planar chiral PPY derivative 59 in good yield (48-92%) and excellent 
enantioselectivity (up to 91% ee).8 However the diastereoselectivity was typically 
moderate (up to 4.5:1 dr syn:anti) and alkylarylketenes were not tolerated in this 
process (Scheme 59). 
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Scheme 59: Synthesis of α ,α-disubstituted β-lactones 
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As previously summarised (Chapter 1, 4.1.2)) Ye has employed NHCs to catalyse 
the formal [2+2] cycloaddition between alkylarylketenes and highly reactive 
2-oxo-aldehydes or trifluoromethylketones. Notably the reported methodology for 
2-oxo-aldehydes failed for the cycloaddition of 2-chlorophenylethylketene and the 
less reactive 4-chlorobenzaldehyde. The current state of the art was reported by the 
group of Kerrigan (during the course of our own investigations) who showed the 
viability of a chiral C2-symmetric diphosphine 232 catalysed the formal [2+2] 
cycloaddition between alkylarylketenes and various benzaldehyde derivatives 
(Scheme 60). anti β-Lactones were obtained in good yield (typically >60%) and in 
excellent diastereo- and enantiocontrol (typically >90:10 dr and up to 99% ee). In this 
report optimum diastereocontrol is obtained when less sterically demanding alkyl 
groups are employed: with methyl or ethyl groups, the lactones are obtained in 
typically >90:10 dr; the use of a butyl group gave significantly reduced dr to 53:47 
(anti:syn). Kerrigan and co-workers postulate addition of the phosphine to the 
aldehyde to generate a phosphonium alkoxide as the first step in the catalytic cycle. 
This is in contrast to other mechanistic propositions (such as that of Ye et al.) who 
favour addition to the ketene as the initial step. 
R1
O
H
232 (10 mol%),
CH2Cl2, ! 78 °C O
O
R1
(231)
51!99% yield, 
up to >95:5 dr
up to >99% ee
R
(63) (230)
R1 = alkyl, aryl
O
RAr
Ar
P P
(232)
 
Scheme 60: Diphosphine catalysed asymmetric β-lactone synthesis from disubstituted ketenes. 
3.0 NHC-catalysed asymmetric β-lactone formation 
3.1 Initial investigations 
Aware of the ability of NHCs to promote asymmetric benzoin reactions of 
benzaldehydes9,10 and ketene dimerisation processes,11 we set out to minimise these at 
the onset of the investigation. Initial studies employed ethylphenylketene and 
triazolium precatalyst 66 with a range of benzaldehydes (Scheme 61, Table 4). While 
benzaldehyde gave no β-lactone product (giving only ketene dimer) (Table 4, Entry 
1), promising reactivity was observed with electron deficient benzaldehydes, 
employing dropwise ketene addition to minimise ketene dimerisation. At 0 ºC, 
benzaldehydes incorporating 4-substituted inductively or mesomerically electron 
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withdrawing groups (4-trifluoromethyl- or 4-nitrobenzaldehyde respectively) gave 
good yields of β-lactones, with moderate preferential anti diastereoselectivity and 
promising levels of enantioselectivity for the minor syn diastereomer (Table 4, Entry 
2 & 3). Improved enantiocontrol was achieved at the detriment of product yield at 
−78 ºC using 4-nitrobenzaldehyde (Table 4, Entry 4 & 5), with ketene dimerisation 
product and starting aldehyde the major reaction components after 12 h. Interestingly, 
syn  diastereoselectivity (89:11 syn:anti) and high ee were observed using 
2-nitrobenzaldehyde (Table 4, Entry 6). 
 
66 (10 mol%),
KHMDS (9 mol%),
toluene, T/°C, 12 h
Ar
O
EtPh
O
O
OEt
Ph
Ar
O
OEt
Ph
N
N
N Ph
BF4
Ph
OTBSPh
H
Ar
(233)(146) (234)
3,4-syn
(235)
3,4-anti
(66)
 
 Scheme 61: Initial investigations of benzaldehyde derivatives.   
Entry Ar Temp (ºC) dr[a] (syn:anti) Yield (%)[b] 
(syn:anti) 
ee (%)[c] 
(syn:anti) 
1[d] Ph 0 −− −− −− 
2[e] 4-CF3C6H4 0 30:70 27, 55 80, 38 
3[f] 4-NO2C6H4 0 40:60 30, 50 81, 14 
4[f] 4-NO2C6H4 −78 to rt 40:60 7, 34 97, 54 
5[f] 4-NO2C6H4 −78 23:77 −, 27 −, 76 
6[g] 2-NO2C6H4 0 89:11 86, − 94, − 
Unless stated ketene added dropwise as a solution in toluene. [a] Calculated by inspection of the crude 
reaction mixture using 1H NMR spectroscopy [b] Isolated yield of single diastereomer. [c] % ee 
determined by HLPC analysis on a chiral stationary phase. [d] Ketene added in a single portion. [e] 1.5 
equiv of aldehyde. [f] 1.5 equiv of ketene. [g] 1.2 equiv of aldehyde. 
Table 4: Initial investigations of benzaldehyde derivatives. 
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3.2 Assignment of the configuration of 236 and 238. 
The diastereoselectivity and the absolute configuration for the β-lactone 236 derived 
from 4-nitrobenzaldehyde was assigned by derivatisation to known hydroxy acid 
237.7 In this instance the absolute configuration of 237 was found to be (R,R) via 
comparison of the specific rotation 
€ 
α[ ]D
20
 −46  (c 0.05, EtOAc, 76% ee) [literature 
€ 
α[ ]D
20 −48  (c 0.32, EtOAc), 87% ee (2R,3R)] (Scheme 62).  The diastereoselectivity 
for 4-trifluorobenzaldehyde derived lactone was assigned in analogy to 236 via 1H 
NMR spectroscopic analysis of the characteristic shift for the lactone C(4)H. 
i. KOH (2.0 equiv), 
THF, 65 °C
HO
O
(R)
(R)
OH
Ph Et
(R)
(R)
O
OEtPh
(236)
76% ee
3,4-anti
O2N
(237)
52% yield
3,4-anti (R,R)
NO2
 
Scheme 62: Determination of the absolute configuration of lactone 236. 
The syn diastereoselectivity observed using 2-nitrobenzaldehyde was initially 
assigned via 1H nuclear Overhauser effect (nOe analysis). A clear signal enhancement 
was observed for the ethyl CH2CH3 protons under irradiation of the signal 
corresponding to proton A (C(4)Ha), confirming their relative relationship as syn.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 33: Assignment of the relative configuration of lactone 238 by 1H NMR nOe analysis. 
1 122334455667788ppm
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3.3 Optimisation of reaction conditions 
Further optimisation of this process was achieved through lowering of the reaction 
temperature, with consistently high levels of diastereo- and enantioselectivity 
observed (Scheme 63, Table 5). Interestingly, lowering the reaction temperature 
below −50 ºC had a detrimental effect on product ee, whilst maintaining good 
diastereoselectivity (Table 5, Entry 4). This was postulated to be due to a 
competitive KHMDS-catalysed racemic pathway at this temperature, as the use of 
KHMDS to promote formal [2+2] cycloadditions of ketenes with imines or carbonyls 
has been previously reported by the group of Wilhelm.12 This was independently 
confirmed by a control reaction in the absence of precatalyst 66 (Table 5, Entry 5). 
Attempted removal of HMDS from the reaction mixture prior to the addition of 
ketene and aldehyde, via concentration in vacuo following a presumed deprotonation 
event, led to reduced yield (45%) and enantioselectivity (95:5 dr, 64% ee) (Table 5, 
Entry 6).  
 
O
OEt
Ph
66 (10 mol%),
KHMDS (9 mol%),
toluene, T/°C, 12 h
H
O
EtPh
O
(146)
NO2
(238)
Ar = 2-NO2-C6H4
(239)
1.2 equiv
NO2
 
Scheme 63: Optimisation of reaction conditions. 
Entry Ar Temp 
(ºC) 
dr[a] 
(syn:anti) 
Yield (%)[b] 
(syn:anti) 
ee (%)[c] 
(syn:anti) 
1[d] 2-NO2C6H4 −15 91:9 66, − 95, − 
2[d] 2-NO2C6H4 −25 92:8 77, − 97, − 
3[d] 2-NO2C6H4 −50 93:7 83, − 93, − 
4[d] 2-NO2C6H4 −78  94:6 86, − 82, − 
5[e][f] 2-NO2C6H4 −78 89:11 −,− −, − 
6[g] 2-NO2C6H4 −78 95:5 45, − 64, − 
Unless stated, ketene added dropwise as a solution in toluene. [a] Calculated by inspection of the crude 
reaction mixture by 1H NMR spectroscopy [b] Isolated yield of single diastereomer. [c] % ee 
determined by HLPC analysis on a chiral stationary phase. [d] 1.2 equiv of aldehyde. [e] Reaction 
carried out in the absence of precatalyst 66. [f] Crude conversion estimated to be >75%. [g] Attempted 
removal of HMDS prior to the ketene addition. 
Table 5: Optimisation of reaction conditions. 
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3.4 Expansion of the protocol to a range of 2-substitued benzaldehyde derivatives 
Aiming to expand the methodology, a range of 2-halosubstituted benzaldehydes were 
also screened under these optimised conditions giving the corresponding β-lactones 
with poor diastereo- but good enantiocontrol (Scheme 64, Table 6). The 
2-halosubstituted β-lactone diastereomers proved challenging to separate from both 
the ketene dimer and/or any residual aldehyde. Purification and characterisation was 
achieved by derivatisation to the corresponding benzylated β-hydroxy 244−246 acids 
to allow determination of enantioselectivity.13 Unfortunately, due to the essentially 
50:50 mixture of the diastereomer and the inability to separate them 
chromographically, the enantioselectivities could not be conclusively assigned to 
either the syn or anti β-lactones and have been arbitrarily assigned.  The requirement 
for an electron withdrawing substituent was further confirmed by using 
2-tolylbenzaldehyde. In this instance, only ketene dimer and the starting aldehyde 
were obtained (Table 6, Entry 4). 
O OH
Ph Et
X
BnO
i. KOH, 65 °C, THF
ii. BnBr (1.2 equiv),
 i-Pr2NEt, DMF
(241): X = F, 50:50 dr
(242): X = Cl, 52:48 dr
(243): X = Br, 56:44 dr
(244): X = F, 51:49 dr, 87 and 69% ee
(245): X = Cl, 66:34 dr, 87 and 76% ee
 
(246): X = Br, 57:43 dr, 95 and 71% ee
O
OEt
Ph
66 (10 mol%),
KHMDS (9 mol%),
toluene, !50 °C
H
O
EtPh
O
(146)
X
(240)
1.2 equiv
X = F, Cl, Br, CF3
X
 
Scheme 64: Expansion of the protocol to a range of 2-substituted benzaldehyde derivatives. 
Entry X dr[a][b]  Yield (%)[c] ee (%)[d] 
(syn:anti)[b] 
1 F 50:50 29 87, 69 
2 Cl 52:48 36 87, 76 
3 Br 56:48 25 95, 71 
4 CH3 −, − − −, − 
Unless stated, ketene added dropwise as a solution in toluene. [a] Calculated by inspection of the crude 
reaction mixture by 1H NMR spectroscopy. [b] Diastereoselectivity was not assigned [c] Isolated yield 
of combined diastereomer following ring opening derivatisation (3 steps). [d] % ee determined by 
HLPC analysis on a chiral stationary phase on the corresponding ring opened derivatised product.  
Table 6: Expansion of the protocol to a range of 2-substituted benzaldehyde derivatives. 
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It is interesting to note that the 2-nitro group is key for high diastereoselectivity and 
that the major diastereomer obtained is the opposite to that for either 4-substituted 
benzaldehydes or the β-lactones derived from chloral (Chapter 3). The 
diastereoselectivity is also the reverse of that obtained by the phosphine catalysis of 
Kerrigan et al. who obtained similar levels of diastereoselectivty (~90:10 dr), but the 
anti diastereomer is preferred. In one isolated example in the work of Kerrigan when 
2-chlorobenzaldehyde is used, the β-lactone formed in high yield but with reduced 
diastereoselectivity 75:25 dr (anti:syn); the enantioselectivity of this reaction was not 
reported. 
3.5 Analysis of the substrate scope with respect to the alkyl substituent 
With 2-nitrobenzaldehyde identified as giving optimal diastereo- and enantiocontrol 
in this process, the scope and limitations of the lactonisation process were defined by 
screening a range of disubstituted ketenes (Scheme 65). In all cases, the 
enantioselectivity was evaluated by chiral HPLC analysis compared to genuine 
racemic samples prepared in an analogous fashion from racemic precatalyst 66. 
Variation of the alkyl chain in a series of alkylphenylketenes showed that 
incorporation of a methyl substituent gave poor dr whilst maintaining high ee 242.  
Ethyl 238 and n-butyl 243 substitution gave β-lactones in high dr and ee, while 
i-butyl substitution leads to high dr but poor ee 244. This trend in diastereoselectivity 
is directly opposite to that obtained by the use of chloral. In that series (Chapter 3) 
the use of a methyl group in the alkyl position improved the diastereoselectivity from 
72:28 for ethylphenylketene to 87:13 for methylphenylketene, whilst lowering the 
enantioselectivity from 92% to 82% ee, respectively. 
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O
OMe
Ph
Ar
O
OEt
Ph
Ar
O
On-Bu
Ph
Ar
O
Oi-Bu
Ph
Ar
O
OR
Ph
Ar
66 (10 mol%),
KHMDS (9 mol%),
toluene, !25 °C
H
O
RPh
O
(146)
NO2
(241)
Ar = 2-NO2-C6H4
(242)
 43:57 dr,a 65% yieldb
90% eec (syn)
90% eec (anti)
(238)
 93:7 dr,a 83% yieldd
93% eec
(243)
 94:6 dr,a 86% yieldd
89% eec
(244)
 94:6 dr,a 65% yieldd
<10% eec
N
N
N Ph
BF4
Ph
OTBSPh
(66)(239)
1.2 equiv
 
For all reactions, ketene was added dropwise as a solution in toluene. [a] Calculated by inspection of the crude 
reaction mixture by 1H NMR spectroscopy. [b] Isolated yield of mixture of diastereomer. [c] % ee determined by 
HLPC analysis on a chiral stationary phase. [d] Isolated yield of single diastereomer.  
Scheme 65: Scope of the reaction with respect to the alkyl substituent. 
3.6 Analysis of the substrate scope with respect to the aryl substituent 
Variation of the aryl unit within a series of ethylarylketenes was also investigated, 
with both electron withdrawing and donating substituents providing β-lactones with 
high dr and ee (Scheme 66). Further substrate variation showed that 
i-propyl-3-thiophenylketene gave β-lactone 252 with poor dr although high ee for the 
anti  diastereomer. In line with the previous result (Scheme 65), the use of a methyl 
unit, this time in combination with a 4-chlorophenyl moiety, provided poor 
diastereoselectivity but high enantioselectivity 248. Consistent with the previous 
findings of Ye,6a and that of (Chapter 3), the employment of ethyl-2-tolylketene with 
2-nitrobenzaldehyde gave no β-lactone products, returning only starting aldehyde and 
a mixture of both ketene dimerisation and formal hydrolysis products. 
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O
OEt
Ar1
O
OEt
Ar1
O
OEt
Ar1
O
OEt
Ar1
O
OEt
Ar
Ar1
66 (10 mol%),
KHMDS (9 mol%),
toluene, !50 °C
H
O
EtAr
O
(146)
NO2
(245)
Ar1 = 2-NO2-C6H4
(246)
 93:7 dr,a 69% yieldb
85% eec
(247)
93:7 dr,a 79% yieldb
86% eec
(249)
 94:6 dr,a 68% yieldb
91% eec
(250)
 93:7 dr,a 51% yieldb
83% eec
N
N
N Ph
BF4
Ph
OTBSPh
(66)
F Cl Br
Me
O
OMe
Ar1
(248)
55:45, dra 24% yieldd
92% eec (syn)
Cl
O
OEt
Ar1
O
Oi-Pr
Ar1
(251)e
93:7 dr,a 75% yieldb
86% eec
(252)
 53:47 dr,a 54% yieldd
58% eec (syn)
92% eec (anti)
MeO
S
(239)
1.2 equiv
 
For all reactions, the ketene was added dropwise as a solution in toluene. [a] Calculated by inspection 
of the crude reaction mixture by 1H NMR spectroscopy. [b] Isolated yield of single diastereomer. [c] % 
ee determined by HLPC analysis on a chiral stationary phase. [d] Isolated yield of combined 
diastereomer. [e] 1.2 equiv of ketene and 1.0 equiv of aldehyde used. 
Scheme 66: Scope of the reaction with respect to the aryl substituent. 
3.7 Mechanistic proposal 
As previously noted the observed trend in diastereoselectivity using NHC-mediated 
catalysis in this process (reduced dr for methylaryl ketenes) is opposite to that using 
phosphine catalysis (high dr for methylaryl ketenes, reduced dr for n-butylaryl 
ketenes).14 Kerrigan favours Lewis base addition to the aldehyde as the initial step in 
the phosphine-catalysed system to give 253. This is followed by addition to the 
ketene, anti to the sterically large aryl group,15 before cyclisation to produce the 
β-lactone products and regeneration of the phosphine catalyst (Fig 34).  
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O
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O
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Ar1
Ar
(231)
syn
(231)
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P P
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Fig 34: Mechanistic proposal from Kerrigan for the diphosphine catalysed β-lactone formation. 
In the NHC-mediated process, initiation through NHC addition to the ketene is 
postulated. As previously summarised for the use of chloral (Chapter 3, 3.8), 
addition of in situ generated NHC 169 to ketene 146, preferentially anti  to the aryl 
unit, generates azolium enolate intermediate 170. Subsequent concerted, but 
asynchronous, formal [2+2] cycloaddition with 2-nitrobenzaldehyde yields 
zwitterionic intermediate 255, with subsequent catalyst regeneration and lactone 
formation.  
 
Fig 35: Mechanistic proposal for the NHC-catalysed β-lactone formation. 
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To confirm that a competing but reversible benzoin reaction is not in operation, 
synthesis of benzoin product 256 was attempted, but was found to be unsuccessful. 
Under the benzoin conditions developed by Connon et al. that have proved optimal 
for a range of aromatic aldehydes,16 no benzoin product could be obtained. Further 
analysis of the literature identified that no known NHC-catalysed benzoin 
condensation for aldehyde 239 has been reported. It is inferred from this information 
that the benzoin condensation of 2-nitrobenzaldehyde is not a likely mechanistic 
pathway under the conditions employed.  
66 (10 mol%),
KHMDS (9 mol%),
toluene, rt
or
30 (2.5 mol%),
Cs2CO3 (2.5 mol%),
THF, rt
H
O NO2
(256)(239)
O
OH
NO2
NO2
N
N
N C6F5
BF4
Ph
OHPh
(30)
 
Scheme 67: Attempted benzoin condensation of 2-nitrobenzaldehyde. 
3.8 Determination of the absolute configuration. 
The absolute and relative configuration of 238 was proven by X-ray crystallography 
and found to be (3S,4R),17 with all other configurations assigned by analogy.18 
Importantly, the absolute sense of induction at the ketene derived stereogenic centre is 
the same as that for β-lactones obtained via the use of chloral. The importance 
difference between the systems is the syn diastereoselectivty observed for the use of 
2-nitrobenzaldehyde, compared to the anti selectivity for the chloral series.  
    
Fig 36: X-ray crystallographic representation of lactone 238 showing the absolute configuration. 
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3.9 Stereochemical considerations 
The rationale for the observed (3S,4R) absolute configuration is initially concurrent 
with that proposed for the use of chloral in (Chapter 3, 3.9) We propose an identical 
enolate geometry and orientation with respect to the trazolium ring, as well as the 
same direction of approach past the N-phenyl substituent. Addition to the Re face of 
the azolium enolate in this manner would account for the same sense of induction at 
the C(3) position of both lactone products (Fig 37).  
 
Fig 37: postulated approach of 2-nitrobenzaldehyde past N-phenyl substituent. 
The difference in diastereoselectivity between the two systems is postulated to be due 
to addition to the Si face of 2-nitrobenzaldehyde, compared to addition to the Re face 
of chloral in the previous series. Importantly, the obtained levels of 
diastereoselectivity for the 2-nitrobenzaldehyde process are significantly greater than 
the chloral series, although as previously shown, they are highly dependent on the 
presence of the 2-nitro functionality. Moreover, the trend in diastereoselectivity with 
respect to the alkyl chain length is reversed for the two series. Greater 
diastereoselectivity is observed for the use of more sterically demanding alkyl groups 
in the 2-nitrobenzaldehyde series. Conversely, the use of these groups in the chloral 
series greatly diminished the dr (Fig 38). Combining these observations it is possible 
to postulate a working stereochemical rationale for the observed trend in 
diastereoselectivity.    
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N
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Ph Ph
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Ph
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N
N
NPh
TMSO
Ph Ph
O
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Ph
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N-Ph substituent
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H
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Ar = 2-NO2-C6H4
(238)
Ar = 2-NO2-C6H4
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Fig 38: Differing facial approaches of 2-nitrobenzaldehyde and chloral. 
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The first consideration is that of the conformation of 2-nitrobenzaldehyde. We 
postulate that due to the steric clash between the formyl group and the 2-nitro 
substituent that the formyl group will be orientated out of the plane of the benzene 
ring. Evidence for this distortion is provided by X-ray crystallographic data of the 
solid state structure of 2-nitrobenzaldehyde reported by Coppens and Schmidt19 (Fig 
39). In this report they quantify the angle of rotation from the plane of the ring as 27 
and 31° for the nitro- and the aldehyde group, respectively. This rotation has also 
been recently analysed in the gas phase by computational methods by González et al. 
who were in agreement with the approximate 30° angle of distortion.20  
   
Fig 39: X-ray crystallographic representation of 2-nitrobenzaldehyde.  
Although solid phase structural characteristics may not be indicative of solution phase 
conformation, by invoking this twisted geometry the preferential addition to the Si 
face of 2-nitrobenzaldehyde can be rationalised. Simplistically via the minimisation of 
steric interactions with the sp3 hybridised alkyl substituent on the azolium enolate. In 
this model the twisted geometry of 2-nitrobenzaldehyde forces it to orientate 
preferenatially anti to the enolate alkyl substituent with the 2-nitro group directed 
away from the aryl group of the enolate. Also maintained is the assumed spacial 
arrangement of the developing oxy-anion, crucial for a concerted but asynchronous 
cycloaddition process (Fig 40). This is consistant with the model proposed for the 
poor diastereoselectivity observed for the use of butylphenylketene in the chloral 
β-lactone series (Chapter 3). 
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Fig 40: Proposal for the observed syn diastereoselectivity 
This model is also consistent with the trend in diastereoselectivity observed for the 
use of 2-nitrobenzaldehyde. The decrease in dr associated with the use of a methyl 
group on the ketene can be attributed to a decrease in the steric clash between the 
methyl group of the azolium enolate and the 2-nitrobenzaldehyde. Competitive Re/Si 
facial approach giving an approximate 50:50 dr. Consistent with this model, an 
increase in the size of the alkyl group on the azolium enolate leads to an improvement 
in diastereoselectivity: with i-butylphenylketene, high dr is indeed obtained (94:6 dr, 
syn:anti). Simplistically, a large alkyl substituent on the azolium enolate reinforces 
the steric clash with the 2-nitrobenzaldehyde, further disfavouring addition to the Re 
face of aldehyde (Fig 41). 
 
Fig 41: Rationale for the observed trend in diastereoselectivity. 
Although no direct X-ray crystallographic or computational evidence could be 
obtained for the solution or solid state conformations of other 2-substituted 
benzaldehydes, it is proposed that a twisting of the aldehyde geometry, as seen in 
2-nitrobenzaldehyde, is not present, resulting in low levels of diastereoselectivity. It is 
reasoned that planar orientation of the aldehyde carbonyl with respect to the benzene 
ring is inadequate to provide significant differentiation between a Re and Si face 
approach, leading to poor diastereoselectivity.  
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3.10 Synthetic utility  
3.10.1 Preparative scale synthesis of β-lactone 238 
To demonstrate the synthetic utility of this process, under optimised conditions, this 
reaction was carried out on a preparative scale (Scheme 68). Low NHC loadings 
(2 mol%), provided >2.5g of lactone 238 as a single diastereomer and in high ee (83% 
yield, 95% ee) that was recrystallised to enantiopurity. As with the scale in the 
β-lactone methodology from chloral, the limitation of this process is the quantity of 
ketene employed. In practise the yields for the synthesis of disubstituted ketenes begin 
to fall sharply on scales above 5 g of acid chloride, with the formation of ~2.5 g of 
ketene product being the approximate limit in our hands under the method employed.  
EtPh
O
O
OEt
Ph
NO2
N
N
N Ph
BF4
Ph
OTBSPh
(66)
66 (2.5 mol%),
KHMDS (2.0 mol%),
toluene, !50 °C
(238)
2.5 g, 83%, 95% ee
recrystallised to >99% ee
(146)
10 mmol scale
H
O NO2
(239)
1.2 equiv
 
Scheme 68: Preparative scale synthesis of β-lactone 238. 
3.10.2 Ring opening of β-lactone 238 with sodium azide  
It was previously shown (Chapter 3) that the ring opening of β-lactones derived from 
ketenes and chloral was not possible using sodium azide under standard conditions. 
As representative of this series of β-lactones, functionalisation of 238 was achieved 
through ring opening with either azide or hydroxide. Following facile opening with 
azide, a Staudinger reduction could be carried out to provide the α,α-disubstituted 
β-amino acid 263, however purification from residual triphenylphosphine oxide 
proved difficult. In an effort to bypass the parent amino acid, the crude product from 
the Staudinger reduction was treated under a range of conditions to affect methyl ester 
formation. However, neither the combination of thionyl chloride/methanol, acetyl 
chloride/methanol or acidic Dowex resin and methanol provided any reasonable 
amount of the methyl ester 264. It is assumed that the acid catalysed methanolysis 
failed due to the sterically encumbered α,α-disubstituted acid, prohibiting addition to 
the carbonyl moiety. 
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Scheme 69: Two step azide reduction and methanoloysis 
Attempts to directly acquire the methyl ester via ring opening with sodium methoxide 
also failed. Hydrogenation of the azide in the presence of di-t-butyl dicarbonate in an 
attempt to directly procure the N-Boc protected acid was also unsuccessful. In 
general, hydrogenation of the azide product did not proceed as cleanly as the 
Staudinger reduction. This is postulated to be due to a competing nitro group 
reduction process. Fortuitously, following overnight reflux in methanol with 1.0 equiv 
of SOCl2, the crude reaction mixture obtained from Staudinger reduction could be 
triturated with CHCl3 to provide the α,α-disubstituted β-amino acid 236 in 74% yield 
and >99% ee. It is assumed that the trituration step is responsible for the increase in 
enantiopurity from 95% to >99% ee. In all cases, the ee was established via 
derivatisation to the benzylated and dibenzylated products 265 and 266 (Scheme 70). 
 NaN3 (2.0 equiv), 
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Scheme 70: Successful two step derivatisation of β-lactone 238 to β-amino acid 263. 
It was expected that the ring opening with azide would proceed with inversion of 
configuration at the C(4) position via an SN2 process.21 This was confirmed by an 
X-ray crystal structure of racemic β-azido ester 265 showing an anti  configuration 
with respect to the aryl groups at C(3)-C(4). 
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Figure 42: X-ray crystallographic representation of (±) azide 265 showing anti relative 
configuration. 
3.10.3 Hydroxide ring opening of β-lactone 238.  
The ring-opened α,α-disubstituted β-hydroxy acid product was obtained simply 
through treatment of lactone 238 with 1 M aqueous KOH, following the procedure of 
Kerrigan,7 in good yield and ee (96%). The enantiomeric excess of the derivatised 
product 267 was determined by chiral HPLC via conversion to the benzyl ester 268. 
The relative syn  configuration is assumed to have been retained, as expected from 
addition to the C(2) carbonyl.  
 
Scheme 71: Hydroxide ring opening of β-lactone 238, followed by carboxylate alkylation. 
4.0 Summary 
In summary, a highly efficient and scalable methodology for the stereocontrolled 
formation of β-lactones from ketenes and bezaldehydes, catalysed by chiral NHCs has 
been evaluated. The optimised reaction proceeds in excellent levels of enantio- and 
diastereoselectivity with 2-nitrobenzaldehyde, and expands the scope of the formal 
[2+2] cycloaddition between ketenes and aldehydes. Notably, no competing benzoin 
reaction or significant ketene dimerisation products were observed under the reaction 
conditions, with the lactone product being readily transformed to synthetically useful 
α,α-disubstituted β-hydroxy- and β-amino acid building blocks. This project has 
BnO
O N3 NO2
Ph Et
(265)
anti
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made significant progress in solving the issues associated with the chloral project 
(Chapter 3), specifically the improvements in dr and aldehyde scope. However this 
process is still limited by the use of isolated ketenes as azolium enolate precursors and 
the requirement for 2-nitrobenzaldehyde to obtain high diastereoselectivity. 
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1.0 Project aim 
As described in (Chapter 3), a novel chlorination process had been identified from 
the reaction of chloral and alkylarylketenes bearing either a 2-substitued aryl group or 
an α-branched alkyl substituent. This proceeded in excellent yield and 
enantioselectivity (up to 94% ee), however it was fundamentally limited by the 
relatively small substrate scope with respect to the ketene. This project will aim to 
develop a general NHC-catalysed asymmetric halogenation protocol for 
alkylarylketenes.  
2.0 Introduction 
Stereogenic halogenated centres have become increasingly important in both synthetic 
and medicinal chemistry. They serve as important chemical handles by which further 
stereocontrolled functionalisation can occur. Recently the incorporation of halogen 
atoms (most noticeably fluorine) has found increasing use in medicinal and materials 
chemistry. 
Within the field of asymmetric halogenations the predominating strategy is the 
generation of a chiral enolate or enolate equivilent that may react in a stereocontrolled 
manner with an electrophilic halogenation source.1 This broad approach can be 
further broken down into sub-categories for the specific formation of a reactive 
enolate or enolate equivalent: (i) the coordination of a chiral Lewis acid followed by 
deprotonation; (ii) the ionic pairing of an asymmetric phase-transfer catalyst with the 
enolate oxygen; (iii) the formation of a chiral enamine by the addition of a chiral 
secondary amine to an aldehyde or a ketone containing a α-proton; (iv) the addition of 
a chiral Lewis base to a ketene to directly form a zwitterionic chiral enolate. Of 
particular interest to this thesis are those methods that employ Lewis basic 
organocatalysts, of which some of the recent advances will be discussed in further 
detail below in a brief overview of the area.  
2.1 Halogenation of β-ketoesters 
β-Ketoesters are one of the most studied substrates in asymmetric halogenation 
reactions due to the facile formation of six-membered chelates with oxophilic chiral 
Lewis acids, rigidifying the transition state to provide facial discrimination and thus 
allowing enantioselective halogenation. The first of these processes to be reported 
was by the group of Togni2 who employed titanium-TADDOL complexes 272 and 
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273 to achieve the unprecedented catalytic asymmetric fluorination, and subsequently 
chlorination,3 of β-ketoesters in up to 90% ee (Scheme 72). The use of such Lewis 
acids in asymmetric halogenation subsequently received attention from a number of 
groups including Sodeoka,4 Cahard5 and Jørgensen.6 
 
Scheme 72: Halogenation of β-ketoesters. 
2.2 Organocatalytic halogenation of aldehydes 
The advent of organocatalysis has led to a proliferation of asymmetric halogenation 
reactions and allowed facile access to new structural motifs, for example stereogenic 
α-halo carbonyl compounds.7 In 2004 the groups of MacMillan8 and Jørgensen9 
reported the asymmetric chlorination of aldehydes. This was rapidly followed by the 
groups of Enders10 and Barbas,11 independently extending this methodology to the 
asymmetric fluorination of aldehydes.12 The chlorination strategy employed by 
MacMillan and co-workers utilised the imidazolidinone catalyst 280 and chlorinating 
agent 275 to provide a range of α-functionalised aldehydes in excellent yield and 
enantioselectivity (Scheme 73). This method accessed enantioenriched α-chloro 
intermediates that were readily transformed to a diverse set of products such as 
epoxides, α-hydroxy acids and amino acids.13  
 
Scheme 73: Asymmetic halogenation of aldehydes. 
2.3 Synthesis of α-halo esters 
As previously described, Rovis et al. have elegantly accessed α-halogenated esters 
from the corresponding α,α-dichloroaldehydes (Chapter 1, Scheme 21). The group 
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of Lectka has extensively studied an alternative approach to α-halo esters via the use 
of mono-substituted ketenes.1a In these reports acyl halides are treated with a chiral 
Lewis base catalyst (such as benzoylquinine 230) and a Brønsted base to generate a 
chiral ammonium enolate in situ that can be asymmetrically halogenated in excellent 
yields and enantioselectivities (Scheme 74).14,15 This method was applicable to both 
chlorination and bromination and later extended to fluorination, however this required 
the addition of a suitable transition metal co-catalyst to increase enolate 
nucleophilicity.16  
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Scheme 74: Synthesis of α-halo esters. 
Although the impressive advancements in organocatalytic asymmetric halogenation 
reactions provide α-halo carbonyl products in excellent yield and enantioselectivities, 
they are generally restricted to the production of secondary halides. Outside the use of 
β-keto esters as substrates, asymmetric catalytic methodology to access tertiary halide 
centres is considerably less well documented. One excellent report to date from the 
group of Fu has employed disubstituted ketenes as azolium enolate precursors in the 
asymmetric halogenation reaction catalysed by planar-chiral PPY derivative 59.17 The 
reaction was applicable to a range of disubstitued ketenes and produced α-chloro 
esters 282, amenable to a range of further derivatisations, in excellent yields and with 
good to excellent levels of stereocontrol (up to 90% yield and 95% ee) (Scheme 75). 
 
Scheme 75: Synthesis of asymmetric tertiary halide centres. 
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Inspired by the work of Lectka and Fu, and in an effort to expand the highly substrate 
specific asymmetric chlorination reaction discovered in (Chapter 2), a generalised 
reaction protocol for the NHC-catalysed asymmetric halogenation of disubstituted 
ketenes was investigated.   
3.0 Asymmetric chlorination of disubstituted ketenes 
3.1 Chlorination of with 2,2,6,6-tetrachlorocyclohexanone  
Initial studies into the viability of an NHC-catalysed asymmetric halogenation 
methodology began by employing chlorination reagent 
2,2,6,6-tetrachlorocyclohexanone 281. Chlorination was chosen as the primary target 
due the relative availability of electrophilic sources of chlorine and specifically 
chlorine source 281 as this was shown to provide the highest enantioselectivities in 
the work of Fu et al.17 Ethylphenylketene, the standard ketene used to screen reactions 
conditions, was employed with a representative range of triazolium and imidazolium 
precatalyst scaffolds in toluene, using either KHMDS or Cs2CO3 as the base with 
which to generate the active NHC in situ at room temperature (Scheme 76). 
Disappointingly the majority of precatalysts tested returned no ester product 283, 
returning the chlorination agent 281 and the acid hydrolysis product from the ketene. 
Precatalyst 66, which was found to be optimal in the previously described β-lactone 
methodology, was also screened under identical conditions, giving ~50% conversion 
to 283 by 1H NMR spectroscopy that was isolated in 47% yield (Table 7, Entry 5).  
 
Scheme 76: Catalyst screen for the use of 2,2,6,6-tetrachlorocyclohexanone 281. 
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Entry Precatalyst Base Yield (%)[a] ee (%)[b] 
1 284 KHMDS − − 
2 70 KHMDS − − 
3 126 KHMDS − − 
4 71 KHMDS − − 
5 66 Cs2CO3 47 <5 
6[c] 66 Cs2CO3 35 <5 
[a] Isolated yield of ester 283. [b] Determined by GC analysis of the corresponding methyl ester 292. 
[c] Reaction performed at −40 °C followed by warming to rt. 
Table 7: Catalyst screen for the use of 2,2,6,6-tetrachlorocyclohexanone 281. 
Due to the failure of the reaction employing achiral precatalyst 284 to provide an 
authentic racemic sample of 283,18 it was converted to known methyl ester 285 via the 
two step procedure reported by Fu (Scheme 77).17 The enantiomeric excess of 285 
was determined by chiral GC analysis and disappointingly was found to be essentially 
racemic. Further reduction of the reaction temperature to −40 °C for 3 h followed by 
warming to rt over 12 h provided no appreciable increase in yield or enantioselectivity 
(35% yield and <5 % ee) (Table 7, Entry 6). 
 
Scheme 77: Transesterification of 283 to allow determination of the enantioselectivity. 
3.2 Chlorination with NCS 
Due to the low reactivity of 281 in the initial protocol, N-chlorosuccinimide (NCS) 
was screened as a potentially more facile chlorinating reagent. Pleasingly, good 
conversions to a proposed succinimide adduct 287 were observed (by 1H NMR 
spectroscopic analysis of the crude reaction mixture) for a range of precatalysts 
(Scheme 78). The proposed chloro-amides proved sensitive to silica chromatography 
so unambiguous structural assignment could not be made. To resovle this problem the 
crude reaction mixture was directly submitted to methanolysis (MeOH, DMAP) to 
yield the methyl ester products in moderate yield over the two steps. The 
enantioselectivity was evaluated by chiral GC and found to be low in all cases (Table 
8). To investigate the reasonable reactivity but consistently low levels of 
enantioselectivity for the procedure employing N-chlorosuccinimide, a background 
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reaction in the absence of the azolium salt was conducted. It was found that KHMDS 
alone (1 equiv) was not able to promote the chlorination reaction, however Cs2CO3 (1 
equiv) did provide efficient conversion to the succinimide adduct 287. Throughout 
these studies a sub-stoichiometric quantity of base was employed to minimise any 
background reaction, however base catalysed, or other feasible background reactions, 
cannot be completely ruled out in many of these cases. 
Ph Et
O
precatalyst X (10 mol%),
base (9 mol%),
toluene, ! 40 °C
Ph
Cl Et
O
(286)(146) (287)
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Scheme 78: Catalyst screen for the use of NCS. 
Entry Precatalyst Base Yield (%)[a] ee (%)[b] 
1 284 KHMDS − − 
2 70 KHMDS 39 <5 
3 126 KHMDS 39 11 
4 71 KHMDS 15 <5 
5 66 Cs2CO3 28 <5 
[a] Isolated yield of the methyl ester 292 (over two steps). [b] Determined by chiral GC analysis of the 
corresponding methyl ester 292. 
Table 8: Catalyst screen for the use of NCS. 
3.3 Chlorination with hexachloroacetone  
With improvements made in reactivity but with still consistently low levels of 
enantioselectivity, hexachloroacetone was next evaluated as a chlorination reagent. 
Under the reaction conditions employed for NCS, hexachloroacetone provided good 
conversions and on this occasion moderate to good yields of isolable ester 289 
(Scheme 79). The enantioselectivites obtained using precatalysts 126, 71, 66, were 
determined via derivatisation to the corresponding methyl esters 285, were equally 
low as with the previous chlorination reagents. The use of aminoindanol derived 
precatalyst 70 however provided the first promising enantioselectivity of 29% ee 
(Table 9, Entry 2). In control experiments both KHMDS and Cs2CO3 (1 equivalent) 
were found to be unable to promote the background chlorination reaction. 
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Scheme 79: Catalyst screen for the use of hexachloroacetone. 
Entry Precatalyst Base Yield (%)[a] ee (%)[b] 
1 284 KHMDS 44 − 
2 70 KHMDS 47 29 (ent) 
3 126 KHMDS 67 <5 
4 71 KHMDS 72 8 
5 66 Cs2CO3 37 <5 
[a] Isolated yield of 296. [b] Determined by GC analysis of the corresponding methyl ester 285. 
Table 9: Catalyst screen for the use of hexachloroacetone. 
3.4 Chlorination with 2,3,4,5,6,6-hexachlorocyclohexa-2,4-dienone  
3.4.1 Catalyst screen 
Next the chlorinating reagent was changed to 
2,3,4,5,6,6-hexachlorocyclohexa-2,4-dienone 275 that has previously been reported 
for similar organocatalytic systems of the groups of Lectka14 and MacMillan.8 
Pleasingly all chiral NHC precatalysts screened provided good to excellent isolated 
yields of α-chloro perchlorophenyl ester 290 with precatalyst 66 returning the most 
promising ee of 57% (Scheme 80, Table 10). In keeping with the previously variable 
enantioselectivities, precatalysts 70 and 71 resulted in little to no enantioselectivity 
whereas 126 provided 22% ee. Finally N-mesityl precatalyst 112 was screened. In this 
instance, ester 290 was isolated in 72% yield but with no enantioselectivity (Table 10, 
Entry 6).  
 
Scheme 80: Catalyst screen for the use of 2,3,4,5,6,6-hexachlorocyclohexa-2,4-dienone 275. 
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Entry Precatalyst Base Yield (%)[a] ee (%)[b] 
1 284 KHMDS 65 − 
2 70 KHMDS 89 6 
3 126 KHMDS 43 22 
4 71 KHMDS 77 <5 
5 66 Cs2CO3 92 57 
6 112 KHMDS 72 <5 
7[c] 66 Cs2CO3 90 61 
8[d] 66 Cs2CO3 86 53 
[a] Isolated yield of perchlorophenyl ester 290. [b] Determined by GC analysis of the corresponding 
methyl ester 285. [c] 1.1 equiv of ketene was used. [d] The reaction was warmed from −60 °C to rt 
over 12 h 
Table 10: Catalyst screen for the use of 2,3,4,5,6,6-hexachlorocyclohexa-2,4-dienone 275. 
In further optimisation of (Table 10, Entry 5), 1.1 equivalents of ketene were used to 
ensure full consumption of the chlorinating reagent 275, as 290 was often difficult to 
separate from the product 290. These conditions proved optimal as lowering the 
reaction temperature to −60 °C suppressed reactivity, whilst slow warming from 
−60 °C to room temperature gave slightly diminished enantioselectivity (Table 10 
Entry 8).  
3.4.2 Assignment of absolute configuration 
X-ray crystallographic analysis of racemic compound 290 provided unambiguous 
structural identification while comparison of the specific rotation and GC retention 
times of the methyl ester 285 from (Table 10, Entry 7) with the literature17 confirmed 
the absolute configuration as (R) (Scheme 81).   
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Fig 43: X-ray crystallographic representation of (±)-290. 
 
Scheme 81: Determination of the absolute configuration of 297. 
3.4.3 Analysis of quinoline derived chlorinating reagent 291  
The increased reactivity of the chlorination reagent 275 is in line with the 
electrophilicities reported by Mayr and co-workers19 who calculate 275 to be a 104 to 
105- fold more electrophilic than 291. To validate further the need for a strong 
electrophile to achieve good yields, chlorination reagent 291 was prepared from 
8-hydroxyquinoline20 and tested in this system, failing to provide any conversion to 
the desired product, even at rt (Scheme 82). 
 
Scheme 82: Analysis of quinoline derived chlorinating reagent 291. 
3.4.4 Analysis of substrate scope 
With an optimised procedure functioning in high yield, albeit with moderate 
enantioselectivity, extension of the alkyl chain to an n-butyl substituent was 
undertaken. The reaction proceeded in similar yield, however the enantioselectivity 
was reduced to 34% ee (Scheme 83).  
 
 [a] Determined by 1H NMR spectroscopic analysis of the (S)-α-methylbenzylamide  
Scheme 83: Use of an n-butyl alkyl substituent. 
In general the ester products proved challenging to separate by chiral HPLC so 
alternative methods were used to determine product enantioselectivity. In the absence 
of literature chiral GC conditions for the methyl ester derivatives other than 285, it 
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was found that amidation with (S)-α-methylbenzylamine provided clean conversion 
to a diastereomeric mixture of amides 297 that could be analysed by 1H NMR 
spectroscopy. The amides proved sensitive to further purification with a tendency to 
undergo elimination, however 1H NMR spectroscopic analysis of the crude reaction 
product provided a sufficiently accurate means to assess the enantiomeric excess of 
chlorinated esters via determination of the diastereomeric ratio of derivatives 297 
(Scheme 84).  
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Scheme 84: Method for the determination of the enantioselectivity via derivatisation. 
This method was validated on ester 285 via comparison with the enantioselectivity 
determined by chiral GC, with minimal variance observed (Scheme 85).21 
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[a] Determined by 1H NMR spectroscopic analysis of the (S)-α-methylbenzylamide [b] Determined by 
chiral GC analysis of the corresponding methyl ester 285 
Scheme 85: Determination of the enantioselectivity via two separate methods. 
Substitution on the aryl portion of the ketene was investigated with both electron 
donating and withdrawing groups in the 4-position providing good to excellent yields 
and moderate levels of enantiocontrol (44 to 48% ee) (Scheme 86). Finally a 
2-substituent on the aryl portion, previously shown to either reduce greatly or alter 
reactivity, was well tolerated in this case proceeding in 91% yield, however with 
diminished enantioselectivity (26% ee). In an attempt to rationalise the moderate 
levels of enantioselectivity in this reaction the background reaction in the absence of 
precatalyst 66 was evaluated. In this instance employing 1.0 equiv of Cs2CO3 at rt 
resulted in smooth conversion to the chlorinated product highlighting the trade-off 
between necessarily high electrophilicity of the chlorinating reagent and the 
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consequence of competing racemic background pathways.  
 
[a] 1.5 equiv of ketene and 25 mol% of 66 were used [b] Determined by 1H NMR spectroscopic 
analysis of the (S)-α-methylbenzylamide. 
Scheme 86: Analysis of the substrate scope with respect to the aryl substituent. 
3.4.5 Mechanistic proposal 
Two notable mechanistic postulates exist for this reaction that differ fundamentally in 
the role of the NHC. As previously rationalised, attack of the NHC anti to the phenyl 
group can lead to azolium enolate species 170. Subsequent stereoselective 
chlorination renders the α-chloroazolium 304 that undergoes nucleophilic attack from 
the previously liberated perchlorophenolate anion to release the NHC catalyst and 
form α-chloroester 290.  
 
Fig 44: Postulated mechanism via initial addition of the NHC to the ketene. 
In addition to this stepwise azolium enolate pathway a concerted process may be in 
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operation. This reaction mechanism featuring a six-membered transition state 304 
involving Cl agent 275 was considered by Lectka and co-workers in analogous 
reseach.14 However following computation analysis it was deemed unlikely due to the 
requirement for a highly bent µ-Cl anionic interaction 306 that was disfavoured when 
compared to a linear arrangement of the C-Cl-C motif 305.  
Cl
Cl
Cl
Cl
Cl
O
Cl
O
NHC
Ph Et
H3C Cl CH3 H3C
Cl
CH3
(304) (305) (306)  
Fig 45: Postulated concerted process via the bent µ-Cl anionic interaction 306. 
A second plausible reaction mechanism involves the initial formation of a chlorinated 
NHC following abstraction of a Cl atom from 275 by the NHC. Addition of the 
perchlorophenol to the ketene could then produce prochiral enolate 308. This enolate 
could then be chlorinated by 307 in a stereoselective fashion to yield the final ester 
290 and regenerate the NHC. This mechanistic postulate was proposed by Fu, in 
conjuction with the azolium enolate mechanism above.17  
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Fig 46: Postulated mechanism for via initial chlorination of the NHC. 
At this stage our investigations have not provided any clear evidence that would rule 
out either mechanistic pathway. However, if consistent with the initial stages of 
previous mechanistic rationales (Chapter 3, 3.8), addition to the ketene as the initial 
step in this pathway would be favoured.  
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3.4.6 Stereochemical considerations. 
Given the ambiguity regarding the mechanistic pathway, and the low levels of 
observed enantioselectivity, defining an unambiguous rationale for the observed (R) 
absolute configuration is challenging. Some limited evidence may be taken from the 
observation that both the chlorination reaction described here and the β-lactone 
formation (Chapter 3 and 4) proceed with the same sense of induction at the ketene 
centre. This sense of induction is that obtained via addition from the Re face of the 
enolate, assuming that it adopts the orientation proposed in (Chapter 3, 3.9). It is 
therefore postulated that addition from the Re face of the enolate is favoured, with the 
chlorinating reagent 275 approaching past the N-aryl substituent rather than the bulky 
stereodirecting unit (Fig 47).  
 
Fig 47: Rationale for the absolute configuration. 
The explanation for the modest levels of enantioselectivity observed for the 
chlorination reaction when compared to the β-lactone formation is not immediately 
clear. It could be due to a more facile racemic background reaction or the different 
steric demand placed upon the system for the use of chlorination reagent 285.  
 
4.0 Extension to the asymmetric bromination of ketenes. 
4.1 Use of NBS and brominating reagent 311. 
With a viable, but modest, enantioselective method for the asymmetric chlorination of 
ketenes established, attempts were made to expand the process to bromination. Lectka 
et al. have previously shown their methodology developed for chlorination could be 
applicable to bromination, although significant investigation was required to optimise 
this process.21 With this in mind initial studies applied the previously developed 
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conditions to bromination reagents 310 and 311. N-Bromosuccinamide (NBS) was 
selected due to its commercial nature but provided no promising conversion. Given 
the likely inherent problems with product stability, as previously found with the NCS 
series, coupled with literature precedent for its ineffectiveness in a similar system,23 
further evaluation of its use was not attempted. Tribromoquinolinone 311,22a 
structurally related to 291, was next selected for evaluation. It was however limited by 
its poor solubility at rt in a range of representative solvents employed in NHC 
reactions (toluene, THF, CH2Cl2) and no promising conversion was seen, even at rt 
(Scheme 87).  
 
Scheme 87: Attempted bromination with NBS or brominating reagent 311. 
4.2 Use of polybrominated p-quinone brominating reagent. 
Finally polybrominated p-quinone 312, prepared from commercially available 
tribromophenol, which has been utilised by the group of Letcka, was tested.22 
Pleasingly, under the optimum reaction conditions developed for the chlorination with 
285, tribromophenolic esters were obtained in synthetically useful yields but generally 
low enantioselectivites. The reaction proved especially facile under the catalytic 
influence of 66 with an isolated 92% yield and a moderate ee of 46%. As with some 
previously utilised halogenation reagents there is an efficient background reaction in 
the absence of precatalyst with either KHMDS or Cs2CO3. 
 
Scheme 88: Catalyst screen for the use of brominating reagent 312. 
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Entry Precatalyst Base Yield (%)[a] ee (%)[b] 
1 284 KHMDS − N/A 
2 71 KHMDS 55 12 
3 70 KHMDS 61 <10 
4 126 KHMDS 54 <10 
5 66 Cs2CO3 92 46 
[a] Isolated yield of ester 313. [b] Determined by chiral HPLC analysis [c] 
Table 11: Catalyst screen for the use of brominating reagent 312. 
5.0 Asymmetric fluorination of ketenes. 
The report of Lectka et al. provides evidence for the difficulties associated with 
extension of azolium enolate methodologies to fluorination.16 In the previously 
mentioned study a catalytic, enantioselective, ‘dual activation’ strategy was necessary 
to obtain a range of products in both high yield and enantiomeric excess. Specifically 
a transition metal co-catalyst was required to increase enolate nucleophilicity 
(Scheme 89). Feasibly, the enolate generated from an NHC could have higher 
nucleophilicity than the cinchona alkaloid derived ketene enolate employed by 
Lectka, thus removing the need for a transition metal co-catalyst. 
N
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Scheme 89: Duel activation strategy for the asymmetric fluorination. 
Unfortunately, under a range of conditions, employing various NHC precatalysts, no 
reaction was observed (Scheme 90). In all cases only phenylbutyric acid, from ketene 
hydrolysis, and unreacted N-fluorobenzenesulfonimide (NFSI) (observed by 19F NMR 
spectroscopy) were obtained. We inferred from this, and as suggested by Leckta, that 
the azolium enolates produced from NHCs or cinchona alkaloid derivatives are 
insufficiently nucleophilic to afford fluorination via the use of standard fluorination 
agents, such as NFSI. Further investigations into the effectiveness of Lewis acidic 
additives was not undertaken as they were not believed to be compatible with such 
Lewis basic ligands for complexation. Subsequently the group of Scheidt has shown 
the viability of co-operative catalysis between NHCs and Lewis acids.24 
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Scheme 90: Failed NHC-catalysed asymmetric fluorination. 
6.0 Summary 
It has been demonstrated that NHCs are viable Lewis base catalysts for the 
α-chlorination and α-bromination of disubstituted ketenes. A range of chlorination 
agents were screened with 275 proving optimal, giving excellent yields of tertiary 
α-chloro esters in one step. Chiral NHC precatalyst 66 shows promising levels of 
enantioselectivity (up to 61% ee).  
The corresponding bromination reaction could also be readily achieved, however the 
enantioselectivity was low to moderate, with a maximum achievement of 46% ee. 
Finally further extension to a synthetically attractive fluorination methodology was 
unsuccessful. In line with previous reports it is assumed that the azolium enolate lacks 
sufficient nucleophilicity to react with fluorination reagents such as NFSI.  
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1.0 Project aim 
As highlighted in (Chapters 3 & 4), the use of isolable alkylarylketenes limits the 
available substitution pattern for NHC derived azolium enolates. One method by 
which the more reactive non-isolable mono-substituted ketene motif has been 
accessed is via in-situ dehydrohalogention of the requisite acid chloride.  
To date, this method has not been demonstrated in the presence of NHCs, being 
primarily limited to the use of Cinchona type Lewis bases. The generation of mono-
substituted azolium enolates of this type within the area of NHC catalysis has recently 
been investigated via the use of enals or α-functionalised aldehydes as 
mono-substituted ketene surrogates, as reviewed in (Chapter 1).  
The goal of this project was to explore and optimise the ability of 
α-aroyloxyaldehydes to function as efficient azolium enolate precursors.  Key to this 
research is the greater utility associated with α-aroyloxyaldehydes when compared to 
ketenes due to their increased stability. It was also envisioned that a wider substrate 
scope could be accessed, with the previous azolium enolate research (Chapters 3 & 
4) being limited by the prerequisite for the alkylaryl substitution pattern.  
2.0 Introduction 
As previously outlined in (Chapter 1, Fig 10), the treatment of a suitably 
α-functionalised aldehyde with an NHC can lead to azolium enolate species 99 via 
elimination from the Breslow intermediate 101. Initial pioneering work in this field 
focused on the protonation of enolate 99 to generate an activated acylazolium 102 that 
could undergo redox esterification and amidation reactions (Fig 48).  
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Fig 48: Generation of azolium enolates from α-functionalised aldehydes. 
2.1 The use of α-functionalised aldehydes as precursors for acylazolium ions 
The first reports in this field were by Rovis and co-workers who employed secondary 
and tertiary α-halo aldehydes to provide various ester products 320,1 and that by Bode 
et al. who utilised epoxy aldehydes for the generation of anti β-hydroxy esters2 325 
(Scheme 91). 
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Scheme 91: Redox esterification generation of an acylazolium. 
Although these processes allowed rapid and atom economical entry into carboxylate 
motifs, the extension to amide bond formation remained a significant challenge. Only 
isolated reports from the groups of Rovis2 and Scheidt,3 who employed aniline and 
vinylogous imides respectively, managed to overcome the inherent problem of 
competing imine formation during any attempted internal redox amidation process. A 
second difficulty associated with the redox amination processes is the slow reaction of 
an amine with an acylazolium compared to reaction with alcohols. Specifically the 
rate of collapse of the tetrahedral intermediate 329 formed from addition of an amine 
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to an acyl azolium is significantly slower than the corresponding intermediate 327 
formed from addition of an alcohol to an acylazolium (Fig 49).4 
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Fig 49: NHC-catalysed esterification and amidation.  
An elegant solution to this problem was reported independently by the groups of 
Bode5 and Rovis6 in 2007. Bode et al. utilised imidazole as an additive to form 
rapidly and preferentially an acyl imidazole species 336 that can be intercepted with a 
range of primary and secondary amines to afford a range amides 344 (Scheme 92). 
The method was also compatible with the use of other acylazolium precursors such as 
α-chloro aldehydes and enals.  
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Scheme 92:  The use of imidazole as an additive in the redox amidation of cyclopropyl aldehydes. 
Rovis et al. have employed a similar strategy using 1-hydroxy-7-azabenzotriazole 
(HOAt) 341 as a co-catalyst, shuttling the acyl azolium through to an activated 
carboxylate 342 that undergoes nucleophilic attack by an amine to afford the amide 
products 339 (Scheme 93). Although these advancements provide redox amidation 
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products they are limited by the requirement of an additive and the relative instability 
of the α-functionalised aldehydes employed. 
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Scheme 93: Development of a redox amination process. 
The current state of the art in redox aminations is the methodology developed by 
Bode and co-workers.4 In this report, crystalline α’-hydroxyenones 343 serve as 
surrogates for α-functionalised aldehydes that eliminate the possibility for competing 
imine formation. The reaction mechanism proceeds via addition of the NHC to the 
enone, followed by retro benzoin reaction to release acetone and generate the 
conjugated Breslow intermediate. β-Protonation of this homoenolate species leads to 
the active acylazolium 346, itself only a slow acylating agent for amines, but which is 
readily converted to the activated carboxylate by addition of co-catalytic 
1,2,4-triazole 347.  This species functions as a highly reactive amine acylating agent 
that allows the formation of a range of primary and secondary amides, as well as 
chemoselective amide formation from amino-alcohols (Scheme 94).  
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Scheme 94: The use of α’-hydroxyenones as redox amination precursors. 
2.2 The use of α-functionalised aldehydes as precursors for azolium enolates 
Along with ketenes and enals, α-functionalised aldehydes provide access to reactive 
azolium enolates for a range of asymmetric carbon-carbon bond forming reactions 
(Fig 50). 
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Fig 50: Generation of azolium enolates. 
The use of ketenes and enals was reviewed in the introduction (Chapter 1, 4.2 & 4.3) 
and will not be further elaborated upon in this section. However a selected range of 
examples of α-functionalised aldehyde reactivity will be discussed below. 
 
In an extension to the initial report of the use of α-chloroaldehydes from Bode and 
co-workers summarised in the introduction, a 2008 report of Bode et al. documents 
the use of α-chloroaldehyde bisulfite adducts 349 as effective azolium enolate 
precursors.7 Under biphasic reaction conditions the protocol was effective for a range 
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of substituted β,γ-unsaturated α-ketoesters 350 in a [4+2] hetero Diels-Alder reactions 
proceeding in good yield (40–90%) and outstanding diastereo- and 
enantioselectivitiess (>95:5 dr and typically >99% ee). These precursors provide 
greater stability than the α-functionalised aldehydes and importantly represent a novel 
solution to the enantioselective addition of a acetate equivalent via the use of 
commercially available aldehyde surrogate 349 (R = H) (Scheme 95).  
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Scheme 95: The use of α-chloroaldehyde bisulfite salts as bench stable α-functionalised 
aldehydes. 
α-Chloroaldehydes were also employed by the group of Kobayashi who aimed to 
expand the methodology to the synthesis of trans stereoisomers of nitrogen 
substituted dihydropyran-2-ones from the NHC-catalysed cycloaddition of 
α,β-disubstituted enones 363 and 2-chloropropanal 362 (Scheme 96).8 This 
methodology proceeds in high enantioselectivity (up to 98% ee) for a limited range of 
nitrogen containing acceptors. Contrary to the predicted stereochemical outcome the 
syn isomer predominates, leading the authors to propose a stepwise, rather than a 
concerted process.  
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Scheme 96: Synthesis of dihydropyran-2-ones from 2-chloropropanal. 
In 2009 the group of Scheidt showed that α-aryloxyacetaldehydes 364 are competent 
enolate equivalents in the NHC-catalysed Mannich reaction with imines 365 (Scheme 
97).9 The reaction was applicable to a range of aryl imines with in situ generation of 
the corresponding amides 366 in good yields (56-75%) and with excellent 
enantiocontrol (typically >90% ee), however only the parent unsubstituted 
α-aryloxyacetaldehyde was demonstrated. Other products such as the carboxylic acid, 
methyl ester or 1,3-aminoalcohol could also be obtained by correct choice of 
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additional reagent following consumption of the starting material (MeOH/aq. NaOH, 
sodium methoxide or LiBH4 respectively) (Scheme 97). The general utility of this 
methodology is reduced by the availability of the precursors, with the number of 
readily prepared α-aryloxyacetaldehydes limited.  
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Scheme 97: Use of α-aryloxyacetaldehydes as enolate equivalents. 
The aryloxy leaving group is key to the postulated mechanistic rational in what the 
authors describe as “rebound-activation”. The cycle begins with initial NHC addition 
and tautomerisation to the Breslow intermediate 368, followed by elimination of 
aryloxy anion 370 to form the azolium enolate 369. Subsequent C-C bond formation 
provides intermediate 371 with acylation of this species by aryloxy anion 370 
providing the ester 372 and regenerating the NHC. Transamidation of this ester in situ 
provided the amide products (Fig 51). 
ArO
O
H
Ar1
NTs
H
(364)
(365)
(369)
R N
R
N
N
Mes
BF4
ArO
OH
N
N
N
Mes
R
R
H
H OH
N
N
NMes R
R
O
N
N
N
Mes
RNH
Ar1
Ar1
NH O
OAr
R ArO
Activation
Rebound
(372)
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N N
N
Mes
BF4
O
Ph (367)
Ts
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Fig 51: Mechanistic rationale for the use of α-aryloxyacetaldehydes. 
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3.0 Previous work within the group 
Previous work in this area from within our group aimed to develop an alternative 
bench stable α-functionalised aldehyde that would provide further ease of procedure 
compared to the frequently employed, but sensitive α-haloaldehydes.10 
α-Aroyloxyaldehydes were found to be adequate leaving groups in this methodology, 
and subsequently selected as efficient redox precursors due to their prolonged stability 
and general ease of synthesis. They can be readily prepared in one-step form the 
corresponding aldehyde utilising an α-oxidation reagent developed by Tomkinson,11 
itself readily prepared on >50 g scale (vide infra). A range of ester products could be 
accessed and employment of phenol followed by addition of benzylamine to the crude 
reaction mixture allowed a redox amidation process to be realised.  
α-Aroyloxyaldehydes were shown to be competent precursors for C–C bond forming 
reactions with an isolated preliminary result employing β,γ-unsaturated α-ketoester 
375 in a  [4+2] cycloaddition in a promising yield (54%) and dr (69:31). In this report 
N-mesityl NHC precatalyst 335 was found to be a uniquely reactive catalyst 
architecture. As summarised in (Chapter 1, 4.2) there is a general requirement for the 
use of N-mesityl NHCs for reactions involving α-functionalised aldehydes. 
335 (20 mol%), 
NEt3 (1.5 equiv),
THF
O
O
H
O
OR
N N
N
Mes
BF4
(335)(374)
PNP = 4-NO2C6H4
Ph
O
PNP Ph
O
CO2Et
O
O
CO2EtPh
Ph
335 (20 mol%), 
NEt3 1.5 (equiv),
THF
ROH (2.0 equiv)
(376)
54% yield
69:31 dr
(375)
(0.6 equiv)
(373)
Ph
 
Scheme 98: Development of α-aroyloxyaldehydes as efficient acylazolium precursors. 
4.0 Development of α-aroyloxyaldehyde 374 as a bench stable ketene surrogate 
4.1 Synthesis of α-aroyloxyaldehyde 374 
Studies began by ensuring the literature procedure10 for the synthesis of 
α-aroyloxyaldehyde 374 was sufficiently robust to provide material for an 
optimisation project. Although proceeding in relatively poor overall yield 
(approximately 25% for the three steps) scaling up of the reported procedure could 
conveniently provide a 1 g quantity of the necessary α-aroyloxyaldehyde.  
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 (1.1 equiv), 
THF,!78 °C
Ph
O
H
Ph
OMgBr
Ph
O
O
NO2
i. LiCl (1.2 equiv),
O3, CH2Cl2. !78 °C
DMS
(374)
PNP = 4-NO2C6H4
1.1 g, 71%
(377) (378)
O
O
HPh
O
PNP
(379)
37% over 2 steps
  ii. 4-NO2-C6H4COCl
(1.2 equiv), THF,
!78 °C to rt, 2 h
MgBr
 
Scheme 99: Synthesis of α-aroyloxyaldehyde 374. 
4.2 Synthesis of α-ketoester 381 
With sufficient quantities of the α-aroyloxyaldehyde 374 in hand, studies were 
directed towards the optimisation of the cycloaddition reaction. It has been reported in 
similar [4+2] processes employing α-ketoester substrates such as 381 that the ester 
portion can play a key role in the diastereoselectivity,12 specifically that a methyl ester 
was optimal for high diastereoselectivity. Accordingly methyl ester 381 was prepared 
from the parent potassium salt (Scheme 100)13,14 and tested under a range of reaction 
conditions.   
MeI (1.5 equiv), 18-crown-6,
DMF, 50 °C, 24 h
Ph
O
CO2Me
(380)
Ph
O
CO2K
(381)
3.7 g, 21% yield  
Scheme 100: Synthesis of α-keteoester 381. 
4.3 Optimisation of conditions for the use of α-aroyloxyaldehyde 374 
Employing 20 mol% achiral precatalyst 335, 1.0 equiv α-ketoester 381, 1.5 equiv of 
α-aroyloxyaldehyde 374 and 1.5 equiv of Et3N, the reaction gave both promising 
yield and an improved dr when compared to the previously reported reaction with 
ethyl ester 375 (Scheme 101). When chiral precatalyst 112 was used under identical 
reaction conditions the dr increased further and there was a small but appreciable 
increase in isolated yield (Table 12, Entry 2). The enantiomeric excess of 382 was 
established via chiral HPLC and found to be exquisite (>99% ee). This is consistent 
with the reported use of this catalyst in a similar system utilising α-chloro aldehydes 
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as azolium enolate precursors.7,15 This catalyst was employed due the necessity for an 
N-mesityl substituent and its success in related literature processes. Attempts to lower 
both the catalyst loading and the number of equivalents of 374 (Table 12, Entry 3) 
led to reduced conversions and lower dr. Under these conditions the dr could be 
improved up to >99:1 by lowering of the reaction temperature, however at the 
detriment of reduced product conversions (Table 12, Entry 4 & 5).  
112 (10 mol %), 
NEt3 (1.1 equiv),
THF
O
O
H
(374) (1.1 equiv)
PNP = 4-NO2C6H4
Ph
O
PNP
Ph
O
CO2Me
O
O
CO2MePh
Ph
(381)
N N
N
Mes
O Cl
(112)(382)
 
Scheme 101: Optimisation of reaction conditions for use if benzyl substituted 
α-aroyloxyaldehyde  
Entry Precatalyst, 
(mol%) 
Temperature 
(°C) 
Time  
(h) 
Conversion 
(%)[a]  
dr[a] Yield  
(%)[b] 
ee (%)[c] 
1[d] 335, 20 rt 16 >80 84:16 37 NA 
2[d] 112, 20 rt 5 >90 92:8 50 >99% 
3 112, 10 rt 12 85 84:16 − − 
4 112, 10 0 12 65 97:3 − − 
5 112, 10 −78 12 45 >99:1 − − 
[a] Calculated by inspection of the crude reaction mixture using 1H NMR spectroscopy. [b] Isolated 
yield of single diastereomer. [c] ee % determined by HLPC analysis on a chiral stationary phase. [d] 
1.5 equiv of aldehyde and 1.5 equiv of Et3N.  
Table 12: Optimisation of reaction conditions for use if benzyl substituted α-aroyloxyaldehyde 
374. 
Literature examples typically require at least 1.5 equivalents of the α-functionalised 
aldehyde for good yields in azolium enolate reactions,7,15 so this stoichometry was 
employed for the remainder of the optimisation. Employing these conditions the 
catalyst loading could be lowered to 10 mol% with excellent conversion and dr 
(Table 13, Entry 1). Pleasingly, under these conditions, lowering the reaction 
temperature and allowing slow warming to rt overnight provided both excellent 
conversions and improved diastereoselectivity (98:2 dr). As anticipated, the lactone 
product, isolated in excellent yield, retained the high degree of enantioselectivity 
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(>99% ee) (Table 13, Entry 2). A single diastereoisomeric product could be obtained 
by maintaining a reaction temperature of 0 °C, however this had a detrimental effect 
on conversion (Table 13, Entry 3). It has been reported that EtOAc could provide a 
rate enhancement in similar reactions via the precipitation of Et3N.HCl from the 
reaction solution.15 In this case employing EtOAc as the reaction solvent under 
identical conditions to provided no significant increase in reaction rate and no further 
optimisation of solvent was undertaken. 
112 (10 mol %), 
NEt3 (1.5 equiv),
THF
O
O
H
(374) (1.5 equiv)
PNP = 4-NO2C6H4
Ph
O
PNP
Ph
O
CO2Me
O
O
CO2MePh
Ph
(381)
N N
N
Mes
O Cl
(112)(382)
 
Scheme 102: Effect of temperature whilst employing 1.5 equiv of α-aroyloxyaldehyde 374. 
Entry Temperature 
(°C) 
Time (h) Conversion 
(%)[a]  
dr[a] Yield 
(%)[b] 
ee (%)[c] 
1 rt 12 >90 85:15 − − 
2 0 to rt 12 >90 98:2 93 >99 
3 0 12 60 >95:5 − − 
 [a] Calculated by inspection of the crude reaction mixture using 1H NMR spectroscopy. [b] Isolated 
yield of single diastereomer. [c] ee % determined by HLPC analysis on a chiral stationary phase.  
Table 13: Effect of temperature whilst employing 1.5 equiv of α-aroyloxyaldehyde 374. 
4.4 Assignment of relative and absolute configuration  
In all cases both the relative and absolute configurations were assigned in analogy to 
the literature.15 As we rationalise the reaction proceeding via an identical enolate 
species, it is presumed that the reaction employing the α-ketoester substrate 381 will 
proceed via the same mechanistic course as proposed by Bode et al. for the isomeric 
α-β-unsaturated ketones 383, thus resulting in a identical stereochemical outcome 
(Scheme 103). 
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112 (0.5 mol%), 
NEt3 (1.5 equiv),
EtOAc
O
Cl
H
(384)
R = Ph
Ph
MeO2C
O
Ph (S)(S)
O
O
PhMeO2C
Ph N N
N
Mes
O Cl
(112)(383)
(1.6 equiv)
(385)
X = Ph, 70% yield, 94:6 dr, 
99% ee, (S,S)
Ph
O
CO2Me
(S)
(S)
O
O
CO2MePh
Ph N N
N
Mes
O Cl
(112)(381)
(1.5 equiv)
(383)
X = Ph, 93% yield, 
98:2 dr, 99% ee
112 (10 mol%), 
NEt3 (1.5 equiv),
THF
O
O
H
(374) (1.5 equiv)
PNP = 4-NO2C6H4
Ph
O
PNP
Bode et al.
This work  
Scheme 103: Assignment of the relative and absolute configuration by analogy. 
The stereochemistry was further verified by the use of oxodiene 386 as a substrate in 
our developed methodology from α-aroyloxyaldehyde 374. Accordingly, under the 
developed reaction conditions, 387 was isolated in 79% yield using precatalyst 112. 
The specific rotation of this substrate was then compared to the literature8 [387 
! 
["]D20+173 (c 1.05, CHCl3) literature value +107 (c 1.82, CHCl3, 99% ee)], identifying 
387 as (3S,4S). 
112 (10 mol%), 
NEt3 (1.5 equiv),
THF
EtO2C
O
Ph (S)(S)
O
O
PhEtO2C
Ph
(386)
(1.6 equiv)
(387)
79% yield, 98:2 dr,
O
O
H
(374) (1.5 equiv)
PNP = 4-NO2C6H4
Ph
O
PNP
 
Scheme 104: Synthesis of literature compound 387 from α-aroyloxyaldehyde 374. 
4.5 Effect of catalyst loading 
Previous literature has shown that precatalyst 112 is effective at low catalyst loadings 
(as low as 0.5 mol%) when employing α-chloroaldehydes15 as azolium enolate 
precursors. The efficiency of α-aroyloxyaldehydes 112 at low catalyst loadings was 
investigated by the use of 1 mol% of 112, initially at rt. The reaction was found to be 
complete after an extended reaction time of 48 h, though with diastereoselectivity 
76:24. The enantioexcess for the major diastereomer remained  exquisite (99%), as 
did the ee of the minor (>99% ee) (Scheme 104).    
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112 (1 mol %), 
NEt3 1.5 equiv,
THF
O
O
H
(374) (1.5 equiv)
PNP = 4-NO2C6H4
Ph
O
PNP
Ph
O
CO2Me
O
O
CO2MePh
Ph
(381) (382)
76:24 dr, syn:anti
syn 51% yield, 99% ee
anti 19% yield, >99% ee  
Scheme 104: Reaction performed with 1 mol% of precatalyst 112. 
4.6 Investigations into the epimerisation and isomerisation of lactone 382 
As previous reactions employing precatalyst 112 had proceeded with excellent 
diastereoselectivity, it was postulated that the moderate diastereocontrol in this case 
could be due to a base or NHC mediated epimerisation of the major syn diastereomer 
to the anti product. To test this hypothesis, an isolated sample of the diastereo- and 
enantiomerically pure syn lactone 382 was resubjected to various reaction conditions. 
Initially, the effect of the NHC catalyst was evaluated by resubjecting syn lactone 382 
to 15 mol% precatalyst 112 and 15 mol% Et3N for 65 h. Under these conditions 
epimerisation of the syn to the anti lactone was observed with a reduction in the dr 
from >95:5 to 89:11 (Table 14, Entry 1). There was also a significant quantity of 
isomerised lactone 388 (41:59 dr), in which the olefinic double bond has isomerised 
out of conjugation with the ester. A smaller amount of isomerisation to lactone 389 
was also observed, as the result of the isomerisation of the double bond into 
conjugation with the lactone carbonyl. To examine the effect of Et3N on this process, 
15 mol% of base was used in the absence of precatalyst 112 (Table 14, Entry 2). It 
was found that both the amount of epimerisation and isomerisation were greatly 
reduced, suggesting an enhanced propensity of the NHC to facilitate the proton 
transfer process when compared to Et3N. It was shown that by employing 1.0 
equivalent of Et3N, an increased percentage of isomerisation of the parent lactone 
could be seen (Table 14, Entry 3), with further reaction times favouring increased 
isomerisation to 389 (Table 14, Entry 4). It is therefore postulated that the free NHC 
is the main facilitator of epimerisation, with Et3N favouring isomerisation, with 
longer reaction times leading to the formation of the presumably thermodynamically 
favoured lactone 389. Due to the inherent difficulties in isolation of the various 
products from the reaction mixtures, more detailed analysis of these processes, along 
with clarification of enantioselectivity, was not undertaken.15 
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112 (15  mol %), 
NEt3, THF O
O
CO2MePh
PhO
O
CO2MePh
Ph
(382)
>20:1 dr, >99% ee
O
O
CO2MePh
Ph O
O
CO2MePh
Ph
(389)(382) (388)
 
Scheme 106: Stability of lactone 382 to the reaction conditions. 
Entry Time (h) Ratio 382:388:389[a] 
1[b] 65 50 
89:11 dr[a] 
30 
41:59 dr[a] 
20 
2[c] 65 92 
93:7 dr[a] 
8 
45:55 dr[a] 
0 
3[d] 65 48 
94:6 dr[a] 
37 
40:60 dr[a] 
15 
4[e] 185 27 
80:20 dr[a] 
14 
48:52 dr[a] 
59 
[a] Analysed by 1H NMR spectroscopy [b] 15 mol% 112 and 15 mol% Et3N were used [c] 15 mol% 
Et3N was used [d] 1.0 equiv Et3N used [e] Entry 3 was resubjected to a further 120 h under identical 
conditions to entry 3. 
Table 14: Stability of lactone 382 to the reaction conditions. 
4.7 Attempted ring opening of lactone 382 with pyrrolidine 
Further evidence for the processes operating during the isomerisation was gained 
during attempted ring opening of 382 using pyrrolidine (Scheme 107). No ring 
opened product could be observed with complete isomerisation to 389 within 12 h. 
This is rationalised by the increased basicity of pyrrolidine when compared to Et3N. 
O
O
CO2MePh
Ph
(382)
>20:1 dr, >99% ee
N
H
(1.2 equiv),
CH2Cl2, rt, 12 h
O
O
CO2MePh
Ph
(389) 
50% yield  
Scheme 107: Isomerisation of lactone 382 via treatment with pyrrolidine. 
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5.0 Synthesis of a range of α-aroyloxyaldehydes 
After optimisation of conditions for the formation of lactone 382 in excellent yield 
(up to 93%), diastereo- and enantioselectivity (up to >98:2 dr and >99% ee), attention 
was turned to different α-aroyloxyaldehyde starting materials. The following four 
substrates 390−393 were selected as representative examples to test the limits of the 
system with respect to alkyl substitution and branching. Substrates 394 and 395 were 
not tested as previous investigations had shown them to be either unreactive to NHC 
redox esterification or prone to rearrangement under the basic reaction conditions 
required.17 
O
O
H
O
PNP
(390)
O
O
H
O
PNP
(391)
O
O
H
O
PNP
(392)
O
O
H
O
PNP
(393)
O
O
H
O
PNP
(394)
Ph
O
O
H
O
PNP
(395)  
Fig 52: A range of potential α-aroyloxyaldehydes. 
5.1 Synthesis of α-aryloxylation reagent 397 
The most efficient method to prepare a range of differentially substituted 
α-aroyloxyaldehydes on scale is to simply treat the requisite commercially available 
aldehyde precursor with the α-aryloxylation reagent derivative 397, the general 
structure of which was initially developed by Tomkinson et al. (Scheme 108).11  
R
O
O
H
(398)
PNP = 4-NO2C6H4
O
PNP
R
O
H
O
H
N
O2N
O
Me
•HCl
(396) (397)
1.1 equiv
DMSO, rt,  12 h
 
Scheme 108: One step synthesis of α-aroyloxyaldehydes from the requite aldehyde. 
This reagent had previously been synthesised and reported in the literature according 
to (Scheme 109) from N-methylhydroxylamine hydrochloride.10 This preparation was 
carried out on 25 g scale to provide the final reagent in greater than >70 g in a 50% 
yield over the three steps.  
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O
N
O2N
O
MeH
N
OH
•HCl
i. K2CO3 (0.5 equiv), 
Boc2O (1.1 equiv),
THF/H2O 1:1
ii. 4-NO2-C6H4COCl
Et3N (1.0 equiv), DMAP 
2 mol%, CH2Cl2
O
H
N
O2N
O
Me
•HCl
Boc
4 M HCl dioxane
(399) (400) (397)  
Scheme 109: Synthesis of α-aryloxylation reagent 397. 
Accordingly α-aroyloxyaldehydes 390, 391 and 392 were synthesised via the use of 
reagent 397 or by the multistep method outlined earlier in the synthesis of 
α-aroyloxyaldehyde 374. 
O
O
H
O
PNP
O
O
H
O
PNP
O
O
H
O
PNP
(390)
1.5 g, 47% yield over two steps 
from valeraaldehyde[a] 
or
2.4 g, 36% yield from hexanal[b]
(391)
0.94 g, 24% yield over two steps 
from i-valeraldehyde[a]
(392)
0.92 g, 46% yield over two steps 
from i-butyraldehyde[a]
or
0.46 g, 74% from i-valeraldehyde[b]  
[a] Prepared via the two step Grignard addition, acylation and ozonoloysis protocol. [b] Prepared by 
the use of α-aryloxylation reagent 397. 
Fig 53: Synthesis of α- aroyloxyaldehyde 390, 391 and 392. 
6.0 Use of α-aroyloxyaldehyde 390 in the reaction protocol 
n-Butyl substituted α-aroyloxyaldehyde 390 was tested under standard reaction 
conditions with either achiral precatalyst 335 or the aminoindanol derived precatalyst 
112. The reaction employing precatalyst 355 proceeded in excellent dr, albeit with 
reduced conversion to the lactone 401. The starting α-ketoester 381 was not fully 
consumed and there was evidence for isomerisation of lactone 401, as previously 
identified with lactone 382 (Table 15, Entry 1). Employing precatalyst 112 and 
closely monitoring the reaction by TLC to minimise the exposure time for the lactone 
product 401 to the reaction conditions provided 393 in both excellent diastereo- and 
enantioselectivity and in good isolated yield (Table 15, Entry 2). 
335, 112 (10 mol %), 
NEt3 (1.5 equiv), 
THF, rt, 24 h
n-Bu
O
O
H
(390) (1.5 equiv)
PNP = 4-NO2C6H4
O
PNP
Ph
O
CO2Me
O
O
CO2MePh
n-Bu
(381) (401)
 
Scheme 110: Use of n-butyl α-aroyloxyaldehyde 390 in the reaction protocol. 
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Entry Precatalyst  Time (h) Conversion 
(%)[a]  
dr[a] Yield 
(%)[b] 
ee (%)[c] 
1 335 12 75 92:8 40 NA 
2 112 3 >90 >95:5 63 >99 
[a] Calculated by inspection of the crude reaction mixture using 1H NMR spectroscopy. [b] Isolated 
yield of single diastereomer. [c] ee % determined by HLPC analysis on a chiral stationary phase.  
Table 15: Use of n-butyl α-aroyloxyaldehyde 390 in the reaction protocol. 
6.1 Effect of catalyst loading  
The effect of catalyst loadings was next investigated, with initial lowering to 1 mol%, 
pleasingly operating in excellent yield, diastereo- and enantioselectivities (Table 16, 
Entry 1). Further lowering of the loading to 0.5 mol% resulted in impractically long 
reaction times, lower dr and a poor isolated yield (Table 16, Entry 2).  
112 (X mol %), 
NEt3 (1.5 equiv), 
THF, rt, 24 h
n-Bu
O
O
H
(390) (1.5 equiv)
PNP = 4-NO2C6H4
O
PNP
Ph
O
CO2Me
O
O
CO2MePh
n-Bu
(381) (401)
 
Scheme 111: Effect of catalyst loading.  
Entry Precatalyst 
(mol%) 
Time (h) Conversion 
(%)[a]  
dr[a] Yield 
(%)[b] 
ee (%)[c] 
1 112, 1.0 9 >90 >95:5 69 >99 
2 112, 0.5 84 <50[d] 95:5 12 >99 
[a] Calculated by inspection of the crude reaction mixture using 1H NMR spectroscopy. [b] Isolated 
yield of single diastereomer. [c] ee % determined by HLPC analysis on a chiral stationary phase [d] 1H 
NMR analysis of the crude also indicated the presence of an isomerised product in approximately a 
33:66 ratio with lactone 393. 
Table 16: Effect of catalyst loading.  
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6.2 Preparative scale reaction using n-butyl α-aroyloxyaldehyde 390 
Due to the decreased reaction time and lower catalyst loadings associated with 
α-aroyloxyaldehyde 390, this substrate was chosen to demonstrate the utility of this 
reaction process by performing the reaction on increased scale. Lactone 401 was 
obtained in a moderate yield (41%), with superb diastereo- and enantiocontrol (>95:5 
dr and >99 % ee) (Scheme 112). 
 
112 (1 mol %), 
NEt3 (1.5 equiv), 
THF, rt, 24 h
n-Bu
O
O
H
(390) (1.5 equiv)
PNP = 4-NO2C6H4
O
PNP
Ph
O
CO2Me
O
O
CO2MePh
n-Bu
(381) (393)
0.7 g, 41% yield
>95:5 dr, 98% ee  
Scheme 112: Preparative scale reaction using α-aroyloxyaldehyde 390. 
7.0 Use of α-aroyloxyaldehyde 391 in the reaction protocol 
The next aldehyde to be screened was the analogue 391. Under the established 
reaction conditions employing achiral precatalyst 355, lactone 402 was obtained in 
33% yield with excellent diastereoselectivity (>95:5 dr) (Table 17, Entry 1). The 
aminoindanol derived precatalyst 112 provided improved conversions and isolated 
yield (47%) while maintaining the excellent diastereoselectivity (>95:5 dr). As with 
previous examples, the reaction proceeded with outstanding enantioselectivity (>99% 
ee) (Table 17, Entry 2). Prolonging the reaction time led to reduced dr and the 
formation of a proposed isomerisation product 403 in a 72:28 ratio of 394 to 395 with 
395 as an approximately 30:70 ratio of diastereomers (Table, 17, Entry 3).18 
Although β-branching was readily tolerated, the reaction was equally susceptible to 
isomerisation as observed in previous substrates, making purification difficult and 
leading to reduced isolated yields.  
112 or 335 (X mol %), 
NEt3 (1.5 equiv), THFi-Bu
O
O
H
(391) (1.5 equiv)
PNP = 4-NO2C6H4
O
PNP
Ph
O
CO2Me
O
O
CO2MePh
i-Bu
(381) (402)
O
O
CO2MePh
i-Bu
(403)
 
Scheme 113: Use of α-aroyloxyaldehyde 391 in the reaction protocol. 
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Entry Precatalyst 
(mol%) 
Time (h) Conversion 
(%)[a]  
dr[a] Yield 
(%)[b] 
ee (%)[c] 
1 355, 20 12 60[d] >95:5 33 NA 
2 112, 10 16 >90 >95:5 47 >99 
3 112, 10 24 >90[e] 96:4 63 >99 
[a] Calculated by inspection of the crude reaction mixture using 1H NMR spectroscopy. [b] Isolated 
yield of a single diastereomer. [c] ee % determined by HLPC analysis on a chiral stationary phase. [d] 
1H NMR spectroscopic analysis of the crude did not indicate the presence of isomerised product 403 
with incomplete consumption of α-ketoester 381. [e] 1H NMR spectroscopic analysis of the crude 
indicated approximately 30% of the isomerised lactone 403 with an approximate 30:70 dr. 
Table 17: Use of α-aroyloxyaldehyde 391 in the reaction protocol. 
8.0 Use of α-aroyloxyaldehyde 392 in the reaction protocol 
The final α-aroyloxyaldehyde to be screened was the i-propyl substituted analogue 
392. In this instance the reaction with achiral NHC precursor 355 proceeded to 
approximately 50% consumption of the aldehyde after 16 h, giving a 67:33 ratio of 
lactone 404 (>95:5 dr) and the isomerised compound 405 (55:45 dr) (Table 18. 
Entry 1). Use of precatalyst 112 increased the crude product conversion to ~80%, 
however the ratio of desired lactone 404 (>95:5 dr) to the isomerised product 405 
(47:53 dr) was 47:53 in favor of the isomerisation (Table 18, Entry 2). Owing to the 
large number of products obtained, including the two starting materials and the 
desired and isomerised lactones (the latter being a mixture of two diastereomers), no 
authentic samples could be obtained and no further investigations were conducted.19 
112 (10 mol %), 
NEt3 (1.5 equiv), 
THF, 16 h
i-Pr
O
O
H
(392) (1.5 equiv)
PNP = 4-NO2C6H4
O
PNP
Ph
O
CO2Me
O
O
CO2MePh
i-Pr
(381) (396)
O
O
CO2MePh
i-Pr
(397)
 
Scheme 114:  Use of i-propyl α-aroyloxyaldehyde 392 in the reaction protocol. 
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Entry Precatalyst 
(mol%) 
Time (h) Conversion[a] 
(%)  
Ratio 
396:397[a] 
dr 396[a] dr 397[a] 
1 355, 10 18 50 67:33 >95:5 55:45 
2 112, 10 18 80 47:53 >95:5 47:53 
[a] Calculated by inspection of the crude reaction mixture using 1H NMR  
Table 18:  Use of i-propyl α-aroyloxyaldehyde 392 in the reaction protocol. 
9.0 Synthesis of unsubstituted α-aroyloxyaldehyde 393  
The development and use of α-aroyloxyaldehyde 393 is an attractive proposal, as it 
would allow formal access to enantioselective acetate additions. In a similar vein, 
Bode et al. have overcome the safety and practicality issues associated with the 
formation of α-chloroacetaldehyde by developing commercially available bisulfite 
salt 406 as a viable precursor (Fig 54).   
(393)
PNP = 4-NO2C6H4
O
O
NO2
O
H
(406)
Bode et al
OH
NaO3S
Cl
O
NHC
NHC
(407)
acetate enolate 
surrogate  
Fig 54: Rationale for the synthesis of unsubstituted α-aroyloxyaldehyde 393. 
Initial attempts to employ the α-aroyloxylation agent 397 in combination with 
acetaldehyde proved unsuccessful with no obvious aldehyde products obtained. The 
alternative method via acylation of allyl alcohol followed by the previously developed 
ozonoloysis conditions also proved unsuccessful; cleavage of the double bond was 
noted by 1H NMR spectroscopic analysis of the crude reaction product, as was 
formation of an aldehyde, however repeated chromatographic purification gave none 
of the desired product. Due to the likely inherent instability of 393, and difficulties 
involved in purification, no further attempts at either synthesis or isolation were 
attempted (Scheme 115). 
 
Chapter 6: Development of α-Aroyloxyaldehydes as Bench Stable Mono-Substituted Ketene 
Surrogates 
 131 
O
O
NO2
O3, CH2Cl2. !78 °C
(393)
PNP = 4-NO2C6H4
(410)
81% yield
O
O
NO2
CH2Cl2, Et3N (1.05 equiv), 
DMAP (0.1 equiv), 0 °C to rt
O
NO2
Cl
(409) (1.0 equiv),
OH
O
H
(408)
 
Scheme 115: Attempted synthesis of unsubstituted α-aroyloxyaldehyde 393. 
10.0 Mechanistic proposal 
In line with other similar process,1,7,15 our mechanistic proposal begins with NHC 
addition to aldehyde 374 to form the adduct 413. Formation of the Breslow-type 
intermediate 414, then subsequent elimination of the carboxylate to generates enolate 
414. This then undergoes a [4+2] cycloaddition reaction with α-ketoester 381 to 
furnish intermediate 417, which collapses with concurrent formation of lactone 382 
and regeneration of the NHC catalyst (Fig 55). A two step Michael 
addition-lactonisation mechanism is not conclusively ruled out at this stage but has 
been deemed unlikely by Bode and co-workers for a related system due to the 
requirement for exclusive reaction from the s-cis conformation of the α,β-unsaturated 
acceptor.20  
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Fig 55: Mechanistic proposal. 
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11.0 Rationale for the observed absolute configuration 
The origin of the enantioselectivity can be explained via a similar rationale to that 
proposed by Bode and co-workers for analogous reactions with enals as azolium 
enolate precursors.21 In this postulation the enolate is positioned in an almost 
perpendicular orientation to the triazolium ring with the N-mesityl substituent 
effectively blocking approach from one face (Fig 56). From this orientation an endo 
selective Diels-Alder reaction (with respect to the orientation of the α,β-unsaturated 
ketoester and the enolate oxygen) from the (Z)-enolate would render the required 
stereochemical outcome. The conformation of the enolate was supported by 
computational studies that calculated the perpendicular enolate orientation to be the 
lowest in energy. It is therefore proposed that this is the operative geometry in the 
transistion state leading to the observed configuration however this has not been 
conclusively proven. This perpendicular orentation of the enolate with respect to the 
triazolium ring was also postulated in the pre-transition state assembly for the 
NHC-catalysed β-lactone formation (Chapter 2 & 3).  
 
Fig 56: Calculated (HF 6-31G*) structure for the lowest energy enolate accompanied by pictorial 
representation. The oxygen resides on the same face as the indene ring. Extracted without 
permission from Bode et al. Proc. Natl. Acad. Sci. 2010, 107, 20661-20665.  
12.0 Summary  
In conclusion, it has been shown that 4-nitrobenzoyloxyaldehydes are bench stable 
azolium enolate precursors and serve as effective surrogates for monosubstituted 
ketenes. Initial [4+2] cycloaddition studies with a limited range of aldehydes have 
shown the ability of precatalyst 112 to function with outstanding levels of diastereo- 
and enantioselectivity. The limits of the aldehyde substitution pattern with respect to 
alkyl branching were established with α-branching poorly tolerated in the reaction. 
Product stability studies showed that isomerisation and epimerisation are unwanted 
side reactions of the lactone products. This reaction manifold has improved utility and 
practicality when compared to the previous work employing isolable alkylarylketenes. 
Although not directly demonstrated, this protocol may overcome the limitations of 
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scale placed upon the use of alkyarylketenes by the use of bench stable 
α-aroyloxyaldehyde. This methodology also allows access to substitution patterns that 
would be formally obtained by reactive and non-isolable mono-substituted ketenes 
that require in situ formation under strictly anhydrous conditions. This protocol also 
functions in exquisite diastereo- and enantioselctivity with superior results compared 
to those obtained for NHC-catalysed formal cycloadditions of alkylarylketenes.  
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Conclusions 
This thesis has documented extensive investigations into the generation and reactivity 
of azolium enolates derived predominatly from alkylarylketenes and NHCs. Various 
asymmetric methodologies have been developed that further the current literature on 
formal [2+2] and [4+2] NHC-catalysed cycloadditions of azolium enolates, as well as 
demonstrating their use for asymmetric halogenation reactions.  
Firstly the NHC-catalysed formal [2+2] cycloaddition between alkylarylketenes and 
chloral has been reported. This methodology has expanded the field of asymmetric 
α,α-disubstituted β-lactone synthesis operating in good yield, diastereo- and 
enantioselectivity (up to 95% yield, 88:12 dr (anti:syn) and 94% ee). Although a 
highly scalable process (up to 3 g scale), limited derivatisation strategies did not allow 
transformation to the targeted aminoacid type motif and thus the genuine synthetic 
utility of this process was not realised. 
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Scheme 116: NHC-catalysed asymmetric β-lactone formation from alkylarylketenes and chloral. 
 
Interestingly, the use of a ketene bearing a 2-substituent on the aryl ring, or one that 
included an α-branched alkyl group, led to an exclusive chlorination pathway. This is, 
to the best of our knowledge, the first use of chloral as an electrophilic chlorination 
agent. This methodology was found to be applicable to a range of 2-arylsubstituted 
alkylarylketenes in good yield and enantioselectivity (typically >70% yield and 80% 
ee). A rationale for both the chemoselectivity and the observed stereochemical 
outcome of both lactonisation and chlorination reactions was proposed that is in 
consistent with the observed trends in stereoselectivity.  
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Scheme 117: NHC-catalysed asymmetric chlorination of alkylaryl ketenes with chloral. 
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A second methodology to access the β-lactone motif was also reported via an 
NHC-catalysed formal [2+2] cycloaddition between alkylarylketenes and 
benzaldehydes. The optimised reaction proceeds in excellent levels of diastereo- and 
enantioselectivity with 2-nitrobenzaldehyde (up to 94:6 dr (syn:anti) and 95% ee), 
and expands the scope of the formal [2+2] cycloaddition between ketenes and 
aldehydes. Notably, no competing benzoin reaction was observed under the reaction 
conditions, with the lactone product being readily transformed to synthetically useful 
α,α-disubstituted β-hydroxy- and β-amino acid building blocks. 
11 examples up to 94:6 dr, anti:syn, 
83% yield and 94% ee
O
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Scheme 118: NHC-catalysed asymmetric β-lactone formation from alkylarylketenes and 
benzaldehydes. 
Building upon the specific asymmetric chlorination reaction discovered with chloral, 
a general methodology has demonstrated that NHCs are viable Lewis base catalysts 
for the α-chlorination and α-bromination of alkylarylketenes. A range of halogenating 
reagents were screened with 275 proving optimal, giving excellent yields of tertiary 
α-haloesters. Chiral NHC precatalyst 66 shows promising levels of enantioselectivity 
(up to 61% ee) however the typically level of enantiomericexcess was only moderate 
(typically ~40% ee). The corresponding bromination reaction could also be readily 
achieved, however the enantioselectivity was low to moderate, with a high of 46% ee.  
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Scheme 119: Catalytic asymmetric halogenation of alkylaryl ketenes. 
Efforts to expand the practicality of azolium enolate processes focused on the use of 
α-aroyloxyaldehydes as bench stable mono-substituted ketene surrogates. A range of 
differentially substituted α-aroyloxyaldehydes allowed access to δ-lactones via an 
NHC-catalysed [4+2] cycloaddition between azolium enolates and β,γ-unsaturated 
α-ketoesters. The reaction proceeds with outstanding levels of diastereo- and 
enantioselectivity (typically >95:5 dr and >99% ee). Importantly this process has 
improved utility and practicality when compared to the previous work employing 
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isolable alkylarylketenes due to the bench stability of α-aroyloxyaldehydes. Although 
not directly demonstrated, it is envisioned that this protocol would overcome the 
limitations of scale placed upon the use of alkylarylketenes. 
Ph
O
CO2Me
O
Ph CO2Me
O
Inital investigation 
up to 93% yield,
 >99:1 dr and >99% ee
R
112 (10 mol%),
Et3N (1.5 equiv),
THF, rt, 3!12 h
PNP = 4-NO2C6H4
R = Bn, Bu, i-Bu, i-Pr
R
O
O
H
O
PNP
N N
N
Mes
O Cl
(112)
 
Scheme 120: α-Aroyloxyaldehydes as bench stable mono-substituted ketene surrogates. 
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General experimental information  
Reactions involving moisture sensitive reagents were carried out under an argon 
atmosphere using standard vacuum line techniques in addition to dry solvents. All 
glassware used was flame dried and cooled under vacuum.  
Solvents (THF, CH2Cl2, toluene, hexane and Et2O ) were obtained anhydrous and 
purified by an alumina column (Mbraun SPS-800). Petrol is defined as petroleum 
ether 40-60 °C. All other solvents were used as supplied without further purification 
unless stated otherwise.  
Unless stated chemicals were purchased from Acros-UK, Sigma-Aldrich, Alfa Aeasar 
or Fisher.  
Potassium bis(trimethylsilyl)amide (KHMDS) was used as a 0.5 M solution in toluene 
as supplied (Aldrich). Chloral was distilled from CaH2 before use. The required 
aldehydes where purified by kugelrohl distillation under reduced pressure prior to use. 
2,2,6,6-tetrachlorocyclohexanone (Aldrich) was recrystallised from CH2Cl2/pentane.  
Room temperature (rt) refers to 20-25 °C. Temperatures of 0 °C and −78 °C were 
obtained using ice/H2O and CO2(s)/acetone baths respectively. Temperatures of 0 °C 
to −50 °C were obtained using an immersion cooler (HAAKE EK 90). Reflux 
conditions were obtained using an oil bath equipped with a contact thermometer. In 
vacuo refers to the use of a Büchi Rotavapor R-2000 rotary evaporator with a 
Vacubrand CVC2 vacuum controller or a Heidolph Laborota 4001 rotary evaporator 
with a vacuum controller.  
Analytical thin layer chromatography was performed on pre-coated aluminium plates 
(Kieselgel 60 F254 silica). TLC visualisation was carried out with ultraviolet light (254 
nm), followed by staining with a 1% aqueous KMnO4 solution. Flash silica 
chromatography was performed on Kieselgel 60 silica in the solvent system stated.  
1H, 13C and 19F nuclear magnetic resonance (NMR) spectra were acquired on either a 
Bruker Avance 300 (300 MHz, 1H, 75 MHz 13C), a Bruker Avance II 400 (400 MHz, 
1H, 376 MHz 19F, 100 MHz 13C) or a Bruker Ultrashield 500 (500 MHz, 1H, 125 
MHz 13C) spectrometer at ambient temperature in the deuterated solvent stated. All 
chemical shifts are quoted in parts per million (ppm) relative to the residual solvent as 
the internal standard. All coupling constants, J, are quoted in Hz and reported low to 
high. Multiplicities are indicated by: s (singlet), d (doublet), t (triplet), q (quartet), 
sept (septet), m (multiplet), dd (doublet of doublets), ddd (doublet of doublet of 
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doublets, dt (doublet of triplets), dq (doublet of quartets) and td (triplet of doublets). 
The abbreviation Ar is used to denote aromatic, Ph to denote phenyl, Nap to denote 
napthyl, Bn to denote benzyl, br to denote broad, and app to denote apparent.  
Infrared spectra (νmax) were recorded on either a Perkin-Elmer Spectrum GX FT-IR 
spectrometer using either thin films on NaCl plates, KBr discs or a Shimadzu 
IRAffinity-1 using a Pike attenuated total reflectance (ATR) accessory.  
Melting points were recorded on an Electrothermal 9100 melting point apparatus and 
are uncorrected. Decomp refers to decomposition.  
HPLC analyses were obtained on either a Gilson HPLC consisting of a Gilson 305 
pump, Gilson 306 pump, Gilson 811C dynamic mixer, Gilson 805 manometric 
module, Gilson 401C dilutor, Gilson 213XL sample injector and sample detection 
was performed with a Gilson 118 UV/vis detector. Or a Shimadzu HPLC consisting 
of a DGU-20A5 degasser, LC-20AT liquid chromatograph, SIL-20AHT autosampler, 
CMB-20A communications bus module, SPD-M20A diode array detector and a CTO-
20A column oven which allowed the temperature to be set from 25-40 °C. Separation 
was achieved using the DACIEL CHIRALPAK or CHIRALCEL column stated. All 
chiral HPLC traces were compared to the authentic racemic spectrum prepared in 
analogous fashion. 
GC analysis was performed on a Fison 800 gas chromatograph using a CP-Chirasil-
Dex CB columnunder the conditions stated. 
Mass spectrometry (m/z) data were acquired by electrospray ionisation (ESI), electron 
impact (EI), atmostpheric solids analysis probe (ASAP) or nanospray ionisation (NSI) 
at the EPSRC National Mass Spectrometry Service Centre, Swansea.  
Optical rotations were measured on a Pertin Elmer Precisely/Model-341 polarimeter 
operating at the sodium D line with a 100 mm path cell at rt. 
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Experimental information for chapter 2 
 
Preparation of acid chlorides 
All acid chlorides previously reported in the literature were prepared via a slight 
modification of the method of Smith.1 
Thionyl chloride (3 equiv) was added to a solution of the corresponding acid (1 equiv) 
in toluene at room temperature and the reaction mixture was warmed to 80 °C and 
stirred 12 hours. Solvents were evaporated under reduced pressure and the crude oil 
purified by Kugelrohr distillation to give the corresponding acid chloride. 
 
(415)-2-(2-Tolyl)hexanoyl chloride 
O
Cl
n-Bu
(415)  
Following the procedure reported by Fu2 n-BuLi 2.5M (46.6 mL, 103 mmol moles, 
2.2 equiv) was added dropwise at −78 °C over 15 mins to a solution of 2(2-
tolyl)acetic acid (7.00 g, 46.6 mmol, 1.0 equiv) in THF (150 mL). The solution was 
then warmed to rt and stirred for a further 45 mins before 1-bromobutane (20.0 mL, 
186 mmol, 4.0 equiv) was added and the solution stirred overnight at rt. The reaction 
was quenched via carful addition of 5% HCl (75 mL) before extraction with Et2O (3 × 
100 mL) and drying over MgSO4. Filtration and concentration in vacuo yielded 8.5 g 
of crude 2-(2-tolyl)hexanoic acid that was used without further purification.  
Thionyl chloride (5.60 mL, 82.3 mmol, 2.0 equiv) was added dropwise to a solution 
of crude 2-(2-tolyl)hexanoic acid (8.5 g, 41.1 mmol, 1.0 equiv) in toluene 150 mL at 
75 °C and stirred overnight. Concentration and kugelrohr distillation 155 – 160 °C (7 
mbar) provided the title compound as a pale yellow oil; (8.7 g, 83% yield over 2 
steps); νmax (thin film)/cm-1 2958, 1793 (C=O), 1493, 1463, 980, 912 and 740; 1H 
NMR (400 MHz, CDCl3) δH 0.88 (3H, t, J 7.1, n-BuCH3), 1.20-1.27 (1H, m, 
n-BuCH2), 1.29-1.37 (3H, m, n-BuCH2), 1.74-1.83 (1H, m, n-Bu CH2), 2.12-2.22 
(1H, m, n-BuCH2), 2.42 (3H, s, ArCH3) 4.24 (1H, app t, J 7.4, CH(Ar)Bu), 7.2-7.24 
(4H, m, ArH); 13C NMR (100 mHz CDCl3): δC 13.9 (n-BuCH3), 19.9 (ArCH3), 22.5 
(n-BuCH2), 29.3 (n-BuCH2), 33.0 (n-BuCH2), 59.1 (CH(Ar)Bu), 126.8 (ArCH), 127.1 
(ArCH), 128.0 (ArCH), 131.0 (ArCH), 134.9 (ArC), 136.7 (ArCH) and 174.9 (C=O). 
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(416)-2-(Naphthalen-2-yl)propanoyl chloride 
O
Cl
(416)  
Following the procedure reported by Fu:2 n-Buli 2.5M (47.3 mL, 118 mmol moles, 
2.2 equiv) was added dropwise at −78 °C over 15 mins to a solution of 1-
napthylacetic acid (10.0 g, 57.7 mmoles, 1.0 equiv) in THF (200 mL). The solution 
was then warmed to rt and stirred for a further 45 mins before methyliodide (5.01 mL, 
80.6 mmol, 1.5 equiv) was added and the solution stirred overnight at rt. The reaction 
was quenched via carful addition of 2M HCl (75 mL) before extraction with Et2O (3 × 
100 mL) and drying over MgSO4. Filtration and concentration in vacuo yielded 6.8 g 
of crude 2-(naphthalen-2-yl)propanoic acid that was used without further purification.  
Thionyl chloride (3.70 mL, 51.2 mmol, 1.5 equiv) was added dropwise to a solution 
of crude 2-(naphthalen-2-yl)propanoic acid (6.8 g, 34.1 mmol, 1.0 equiv) in toluene 
50 mL at 75 °C and stirred for 3h. Concentration and kugelrohr distillation 190 – 200 
°C (5 mbar) provided the title compound as a pale orange oil; (6.0 g, 47% yield over 2 
steps); νmax (thin film)/cm-1 3062, 2985, 1834, 1787 (C=O), 1598, 1512, 918, and 778; 
1H NMR (400 MHz, CDCl3) δH 1.77 (3H, d, J 7.0, CH3), 4.92 (1H, q, J 7.0, 
CH(Nap)Me), 7.45-7.53 (2H, m, NapH), 7.55-7.64 (2H, m, NapH), 7.87 (1H, d, J 7.9, 
NapH), 7.93 (1H, dd, J  8.3, 1.2, NapH) and 8.03 (1H, d, J 8.4, NapH); 13C NMR (100 
mHz CDCl3): δC 18.8 (CH3), 53.5 (CH(Nap)Me), 122.8 (NapCH), 125.7 (NapCH), 
125.9 (NapCH), 126.3 (NapCH), 127.2 (NapCH), 129.2 (NapCH), 129.5 (NapCH), 
131.4 (NapC), 134.2 (NapC), 134.4 (NapC) and 176.3 (C=O). 
 
(417)-2-(Naphthalen-2-yl)hexanoyl chloride 
O
Cl
n-Bu
(417)  
Following the procedure reported by Fu:2 n-BuLi 2.5M (47.3 mL, 118 mmol moles, 
2.2 equiv) was added dropwise at −78 °C over 15 mins to a solution of 1-
napthylacetic acid (10.0 g, 57.7 mmol, 1.0 equiv) in THF (200 mL). The solution was 
then warmed to rt and stirred for a further 45 mins before 1-bromobutane (12.4 mL, 
115 mmol, 2.0 equiv) was added and the solution stirred overnight at rt. The reaction 
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was quenched via carful addition of 5% HCl (75 mL) before extraction with Et2O (3 × 
100 mL) and drying over MgSO4. Filtration and concentration in vacuo yielded 13.9 g 
of crude 2-(naphthalen-2-yl)hexanoic acid that was used without further purification.  
Thionyl chloride (6.30 mL, 86.6 mmol, 1.5 equiv) was added dropwise to a solution 
of crude 2-(naphthalen-2-yl)hexanoic acid (13.9 g, 57.7 mmol, 1.0 equiv) in toluene 
50 mL at 75 °C and stirred for 3 h. Concentration and kugelrohr distillation 200 – 220 
°C (5 mbar) provided the title compound as a pale colourless oil; (11.9 g, 79% yield 
over 2 steps); νmax (thin film)/cm-1 3051, 2958, 1790 (C=O), 1598, 1513, 1466 and 
779; 1H NMR (400 MHz, CDCl3) δH 0.88 (3H, t, J 6.6, n-BuCH3), 1.26-1.44 (4H, m, 
n-BuCH2) 1.94-2.03 (1H, m, n-BuCH2), 2.31-2.4 (1H, m, n-BuCH2), 4.78 (1H, app t, 
J 7.3, CH(Nap)Bu), 7.45-7.55 (3H, m NapH), 7.57-7.61 (1H, m, NapH), 7.86 (1H, d, 
J 7.7 NapH) 7.91 (1H, d, J 8.0 NapH) and  8.06 (1H, d, J 8.5 NapH);  13C NMR (100 
mHz CDCl3): δC 14.0 (n-BuCH3), 22.7 (n-BuCH2), 29.8 (n-BuCH2), 33.3 (n-BuCH2), 
58.9 (CH(Nap)Bu, 122.8 (NapCH), 125.8 (NapCH), 126.0 (NapCH), 126.2 (NapCH), 
127.1 (NapCH), 129.0 (NapCH), 129.4 (NapCH), 131.7 (NapC), 132.7 (NapC), 134.3 
(NapC) and 175.5 (C=O). 
 
Preparation of ketenes  
 
Representative procedure:  
(146)-Ethylphenylketene 
O
(146)  
A flame dried two-neck round bottom flask separated by a sintered adaptor to a 
second two-neck round bottom flask under an argon atmosphere is charged with 
strictly anhydrous Et2O  (45 mL), 2-phenylbutanoyl chloride (3.00 g, 16.4 mmol, 1.0 
equiv) and cooled to 0 °C. Dropwise addition over 30 min of Et3N,  (2.52 mL, 18.1 
mmol, 1.1 equiv) formed a bright yellow solution and a white precipitate that was 
stirred overnight at 0 °C. The solution was then warmed to rt after which filtration 
under argon and concentration gave a bright yellow oil; Transfer via cannula to a 
flame dried kugelrohl flask and distillation 80-90 °C (5 mbar)  3 gave 
ethylphenylketene as a light yellow oil; (1.4 g, 60% yield); 1H NMR (300 MHz, 
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CDCl3) δH 1.24 (3H, t, J 7.4, CH2CH3), 2.44 (2H, q, J 7.4, CH2CH3), 7.02-7.10 (3H, 
m, PhH-3,4,5) and 7.28-7.35 (2H, m, PhH-2,6). 
 
(418)-Methylphenylketene 
O
(418)  
Following the representative procedure: 2-phenylpropanoyl chloride (4.05g, 24.0 
mmol, 1.0 equiv), Et3N (3.34 mL, 24.0 mmol, 1.0 equiv) in Et2O  (50 mL) at 0 °C 
overnight gave, after kugelrohl distillation 60-80 °C (5 mbar) {literature 50 °C, (5 
mbar)}3 a yellow/orange oil; (1.44 g, 45% yield); 1H NMR (400 MHz, CDCl3) δH 1.92 
(3H, s, CH3), 6.93-6.95 (2H, m, PhH), 6.97-7.01 (1H, m, PhH) and 7.21-7.25 (2H, m, 
PhH). 
 
(419)-Butylphenylketene  
n-Bu
O
(419)  
Following the representative procedure: 2-phenylhexanoyl chloride (3.00 g, 14.2 
mmol, 1.0 equiv), Me2EtN (1.70 mL, 15.7 mmol, 1.1 equiv) in Et2O  (45 mL) at 0 °C 
overnight gave, after kugelrohl distillation 110-120 °C (5 mbar) {literature 88 °C (2 
mbar)}4 a yellow/orange oil; (1.26 g, 51% yield); 1H NMR (300 MHz, CDCl3) δH 0.87 
(3H, app t, J 7.2, n-BuH), 1.30-1.53 (4H, m, n-BuH), 2.32 (2H, t, J 7.4, n-BuH), 6.93-
7.01 (3H, m, ArH) and 7.19-7.25 (2H, m, ArH). 
 
(60)-i-Butylphenylketene  
i-Bu
O
(60)  
Following the representative procedure: 4-methyl-2-phenylpentanoyl chloride (3.80 g, 
18.0 mmol, 1.0 equiv), Me2EtN (2.15 mL, 20.0 mmol, 1.1 equiv) in Et2O  (45 mL) at 
0 °C overnight gave, after kugelrohl distillation 110-117 °C (5 mbar) {literature 37-46 
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°C, (1 mbar)}5 a yellow/orange oil; (1.75 g, 56% yield); 1H NMR (300 MHz, CDCl3) 
0.92 (6H, d, J 6.6, i-Bu(CH3)2), 1.66-1.83 (1H, m, i-BuCH), 2.19 (2H, d, J 7.0, i-
BuCH2), 6.95-7.01, (3H, m, PhH-3,4,5) and 7.17-7.25 (2H, m, PhH-2,6).   
 
(420)-Methyl-4-tolylketene 
O
(420)  
Following the representative procedure: 2-(4-tolyl)propanoyl chloride (3.16 g, 17.3 
mmol, 1.0 equiv), Et3N (2.42 mL, 17.3 mmol, 1.0 equiv) in Et2O  (40 mL) at 0 °C 
overnight gave, after kugelrohl distillation 110 °C (7 mbar) a yellow/orange oil; (1.81 
g, 72% yield); 1H NMR (300 MHz, CDCl3) δH 1.90 (3H, s, CH3), 2.23 (3H, s, ArCH3), 
6.34 (2H, d, J 8.2, ArH) and 7.04 (2H, d, J 8.2, ArH). 
 
(421)-Ethyl-4-tolylketene 
O
(421)  
Following the representative procedure: 2-(4-tolyl)butanoyl chloride (2.16 g, 11.0 
mmol, 1.0 equiv), Et3N (1.53 mL, 11.0 mmol, 1.0 equiv) in Et2O  (40 mL) at 0 °C 
overnight gave, after kugelrohl distillation 110-120 °C (7 mbar) {literature 68-72 °C, 
(0.4 mbar)}6 a yellow/orange oil; (0.92 g, 52% yield); 1H NMR (300 MHz, CDCl3) δH 
1.29 (3H, t, J 7.4, CH2CH3), 2.40 (3H, s, ArCH3), 2.50 (2H, q, J 7.4, CH2CH3), 7.02 
(2H, d, J 8.1, ArH) and 7.21 (2H, d, J 8.1, ArH). 
 
(422)-Ethyl-4-flourophenylketene  
O
F
(422)  
Following the representative procedure: 2-(4-fluorophenyl)butanoyl chloride (2.70 g, 
13.5 mmol, 1.0 equiv), EtMe2N (1.60 mL, 14.8 mmol, 1.1 equiv) in Et2O  (40 mL) at 
0 °C overnight gave, after kugelrohl distillation 104-110 °C (7 mbar); a yellow/orange 
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oil;  (1.21 g, 55% yield); νmax (thin film)/cm-1 2100;  1H NMR (300 MHz, CDCl3) δH 
1.13 (3H, t, J 7.4, CH2CH3), 2.33 (2H, q, J 7.4, CH2CH3) and 6.87-7.97 (4H, m, ArH); 
13C NMR (75 MHz CDCl3): δC  12.9 (CH3), 17.5 (CH2CH3), 41.1 (C=C=O), 116.1 (d, 
J 21.7, ArCH-3,5), 125.5 (d, J 7.6, ArCH-2,6), 128.5 (d, J 3.1, ArC-1), 160.5 (d, J 
243.4, ArC-4) and 205.7 (C=C=O). 
 
(423)-Ethyl-4-chlorophenylketene  
O
Cl
(423)  
Following the representative procedure: 2-(4-chlorophenyl)butanoyl chloride (763  
mg, 3.51 mmol, 1.0 equiv), Et3N (0.49 mL, 3.51 mmol, 1.0 equiv) in Et2O  (20 mL) at 
0 °C overnight gave, after kugelrohl distillation 125-135 °C (7 mbar); a yellow/orange 
oil;  (368 mg, 56% yield); νmax (thin film)/cm-1 2097;  1H NMR (300 MHz, CDCl3) δH 
1.34 (3H, t, J 7.4, CH2CH3), 2.53 (2H, q, J 7.4, CH2CH3), 7.05-7.09 (2H, m, ArH ) 
and 7.37-7.42 (2H, m, ArH).  
 
(444)-Methyl-4-chlorophenylketene  
O
Cl
(444)  
Following the representative procedure: 2-(4-chlorophenyl)propanoyl chloride (2.3  g, 
11.3 mmol, 1.0 equiv), Me2EtN (1.35 mL, 12.5 mmol, 1.1 equiv) in Et2O  (45 mL) at 
0 °C overnight gave, after kugelrohl distillation 118 °C (7 mbar); a yellow/orange oil;  
(1.0 g, 53% yield); 1H NMR (300 MHz, CDCl3) δH 1.91 (3H, s, CH3), 6.85 (2H, d, J 
8.7, ArH) and 7.20 (2H, d, J 8.7, ArH).  
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(424)-Ethyl-4-bromophenylketene  
O
Br
(424)  
Following the representative procedure: 2-(4-bromophenyl)butanoyl chloride (5.00 g, 
19.1 mmol, 1.0 equiv), Et2MeN (2.30 mL, 21.0 mmol, 1.1 equiv) in Et2O  (45 mL) at 
0 °C overnight gave, after kugelrohl distillation 180 °C (7 mbar); a yellow/orange oil;  
(1.21 g, 28% yield); νmax (thin film)/cm-1 2100;  1H NMR (300 MHz, CDCl3) δH 1.13 
(3H, t, J 7.4, CH2CH3), 2.33 (2H, q, J 7.4, CH2CH3), 6.87-7.97 and (4H, m, ArH); 13C 
NMR (75 mHz CDCl3): δC 11.7 (CH3), 15.9 (CH2CH3), 40.7 (C=C=O), 116.2 (ArC-
4), 124.4 (ArCH), 130.9 (ArCH), and 203.2 (C=C=O), ArC-1 could not be resolved. 
 
(425)-Ethyl-4-methoxyphenylketene  
O
O
(425)  
Following the representative procedure: 2-(4-methoxyphenyl)butanoyl chloride (3.00 
g, 14.1 mmol, 1.0 equiv), Et3N (3.93 mL, 28.2 mmol, 2.0 equiv) in Et2O  (45 mL) at 0 
°C overnight gave, after kugelrohl distillation 140-150 °C (3 mbar); a yellow/orange 
oil; (1.19 g, 48% yield); νmax (thin film)/cm-1 2096; 1H NMR (300 MHz, CDCl3) δH 
1.21 (3H, t, J 7.4, CH2CH3), 2.41 (2H, q, J 7.4, CH2CH3), 3.79 (3H, s, ArCH3), 6.86-
6.91 (2H, m, ArH-3,5) and 6.95-6.99 (2H, m, ArH-2,6). 
 
(213)-i-Propyl-3-thionylketene 
S
O
(213)  
Following the literature procedure of Fu:7 3-methyl-2-(thiophen-3-yl)butanoyl 
chloride (2.27 g, 11.2 mmol, 1.0 equiv), Me2EtN (5.46 mL, 50.4 mmol, 4.5 equiv) in 
THF (30 mL) at 0 °C for 10 min then rt for 4.5 h gave, after kugelrohl distillation 
85-90 °C (3 mbar) {literature 71-73 °C}7 a yellow/orange oil; (1.09 g, 59% yield); 1H 
NMR (300 MHz, CDCl3) δH 1.25 (6H, d, J 6.7, CH(CH3)2), 2.77 (1H, sep, J 6.7, 
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CH(CH3)2), 6.79-6.82 (2H, m, ArH) and 7.33-7.35 (1H, m, ArH). 
 
(426)-Methyl-2-tolylketene 
O
(426)  
Following the literature procedure of Fu:8 2-(2-tolyl)propanoyl chloride (3.55 g, 19.4 
mmol, 1.0 equiv), Me2EtN, added at 0 °C over 5 mins (10.5 mL, 97.2 mmol, 5.0 
equiv) in THF (45 mL) then rt overnight gave, after kugelrohl distillation 69 °C (3 
mbar) {literature 43 °C, (0.5 mbar)}8 (997 mg, 35% yield); 1H NMR (400 MHz, 
CDCl3) δH 1.97 (3H, s, CH3), 2.23 (3H, s, ArCH3), 6.95-7.01 (2H, m, ArH), 7.05-7.07 
(1H, m, ArH) and 7.10-7.15 (1H, m, ArH). 
 
(427)-Ethyl-2-tolylketene 
O
(427)  
Following the literature procedure of Fu:5 2-(2-tolyl)butanoyl chloride (3.45 g, 17.5 
mmol, 1.0 equiv), Me2EtN, added in a single charge (7.60 mL, 70.2 mmol, 4.0 equiv) 
in THF (40 mL) at 0 °C overnight gave, after kugelrohl distillation 97 °C (3 mbar) 
{literature 32-33 °C, (0.3 mbar)}5 (997 mg, 35% yield); 1H NMR (300 MHz, CDCl3) 
δH 1.18 (3H, t, J 7.4 CH2CH3), 2.32 (3H, s, ArCH3), 2.48 (2H, q, J 7.4 CH2CH3) and 
7.07-7.23 (4H, m, ArH). 
 
(428)-Ethyl-2-tolylketene 
n-Bu
O
(428)  
Following the representative procedure: 2-(2-tolyl)hexanoyl chloride (3.39 g, 15.1 
mmol, 1.0 equiv), Me2EtN, added in a single charge (7.40 mL, 68.0 mmol, 4.5 equiv) 
in THF (45 mL) at 0 °C overnight gave, after kugelrohl distillation 147 °C (3 mbar); 
(1.56 g, 55% yield); νmax (thin film)/cm-1 2095; 1H NMR (400 MHz, CDCl3) δH 0.94 
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(3H, t, J 7.2, n-Bu), 1.38-1.55 (4H, m, n-Bu), 2.33 (3H, s, ArCH3), 2.46 (2H, t, J 7.3, 
n-Bu) and 7.09-7.24 (4H, m, ArH); 13C NMR (75 mHz CDCl3): δC 13.9 (n-BuCH3), 
20.9 (ArCH3), 22.4 (n-BuCH2), 26.4 (n-BuCH2), 30.5 (n-BuCH2), 35.7 (C=C=O), 
125.7 (ArCH), 126.5 (ArCH), 126.7 (ArCH), 130.6 (ArCH), 131.0 (ArC), 135.7 
(ArC) and 200.1 (C=C=O). 
 
(179)-Ethyl-(2-chlorophenyl)ketene 
Cl
O
(179)  
Following the literature procedure of Ye7: 2-(2-chlorophenyl)butanoyl chloride (3.00 
g, 13.8 mmol, 1.0 equiv), Me2EtN (5.99 mL, 55.3 mmol, 4.0 equiv) in Et2O (45 mL) 
at 0 °C overnight gave, after kugelrohl distillation 137 °C (3 mbar) {literature 65-67 
°C, (0.2 torr)}6 ( 1.32g, 52% yield); 1H NMR (400 MHz, CDCl3) δH 1.14 (3H, t, J 7.4 
CH2CH3), 2.42 (2H, q, J 7.4 CH2CH3), 6.94-6.98 (2H, m, ArH), 7.14-7.18 (1H, m, 
ArH) and 7.24 (1H, dd, J 1.3, 8.3 ArH). 
 
(208)-Ethyl-2-methoxyphenylketene  
O
(208)
OMe
 
Following the representative procedure: 2-(2-methoxyphenyl)butanoyl chloride (3.81 
g, 17.9 mmol, 1.0 equiv), Me2EtN (7.6 mL, 70.2 mmol, 4.0 equiv) in THF (30 mL) at 
0 °C overnight gave, after kugelrohl distillation 140 °C (3 mbar) {literature 60 °C, 0.3 
mbar}; a yellow/orange oil; (1.19 g, 48% yield); 1H NMR (300 MHz, CDCl3) δH 1.15 
(3H, t, J 7.4, CH2CH3), 2.34 (2H, q, J 7.4, CH2CH3), 3.79 (3H, s, ArCH3), 6.69-6.71 
(1H, m, ArH), 6.81-6.83 (1H, m, ArH), 6.89 (1H, app td, J 7.5, 1.2, ArH) and 6.95-
6.99 (1H, m, ArH) 
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(429)-Methyl-2-napthylketene 
O
(429)  
Following the representative procedure: 2-(naphthalen-2-yl)propanoyl chloride (2.79 
g, 12.8 mmol, 1.0 equiv), Me2EtN, added in a single charge (5.50 mL, 51.0 mmol, 4.0 
equiv) in THF (25 mL) at 0 °C overnight gave, after kugelrohl distillation 180 °C (3 
mbar); (960 mg, 42% yield); νmax (thin film)/cm-1 2099; 1H NMR (400 MHz, CDCl3) 
δH 2.22 (3H, s, CH3), 7.35 (1H, dd, J 7.3 1.1, NapH), 7.46-7.58 (3H, m, NapH), 7.73 
(1H, d, J 8.2, NapH), 7.89 (1H, dd, J 6.8, 2.6, NapH) and 8.04-8.07 (1H, m, NapH); 
13C NMR (100 mHz CDCl3): δC 12.4 (CH3), 29.3 (C=C=O), 124.2 (NapCH), 124.7 
(NapCH), 125.9 (NapCH), 126.0 (NapCH), 126.1 (NapCH), 126.8 (NapCH), 129.0 
(NapCH), 130.0 (NapC), 131.1 (NapC), 134.2 (NapC) and 200.3 (C=C=O). 
 
(196)-Ethyl-2-napthylketene 
O
(196)  
Following the literature procedure of Fu:9 2-(naphthalen-2-yl)butanoyl chloride (8.80 
g, 37.8 mmol, 1.0 equiv), Me2EtN, (16.0 mL, 148 mmol, 4.0 equiv) in THF (50 mL) 
at 0 °C overnight gave, after kugelrohl distillation 175 °C (3 mbar) {literature 80 °C, 
(0.2 torr)}9 (3.04 g, 41% yield); 1H NMR (300 MHz, CDCl3) δH 1.25 (3H, t, J 7.4, 
CH2CH3), 2.63 (2H, q, J 7.4, CH2CH3), 7.41-7.60 (4H, m, NapH), 7.77 (1H, d, J  8.0, 
NapH) 7.88-7.91 (1H, m, NapH) and 8.08-8.12 (1H, m, NapH). 
 
(430)-Butyl-2-napthylketene 
n-Bu
O
(430)  
Following the representative procedure: 2-(naphthalen-2-yl)hexanoyl chloride (6.04 g, 
23.0 mmol, 1.0 equiv), Me2EtN, added in a single charge (10.0 mL, 92.6 mmol, 4.0 
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equiv) in THF (30 mL) at 0 °C overnight gave, after kugelrohl distillation 198 °C (3 
mbar); (2.78 g, 54% yield); νmax (thin film)/cm-1 2098; 1H NMR (300 MHz, CDCl3) δH  
0.96 (3H, t, J 7.2, n-Bu), 1.44-1.60 (4H, m, n-Bu), 2.61 (2H, t, J 7.3, n-Bu), 7.42-7.61 
(4H, m, NapH), 7.78 (1H, d, J 7.9, NapH), 7.90 (1H, dd, J 7.4, 2.1, NapH) and 8.11-
8.14 (1H, m, NapH) 13C NMR (100 mHz CDCl3): δC 13.9 (n-BuCH3), 22.4 (n-
BuCH2), 27.1 (n-BuCH2), 30.7 (n-BuCH2), 34.2 (C=C=O), 124.6 (NapCH), 125.8 
(NapCH), 126.0 (NapCH), 126.2 (NapCH), 126.3 (NapCH), 127.1 (NapCH), 128.9 
(NapCH and NapC), 131.9 (NapC), 134.3 (NapC) and 199.4 (C=C=O). 
 
(194)-i-Propylphenylketene 
O
(194)  
Following the representative procedure: 3-methyl-2-phenylbutanoyl chloride (3.65 g, 
18.6 mmol) and Me2EtN (9.02 mL, 83.5 mmol, 4.5 equiv) in THF at rt overnight gave 
after Kugelrohr distillation 87-92 °C (5 mbar) {literature 90-94 °C (2 mbar)} 10 (1.48 
g, 50%); δH (300 MHz, CDCl3) 1.23 (6H, d, J 6.7, CH(CH3)2), 2.83 (1H, sept, J 6.7, 
CH(CH3)2), 7.05-7.10 (3H, m, ArH) and 7.28-7.34 (2H, m, ArH) 
 
Synthesis of precatalyst 66 
 
The following series of reactions were carried out at AstraZeneca Process Research 
and Development facility in Macclesfield. All anhydrous solvents and chemicals were 
purchased from Aldrich and used without further purification. 1H nuclear magnetic 
resonance (NMR) spectra were acquired on a Bruker Avance II 400 (400 MHz, 1H) 
and room temperature (rt) refers to 20-25 °C. Temperatures of 0 °C and −78 °C were 
obtained using ice/H2O and CO2(s)/acetone baths respectively. (±)-(66) was prepared 
in an identical manner to that reported for (S)-(66)  
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(130)-(S)-Methyl 5-oxopyrrolidine-2-carboxylate 
N
H
O
O
MeO
(130)  
Following the procedure of O’Leary;11 Amberlyst 15 wet resin (40 g, 40% w/w) was 
added to a solution of (S)-pyroglutamic acid  (100 g, 7.74 mol) in methanol (400 ml). 
The mixture was refluxed for 24 h, cooled, filtered and concentrated in vacuo to 
provide the product as a yellow oil with no purification necessary; (108 g, 97%); Data 
in accordance with the literature;11 1H NMR (400 MHz, CDCl3) δH 2.24-2.48 (4H, m, 
CH2), 3.77 (3H, s, OCH3), 4.20-4.28 (1H, m, CH) and  6.86 (1H, br s, NH).  
 
(131)-(S)-5-(Hydroxydiphenylmethyl)pyrrolidin-2-one 
N
H
O
Ph
OH
Ph
(131)  
A solution of 130 (46.0 g, 0.32 moles, 1.0 equiv) in anhydrous THF (500 mL) in a 2 L 
four neck round bottom flask equipped with an overhead stirrer under a nitrogen 
atmosphere was cooled to −78 °C. Phenyllithium as a 1.8 M in Bu2O (625 mL, 1.23 
mol, 3.5 equiv) was added via cannula over 1 h as to maintain the reaction 
temperature below −50 °C. The solution was then allowed to warm to rt over 12 h 
before cooling to 0 °C. Saturated NH4Cl(aq) (250 mL) was added dropwise, 
maintaining the reaction temperature <10  °C before a more rapid second addition of 
saturated NH4Cl(aq) (250 mL). Following the second addition a thick white slurry 
formed that was directly filtered and dried in a vacuum oven to provide crude 131. 
Partial concentration of the organic filtrate and precipitation on standing for 12 h 
provided a second crop of crude 131.12 The combined crude  was heated to near reflux 
in EtOAc (500 mL) before the addition of the minimum quantity of methanol to allow 
dissolution (50 mL). The solution was cooled to 50 °C and held for 0.5 h at which 
point 131 crystallised. The slurry was further cooled to 25 °C before filtration 
provided 131 as a colourless solid13; (41.2 g, 57% yield); mp 174-176 °C; 1H NMR 
(400 MHz, CDCl3) δH   Data in accordance with the literature.14 1.82-1.91 (1H, m, 
CH2), 1.98-2.05 (1H, m, CH2), 2.12-2.20 (1H, m, CH2), 2.22-2.31 (1H, m, CH2), 4.61-
4.62, (1H, m, CH), 7.19-7.24 (2H, m, PhH), 7.26-7.30 (2H, m, PhH), 7.35-7.38 (2H, 
m, PhH), 7.45-7.48 (2H, m, PhH) and 7.48-7.51 (2H, m, PhH) 
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(132)-(S)-5-(((t-Butyldimethylsilyl)oxy)diphenylmethyl)pyrrolidin-2-one 
N
H
O
Ph
TBSO
Ph
(132)  
Following the procedure of Enders:14 Tert-butyldimethylsilyl triflate (84.8 mL, 0.369 
mol, 2.5 equiv) and 2,6-lutidine (51.3 mL, 0.443 mol, 3.0 equiv) were added dropwise 
to a solution of 131 (39.5 g, 0.148 mol, 1.0 equiv) in CH2Cl2 (1 L) at 0 °C. After 
being stirred overnight at room temperature, the reaction mixture was quenched with 
5% aqueous HCl (200 mL). The aqueous layer was extracted (CH2Cl2, 3 × 100 mL) 
and the organics combined, dried (Na2SO4) before concentration in vacuo to yield  
crude 132 as a colourless solid. The solid was then washed with hexane, dissolved in 
EtOAc and loaded onto a 10 cm diameter sinter filter packed with 5 cm of silica. This 
was eluted with a 1:1 mixture of petrol:EtOAc collecting the first 1 L, concentration 
in vacuo yielded pure 132 as a colourless solid; (32.4 g, 57%); mp 150-152 °C;
! 
"[ ]D
20
  
−46 (c 1.00, CHCl3) {literature value14 −65 (c 1.01, CHCl3)}; 1H NMR (400 MHz, 
CDCl3) δH   −0.39 (3H, s, SiCH3), −0.34 (SiCH3), 0.95 (9H, s, Sit-BuH), 0.97-1.09 
(1H, m, CH2), 1.82-1.90 (1H, m, CH2), 2.06-2.21 (2H, m, CH2), 4.64 (1H, dd, J 8.5, 
3.1, CH), 5.80 (1H, br s, NH) and 7.30-7.36 (10H, m, PhH). Data in accordance with 
the literature.14 
 
(66)-(S)-5-(((t-Butyldimethylsilyl)oxy)diphenylmethyl)-2-phenyl-6,7-dihydro-5H-
pyrrolo[2,1-c][1,2,4]triazol-2-ium tetrafluoroborate 
N
N
N Ph
BF4
Ph
OTBSPh
(66)  
To an oven dried 250 mL four neck round bottom flask under nitrogen was added 132 
(20 g, 52.4 mmol, 1.0 equiv) and anhydrous CH2Cl2 (50 mL). To this solution was 
added trimethyloxonium tetrafluoroborate (8.49 g, 57.7 mmol, 1.1 equiv) and the 
solution stirred for 6 h15 after which NMR indicated the absence of starting material. 
Phenylhydrazine (5.70 mL, 57.7 mmol, 1.1 equiv) was added and the reaction mixture 
was stirred for 12 h. The solution was concentrated in vacuo to a pale yellow foam 
that was used in the next step without further purification. The crude was suspended 
in triethylorthoformate (50 mL) heated to 80 °C and the minimum quantity of 
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methanol was added to facilitate dissolution. The solution was heated for 6 h16 before 
cooling to rt overnight. The precipitated precatalyst 66 was filtered and washed with 
Et2O and cold EtOAc to provide crude 66. This was then recrystallised in methanol 
(~150 mL) to provide (S)-66 as a dark yellow/brown solid; (18.3 g, 61%); mp 182-
186 °C {literature value17 210-220} °C; 
! 
"[ ]D
20
−123 (c 1.00, MeCN) {literature value17 
−112 (c 0.5, MeCN)}; 1H NMR (400 MHz, CDCl3) δH −0.35 (3H, s, SiCH3), −0.32 
(SiCH3), 0.94 (9H, s, Sit-BuH), 1.61-1.70 (1H, m, CH2), 2.74-2.81 (1H, m, CH2), 
2.86-2.93 (1H, m, CH2), 3.15-3.26 (1H, m, CH2), 6.12 (1H, dd, J 8.9, 1.2, CH), 7.14 
(2H, br s, NPhH-2,6), 7.34 (2H, t, J 7.4, PhH), 7.40-7.47 (4H, m, PhH), 7.51, 7.57 
(5H, m, PhH), 7.67-7.71 (2H, m, PhH), and 9.08 (1H, s, NCHN). Data in accordance 
with the literature.14 
 
Experimental information for chapter 3 
 
General experimental procedures 
 
General procedure (1): Lactonisation and chlorination at 0 °C. 
 To a flame dried Schlenk flask under an argon atmosphere was added NHC 
precatalyst (0.10 mmol), base (0.09 mmol) and toluene (6 mL) and the mixture stirred 
for 15 min. The mixture was then cooled to 0 °C in an ice/H2O bath followed by 
addition of a 0 °C solution of the requisite ketene (1.00 mmol) in toluene (12 mL), 
immediately followed by chloral (1.00 mmol). Toluene (2 mL) was added to wash 
residual reactants into solution and the reaction was stirred for the stated time at 0 °C 
before opening the flask to the air for 30 min and concentration in vacuo. The 
resulting crude residue with the stated diastereomeric ratio was purified by flash silica 
chromatography (Et2O :petrol) to provide either the isolated anti or syn diastereomer 
as stated. 
 
General procedure (2): Lactonisation and chlorination at 0 °C with dropwise 
ketene addition. 
 To a flame dried Schlenk flask under an argon atmosphere was added NHC 
precatalyst (0.10 mmol), base (0.09 mmol) and toluene (6 mL) and the mixture stirred 
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for 15 min. The mixture was then cooled to 0 °C in an ice/H2O bath followed by 
addition of chloral (1.00 mmol). A 0 °C solution of the requisite ketene (1.00 mmol) 
in toluene (12 mL) was subsequently added over 0.5 h. The reaction was stirred for an 
additional 3 h at 0 °C before opening the flask to the air for 0.5 h and concentration in 
vacuo. The resulting crude residue with the stated diastereomeric ratio was purified by 
flash silica chromatography (Et2O :petrol) to provide either the isolated anti or syn 
diastereomer as stated. 
 
(147)-Anti-(3S,4R)-3-ethyl-3-phenyl-4-(trichloromethyl)oxetan-2-one and (148)-Syn-
(3S,4R)-3-ethyl-3-phenyl-4-(trichloromethyl)oxetan-2-one 
O
Cl3C
H
O
O
H
Cl3C
O
(147)-anti (148)-syn  
Following general procedure 1: NHC precatalyst 66 (28.5 mg, 0.05 mmol, 0.10 
equiv), KHMDS (0.09 mL, 0.045 mmol, 0.09 equiv), ethylphenylketene 146 (73.0 
mg, 0.50 mmol, 1.00 equiv) and chloral (0.05 mL, 0.50 mmol, 1.0 equiv) in toluene 
(10 mL) at 0 °C for 3 h gave crude product (dr 72:28, anti:syn) that was purified by 
flash silica chromatography (2% Et2O :petrol) to give:  
Anti (eluted first) as a colourless solid; (90 mg, 61% yield); mp 90-92 °C; 
! 
"[ ]D
20
+38.0 
(c 0.65, MeOH); Chiral HPLC analysis; Chiralpak AS-H (3% IPA:hexane, flow rate 1 
mL min-1, 220 nm) tR major (3S,4R): 4.7 min, tR minor (3R,4S): 8.6 min, 92% ee; νmax 
(KBr)/cm-1 2986, 1829 (C=O), 1493, 1450, 1097, 832, 808 and 758; 1H NMR (400 
MHz, CDCl3) δH 0.86 (3H, t, J 7.4, CH2CH3 ), 2.04 (1H, dq, J 14.0, 7.2, CHAHBCH3), 
2.85 (1H, dq, J 14.0, 7.2, CHAHBCH3), 5.06 (1H, s, CHCCl3), and 7.34-7.41 (1H, m, 
PhH-4) and 7.42-7.44 (4H, m, PhH); 13C NMR (75 MHz CDCl3): δC 8.9 (CH2CH3), 
24.6 (CH2CH3), 69.9 (C(Ph)Et), 88.1 (CH(CCl3)), 95.6 (CCl3), 126.4 (PhCH), 128.3 
(ArC-4), 129.3 (PhCH), 137.0 (PhC-1) and 168.9 (C=O); m/z: (ESI+) 292.0 
(M(35Cl))+ HRMS [M+]: found 291.9817; calcd 291.9819 (−) 0.7 ppm;  
Syn (eluted second) as a colourless solid; (41 mg, 28% yield); mp 88-90 °C; 
! 
"[ ]D
20
+43 
(c 1.1, MeOH); Chiral HPLC analysis; Chiralcel OJ-H (3% IPA:hexane, flow rate 1 
mL min-1, 220 nm) tR major (3S,4S): 9.9 min, tR minor (3R,4R): 12.0 min, 88% ee; 
νmax (KBr)/cm-1 2985, 1840 (C=O), 1497, 1450, 1099, 830 (CCl3), 803 (CCl3), 754 
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(CCl3); 1H NMR (400 MHz CDCl3): δH 0.95 (3H, t, J 7.4, CH2CH3), 2.32-2.47 (2H, 
m, CH2CH3), 4.94 (1H, s, CHCCl3), 7.33-7.35 (3H, m, PhH-3,4,5) and 7.46-7.48 (2H, 
m, PhH-2,6); 13C NMR (100 MHz CDCl3): δC 8.8 (CH2CH3), 33.2 (CH2CH3), 69.6 
(C(Ph)Et), 86.9 (CH(CCl3)), 95.5 (CCl3), 128.2 (PhCH), 128.4 (PhC-4), 128.3 
(PhCH), 131.4 (PhC-1), and 169.2 (C=O); m/z: (ESI+) 292.0 (M(35Cl))+ HRMS [M+]: 
found 291.9819; calcd 291.9819 (−/+) 0.0 ppm. 
 
 
(147)-Anti-(3S,4R)-3-ethyl-3-phenyl-4-(trichloromethyl)oxetan-2-one and (148)-Syn-
(3S,4S)-3-ethyl-3-phenyl-4-(trichloromethyl)oxetan-2-one: Preparative scale 
O
Cl3C
H
O
O
H
Cl3C
O
(147)-anti (148)-syn  
Scheme 43. Following general procedure 2: NHC precatalyst 66 (214 mg, 0.38 mmol, 
0.025 equiv), KHMDS (0.72 mL, 0.36 mmol, 0.024 equiv), ethylphenylketene 146 
(2.19 g, 15.0 mmol, 1.00 equiv) and chloral (1.46  mL, 15.0 mmol, 1.0 equiv) in 
toluene 300 mL at 0 °C for 3 h gave crude product (dr 74:26, anti:syn) that was 
purified by flash silica chromatography (2% Et2O :petrol)  
Anti (eluted first) as a colourless solid; (2.40 g, 54% yield); mp 88-86 °C; 
! 
"[ ]D
20 +54 
(c 0.71, CHCl3); Chiral HPLC analysis; Chiralpak AS-H (3% IPA:hexane, flow rate 1 
mL min-1, 220 nm) tR major (3S,4R): 4.7 min, tR minor (3R,4S): 9.7 min, 94% ee;  
Syn (eluted second) as a colourless solid; (0.96 g, 22% yield); mp 74-78 °C; 
! 
"[ ]D
20 +81 
(c 0.51, CHCl3); Chiral HPLC analysis; Chiralcel OJ-H (3% IPA:hexane, flow rate 1 
mL min-1, 220 nm) tR major (3S,4S): 8.1 min, tR minor (3R,4R): 11.6 min, 92% ee; 
 
A portion of anti (296 mg, 1.01 mmol) 147 and syn (248 mg, 0.845 mmol) 148 were 
recrystallised from petrol/EtOAc to provide material of  >99% ee for X-ray 
crystallographic analysis. 
Anti (254 mg, 82% yield); mp 95-96 °C; 
! 
"[ ]D
20
+54 (c 0.12, CHCl3); Chiral HPLC 
analysis; Chiralpak AS-H (3% IPA:hexane, flow rate 1 mL min-1, 220 nm) tR major 
(3S,4R): 4.7 min, tR minor (3R,4S): 8.6 min, >99% ee; Syn (221, 89% yield); mp 92-
94 °C 
! 
"[ ]D
20 +118 (c 0.17, CHCl3); Chiral HPLC analysis; Chiralcel OJ-H (3% 
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IPA:hexane, flow rate 1 mL min-1, 220 nm) tR major (3S,4S): 10.0 min, tR minor 
(3R,4R): 13.5 min, >99% ee; 
 
(152)-Anti-(3S,4R)-3-methyl-3-phenyl-4-(trichloromethyl)oxetan-2-one and (152)-
Syn-(3S,4S)-3-methyl-3-phenyl-4-(trichloromethyl)oxetan-2-one  
O
Cl3C
H
O
O
H
Cl3C
O
(152)-anti (152)-syn  
Scheme 40. To a flame dried Schlenk flask under an argon atmosphere was added 
NHC precatalyst 66 (57.0 mg, 0.10 mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 
mmol, 0.09 equiv) and toluene (6 mL) and the mixture stirred for 15 min. The mixture 
was then cooled to 0 °C in an ice/H2O bath followed by addition of chloral (0.10 mL, 
1.00 mmol, 1.0 equiv). A 0 °C solution of the methylphenylketene 418 (132 mg, 1.00 
mmol, 1.0 equiv) in toluene (14 mL) was subsequently added dropwise over 0.5 h. 
The reaction was stirred for an additional 3 h at 0 °C before opening the flask to the 
air for 30 min. The solution was then passed through a plug of silica, washed with 
toluene and concentrated in vacuo to yield the combined syn and anti diastereomers 
(dr 88:12, anti:syn) as a colourless solid; (265 mg, 95% yield):  
Anti; mp 68−72 °C; 
! 
"[ ]D
20
+21 (c 0.15, CHCl3); Chiral HPLC analysis; Chiralpak 
AS-H (3% IPA:Hexane, flow rate 1 mL min-1, 220 nm) tR major (3S,4R): 5.4 min, tR 
minor (3R,4S): 11.4 min, 82% ee; νmax (KBr)/cm-1 3060, 1846 (C=O), 1266, 1086, 939 
and 740; 1H NMR (300 MHz, CDCl3) δH 1.89 (3H, s, CH3), 5.16 (1H, s, CHCCl3) and 
7.36-7.46 (5H, m, PhH), 13C NMR (75 MHz CDCl3): δC 19.4 (CH3), 65.5 (C(Ph)Me), 
87.2 (CH(CCl3)), 95.6 (CCl3), 125.4 (PhCH), 128.4 (PhC-4), 129.5 (PhCH), 139.5 
(CPh-1) and 169.7 (C=O); m/z: (CI+) (M(35Cl))+ HRMS C11H13O2NCl3 [M+NH4]+: 
found 296.0006; calcd 296.0003 (−) 1.1 ppm.  
Syn; Chiral HPLC analysis; Chiralpak AS-H (1% IPA:hexane, flow rate 1 mL min-1, 
220 nm) tR major (3S,4S): 16.6 min, tR minor (3R,4R): 20.2 min, 78% ee; 1H NMR 
(300 MHz, CDCl3, Characteristic signals) δH 2.00 (3H, s, CH3) and 4.98 (1H, s, 
CHCCl3); 13C NMR (75 MHz CDCl3, Characteristic signals): δC 67.1 (C(Ph)Me), 
95.34 (CCl3), 128.2(PhCH), 128.3 (PhCH), 128.5 (PhCH-4), 132.8 (PhC-1) and 169.9 
(C=O). 
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(154)-Anti-(3S,4R)-3-butyl-3-phenyl-4-(trichloromethyl)oxetan-2-one and (154)-Syn-
(3S,4S)-3-butyl-3-phenyl-4-(trichloromethyl)oxetan-2-one 
 
O
n-Bu
Cl3C
H
O
O
n-Bu
H
Cl3C
O
(154)-anti (154)-syn  
Scheme 40. Following general procedure 1: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), butylphenylketene 
419 (174 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 mmol, 1.0 equiv) in 
toluene (20 mL) at rt for 3 h gave crude product (dr 69:31, anti:syn) that was purified 
by flash silica chromatography (2% Et2O :petrol) to give a mixture of anti and syn 
(240 mg, 75% yield);  
Anti (eluted first) as a colourless solid; mp 58 °C; 
! 
"[ ]D
20
+42 (c 0.45, CHCl3); Chiral 
HPLC analysis; Chiralpak AS-H (3% IPA:hexane, flow rate 1 mL min-1, 220 nm) tR 
major (3S,4R): 4.6 min, tR minor (3R,4S): 8.9 min, 88% ee. νmax (thin film)/cm-1 3055, 
1841 (C=O), 1099, 937, 896 and 833; 1H NMR (400 MHz, CDCl3) δH 0.80 (3H, t, J 
7.3, n-BuCH3 ), 0.85-0.98 (1H, m, n-BuCH2), 1.15-1.26 (2H, m, n-BuCH2), 1.43-1.52 
(1H, m, n-BuCH2), 2.01 (1H, app td, J 13.2, 4.7, n-BuCHAHB), 2.73 (1H, ddd, J 13.2, 
12.2, 4.3, n-BuCHAHB), 5.03 (1H, s, CHCCl3) and 7.36-7.45 (5H, m, PhH); 13C NMR 
(75 MHz CDCl3): δC 13.7 (n-BuCH3), 22.8 (n-BuCH2), 26.4 (n-BuCH2), 31.0 (n-
BuCHAHB), 69.5 (C(Ph)Bu), 88.1 (CH(CCl3)), 95.6 (CCl3), 126.2 (PhCH), 128.3 
(PhCH-4), 129.2 (PhCH), 137.5 (PhC-1) and 169.0 (C=O); m/z: (CI+) (M(35Cl))+ 
HRMS C14H19O2NCl3 [M+NH4]+: found 338.0475; calcd 338.0476 (−) 0.3 ppm. 
Syn 1H NMR (400 MHz CDCl3, Characteristic signals): δH 4.77 (1H, s, CHCCl3) 13C 
NMR (100 MHz CDCl3, Characteristic signals): δC 13.9 (n-BuCH3), 22.7 (n-BuCH2), 
26.4 (n-BuCH2), 69.3 (C(Ph)Bu), 87.2 (CH(CCl3)) and 169.4 (C=O). 
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(155)-Anti-(3S,4R)-3-isobutyl-3-phenyl-4-(trichloromethyl)oxetan-2-one and (155)-
Syn-(3S,4R)-3-isobutyl-3-phenyl-4-(trichloromethyl)oxetan-2-one 
O
i-Bu
Cl3C
H
O
O
i-Bu
H
Cl3C
O
(155)-anti (155)-syn  
Scheme 40. Following general procedure 1: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.1 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), i-butylphenylketene 
60 (174 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 mmol, 1.0 equiv) in 
toluene (20 mL) at 0 °C for 3 h gave crude product (dr 42:58, anti:syn) that was 
purified by flash silica chromatography (1% Et2O :petrol) to give a partially separable 
mixture of anti and syn diastereomers (274 mg, 85% yield);  
Anti (eluted first) as a colourless solid; mp 86 °C; 
! 
"[ ]D
20
 +13 (c 0.3, CHCl3); νmax 
(KBr)/cm-1 2961, 1834 (C=O), 1492, 1449, 1095, 933, 848, 825, 782, 727 and 701; 1H 
NMR (300 MHz, CDCl3) δH 0.65 (3H, t, J 6.7, i-Bu(CH3)2),  0.96 (3H, t, J 6.7, i-
Bu(CH3)2), 1.45-1.51 (1H, m, i-BuCH), 2.08 (1H, dd, J 14.1, 4.3, i-BuCHAHB), 2.55 
(1H, dd, J 14.1, 7.9, i-BuCHAHB), 4.95 (1H, s, CHCCl3) and 7.34-7.47 (5H, m, PhH); 
13C NMR (100 MHz CDCl3): δC 23.2 (CH3), 24.6 (CH3), 24.8 (CH), 39.7 (CH2), 69.9, 
(C(Ph)i-Bu) 88.2 (CH(CCl3)), 95.8 (CCl3), 126.6 (PhCH), 128.6 (PhCH-4), 129.5 
(PhCH), 137.9 (CPh-1) and 168.9 (C=O); m/z: (ASAP) (M(35Cl))+ HRMS 
C14H19O2NCl3 [M+NH4]+: found 338.0476; calcd 338.0476 (±) 0.0 ppm. 
Syn (eluted second) as a colourless solid: mp 78 °C; 
! 
"[ ]D
20
+90 (c 0.05, CHCl3); Chiral 
HPLC analysis; Chiralcel OJ-H (3% IPA:hexane, flow rate 0.2 mL min-1, 220 nm) tR 
major (S,S): 30.8 min, tR minor (S,R): 39.1 min, 84% ee; νmax (KBr)/cm-1 2956, 1840 
(C=O), 1496, 1450, 1096, 930, 804, 762 and 701; 1H NMR (300 MHz CDCl3): δH 
0.75 (3H, t, J 6.7, i-Bu(CH3)2),  0.94 (3H, t, J 6.7, i-Bu(CH3)2), 1.57-1.65 (1H, m, i-
BuCH), 2.13 (1H, dd, J 14.1, 4.3, i-BuCHAHB), 2.45 (1H, dd, J 14.1, 7.9, i-
BuCHAHB), 4.87 (1H, s, CHCCl3), 7.32-7.36 (3H, m, PhH) and 7.47-7.51 (2H, m, 
PhH); 13C NMR (100 MHz CDCl3): δC 23.3 (CH3), 24.1 (CH3), 25.0 (CH), 48.7 
(CH2), 69.2 (C(Ph)i-Bu), 87.8 (CH(CCl3)), 95.7 (CCl3), 128.4 (PhCH), 128.6 (PhCH-
4), 128.9 (PhCH), 131.5 (PhC-1) and 169.4 (C=O); m/z: (ESI+) (M(35Cl))+ HRMS 
C14H15O2Cl3 [M+]: found 320.0130; calcd 320.0132 (−) 0.7 ppm. 
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(160)-Anti-(3S,4R)-3-methyl-3-(4-tolyl)-4-(trichloromethyl)oxetan-2-one and (160)-
Syn-(3S,4S)-3-methyl-3-(4-tolyl)-4-(trichloromethyl)oxetan-2-one 
O
Cl3C
H
O
O
H
Cl3C
O
(160)-anti (160)-syn  
Scheme 41. Following general procedure 1: NHC precatalyst 66 (23.7 mg, 0.04 
mmol, 0.10 equiv), KHMDS (0.08 mL, 0.04 mmol, 0.09 equiv), methyl-4-tolylketene 
420 (61 mg, 0.42 mmol, 1.0 equiv) and chloral (0.04 mL, 0.42 mmol, 1.0 equiv) in 
toluene 20 mL at 0 °C for 3 h gave crude product (dr 88:12, anti:syn) that was 
purified by flash silica chromatography (2% Et2O :petrol);  
Anti (eluted first) as a colourless solid; (83 mg, 57% yield); mp 114-118 °C; 
! 
"[ ]D
20
+25 
(c 0.19, CHCl3); Chiral HPLC analysis; Chiralpak AS-H (3% IPA:hexane, flow rate 1 
mL min-1, 220 nm) tR major (3S,4R): 5.4 min, tR minor (3R,4S): 11.7 min, 82% ee; 
νmax (KBr)/cm-1 3055, 2987, 1846 (C=O), 1515, 1104, 939 and 831; 1H NMR (300 
MHz, CDCl3) δH 1.87 (3H, s, CH3), 2.37 (3H, s, ArCH3), 5.06 (1H, s, CHCCl3), 
7.22-7.24 (2H, m, ArH-3,5) and 7.31-7.35 (2H, m, ArH-2,6); 13C NMR (75 MHz 
CDCl3): δC 19.4 (ArCH3), 21.2 (CH3), 65.3 (C(Ar)Me), 87.5 (CH(CCl3)), 95.7 (CCl3), 
125.3 (ArCH-2,6), 130.2 (ArCH-3,5), 136.7 (ArC-1), 138.4 (ArC-4) and 169.9 
(C=O); m/z: (CI+) (M(35Cl))+ HRMS C12H15Cl3O2N1 [M+NH4]+: found 310.0163; 
calcd 310.0166 (+) 1.0 ppm. 
Syn (eluted second) as a colourless solid; (15 mg, 12% yield); mp 98-102 °C; 
! 
"[ ]D
20
+88  (c 0.10, CHCl3); Chiral HPLC analysis; Chiralcel OJ-H (3% IPA:hexane, 
flow rate 1 mL min-1, 220 nm) tR minor (3R,4R): 14.9 min, tR major (3S,4S): 18.2 min, 
76% ee; νmax (KBr)/cm-1  3055, 2987, 1849 (C=O), 1517, 1451, 1422, 1086 and 819; 
1H NMR (300 MHz CDCl3): δH 1.96 (3H, s, CH3), 2.34 (3H, s, ArCH3), 4.95 (1H, s, 
CHCCl3), 7.14 (2H, d, J 7.9, ArH-3,5) and 7.31-7.35 (2H, m, ArH-2,6); 13C NMR (75 
MHz CDCl3): δC 21.1 (ArCH3), 26.4 (CH3), 64.8 (C(Ar)Me), 88.0 (CH(CCl3)), 95.3 
(CCl3), 128.0 (ArCH-2,6), 128.9 (ArCH-3,5), 130.0 (ArC-1), 138.3 (ArC-4) and 
170.0 (C=O); m/z: (CI+) (M(35Cl))+ HRMS C12H11Cl3O2 [M+]: found 291.9819; calcd 
291.9817 (−) 0.7 ppm. 
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(159)-Anti-(3S,4R)-3-ethyl-3-(4-tolyl)-4-(trichloromethyl)oxetan-2-one and (159)-
Syn-(3S,4S)-3-ethyl-3-(4-tolyl)-4-(trichloromethyl)oxetan-2-one. Preparative scale 
O
Cl3C
H
O
O
H
Cl3C
O
(159)-anti (159)-syn  
Scheme 41. Following general procedure 1: NHC precatalyst 66 (71.2 mg, 0.13 
mmol, 0.25 equiv), KHMDS (0.24 mL, 0.12 mmol, 0.24 equiv), ethyl-4-tolylketene 
421 (80 mg, 0.50 mmol, 1.0 equiv) and chloral (0.05 mL, 0.05 mmol, 1.0 equiv) in 
toluene (10 mL) at 0 °C for 3 h gave crude product (dr 73:27, anti:syn) that was 
purified by flash silica chromatography (2% Et2O :petrol);  
Anti (eluted first) as a colourless solid; (84 mg, 54% yield); mp 102-106 °C; 
! 
"[ ]D
20
+42  
(c 0.19, CHCl3); Chiral HPLC analysis; Chiralpak AS-H (3% IPA:hexane, flow rate 1 
mL min-1, 220 nm) tR major (3S,4R): 4.6 min, tR minor (3R,4S): 9.8 min, 88% ee; νmax 
(KBr)/cm-1 2987, 1837 (C=O), 1515, 1252, 1093, 929, 831, 820, 804 and 740; 1H 
NMR (300 MHz, CDCl3) δH 0.86 (3H, s, CH2CH3), 2.02 (1H, dq, J 13.8, 7.5, 
CHAHBCH3), 2.37 (3H, s, ArCH3), 2.83 (1H, dq, J 13.8, 7.5, CHAHBCH3), 5.03 (1H, 
s, CHCCl3), 7.22-7.24 (2H, m, ArH-3,5) and 7.29-7.32 (2H, m, ArH-2,6); 13C NMR 
(100 MHz CDCl3): δC 8.8 (CH3), 21.0 (ArCH3), 24.3 (CH2), 69.5 (C(Ar)Et), 88.1 
(CH(CCl3)), 95.5 (CCl3), 126.1 (ArCH-2,6), 129.7 (ArCH-3,5), 133.9 (ArC-1), 138.1 
(ArC-4) and 169.0 (C=O); m/z: (CI+) (M(35Cl))+ HRMS C13H17O2N1Cl3 [M+NH4]+: 
found 324.0325; calcd 324.0319 (+) 1.7 ppm. 
Syn (eluted second) as a colourless solid; (25 mg, 15% yield); mp 132-140 °C; 
! 
"[ ]D
20
  
+35 (c 0.13, CHCl3); Chiral HPLC analysis; Chiralcel OJ-H (3% IPA:hexane, flow 
rate 1 mL min-1, 220 nm) tR minor (3R,4R): 14.9 min, tR major (3S,4S): 18.2 min, 76% 
ee; νmax (CH2Cl2 solution)/cm-1  2979, 1839 (C=O), 1516, 1092, 925, 896, 836 and 
819; 1H NMR (300 MHz CDCl3): δH 0.88 (3H, s, CH2CH3), 2.23-2.36 (2H, m, 
CH2CH3), 2.33 overlapping (3H, s, ArCH3), 4.84 (1H, s, CHCCl3), 7.06-7.09 (2H, m, 
ArH-3,5) and 7.31-7.34 (2H, m, ArH-2,6); 13C NMR (75 MHz CDCl3): δC 8.8 (CH3), 
21.2 (ArCH3), 33.1 (CH2), 69.4 (C(Ar)Et), 86.9 (CH(CCl3)), 95.6 (CCl3), 128.2 (ArC-
1), 128.4 (ArCH), 128.9 (ArCH), 138.2 (CAr-4) and 169.4 (C=O); m/z: (ASAP) 
(M(35Cl)+NH4)+ HRMS C13H13Cl3O2NH4: found 324.0322; calcd 324.0319 (+) 0.8 
ppm. 
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(161)-Anti-(3S,4R)-3-(4-methoxyphenyl)-3-ethyl-4-(trichloromethyl)oxetan-2-one –
and Syn-(3S,4S)-3-(4-methoxyphenyl)-3-ethyl-4-(trichloromethyl)oxetan-2-one 
O
Cl3C
H
O
O
H
Cl3C
O
(161)-anti (161)-syn
MeO MeO
 
Scheme 41. Following general procedure 1: NHC precatalyst 66 (57 mg, 0.10 mmol, 
0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethyl-4-
methoxyphenylketene 425 (176 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 
mmol, 1.0 equiv) in toluene (20 mL) at 0 °C for 3 h gave crude product (dr 75:25, 
anti:syn) that was purified by flash silica chromatography (5% Et2O :petrol)  
Anti (eluted first) as a colourless solid; (172 mg, 53% yield); mp 62-64 °C; 
! 
"[ ]D
20
+48  
(c 0.50, CHCl3); Chiral HPLC analysis; Chiralpak AS-H (3% IPA:hexane, flow rate 1 
mL min-1, 220 nm) tR major (3S,4R): 4.6 min, tR minor (3R,4S): 9.8 min, 88% ee; νmax 
(KBr)/cm-1 3055, 2987, 1836 (C=O), 1514, 1185, 1095, 1033, 951, 929, 896 and 834; 
1H NMR (300 MHz, CDCl3) δH 0.86 (3H, t, J 7.4, CH2CH3), 2.00 (1H, dq, J 13.8, 7.5, 
CHAHBCH3), 2.82 (1H, dq, J 13.8, 7.1, CHAHBCH3), 3.83 (3H, s, OCH3), 5.02 (1H, s, 
CHCCl3), 6.93-6.96 (2H, m, ArH-3,5) and 7.32-7.35 (2H, m, ArH-2,6); 13C NMR (75 
MHz CDCl3): δC 8.9 (CH3), 24.6 (CH2), 55.4, (ArOCH3) 69.4 (C(Ar)Et), 88.4 
(CH(CCl3)), 95.7 (CCl3), 114.6 (ArC-1), 127.6 (ArC-3,5), 129.1 (ArC-2,6), 159.5 
(ArC-4)  and 169.2 (C=O); m/z: (CI+) (M(35Cl))+ HRMS C13H17O3N1Cl3 [M+NH4]+: 
found 340.0269; calcd 340.0269 (+) 0.1 ppm. 
Syn (eluted second) as a colourless solid; (54 mg, 17% yield); mp 82-84 °C; 
! 
"[ ]D
20 
+90 (c 0.50, CHCl3); Chiral HPLC analysis; Chiralcel OJ-H (1% IPA:hexane, flow 
rate 1 mL min-1, 220 nm) tR major (3S,4S): 16.1 min, tR minor (3R,4R): 20.8 min, 84% 
ee; νmax (KBr)/cm-1  2925, 1836 (C=O), 1612, 1516, 1254, 1186, 1093, 1035, 924 and 
832; 1H NMR (300 MHz CDCl3): δH 0.94 (3H, t, J 7.4, CH2CH3), 2.28-2.43 (2H, m, 
CH2CH3), 3.81 (3H, s, OCH3), 4.90 (1H, s, CH(CCl3)), 6.86 (2H, d, J 9.0 ArH) and 
7.36 (2H, d, J 9.0, ArH); 13C NMR (75 MHz CDCl3): δC 8.8 (CH3), 33.1 (CH2), 55.3 
(ArOCH3), 69.2 (C(Ar)Et), 86.9 (CH(CCl3)), 95.7 (CCl3), 113.6 (ArC-1), 123.0 (ArC-
3,5), 129.9 (ArC-2,6), 159.5 (ArC-4) and 169.5 (C=O); m/z: (EI+) (M(35Cl))+ HRMS 
C13H13O3Cl3 [M+]: found 321.9923; calcd 321.9925 (−) 0.6 ppm. 
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(165)-Anti-(3S,4R)-3-(4-fluorophenyl)-3-ethyl-4-(trichloromethyl)oxetan-2-one and 
(165)-Syn-(3S,4S)-3-(4-fluorophenyl)-3-ethyl-4-(trichloromethyl)oxetan-2-one and  
O
Cl3C
H
O
O
H
Cl3C
O
(165)-anti (165)-syn
F F
 
Scheme 42. Following general procedure 2: NHC precatalyst 66 (28.0 mg, 0.05 
mmol, 0.10 equiv), KHMDS (0.09 mL, 0.05 mmol, 0.09 equiv), ethyl-4-
fluorophenylketene 422 (82.1 mg, 0.50 mmol, 1.0 equiv) and chloral (0.05 mL, 0.05 
mmol, 1.0 equiv) in toluene (10 mL) at 0 °C for 3 h gave crude product (dr 69:31, 
anti:syn) that was purified by flash silica chromatography (2% Et2O :petrol) 
 Anti (eluted first) as a colourless solid; (80 mg, 51% yield); mp 85-86 °C; 
! 
"[ ]D
20 +58 
(c 0.5, CHCl3); Chiral HPLC analysis; Chiralpak AS-H (0.5 % IPA:hexane, flow rate 
1 mL min-1, 220 nm) tR major (3S,4R): 5.6 min, tR minor (3R,4S): 13.4 min, 94% ee. 
νmax (KBr)/cm-1 2979, 2938, 1840 (C=O), 1606, 1514, 1229, 1166, 1098, 912, 840, 
829, 820, 798, 759, 660, 643 and 535; 1H NMR (300 MHz, CDCl3) δH 0.86 (3H, t, J 
7.4, CH2CH3), 2.01 (1H, dq, J 13.8, 7.5, CHAHBCH3), 2.86 (1H, dq, J 13.8, 7.1, 
CHAHBCH3), 5.03 (1H, s, CHCCl3), 7.10-7.18 (2H, m, ArH-3,5) and 7.39-7.44 (2H, 
m, ArH-2,6); 13C NMR (75 MHz CDCl3): δC 8.9 (CH3), 24.6 (CH2), 69.3 (C(Ar)Et), 
88.1 (CH(CCl3)), 95.4 (CCl3), 116.3 (d, J 22.1, ArCH-3,5), 128.2 (d, J 8.2, ArCH-
2,6), 132.8 (d, J 3.3, ArC-1) 162.5 (d, J 248.2, ArC-4) and 168.7 (C=O); m/z: (EI+) 
(M(35Cl))+ HRMS, C12H10O2Cl3F1 [M+]: found 309.9724; calcd  309.9725 (−) 0.3 
ppm. 
 Syn (eluted second) as a colourless solid; (35 mg, 22% yield); mp 90-92 °C; 
! 
"[ ]D
20  
+128 (c 0.05, CHCl3); Chiral HPLC analysis; Chiralpak AS-H (1% IPA:hexane, flow 
rate 1.0 mL min-1, 220 nm) tR minor (3R,4R): 6.7 min, tR major (3S,4S): 8.0 min, 97% 
ee; νmax (KBr)/cm-1  2979, 2937, 1840 (C=O), 1606, 1514, 1465, 1229, 1166, 1143, 
1098, 1015, 912, 930, 840, 829, 819, 798, 759, 727, 760, 660, 643 and 535; 1H NMR 
(500 MHz CDCl3): δH 0.96 (3H, t, J 7.4, CH2CH3), 2.32-2.44 (2H, m, CH2CH3), 4.93 
(1H, s, CHCCl3), 7.02-7.08 (2H, m, ArH-3,5) and 7.43-7.48 (2H, m, ArH-2,6);  13C 
NMR (100 MHz CDCl3): δC 8.7 (CH3), 33.2 (CH2), 68.9 (C(Ar)Et), 86.8 (CH(CCl3)), 
95.4 (CCl3), 115.3 (d, J 22.1, ArCH-3,5), 127.2 (d, J 3.3, ArC-1), 130.4 (d, J 8.2, 
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ArCH-2,6) 162.5 (d, J 248.6, ArC-4) and 169.0 (C=O); m/z: (EI+) (M(35Cl))+ HRMS 
C12H10O2Cl3F1 [M+]: found 309.9723; calcd 309.9725 (−) 0.6 ppm. 
 
(166)-Anti-(3S,4R)-3-(4-chlorophenyl)-3-ethyl-4-(trichloromethyl)oxetan-2-one and 
(166)-Syn-(3S,4S)-3-(4-chlorophenyl)-3-ethyl-4-(trichloromethyl)oxetan-2-one 
O
Cl3C
H
O
O
H
Cl3C
O
(166)-anti (166)-syn
Cl Cl
 
Scheme 42. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethyl-4-
chlorophenylketene 423 (181 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 
mmol, 1.0 equiv) in toluene (20 mL) at 0 °C for 3 h gave crude product (dr 74:26, 
anti:syn) that was purified by flash silica chromatography (2% Et2O :petrol)  
Anti (eluted first) as a colourless solid; (220 mg, 67% yield); mp 78-81 °C; 
! 
"[ ]D
20
+50  
(c 0.50, CHCl3); Chiral HPLC analysis; Chiralpak AS-H (3% IPA:hexane, flow rate 1 
mL min-1, 220 nm) tR major (3S,4R): 5.6 min, tR minor (3R,4S): 9.3 min, 92% ee; νmax 
(KBr)/cm-1 2919, 1837 (C=O), 1713, 1494, 1261, 1095, 1016, 831, 804 and 761; 1H 
NMR (300 MHz, CDCl3) δH 0.86 (3H, t, J 7.2, CH2CH3), 2.02 (1H, dq, J 14.1, 7.2, 
CHAHBCH3), 2.87 (1H, dq, J 14.1, 7.2, CHAHBCH3), 5.02 (1H, s, CHCCl3) and 
7.36-7.44 (4H, m, ArH); 13C NMR (100 MHz CDCl3): δC 9.0 (CH3), 24.6 (CH2), 69.5 
(C(Ar)Et), 88.0 (CH(CCl3)), 95.4 (CCl3), 127.9 (ArCH), 129.6 (ArCH), 134.6 (ArC-
4), 135.5 (ArC-1) and 168.6 (C=O); m/z: (CI+) (M(35Cl))+ HRMS C12H14O2N1Cl4 
[M+NH4]+: found 343.9771; calcd 343.9773 (−) 0.6 ppm. 
Syn (eluted second) as a colourless solid; (69 mg, 21% yield); mp 118-120 °C; 
! 
"[ ]D
20
+94  (c 0.13, CHCl3); Chiral HPLC analysis; Chiralpak AS-H (3% IPA:hexane, 
flow rate 0.5 mL min-1, 220 nm) tR major (3S,4S): 17.1 min, tR minor (3R,4R): 20.7 
min, 84% ee; νmax (KBr)/cm-1  3055, 2986, 1849 (C=O), 1517, 1451, 1422, 1096, 926, 
896, 838 and 819; 1H NMR (300 MHz CDCl3): δH 0.96 (3H, t, J 7.4, CH2CH3), 2.34-
2.41 (2H, m, CH2CH3), 4.94 (1H, s, CHCCl3), 7.32-7.36 (2H, m, ArH) and 7.40-7.43 
(2H, m, ArH); 13C NMR (100 MHz CDCl3): δC 8.7 (CH3), 33.1 (CH2), 69.0 (C(Ar)Et), 
86.8 (CH(CCl3)), 95.4 (CCl3), 128.5 (ArCH), 129.9 (ArCH), 130.0 (ArC), 134.6 
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(ArC)  and 168.8 (C=O); m/z: (CI+) (M(35Cl))+ HRMS C12H14O2N1Cl4 [M+]: found 
343.9769; calcd 343.9773 (−) 1.2 ppm. 
 
(167)-Anti-(3S,4R)-3-(4-bromophenyl)-3-ethyl-4-(trichloromethyl)oxetan-2-one and 
(167)-Syn-(3S,4S)-3-(4-bromophenyl)-3-ethyl-4-(trichloromethyl)oxetan-2-one and  
O
Cl3C
H
O
O
H
Cl3C
O
(167)-anti (167)-syn
Br Br
 
Scheme 42. Following general procedure 2: NHC precatalyst 66 (28.0 mg, 0.05 
mmol, 0.10 equiv), KHMDS (0.09 mL, 0.05 mmol, 0.09 equiv), ethyl-4-
bromophrnylketene 424 (113 mg, 0.50 mmol, 1.0 equiv) and chloral (0.05 mL, 0.05 
mmol, 1.0 equiv) in toluene (10 mL) at 0 °C for 3 h gave crude product (dr 75:25, 
anti:syn) that was purified by flash silica chromatography (1% Et2O :petrol)  
Anti (eluted first) as a colourless solid; (115 mg, 62% yield); mp 76-78 °C; 
! 
"[ ]D
20
+31 
(c 0.25, CHCl3); Chiral HPLC analysis; Chiralpak AS-H (1% IPA:hexane, flow rate 1 
mL min-1, 220 nm) tR major (3S,4R): 6.1 min, tR minor (3R,4S): 11.6 min, 90% ee; 
νmax (KBr)/cm-1 2971, 1831 (C=O), 1489, 1399, 1261, 1102, 1012, 954, 930,  834, 
803, 757, 735, 716, 656 and 526; 1H NMR (400 MHz, CDCl3) δH 0.86 (3H, t, J 7.4, 
CH2CH3), 2.01 (1H, dq, J 14.1, 7.2, CHAHBCH3), 2.86 (1H, dq, J 14.1, 7.1, 
CHAHBCH3), 5.01 (1H, s, CHCCl3), 7.30-7.33 (2H, m, ArH) and 7.56-7.59 (2H, m, 
ArH); 13C NMR (75 MHz CDCl3): δC 7.8 (CH3), 23.3 (CH2), 68.4 (C(Ar)Et), 86.8 
(CH(CCl3)), 94.2 (CCl3), 121.6 (ArC-4), 127.0 (ArCH), 131.4 (ArCH), 134.9 (ArC-1) 
and 167.4 (C=O); m/z: (EI+) (M(35Cl)(Br79))+ HRMS C12H10O2Br1Cl3 [M+]: found 
369.8920; calcd 369.8924 (−) 1.2 ppm. 
Syn (eluted second) as a colourless solid; (37 mg, 17% yield); mp 110-112 °C; 
! 
"[ ]D
20
+86  (c 0.07, CHCl3); Chiral HPLC analysis; Chiralpak AS-H (1% IPA:hexane, 
flow rate 1.0 mL min-1, 220 nm) tR major (3S,4S): 10.0 min, tR minor (3R,4R): 11.2 
min, 82% ee; νmax (KBr)/cm-1  2968, 1838 (C=O), 1493, 1452, 1399, 1254, 1146, 
1099, 1016, 911, 930,  832, 820, 800, 762, 735, 721, 647 and 525; 1H NMR (500 
MHz CDCl3): δH 0.95 (3H, t, J 7.3, CH2CH3), 2.34-2.38 (2H, m, CH2CH3), 4.93 (1H, 
s, CH(CCl3)), 7.35 (2H, d, J 8.2, ArH) and 7.48 (2H, d, J 8.2, ArH); 13C NMR (100 
MHz CDCl3): δC 9.1 (CH3), 33.5 (CH2), 69.4 (C(Ar)Et), 87.2 (CH(CCl3)), 95.7 
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(CCl3), 123.2 (ArC-4), 130.6 (ArCH), 131.0 (ArC-1), 131.9 (ArCH) and 169.2 
(C=O); m/z: (EI+) (M(35Cl)(Br79))+ HRMS C12H10O2Br1Cl3 [M+]: found 369.8926; 
calcd 369.8924 (+) 0.5 ppm. 
 
(168)-(2S,3R)-4,4,4-Trichloro-2-ethyl-2-phenylbutane-1,3-diol 
(168)
HO
OH
CCl3
EtPh
 
Scheme 44. To a 0 °C solution of 147 (200 mg, 0.68 mmol, 1.0 equiv, 94% ee) in dry 
toluene (10 mL) under an argon atmosphere was added toluene (1M solution in 
toluene) (2.38 mL, 2.38 mmol, 3.5 equiv) and the solution was warmed slowly to rt 
over 14 h. The solution was quenched with a solution of Rochelle salt and extracted 
with Et2O (3×25 mL) before concentration in vacuo. This crude product was purified 
by flash silica chromatography (30% Et2O :petrol) to give 168 as a colorless oil;  (86 
mg, 42% yield); 
! 
"[ ]D
20+24 (c 0.27, CHCl3); Chiral HPLC analysis; Chiralpak AD-H 
(5% IPA:hexane, flow rate 1 mL min-1, 220 nm) tR major (2R,3R): 11.6 min, tR minor 
(2S,2S): 15.6 min, 84% ee;  νmax (thin film)/cm-1 3390 (OH), 2926, 1778, 1463, 822 
(CCl3) and 764 (CCl3); 1H NMR (300 MHz, CDCl3) δH 0.83 (3H, t, J 7.4, CH2CH3), 
2.08-2.32 (2H, m, CH2CH3), 4.00 (1H, d, J 11.7, CHAHBOH), 4.30 (1H, d, J 11.7, 
CHAHBOH), 4.63 (1H, s, CH(CCl3)OH), 7.16-7.21 (1H, m, PhH-4), 7.25-7.30 (2H, m, 
PhH-2,6) and 7.35-7.39 (2H, m, PhrH-3,5); 13C NMR (75 MHz CDCl3): δC  8.7 
(CH2CH3), 23.6 (CH2CH3), 51.3 (C(Ph)Et), 67.2 (CH2OH), 88.7 (CH(OH)CCl3), 
102.5 (CCl3), 127.0 (PhC-4), 127.7 (PhC-3,5), 128.5 (PhC-2,6) and 140.8 (PCH-1); 
m/z: (ESI +) (M(35Cl))+ HRMS C13H13O3Cl3 [M+]+: found 330.9829; calcd 330.9832 
(−) 0.8 ppm. 
 
(180)-(S)-2,2-Dichlorovinyl 2-chloro-2-(2-chlorophenyl)butanoate 
O
O
Cl H Cl
ClCl
(180)  
Scheme 48. Following general procedure 1: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethyl-2-
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chlorophenylketene 179 (181 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 
mmol, 1.0 equiv) in toluene (20 mL) at 0 °C for 12 h gave crude product that was 
purified by flash silica chromatography (2% Et2O :petrol) to give 180 as a colorless 
oil; (205 mg, 65% yield); 
! 
"[ ]D
20
+12  (c 0.22, CHCl3); Chiral HPLC analysis; Chiralcel 
OJ-H (1% IPA:hexane, flow rate 1 mL min-1, 220 nm) tR major (S): 7.0min, tR minor 
(R): 9.7 min, 62% ee; νmax (thin film)/cm-1 3094, 2981, 2941, 1771 (C=O), 1469, 
1435, 1286, 1197, 1124, 995, 910 and 752; 1H NMR (300 MHz, CDCl3) δH 0.87 (3H, 
t, J 7.3 CH2CH3), 2.53 (1H, dq, J 14.7, 7.3, CHAHBCH3), 2.67 (1H, dq, J 14.7, 7.3, 
CHAHBCH3), 7.30-7.40 (3H, m, ArH), 7.59 (1H, s, CH(CCl2)), and 7.83-7.85 (1H, m, 
ArH); 13C NMR (100 MHz CDCl3): δC 8.5 (CH3), 31.7 (CH2), 73.8 (C(Ar)Et), 114.6 
(CCl2), 127.1 (ArCH), 130.1 (ArCH), 130.2 (ArCH), 130.8 (ArCH), 131.7 (ArC-2), 
133.4 (CH(CCl2)), 135.2 (ArC-1) and 166.1 (C=O); m/z: (CI+) (M(35Cl))+ HRMS 
C12H14O2N1Cl4 [M+NH4]+: found 343.9778; calcd 343.9773 (+) 1.4 ppm. 
 
 (186)-(S)-2,2-Dichlorovinyl 2-chloro-2-(2-tolyl)propanoate 
O
O
Cl H Cl
Cl
(186)  
Scheme 49. Following general procedure 1: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), methyl-2-tolylketene 
426 (146 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 mmol, 1.0 equiv) in 
toluene (20 mL) at 0 °C for 12 h gave crude product that was purified by flash silica 
chromatography (1% Et2O :petrol) to give 186 as a colorless oil; (152 mg, 52% yield); 
! 
"[ ]D
20
+51  (c 0.35, CHCl3); Chiral HPLC analysis; Chiralcel OJ-H (1% IPA:hexane, 
flow rate 1 mL min-1, 220 nm) tR minor (R): 7.4 min, tR major (S): 8.4 min, 80% ee; 
νmax (thin film)/cm-1 3091, 2977, 1772 (C=O), 1601, 1587, 1489, 1464, 1437, 1283, 
1247, 1195, 1135, 1125, 1089, 1026, 992, 906, 863 and 753; 1H NMR (500 MHz, 
CDCl3) δH 2.22 (3H, s, CH3), 2.30 (3H, s, ArCH3), 7.17-7.19 (1H, m, ArH-6), 7.23-
7.28 (2H, m, ArH-4/5), 7.56 (1H, s, CH(CCl2)), and 762-7.63 (1H, m, ArH-3); 13C 
NMR (125 MHz CDCl3): δC 20.3 (ArCH3), 29.6 (CH3), 68.9 (C(Ar)Me), 114.9 
(CCl2), 125.7 (ArCH-4/5), 126.2 (ArCH-6), 129.1 (ArCH-4/5), 132.2 (ArCH-3), 
133.2 (CH(CCl2)), 136.0 (ArC-2), 137.5 (ArC-1) and 167.7 (C=O); m/z: (EI+) 
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(M(35Cl))+ HRMS C12H14O2N1Cl4 [M+]: found 291.9816; calcd 291.9819 (−) 1.1 
ppm. 
 
(187)-(S)-2,2-Dichlorovinyl 2-chloro-2-(2-tolyl)butanoate 
O
O
Cl H Cl
Cl
(187)  
Scheme 49. Following general procedure 1: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethyl-2-tolylketene 
427 (160 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 mmol, 1.0 equiv) in 
toluene (20 mL) at 0 °C for 12 h gave crude product that was purified by flash silica 
chromatography (1% Et2O :petrol) to give 187 as a colorless oil; (219 mg, 71% yield); 
! 
"[ ]D
20
+130 (c 0.05, CHCl3); Chiral HPLC analysis; Chiralcel OJ-H (0.5% IPA:hexane, 
flow rate 0.2 mL min-1, 220 nm) tR minor (R): 33.4 min, tR major (S): 37.2 min, 82% 
ee; νmax (thin film)/cm-1 3093, 2980, 1768 (C=O), 1460, 1286, 1199, 1122, 991, 908, 
873, 857, 751 and 737; 1H NMR (400 MHz, CDCl3) δH 1.02 (3H, t, J 7.3, CH2CH3), 
2.29 (3H, s, ArCH3), 2.48-2.65 (2H, m, CH2CH3), 7.17-7.19 (1H, m, ArH-6), 7.24-
7.27 (2H, m, ArH-4,5), 7.57 (1H, s, CH(CCl2)), and 762-7.64 (1H, m, ArH-3); 13C 
NMR (75 MHz CDCl3): δC 8.9 (CH3), 20.4 (ArCH3), 33.3 (CH2), 74.1 (C(Ar)Et), 
114.8 (CCl2), 126.1 (ArCH-4/5), 126.6 (ArCH-6), 128.9 (ArCH-4/5), 132.2 (ArCH-
3), 133.1 (CH(CCl2)), 135.8 (ArC-2), 136.6 (ArC-1)  and 167.0 (C=O); m/z: (CI+) 
(M(35Cl))+ HRMS C13H17O2N1Cl3 [M+NH4]+: found 324.0324; calcd 324.0319 (+) 
1.4 ppm. 
 
(188)-(S)-2,2-dichlorovinyl 2-chloro-2-(2-tolyl)hexanoate 
O
On-Bu
Cl H Cl
Cl
(188)  
Scheme 49. Following general procedure 1: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), n-butyl-2-tolylketene 
428 (188 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 mmol, 1.0 equiv) in 
toluene (20 mL) at 0 °C for 12 h gave crude product that was purified by flash silica 
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chromatography (0.33% Et2O :petrol) to give 188 as a colorless oil; (219 mg, 72% 
yield); 
! 
"[ ]D
20
+55  (c 0.95, CHCl3); νmax (thin film)/cm-1 3093, 2961, 2874,  1765 
(C=O), 1488, 1461, 1381, 1284, 1196, 1130, 994, 916, 888, 851, 821, 753, 738, 653 
and 631; 1H NMR (400 MHz, CDCl3) δH 0.93 (3H, t, J 7.0, n-BuCH3), 1.31-1.43 (4H, 
m, n-BuCH2), 2.30 (3H, s, ArCH3) 2.47-2.55 (2H, m, n-BuH), 7.19 (1H, d, J 3.4, 
ArH-6), 7.25-7.28 (2H, m, ArH-4/5), 7.57 (1H, s, CH(CCl2)), and 7.63-7.65 (1H, m, 
ArH-3); 13C NMR (75 MHz CDCl3): δC 13.9 (CH3), 20.4 (ArCH3), 22.6 (CH2), 26.5 
(CH2), 39.9 (CH2), 73.4 (C(Ar)Bu), 114.8 (CCl2), 126.1 (ArCH-4/5), 126.5 (ArCH-6), 
128.8 (ArCH-4/5), 132.2 (ArCH-3), 133.2 (CH(CCl2)), 135.8 (ArC-2), 136.9 (ArC-1)  
and 167.1 (C=O); m/z: (EI+) (M(35Cl))+ HRMS C15H17O2Cl3 [M+]: found 334.0289; 
calcd 334.2089 (+) 0.1 ppm. 
 
(191)-(S)-2,2-Dichlorovinyl 2-chloro-2-(naphthalene-1-yl)propanoate 
O
O
Cl H Cl
Cl
(191)  
Scheme 50. Following general procedure 1: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), methyl-1-
napthylketene 429 (182 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 mmol, 
1.0 equiv) in toluene (20 mL) at 0 °C for 12 h gave crude product that was purified by 
flash silica chromatography (1% Et2O :petrol) to give 191 as a colorless oil; (207 mg, 
63% yield); 
! 
"[ ]D
20 + 108 (c 0.5, CHCl3); Chiral HPLC analysis; Chiralcel OJ-H (1% 
IPA:hexane, flow rate 1 mL min-1, 220 nm) tR minor (R): 7.5 min, tR major (S): 15.5 
min, 84% ee; νmax (thin film)/cm-1 3094, 1768 (C=O), 1646, 1513, 1452, 1377, 1214, 
1124, 971, 883, 851, 778 and 738; 1H NMR (400 MHz, CDCl3) δH 2.43 (3H, s, CH3), 
7.47 (1H, s, CH(CCl2)), 7.49-7.53 (3H, m, NapH), and 7.85-7.96 (4H, m, NapH); 13C 
NMR (100 MHz CDCl3): δC 29.9 (CH3), 68.8 (C(Nap)Me), 115.0 (CCl2), 123.8 
(NapCH), 124.3 (NapCH), 124.9 (NapCH), 126.0 (NapCH), 126.9 (NapCH), 129.5 
(NapCH), 130.1 (NapC), 130.6 (NapCH), 133.2 (CH(CCl2)), 134.3 (NapC), 134.6 
(NapC)  and 168.3 (C=O), m/z: (EI+) (M(35Cl))+ HRMS C15H11O2Cl3 [M+]: found 
327.9817; calcd 327.9819 (−) 0.7 ppm. 
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(192)-(S)-2,2-Dichlorovinyl 2-chloro-2-(naphthalene-1-yl)butanoate 
O
O
Cl H Cl
Cl
(192)  
Scheme 50. Following general procedure 1: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethyl-1-
napthylketene 196 (196 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 mmol, 
1.0 equiv) in toluene (20 mL) at 0 °C for 12 h gave crude product that was purified by 
flash silica chromatography (0.5% Et2O :petrol) to give 192 as a colorless oil; (273 
mg, 80% yield); 
! 
"[ ]D
20 + 96 (c 0.75, CHCl3); Chiral HPLC analysis; Chiralcel OJ-H 
(0.5% IPA:hexane, flow rate 1 mL min-1, 220 nm) tR minor (R): 9.2 min, tR major (S): 
10.5 min, 92% ee; νmax (thin film)/cm-1 3093, 2981, 1762 (C=O), 1650, 1601, 1512, 
1459, 1400, 1345, 1286, 1203, 1124, 986, 804, 775, 652 and 619; 1H NMR (300 
MHz, CDCl3) δH 1.06 (3H, t, J 7.3, CH2CH3), 2.73-2.85 (2H, m, CH2CH3), 7.47-7.56 
(3H, m, NapH), overlapping 7.49 (1H, s, CH(CCl2) 7.87-7.92 (3H, m, NapH) and 
(1H, dd, J 3.1, 6.4, NapH); 13C NMR (75 MHz CDCl3): δC 9.0 (CH3), 33.5 (CH2), 
74.1 (C(Nap)Et), 114.9 (CCl2), 123.5 (NapCH), 124.8 (NapCH), 125.3 (NapCH), 
125.8 (NapCH), 126.9 (NapCH), 129.6 (NapCH), 130.1 (NapC), 130.4 (NapCH), 
133.1 (CH(CCl2)), 133.5 (NapC), 134.3 (NapC) and 167.6 (C=O) m/z: (CI+) 
(M(35Cl))+ HRMS C15H11O2Cl3 [M+NH4]+: found 360.0325; calcd 360.0319 (+) 1.6 
ppm. 
 
(192)-(S)-2,2-Dichlorovinyl 2-chloro-2-(naphthalene-1-yl)butanoate: Preparative 
scale  
O
O
Cl H Cl
Cl
(192)  
Scheme 52. Following general procedure 1: NHC precatalyst 66 (51.0 mg, 0.09 
mmol, 0.025 equiv), KHMDS (0.17 mL, 0.09 mmol, 0.024 equiv), ethyl-1-
napthylketene 196 (702 mg, 3.58 mmol, 1.0 equiv) and chloral (0.35 mL, 3.58 mmol, 
1.0 equiv) in toluene (90 mL) at 0 °C for 3 h gave crude product that was purified by 
flash silica chromatography (0.5% Et2O :petrol) to give 192 as a pale yellow oil;  
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(1.05 g, 86% yield);  
! 
"[ ]D
20
+ 114 (c 0.55, CHCl3); Chiral HPLC analysis; Chiralcel 
OJ-H (0.5% IPA:hexane, flow rate 1 mL min-1, 220 nm) tR minor (R): 10.2 min, tR 
major (S): 12.0 min, 94% ee.  
 
(193)-(S)-2,2-Dichlorovinyl 2-chloro-2-(naphthalene-1-yl)hexanoate 
O
On-Bu
Cl H Cl
Cl
(193)  
Scheme 50. Following general procedure 1: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), n-butyl-1-
napthylketene 430 (224 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 mmol, 
1.0 equiv) in toluene (20 mL) at 0 °C for 12 h gave crude product that was purified by 
flash silica chromatography (1% Et2O :petrol) to give 193 as a colorless oil; (311 mg, 
84% yield); 
! 
"[ ]D
20
+ 88.5 (c 1.0, CHCl3); Chiral HPLC analysis; analysis conducted at 
AstraZeneca Chiralcel OJ-H (10% ethanol:i-hexane, flow rate 1 mL min-1, 220 nm) tR 
minor (R): 1.02 min, tR major (S): 1.22 min, 90% ee; νmax (thin film)/cm-1 3094, 2960, 
2873, 1761 (C=O), 1601, 1513, 1468, 1282, 1199, 1128, 984, 908, 859, 775, 734, 653 
and 619; 1H NMR (400 MHz, CDCl3) δH 0.92 (3H, t, J 7.0, n-BuCH3), 1.37-1.43 (4H, 
br m, n-BuCH2), 2.70-2.77 (2H, br m, n-BuCH2), 7.47 (1H, s, CH(CCl2)), overlapping 
7.51-7.54 (3H, m, NapH), 7.88-7.92 (3H, m, NapH) and 7.96-7.99 (1H, m, NapH); 
13C NMR (75 MHz CDCl3): δC 13.7 (CH3), 22.4 (CH2), 26.3 (CH2), 39.9 (CH2), 73.2 
(C(Nap)Bu), 114.7 (CCl2), 123.3 (NapCH), 124.6 (NapCH), 125.0 (NapCH), 125.6 
(NapCH), 126.6 (NapCH), 129.3 (NapCH), 129.9 (NapC), 130.1 (NapCH), 132.9 
(CH(CCl2)), 133.6 (NapC), 134.1 (NapC) and 167.4 (C=O); m/z: (EI+) (M(35Cl))+ 
HRMS C15H11O2Cl3 [M+]: found 370.0292; calcd 370.0289 (+) 0.9 ppm. 
 
195-(S)-2,2-Dichlorovinyl 2-chloro-3-methyl-2-phenylbutanoate 
O
O
Cl H Cl
Cl
(195)  
Scheme 51. Following general procedure 1: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), i-
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propoylphenylketene 194 (160 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 
mmol, 1.0 equiv) in toluene (20 mL) at 0 °C for 12 h gave crude product that was 
purified by flash silica chromatography (0.5% Et2O :petrol) to give 195 as a colorless 
oil; (266 mg, 86% yield); 
! 
"[ ]D
20 − 6 (c 1.0, CHCl3); Chiral HPLC analysis; Chiralcel 
OJ-H (1% IPA:hexane, flow rate 1 mL min-1, 220 nm) tR major (S): 5.5 min, tR minor 
(R): 8.4 min, 88% ee; νmax (thin film)/cm-13094, 2977, 1755 (C=O), 1494, 1447, 1390, 
1282, 1205, 1126, 1008, 867, 764 and 695; 1H NMR (300 MHz, CDCl3) δH 0.84 (3H, 
d, J 6.5, CH(CH3)2), 1.15 (3H, d, J 6.5, CH(CH3)2), 2.98-3.11 (1H, m, CH(CH3)2),  
7.31-7.41 (3H, m, ArH-3,4,5), 7.51 (1H, s, CH(CCl2)) and 7.63-7.66 (2H, m, ArH-
2,6); 13C NMR (75 MHz CDCl3): δC 17.0 (CH3), 18.8 (CH3), 37.1 (CH), 80.8 (C(Ar)i-
Pr), 114.3 (CCl2), 126.9 (ArC-2,6), 128.5 (ArC-3,5), 128.7 (ArC-4), 133.2 
(CH(CCl2)), 137.1 (ArC-1) and 166.0 (C=O); m/z: (ASAP) (M(35Cl))+ HRMS 
C13H17O2NCl3 [M+NH4]+: found 324.0323; calcd 324.0319 (+) 0.9 ppm. 
 
Assignment of the absolute configuration of 192: (S)-2-chloro-2-(naphthalen-1-yl)-N-
((S)-1-phenylethyl)butanamide  
N
H
(S)
OCl
(197)
(S)
 
Scheme 53. To a solution of 192 (60.0 mg, 0.17 mmol, 1.0 equiv, 94% ee) in CH2Cl2 
(3 mL) at 0 °C, was added Br2 (9 µL, 0.17 mmol, 1.0 equiv) and the solution warmed 
to rt and stirred for 1.5 h. The volatiles were removed in vacuo and the crude material 
dissolved in in THF (3 mL). To this solution was added (S)-(−)-α-methylbenzylamine 
(0.11 mL, 0.87 mmol, 5.0 equiv) and the resulting light blue solution stirred for 16 h 
at rt. The solution was diluted with EtOAc and washed with 2 × 1M HCl, dried 
Na2SO4 and concentrated in vacuo to give crude material that was purified by flash 
silica chromatography (5% to 10% Et2O :petrol) to give a 197 as a pale yellow solid; 
(55 mg, 90% yield); mp 98-100 °C; 
! 
"[ ]D
20 + 110 (c 0.15, CHCl3); νmax (ATR)/cm-1 
3298, 2926, 1645 (C=O), 1510, 1450, 1234, 1132, 1022 and 910 1H NMR (300 MHz, 
CDCl3) δH 0.94 (3H, t, J 7.2, CHAHBCH3), 1.38 (3H, d, J 6.9, CH3), 2.67 (1H, dq, J 
14.3, 7.2, CHAHBCH3), 2.76 (1H, dq, J 14.3, 7.2, CHAHBCH3), 5.16 (1H, app quintet, 
J 7.2, CH(CH3)Ph), 6.44 (1H, d, J 7.8, NH), 7.23-7.27 (3H, m, PhH), 7.29-7.33 (2H, 
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m, PhH), 7.47-7.52 (3H, m, NapH), 7.85-7.91 (3H, m, NapH) and 8.14-8.17 (1H, m, 
NapH); 13C NMR (100 MHz CDCl3): δC 9.4 (CH2CH3), 34.3 (CH3), 49.9 (CH2CH3), 
77.2 (C(Nap)Et), 125.1 (ArC), 125.2 (ArC), 126.1 (ArC), 126.2 (ArC), 126.5 (ArC), 
126.6 (ArC), 126.7 (ArC), 128.9 (ArC), 129.6 (ArC), 130.5 (ArC), 130.8 (ArC), 134.8 
(ArC), 136.1 (ArC), 143.1 (ArC) and 169.9 (C=O); m/z: (ESI+) (M(35Cl))+ HRMS 
C22H23ONCl [M+H]+: found 352.1467; calcd 352.1463 (+) 1.2 ppm.  
 
(209)-3-Ethyl-3-(2-methoxyphenyl)-4-(trichloromethyl)oxetan-2-one and (210)-2,2-
Dichlorovinyl 2-chloro-2-(2-mhoxyphenyl)butanoate.  
O
H
Cl3C
O
(209)-syn
OMe O
O
Cl H Cl
ClMeO
(210)
(~66:33 ratio of 209 to 210)  
Scheme 54. Following general procedure 1: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethyl-2-
methoxyphenylketene 208 (176 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 
mmol, 1.0 equiv) in toluene (20 mL) at 0 °C for 3 h gave crude product as a ~66:33 
mixture of lactone 209 (dr >95:5, syn:anti) and 210 that was purified by flash silica 
chromatography (1% Et2O :petrol) 210 as a colorless oil;  (37 mg, 11% yield); 
! 
"[ ]D
20
+5 (c 0.75, CHCl3); νmax (thin film)/cm-1 3091, 2977, 2940, 1772 (C=O), 1601, 
1587, 1489, 1464, 1437, 1247, 1195, 1135, 1089, 1026, 992, 906, 863, 752 and 616; 
1H NMR (400 MHz, CDCl3) δH 0.87 (3H, t, J 7.3, CH2CH3), 2.37-2.51 (2H, m, 
CH2CH3), 3.77 (3H, s, ArOCH3), 6.87 (1H, dd, J 8.2, 7.5, ArH), 7.02 (1H, td, J 7.6, 
1.1, ArH), 7.34 (1H, ddd, J 8.2, 7.5, 1.6, ArH), 7.55 (1H, s, CH(CCl2)) and 7.65 (1H, 
dd, J 7.5, 1.6, ArH); 13C NMR (100 MHz CDCl3): δC 8.4 (CH3), 31.9 (CH2), 55.5 
(ArOCH3), 72.3 (C(Ar)Et), 110.1 (ArCH), 113.5 (CCl2), 120.7 (ArCH), 126.7 (ArC-
2), 128.4 (ArCH), 130.0 (ArCH), 133.5 (CH(CCl2)), 155.2 (ArC-1) and 167.0 (C=O); 
m/z: (ESI +) (M(35Cl))+ HRMS C13H13O3Cl3 [M+]+: found 321.9928; calcd 321.9925 
(+) 1.0 ppm. 
209 as a colorless solid; (158 mg, 48% yield); mp 76-79 °C; 
! 
"[ ]D
20 +140 (c 0.66, 
CHCl3); Chiral HPLC analysis; Chiralpak AD-H (1% IPA:hexane, flow rate 1 mL 
min-1, 220 nm) tR major (3S,4S): 6.9 min, tR minor (3R,4R) 7.8 min >99% ee; νmax 
Chapter 8: Experimental Information 
 175 
(KBr film)/cm-1 2983, 1832, 1601 (C=O), 1585, 1499, 1464, 1438, 1292, 1256, 1182, 
1148, 1088, 1026, 905, 838 and 809; 1H NMR (400 MHz, CDCl3) δH 0.87 (3H, t, J 
7.4, CH2CH3), 2.27 (1H, dq, J 13.9, 7.0, CH2CH3), 3.01 (1H, dq, J 13.9, 7.0, 
CH2CH3), 3.76 (3H, s, ArOCH3), 4.92 (1H, s, CHCl3) 6.85 (1H, d, J 8.3, ArH), 6.9 
(1H, app t, J 7.5, ArH), 7.30 (1H, m, ArH) and 7.58 (1H, d, J 7.4, ArH); 13C NMR 
(100 MHz CDCl3): δC 9.1 (CH3), 29.8 (CH2), 54.5 (ArOCH3), 68.4 (C(Ar)Et), 87.5 
(CH(CCl3)), 96.4 (CCl3), 110.9 (ArCH), 118.9 (ArC-1), 120.4 (ArCH), 130.1 (ArCH), 
131.4 (ArCH), 156.6 (ArC-2) and 170.4 (C=O); m/z: (ESI+) (M(35Cl))+ HRMS 
C13H13O3Cl3 [M+]+: found 321.9926; calcd 321.9925 (+) 0.4 ppm. 
 
(215)-(S)-2,2-Dichlorovinyl 2-chloro-3-methyl-2-(thiophen-3-yl)butanoate and (214)-
3-Isopropyl-3-(thiophen-3-yl)-4-(trichloromethyl)oxetan-2-one 
O
O
Cl H Cl
Cl
(215)
S
O
Cl3C
H
O
O
H
Cl3C
O
(214)-anti (214)-syn
S S
16:84 dr, anti:syn
(~75:25 ratio of 215 to 214)  
Scheme 55. Following general procedure 1: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), i-propyl-3-
thioylketene 213 (166 mg, 1.00 mmol, 1.0 equiv) and chloral (0.10 mL, 1.00 mmol, 
1.0 equiv) in toluene (20 mL) at 0 °C for 3 h gave crude product as a ~75:25 mixture 
of 215 and β-lactone 214 (dr 84:16, syn:anti)) that was purified by flash silica 
chromatography (1% Et2O :petrol)  
215 as a pale yellow oil;  (99 mg, 32% yield); 
! 
"[ ]D
20
−32 (c 0.70, CHCl3); Chiral 
HPLC analysis; Chiralcel OJ-H (1% IPA:hexane, flow rate 1 mL min-1, 254 nm) tR 
major (S): 5.4 min, tR minor (R): 6.3 min, 78% ee; νmax (thin film)/cm-1 3095, 2976, 
1777 (C=O), 1650, 1465, 1390, 1280, 1187, 1125, 1007, 849, 770, 686 and 649; 1H 
NMR (400 MHz, CDCl3) δH 0.87 (3H, d, J 6.6, CH(CH3)2), 1.10 (3H, d, J 6.6, 
CH(CH3)2), 2.97 (1H, sep, J 6.6, CH(CH3)2), 7.23 (1H, dd, J 5.1, 1.3, ArH), 7.33 (1H, 
dd, J 3.1, 5.1, ArH), 7.52 (1H, dd, J 3.1, 1.3, ArH) and 7.55 (1H, s, CH(CCl2)); 13C 
NMR (100 MHz CDCl3): δC 17.0 (CH3), 18.3 (CH3), 37.8 (CH), 78.5 (C(Ar)i-Pr), 
114.3 (CCl2), 124.7 (ArCH), 126.4 (ArCH), 126.4 (ArCH), 133.2 (CH(CCl2)), 138.7 
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(ArC) and 165.4 (C=O); m/z: (ASAP) [NH4+] (M(35Cl))+ HRMS C11H15O2N1Cl3S1 
[M+]+: found 329.9890; calcd 329.9884 (+) 1.9 ppm. 
214 Syn as pale yellow oil;  (8 mg, 3% yield); 
! 
"[ ]D
20
+213 (c 0.4, CHCl3); νmax 
(KBr)/cm-1 2926, 1840 (C=O), 1642, 1464, 1373, 1262, 1097, 937, 867, 833, 789 and 
757; 1H NMR (400 MHz, CDCl3) δH 1.04 (3H, d, J 6.7, CH(CH3)2), 1.10 (3H, d, J 
6.7, CH(CH3)2), 2.42 (1H, app quintet, J 6.8, CH(CH3)2, 4.98 (1H, s, CHCl3), 7.17 
(1H, dd, J 5.1, 1.3, ArH), 7.30-7.32 (1H, m, ArH) and 7.42 (1H, dd, J  2.9, 1.3, ArH); 
13C NMR characteristic signals (75 MHz CDCl3) δC  69.2 (C(Ar)i-Pr), 84.2 
(CH(CCl3)), 94.6 (CCl3), 123.9 (ArCH), 124.2 (ArCH), 126.7 (ArCH) and 167.9 
(C=O); m/z: (ESI+) (M(35Cl))+ HRMS C11H11O2Cl3S [M+NH4]+: found 311.9541; 
calcd 311.9540 (+) 0.4 ppm. 
 
Experimental information for chapter 4 
 
General experimental procedures 
 
General procedure (1): Reaction Optermisation 
To a flame dried Schlenk flask under an argon atmosphere was added NHC-precursor 
66  (0.1 equiv), KHMDS (0.09 equiv) and toluene (0.4 relative volumes) and the 
mixture stirred for 15 min. The solution was then cooled to the required temperature 
and the requsite aldehyde (1.2 equiv) added followed by the dropwise addition of a 
solution of the ethylphenylketene (1.0 equiv) in toluene (0.6 relative volumes) over 
0.5 h. The solution was stirred for the given period before opening to air for 0.5 h and 
concentration in vacuo. The resulting crude residue was purified by flash silica 
chromatography to provide the title compound. 
 
General procedure (2): Lactonisation with 2-nitrobenzaldehyde and dropwise 
ketene addtion at −50 °C 
To a flame dried Schlenk flask under an argon atmosphere was added NHC-precursor 
66  (0.1 equiv), KHMDS (0.09 equiv) and toluene (0.4 relative volumes) and the 
mixture stirred for 15 min. The solution was then cooled to −50 °C and 2-
nitrobenzaldehyde (1.2 equiv) added followed by the dropwise addition of a solution 
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of the required ketene (1.0 equiv) in toluene (0.6 relative volumes) over 0.5 h. The 
solution was stirred for 3 h before opening to air for 0.5 h and concentration in vacuo. 
The resulting crude residue was purified by flash silica chromatography to provide the 
title compound. 
 
General procedure (3): Benzylation  
To a solution of the requisite compound (1.0 equiv) in the required volume of DMF 
was added benzylbromide (1.2 equiv) and i-Pr2NEt  (1.2 equiv) and the reaction 
stirred at rt for 12 h. The reaction was then diluted with Et2O , washed with 2 M HCl 
and H2O (× 2) before drying (Na2SO4) and concentration in vacuo to afford the crude 
product that was purified by flash silica chromatography to provide the title 
compound.  
 
(431)-Anti-3-Ethyl-3-phenyl-4-(4-(trifluoromethyl)phenyl)oxetan-2-one and (431)-
Syn-3-Ethyl-3-phenyl-4-(4-(trifluoromethyl)phenyl)oxetan-2-one  
OH
O
CF3
OH
O
CF3
(431)-anti (431)-syn  
Table 4 Entry 2. Following general procedure 1: NHC precatalyst 66 (28.5 mg, 0.05 
mmol, 0.10 equiv), KHMDS (0.09 mL, 0.045 mmol, 0.09 equiv), ethylphenylketene 
146 (73.1 mg, 0.50 mmol, 1.0 equiv) and 4-(trifluoromethyl)benzaldehyde (102 µL, 
0.75 mmol, 1.5 equiv) in toluene (10 mL) at 0 °C to rt over 16 h gave crude product 
(dr 72:28, anti:syn) that was purified by flash silica chromatography (3% Et2O 
:petrol) to give  
Anti (eluted first) as a colourless solid; (88 mg, 55% yield); mp 62 °C; 
! 
"[ ]D
20
+ 3.4 (c 
0.5, CHCl3); Chiral HPLC analysis Chiralpak AS-H (1% IPA:hexane, flow rate 1.0 
mL min-1, 220 nm) tR major: 10.4 min, tR minor: 21.9 min, 38% ee; νmax (KBr)/cm-1 
2972, 1827 (C=O), 1621, 1450, 1415, 1324, 1175, 1139, 1101, 1065, 954, 906, 835 
and 700; 1H NMR (400 MHz, CDCl3) δH 0.69 (3H, t, J 7.4, CH2CH3), 1.48 (1H, dq, J 
14.3, 7.2, CH2CH3) 1.71 (1H, dq, J 7.2, 14.3, CH2CH3), 5.72 (1H, s, CH(Ar)), 7.38-
7.50 (5H, m, ArH), 7.61 (2H, d, J 8.2, ArHCF3-3,5) and 7.76 (2H, d, J 8.2, ArHCF3-
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2,6); 19F{1H} NMR (376 MHz, CDCl3) δF −63; 13C NMR (100 MHz, CDCl3) δc 8.3 
(CH3), 27.3 (CH2), 68.9 (C(Ph)Et), 82.0 (ArCH), 123.9 (d, J 272, ArCF3), 125.8 (q, J  
3.6, CArCF3-2,6), 126.2 (d, J  4.3, CArCF3-3,5), 128.1 (ArC), 129.2 (ArC), 129.2 
(ArC), 131.0 (q, J 32.7, CArCF3-4), 137.1(ArC), 138.9 (ArC) and 171.3 (C=O); m/z: 
(ASAP) HRMS [M+] C18H15F3O2N+: found 321.1096; calcd 321.1097 (−) 0.3 ppm. 
Syn (eluted second) as a colorless solid; (55 mg, 28% yield); mp 104–106 °C; 
! 
"[ ]D
20   
−40 (c 0.05, CHCl3); Chiral HPLC analysis Chiralcel OJ-H (5% IPA:hexane, flow 
rate 0.5 mL min-1, 220 nm) tR major: 20.7 min, tR minor: 24.9 min, 80% ee; νmax 
(KBr)/cm-1 2972, 1819 (C=O), 1622, 1496, 1450, 1425, 1335, 1255, 1170, 1119, 
1072, 1018, 949, 882, 835, 755 and 700; 1H NMR (300 MHz, CDCl3) δH 1.07 (3H, t, 
J 7.4, CH2CH3), 2.25-2.44 (2H, m, CH2CH3) 5.59 (1H, s, CH(Ar)), 6.94-6.97 (2H, m, 
ArH-2,6), 7.09-7.12 (3H, m, ArH-3,4,5) and 7.18 (2H, d, J 8.2, ArHCF3-3,5) and 7.42 
(2H, d, J 8.2, ArCF3-2,6); 19F{1H} NMR (376 MHz, CDCl3) δF −63; 13C NMR (100 
MHz, CDCl3) δc 9.3 (CH3), 31.6 (CH2), 71.5 (C(Ph)Et), 82.0 (CHAr), 124.1 (d, J 268, 
ArCF3), 125.1 (q, J 3.6, CArCF3-2,6), 127.1 (ArC), 127.4 (ArC), 127.7 (ArC), 128.7 
(ArC), 130.8 (q, J 32.6, CArCF3-3,5), 134.2 (ArC), 139.3 (CAr) and 171.7 (C=O); 
m/z: (ASAP) HRMS [M+] C18H15F3O2N+: found 321.1100; calcd 321.1097 (−) 0.6 
ppm. 
 
(236)-Anti-(3R,4R)-3-Ethyl-4-(4-nitrophenyl)-3-phenyloxetan-2-one and (432)-Syn-
(3R,4S)-3-Ethyl-4-(4-nitrophenyl)-3-phenyloxetan-2-one 
OH
O
NO2
OH
O
NO2
(236)-anti (432)-syn  
Table 4 Entry 3. Following general procedure 1: NHC precatalyst 66 (28.5 mg, 0.05 
mmol, 0.10 equiv), KHMDS (0.09 mL, 0.045 mmol, 0.09 equiv), ethylphenylketene 
46 (73.1 mg, 0.50 mmol, 1.0 equiv) and 4-nitrobenzaldehyde (75.6 mg, 0.50 mmol, 
1.0 equiv) in toluene (10 mL) at 0 °C to rt over 16 h gave crude product (dr 62:38, 
anti:syn) that was purified by flash silica chromatography (20% Et2O :petrol) to give:  
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Anti (eluted first) as a colourless solid; (74 mg, 50% yield); mp 122-124 °C; 
! 
"[ ]D
20  
−24 (c 0.25, CHCl3); Chiral HPLC analysis Chiralpak AS-H (10% IPA:hexane, flow 
rate 1.0 mL min-1, 220 nm) tR major (R,R): 20.4 min, tR minor (S,S): 30.0 min, 13% ee; 
νmax (KBr)/cm-1 2974, 1818 (C=O), 1603, 1514 (NO2), 1344 (NO2), 1170, 1105, 956, 
904, 858, 759 and 699; 1H NMR (400 MHz, CDCl3) δH 0.69 (3H, t, J 7.4, CH2CH3), 
1.48 (1H, dq, J 14.2, 7.2, CH2CH3) 1.68 (1H, dq, J 7.2, 14.2, CH2CH3), 5.75 (1H, s, 
CH(Ar)), 7.37-7.50 (5H, m, ArH), 7.65-7.68 (2H, m, ArH-NO2-2,6) and 8.34-8.38 
(2H, m, ArH-NO2-3,5); 13C NMR (100 MHz, CDCl3) δc 8.4 (CH3), 27.3 (CH2), 69.3 
(C(Ph)Et), 81.6 (CHAr), 124.1 (CArNO2-3,5), 126.2 (PhC-2,6), 126.7 (CArNO2-2,6), 
128.3 (PhC-4), 129.3 (PhC-3,5), 136.7(PhC-1), 142.1 (CArNO2-1), 148.2 (CArNO2-
4) and 170.8 (C=O); m/z: (ASAP) HRMS [M+] C17H16O4N+: found 298.1070; calcd 
298.1074 (−) 1.3 ppm. 
Syn (eluted second) as a colourless solid (45 mg, 30% yield); mp 90-92 °C;  
! 
"[ ]D
20 −14 
(c 0.55, CHCl3); Chiral HPLC analysis Chiralcel OJ-H (10% IPA:hexane, flow rate 
1.0 mL min-1, 220 nm) tR major (R,S): 36.0 min, tR minor (S,R): 43.8 min, 82% ee; 
νmax (KBr)/cm-1 2973, 1815 (C=O), 1604, 1516 (NO2), 1352 (NO2), 1127, 945, 892, 
858, 752 and 699; 1H NMR (400 MHz, CDCl3) δH 1.08 (3H, t, J 7.4, CH2CH3), 2.27-
2.49 (2H, m, CH2CH3) 5.63 (1H, s, CH(Ar)), 6.94-6.97 (2H, m, PhH-2,6), 7.08-7.15 
(3H, m, ArH-3,4,5), 7.23-7.26 (2H, m, ArH-NO2-2,6) and 8.01-8.03 (2H, m, ArH-
NO2-3,5); 13C NMR (100 MHz, CDCl3) δc 9.3 (CH3), 31.3 (CH2), 72.2 (C(Ph)Et), 
81.5 (CHAr), 123.3 (CArNO2-3,5), 126.8 (PhC-2,6), 127.6 (CArNO2-2,6), 127.8 
(PhC-4), 128.7 (PhC-3,5), 133.6 (PhC-1), 142.4 (CArNO2-1), 147.8 (CArNO2-4) and 
171.2 (C=O); m/z: (ASAP) HRMS [M+] C17H16O4N+: found 298.1073; calcd 
298.1074 (−) 0.3 ppm. 
 
Table 4, Entry 5 Anti (76% ee, obtained from the reaction at −78 °C with dropwise 
addition of 1.5 equiv of ethylphenylketene over 0.5 h) derivitised to the corresponding 
β-hydroxy acid following the procedure of Kerrigan.18 236 (80 mg, 0.27 mmol, 1.0 
equiv), KOH (0.54 mL, 0.53 mmol, 2.0 equiv), THF (1mL) gave after 3 h 237 as a 
colourless gum; (45 mg, 52% yield); 
! 
"[ ]D
20 −46  (c 0.05, EtOAc) {literature18  −47.5  
(c 0.32, EtOAc), 87% ee (R,R)} confirming the absolute stereochemistry of 337 to be 
(R,R); 1H NMR (300 MHz, CDCl3) δH 1.15 (3H, t, J 7.4 CH2CH3), 1.93-2.05 (1H, m, 
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CH2CH3), 2.09-2.01 (1H, m, CH2CH3), 5.44 (1H, s, C(OH)H), 6.93 (2H, d, J 8.8 
ArH), 7.03-7.07 (2H, m, ArH), 7.29-7.32 (3H, m, ArH) and 7.95 (2H, d, J, 8.8, ArH). 
 
(238)-(3S,4R)-3-Ethyl-4-(2-nitrophenyl)-3-phenyloxetan-2-one  
OH
O
NO2
(238)-syn  
Table 5 Entry 3. Following general procedure 2: NHC precatalyst 66 (28.5 mg, 0.05 
mmol, 0.10 equiv), KHMDS (0.09 mL, 0.045 mmol, 0.09 equiv), ethylphenylketene 
146 (73.1 mg, 0.50 mmol, 1.0 equiv) and 2-nitrobenzaldehyde (91 mg, 0.60 mmol, 
1.2 equiv) in toluene (10 mL) at −50 °C for 3.5 h gave crude product (dr 93:7 
syn:anti) that was purified by flash silica chromatography (5% Et2O :petrol) to give: 
 Syn as an off white solid19 (157 mg, 83% yield); mp 58-62 °C [mp of (±) 238 is 86 
°C]; 
! 
"[ ]D
20
−44 (c 0.45, CHCl3); Chiral HPLC analysis Chiralcel OJ-H (5% 
IPA:hexane, flow rate 0.5 mL min-1, 220 nm) tR major: (S,R) 43.7 min, tR minor: (R,S)  
51.1 min, 93% ee; νmax (KBr)/cm-1 3094, 1768 (C=O), 1646, 1513, 1452, 1377, 1214, 
1124, 971, 883, 851, 778 and 738; 1H NMR (400 MHz, CDCl3) δH 1.15 (3H, t, J 7.4, 
CH2CH3), 2.44-2.59 (2H, m, CH2CH3), 6.16 (1H, s, CH(Ar)), 6.91-6.98 (5H, m, 
ArH), 7.20 (1H, app t, J 7.5, ArHNO2-4), 7.40 (2H, app dt, J  7.8,  15.7 15.`ArHNO2-
5,6) and 7.86 (1H, app d, J 8.2, ArHNO2-3); 13C NMR (75 MHz, CDCl3) δc 9.4 (CH3), 
29.4 (CH2), 72.7 (C(Ph)Et), 79.5 (CHAr), 124.7 (CArNO2-3), 126.8 (PhCH), 127.8 
(PhCH-4), 128.2 (CArNO2-6) 128.5 (PhCH), 129.0 (CArNO2-4), 132.8 (CArNO2-1), 
133.8 (PhC-1), 134.1 (CArNO2-5), 146.2 (CArNO2-2) and 172.3 (C=O); m/z: (EI) 
HRMS [M+] C17H16O4N1+: found 298.1078; calcd 298.1074 (+) 1.4 ppm. 
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(244)-Benzyl 2-((2-fluorophenyl)(hydroxy)methyl)-2-phenylbutanoate  
BnO
O OH F
OH
O
F
(241)-50:50 dr (244)-51:49 dr
i. KOH, THF, 65 °C
ii. BnBr, DMF, i-Pr2NEt
 
Table 6 Entry 1. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethylphenylketene 
146 (146 mg, 1.00 mmol, 1.0 equiv) and 2-fluorobenzaldehyde (126 µL, 1.20 mmol, 
1.2 equiv) in toluene (10 mL) at −50 °C for 4 h gave the crude product as an 
inseparable mixture of diastereoisomers (dr 51:49). The crude product was dissolved 
in CH2Cl2 washed with 1 M HCl, dried with Na2SO4, concentrated in vacuo and used 
without further purification. 
To a solution of the crude lactone product (assume 1.0 mmol) in THF (3 mL) was 
added KOH (2 mL, 2.00 mmol, 2.0 equiv) and the resulting bi-phasic mixture stirred 
at 65 °C for 12 h. The solution was cooled to rt, diluted with EtOAc and extracted 
with NaHCO3. The basic aquous phase was re-acidified with 2 M HCl, extracted with 
EtOAc (×3), combined, dried with Na2SO4 and concentrated in vacuo to yield the 
crude hydroxy acid (119 mg, dr 51:49) that was used without further purification.  
Following general procedure 3, (119 mg, assume 0.31mmol, 1.0 mmol), 
benzylbromide (0.06 mL, 0.37 mmol, 1.2 equiv), i-Pr2NEt  (0.07 mL, 0.37 mmol, 1.2 
equiv) in DMF (2 mL) gave after flash silica chromatography (10% Et2O :petrol) 244 
as a colorless oil (112 mg, 51:49 dr, 29% yield, based on ketene); Chiral HPLC 
analysis Chiralpak AD-H (2% IPA:hexane, flow rate 2.0 mL min-1, 220 nm) minor 
diasteroisomer: tR minor: 12.9 min, tR major: 16.3 min, 87% ee; major diasteroisomer: 
tR minor: 23.2 min, tR major: 25.6 min, 69% ee; νmax (KBr)/cm-1 3535, 2970, 1709 
(C=O), 1586, 1491, 1456, 1222, 1124, 758 and 698; 1H NMR (300 MHz, CDCl3) δH: 
0.80 (3H, t, J 7.3, CH2CH3), 0.91 (3H, t, J 7.3, CH2CH3), 1.72-1.97 (3H, m, CH2CH3), 
2.08 (1H, dq, J 14.4, 7.2, CH2CH3), 3.72 (1H, d, J 3.7, OH), 4.07 (1H, d, J 5.7, OH) 
5.10-5.21 (4H, m, OCH2Ph), 5.58 (1H, d, J 5.7, CHOH), 5.73 (1H, d, J 3.7, CHOH), 
5.99 (1H, td, J 1.6, 7.6, ArH), 6.60 (1H, td, J 0.8, 7.6, ArH), 6.71 (1H, ddd, J 10.5, 
18.2, 2, , ArH), 6.81-6.88 (3H, m, ArH), 6.92-7.03 (4H, m, ArH) and 7.02-7.29 (18H, 
m, ArH); 19F{1H} NMR (376 MHz, CDCl3) δF −117 and −116; 13C NMR (75 MHz, 
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CDCl3) δc 9.3 and 9.4 (2 × rotameric CH3), 10.1 (CH3), 25.8 (CH2CH3), 26.6 
(CH2CH3), 60.9 (C(Ph)Et), 61.3 (C(Ph)Et), 67.1 (CH2Bn), 67.2 (CH2Bn), 68.5 and 
68.5 (2 × rotameric CHOH), 72.2 (CHOH), 114.3 (d, J 23 CArF-3), 114.9 (d, J, 23 
CArF-4), 123.1 (d, J 3 CArF-4), 123.7 (d, J 3), 125.9 (d, J 13 CArF-1), 126.9 (d, J 13 
CArF-1), 127.2 (3 × CArH), 128.1 (ArCH), 128.4 (ArCH), 128.5 (ArCH), 128.5 
(ArCH), 128.6 (ArCH), 129.0 (ArCH), 129.2 (ArCH), 129.2 (ArCH), 129.3 (ArCH), 
130.4 (ArCH), 130.5 (ArCH), 135.2 (PhC-1),  135.4 (PhC-1),  137.1 (CBn-1), 139.0 
(CBn-1), 160.1 (d, J 247, CArF-2), 160.2 (d, J 245, CArF-2), 176.1 (C=O) and 176.5 
(C=O), (2 ArC could not be resolved);  m/z: (EI) HRMS [M+NH4] C24H23O3FNH4+: 
found 396.1971; calcd 396.1969 (+) 0.4 ppm. 
 
(245)-Benzyl 2-((2-chlorophenyl)(hydroxy)methyl)-2-phenylbutanoate  
BnO
O OH Cl
OH
O
Cl
i. KOH, THF, 65 °C
ii. BnBr, DMF, i-Pr2NEt
(242)-52:48 dr (245)-66:34 dr  
Table 6, Entry 2. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethylphenylketene 
(146 mg, 1.00 mmol, 1.0 equiv) and 2-chlorobenzaldehyde (140 µL, 1.20 mmol, 1.2 
equiv) in toluene (10 mL) at −50 °C for 4 h gave a crude product as a mixture of 
diastereoisomers (dr 52:48). The crude product was dissolved in CH2Cl2, passed 
through a plug of silca, concentrated in vacuo and used without purification. 
To a solution of the crude lactone product (assume 1.00 mmol) in THF (3 mL) was 
added KOH (2 mL, 2.00 mmol, 2.0 equiv) and the resultant bi-phasic mixture stirred 
at 65 °C for 12 h. The solution was cooled to rt, diluted with EtOAc and extracted 
with NaHCO3. The basic aquous phase was re-acidified with 2 M HCl, extracted with 
EtOAc (×3), combined, dried with Na2SO4 and concentrated in vacuo to yield the 
crude hydroxy acid (177 mg, dr 67:33) that was used without further purification.  
Following general procedure 3, (177 mg, assume 0.51 mmol, 1.0 mmol), 
benzylbromide (0.07 mL, 0.61 mmol, 1.2 equiv), i-Pr2NEt  (0.11 mL, 0.61 mmol, 1.2 
equiv) in DMF (2 mL) gave after silica chromatography (5% Et2O :petrol) 245 as a 
colorless oil (142 mg, dr 66:34, 36% yield, based on ketene); Chiral HPLC analysis 
Chiralpak AD-H (2% IPA:hexane, flow rate 1.0 mL min-1, 220 nm) minor 
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diasteromer: tR minor: 25.8 min, tR major: 40.2 min, 87% ee; major diasteromer: tR 
major: 35.8 min, tR minor: 66.1 min, 76% ee; νmax (KBr)/cm-1 3523, 2940, 1708 
(C=O), 1438, 1216, 1123, 1033, 751 and 697; 1H NMR (300 MHz, CDCl3) 
characteristic data for major diastereoisomer δH: 0.96 (3H, t, J 7.4, CH2CH3), 2.02-
2.12 (1H, m, CH2CH3), 2.19-2.29 (1H, m, CH2CH3), 4.25 (1H, d, J  5.6, OH), 5.30-
5.41 (2H, m, OCH2Ph) and  5.94 (1H, d, J 5.6, CHOH); 1H NMR (300 MHz, CDCl3) 
characteristic data for minor diastereoisomer δH: 1.08 (3H, t, J 7.4, CH2CH3), 2.02-
2.12 (2H, m, CH2CH3), 3.82 (1H, d, J  3.9, OH), 5.30-5.41 (2H, m, OCH2Ph),  6.03 
(1H, d, J 3.9, CHOH) and 6.07 (1H, dd J 1.6, 8.0, ArH); 13C NMR (75 MHz, CDCl3) 
δc: data for combined diastereoisomers: 10.1 (CH3), 10.4 (CH3), 26.2 (CH2 CH3), 26.4 
(CH2CH3), 61.7 (C(Ph)Et), 67.1 (CH2Bn), 67.2 (CH2Bn), 72.0 (CHOH), 74.7 
(CHOH), 125.7 (CArH) , 126.5 (ArCH), 127.2 (ArCH), 127.3 (ArCH), 128.0 (ArCH), 
128.2 (ArCH), 128.4 (ArCH), 128.6 (ArCH), 128.7 (ArCH), 128.7 (ArCH), 128.8 
(ArCH), 128.9 (ArCH), 129.2 (ArCH), 129.4 (ArCH), 129.8 (ArCH), 131.1 (ArCH), 
133.7 (CArCl), 134.5 (CArCl), 135.1 (CArCl), 135.5 (CArCl), 136.7 (PhC-1),  136.9 
(PhC-1),  137.5 (CBn-1), 139.2, (CBn-1), , 176.1 (C=O) and 176.3 (C=O) (3 ArC 
could not be resolved); m/z: (EI) HRMS [M+NH4] C24H23O3ClNH4+: found 412.1675; 
calcd 412.1674 (+) 0.2 ppm. 
 
(246)-Benzyl-2-((2-bromophenyl)(hydroxy)methyl)-2-phenylbutanoate 
BnO
O OH Br
OH
O
Br
(243)-56:44 dr (246)-57:44 dr
i. KOH, THF, 65 °C
ii. BnBr, DMF, i-Pr2NEt
 
Table 6, Entry 3. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethylphenylketene 
(146 mg, 1.00 mmol, 1.0 equiv) and 2-bromobenzaldehyde (140 µL, 1.20 mmol, 1.2 
equiv) in toluene (10 mL) at −50 °C for 4h gave crude product as a mixture of 
diastereoisomers (dr 56:44). The crude product was dissolved in CH2Cl2, passed 
through a plug of silca, concentrated in vacuo and used without purification. 
To a solution of the crude lactone product (assume 1.00 mmol) in THF (3 mL) was 
added KOH (2 mL, 2.00 mmol, 2.0 equiv) and the solution stirred at 65 °C for 12 h. 
The solution was cooled to rt, diluted with EtOAc and extracted with NaHCO3. The 
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basic aqueous phase was re-acidified with 2M HCl, extracted with EtOAc (×3), 
combined, dried with Na2SO4 and concentrated in vacuo to yield the crude hydroxy 
acid (110 mg, dr 55:45) that was used without further purification.  
Following general procedure 3 (110 mg, assume 0.31 mmol, 1.0 mmol), 
benzylbromide (0.04 mL, 0.38 mmol, 1.2 equiv), i-Pr2NEt  (0.07 mL, 0.38 mmol, 1.2 
equiv) in DMF (2 mL) for 16 h gave after flash silica chromatography (5% Et2O 
:petrol); 246 as a colorless oil (112 mg, 57:43 dr, 25% yield, based on ketene); Chiral 
HPLC analysis Chiralpak AD-H (5% IPA:hexane, flow rate 1.0 mL min-1, 220 nm) 
major diastereoisomer: tR minor: 15.0 min, tR major: 22.1 min, 95% ee; minor 
diastereoisomer: tR major: 20.5 min, tR minor: 47.3 min, 71% ee; νmax (KBr)/cm-1 
3527, 2940, 1709 (C=O), 1434, 1215, 1126, 1021, 748 and 698; 1H NMR (400 MHz, 
CDCl3) characteristic data for major diastereoisomer: δH: 0.92 (3H, t, J 7.4, CH2CH3), 
1.86-2.08 (2H, m, CH2CH3), 3.55 (1H, d, J  4.0, OH), 5.19 (2H, s, OCH2Ph), 5.82 
(1H, d, J  4.0, CHOH) and  5.87 (1H, d, J 1.7, 8.0, ArH); 1H NMR (400 MHz, CDCl3) 
characteristic data for minor diastereoisomer: δH: 0.76 (3H, t, J 7.4, CH2CH3), 1.86-
2.08 (2H, m, CH2CH3), 4.08 (1H, d, J  5.8, OH), 5.22 (2H, app q, J 12.4, OCH2Ph) 
and 5.74 (1H, d, J 5.8, CHOH) 13C NMR (75 MHz, CDCl3) data for combined 
diastereoisomers: δc: 10.3 (CH3), 10.4 (CH3), 26.4 (CH2 CH3), 26.5 (CH2 CH3), 61.8 
(C(Ph)Et), 61.9 (C(Ph)Et), 67.0 (CH2Bn), 67.2 (CH2Bn), 74.6 (CHOH), 77.2 
(CHOH), 124.4 (CArBr-2), 125.3 (CArBr-2), 126.2 (ArCH), 127.2 (ArCH), 127.2 
(CArH) , 127.2 (ArCH), 128.1 (ArCH), 128.2 (ArCH), 128.4 (ArCH), 128.5 (ArCH), 
128.5 (ArCH), 128.6 (ArCH), 128.7 (ArCH), 129.2 (ArCH), 129.2 (ArCH), 129.5 
(ArCH), 129.9 (ArCH), 131.4 (ArCH), 132.0 (ArCH), 132.7 (ArCH), 135.0 (PhC-1), 
135.5 (PhC-1),  136.7 (CBn-1), 138.4 (CBn-1), 139.1 (CArBr-1), 139.2 (CArBr-1), 
176.0 (C=O) and 176.1 (C=O)  (2 ArC could not be resolved); m/z: (EI) HRMS 
[M+NH4] C24H23O3BrNH4+: found 456.1166; calcd 456.1169 (−) 0.6 ppm. 
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(242)-3-Methyl-4-(2-nitrophenyl)-3-phenyloxetan-2-one  
OH
O
NO2
OH
O
NO2
(242)-anti(242)-syn  
Scheme 65. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), methylphenylketene 
418 (132 mg, 1.00 mmol, 1.0 equiv) and 2-nitrobenzaldehyde (181 mg, 1.20 mmol, 
1.2 equiv) in toluene (10 mL) at −50 °C for 3.5 h gave the crude product (dr 43:57 
syn:anti) that was purified by flash silica chromatography (5% Et2O :petrol) to give: 
Syn (eluted first) as a colourless solid; (88 mg, 30% yield); mp 68-70 °C;  
! 
"[ ]D
20
−61 (c 
0.15, CHCl3); Chiral HPLC analysis Chiralcel OJ-H (5% IPA:hexane, flow rate 1.0 
mL min-1), 220 nm) tR major (S,R): 32.0 min, tR minor (R,S): 36.2 min, 90% ee; νmax 
(KBr)/cm-1 2925, 1834 (C=O), 1527, 1341, 1351 1246, 1133, 945, 911, 866, 790, 745, 
and 699; 1H NMR (400 MHz, CDCl3) δH 2.20 (3H, s, CH3), 6.22 (1H, s, CH(Ar)), 
7.00-7.07 (5H, m, ArH), 7.31-7.35 (1H, m, ArHNO2-4) 7.52-7.56 (1H, m, ArHNO2-
5/6), 7.61 (1H, d, J 7.7, ArHNO2-5/6) and 7.96 (1H, dd, J 8.2, 1.2, ArHNO2-3); 13C 
NMR (75 MHz, CDCl3) δc  22.8 (CH3), 68.2 (C(Ph)Me), 82.4 (CHAr), 125.2 
(CArNO2-3), 125.9 (PhCH), 128.4 (CPhH-4), 128.5 (CArNO2-6), 128.8 (PhCH), 
129.5 (CArNO2-4), 133.1 (CArNO2-1), 134.6 (CArNO2-5), 134.7 (CPhH-1), 146.6 
(CArNO2-2) and 173.4 (C=O); m/z: (ASAP) HRMS [M+] C16H14O4N+: found 
284.0912; calcd 284.0917 (−) 1.9 ppm.  
Anti (eluted second) as a colourless solid; (103 mg, 35% yield); mp 128–130 °C; 
 
! 
"[ ]D
20
− 41 (c 0.3, CHCl3); Chiral HPLC analysis Chiralpak AS-H (5% IPA:hexane, 
flow rate 1.0 mL min-1, 220 nm) tR major (S,S): 22.5 min, tR minor (R,R): 30.4 min, 
90% ee; νmax (KBr)/cm-1 2982, 1836 (C=O), 1613, 1578, 1526, 1443, 1342, 1125, 
1085, 861, 790, 737, 725 and  630; 1H NMR (400 MHz, CDCl3) δH 1.33 (3H, s, CH3), 
6.14 (1H, s, CH(Ar)), 7.38-7.42 (1H, m, ArH-4), 7.46-7.49 (2H, m, ArH) 7.52-7.54 
(2H, m, ArH), 7.60-7.65 (1H, m, ArHNO2-4), 7.83-7.87 (1H, m, ArHNO2-5/6), 7.96 
(1H, d, J 7.8, ArHNO2-5/6) and 8.24-8.26 (1H, m, ArHNO2-3); 13C NMR (100 MHz, 
CDCl3) δc 15.4 (CH3), 65.8 (C(Ph)Me), 81.9 (CH(Ar)), 125.4 (CArNO2-3), 126.0 
(PhCH), 128.2 (CPhH-4), 128.4 (CArNO2-6), 129.0 (PhCH), 129.7 (CArNO2-4), 
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132.2 (CArNO2-1), 134.8 (CArNO2-5), 137.5 (CPhH-1), 146.7 (CArNO2-2)  and 
172.9 (C=O; m/z: (ASAP) HRMS [M+] C16H14O4N+: found 284.0912; calcd 284.0904 
(+) 2.8 ppm. 
 
(248)-(4-Chlorophenyl)-3-methyl-4-(2-nitrophenyl)oxetan-2-one  
OH
O
NO2
Cl
OH
O
NO2
Cl
(248)-anti(248)-syn  
Scheme 66. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), methyl-4-
chlorophenylketene 444 (167 mg, 1.00 mmol, 1.0 equiv) and 2-nitrobenzaldehyde 
(181 mg, 1.20 mmol, 1.2 equiv) in toluene (10 mL) at −50 °C for 3.5 h gave crude 
product (dr 55:45 syn:anti) that was purified by flash silica chromatography (5% Et2O 
:petrol) to give 248 syn as an off white solid (75 mg, 24% yield); mp 92-94 °C;   
! 
"[ ]D
20
−49 (c 0.15, CHCl3); Chiral HPLC analysis Chiralpak AS-H (5% IPA:hexane, 
flow rate 1.0 mL min-1, 220 nm) tR minor (R,S): 15.6 min, tR major (S,R): 18.1 min, 
92% ee; νmax (KBr)/cm-1 3415, 3110, 1835 (C=O), 1614, 1529, 1494, 1403, 1349, 
1243, 1134, 1094, 1012, 945, 943, 916, 838, 747, 731, 644 and 516; 1H NMR (300 
MHz, CDCl3) δH 2.18 (3H, s, CH3), 6.19 (1H, s, CH(Ar)), 6.96-7.07 (4H, m, p-
ClArH), 7.36-7.42 (1H, m, ArHNO2-4), 7.56-7.63 (2H, m, ArHNO2-5/6) and 8.01 
(1H, dd, J 8.0, 0.9, ArHNO2-3); 13C NMR (100 MHz, CDCl3) δc 22.5 (CH3), 67.2 
(C(PhCl)Me), 81.8( CHAr), 125.0 (CArNO2-3), 128.0 (CArNO2-6), 128.0 (CPhClH), 
128.7 (CPhClH), 129.5 (CArNO2-4), 132.3, (CPhClH-4), 133.0 (CArNO2-1), 134.0 
(CPhClH-1), 134.4 (CArNO2-5), 146.2 (CArNO2-2) and 172.5 (C=O); m/z: (ASAP) 
HRMS [M+] C16H13O4N135Cl1+: found 318.0526; calcd 318.0528 (−) 0.5 ppm. 
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(243)-(3S,4R)-3-Butyl-4-(2-nitrophenyl)-3-phenyloxetan-2-one  
O
n-Bu
H
O
NO2
(243)-syn  
Scheme 65. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), butylphenylketene 
419 (174 mg, 1.00 mmol, 1.0 equiv) and 2-nitrobenzaldehyde (181 mg, 1.20 mmol, 
1.2 equiv) in toluene (10 mL) at −50 °C for 3.5 h gave the crude product (dr 94:6 
syn:anti) that was purified by flash silica chromatography (5% Et2O :petrol) to give 
234 syn as an off white solid (240 mg, 74% yield); mp 64-66 °C; 
! 
"[ ]D
20
−20 (c 0.60, 
CHCl3); νmax (KBr)/cm-1 2958, 1828 (C=O), 1527, 1346, 1117, 918, 790, 744 and 701; 
1H NMR (300 MHz, CDCl3) δH  0.92 (3H, t, J 7.3, n-BuCH3), 1.25-1.34 (1H, m, n-
BuH), 1.36-1.48 (2H, m, n-BuH ), 1.67-1.78 (1H, m, n-BuH ), 2.52-2.59 (2H, m, n-
BuH ), 6.25 (1H, s, CH(Ar)), 7.02-7.06 (5H, m, ArH), 7.29 (1H, ddd, J 8.3, 7.0, 1.5, 
ArHNO2-4), 7.44-7.52 (2H, m, ArHNO2-5/6), 7.96 (1H, dd, J 8.2, 0.8, ArHNO2-3); 
1H NMR (300 MHz, CDCl3) 13C NMR (100 MHz, CDCl3) δc 13.8 (CH3), 22.9 (CH2), 
26.9 (CH2), 36.1 (CH2), 72.4 (C(Ph)Bu), 79.7 (CHAr), 124.7 (CAr-NO2-3), 126.7 
(PhCH), 127.8 (CPhH-4), 128.2 (CAr-NO2-6), 128.5 (PhCH), 129.0 (CAr-NO2-4), 
132.7 (CAr-NO2-1), 134.0 (PhC-1),  134.0 (CAr-NO2-5), 146.5 (CAr-NO2-2) and 
172.1 (C=O); m/z: (ASAP) HRMS [M+] C19H20O4N1+: found 326.1381; calcd 
298.1387 (−) 1.8 ppm. 
243 was ring opened with NaN3 and converted to the benzyl ester 433 to allow chiral 
HPLC analysis: 
 
BnO
O N3
n-Bu
NO2
(433)  
 
A solution of 243 (93 mg, 0.28 mmol, 1.0 equiv) and NaN3 (37 mg, 0.57 mmol, 2.0 
equiv) in DMSO (2 mL) was heated to 65 °C for 48 h. After cooling to rt NaHCO3 
was added and the solution extracted with Et2O . The aqueous was acidified with 2 M 
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HCl and extracted three times with Et2O , washed with water, dried with Na2SO4 and 
concentrated in vacuo to provide the crude azide intermediate that was used without 
further purification.  To a solution of the crude azide (assume 0.28 mmol) in DMF (2 
mL) was added benzylbromide (0.05 mL, 0.34 mmol, 1.2 equiv) and i-Pr2NEt  (0.06 
mL, 0.34 mmol, 1.2 equiv) and stirred overnight at rt. The solution was partially 
concentrated in vacuo, diluted with H2O and extracted with CH2Cl2 (×3). The organic 
phase was then concentrated in vacuo, re-diluted with Et2O  and washed with H2O 
(×3) and brine. The solution was then dried with Na2SO4 and concentrated in vacuo to 
yield the crude product that was purified by flash silica chromatography (5% Et2O : 
petrol) to provide 433 as a colorless oil; (31 mg, 24% yield over two steps); 
! 
"[ ]D
20
+265 (c 0.2, MeOH); Chiral HPLC analysis Chiralpak AD-H (5% IPA:hexane, 
flow rate 1.0 mL min-1, 220 nm) tR minor: 4.9 min, tR major: 6.4 min, 89% ee; νmax 
(thin film)/cm-1 2960, 2104 (N3), 1732 (C=O), 1533, 1358, 1243, 1207, 1132, 950, 
787, 731 and 698; 1H NMR (400 MHz, CDCl3) δH 0.76 (3H, t, J 7.3, nBuCH3 ), 0.84-
0.95 (1H, m, n-BuH ), 1.11-1.31 (2H, m, n-BuH ), 1.39-1.44 (1H, m, n-BuH ), 1.94 
(1H, td, J 13.0, 3.7 n-BuH), 2.45 (1H, td, J 12.9, 4.6 n-BuH ), 4.94 (1H, d, J 12.1, 
BnCH2), 5.11 (1H, d, J 12.1, BnCH2),  6.16 (1H, dd, J 1.1, 8.0, ArHNO2), 6.27 (1H, s, 
CHN3), 6.75 (2H, d, J 7.5 ArHNO2) 7.03-7.25 (10H, m, ArH) and 7.66 (1H, dd, J 1.2, 
8.1, ArHNO2), 13C NMR (100 MHz, CDCl3) δc 13.9 (CH3), 23.2 (CH2), 26.8 (CH2), 
34.8 (CH2), 60.1 (C(Ph)Bu), 60.6 (CH(Ar)N3), 66.9 (CH2Bn), 123.8 (CArNO2), 127.6 
(ArCH), 127.8 (ArCH), 128.4 (ArCH), 128.4 (ArCH), 128.6 (ArCH), 128.7 (ArCH), 
129.0 (ArCH), 130.9 (ArCH), 130.9 (CArNO2-1), 131.6 (CArNO2), 136.2 (CArBn-1), 
137.4 (PhC-1),  151.2 (CArNO2-2)  and 173.2 (C=O); m/z: (EI) HRMS [M+NH4] 
C26H26O4N4NH4+: found 476.2286; calcd 476.2292 (−) 1.3 ppm. 
 
(244)-(3S,4R)-3-Isobutyl-4-(2-nitrophenyl)-3-phenyloxetan-2-one  
O
i-Bu
H
O
NO2
(244)-syn  
Scheme 65. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), 
iso-butylphenylketene 60 (167 mg, 1.00 mmol, 1.0 equiv) and 2-nitrobenzaldehyde 
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(181 mg, 1.20 mmol, 1.2 equiv) in toluene (10 mL) at −50 °C for 6 h gave crude 
product (dr 94:6 syn:anti) that was purified by flash silica chromatography(5% Et2O 
:petrol) to give 244 Syn as an off white solid (95 mg, 30% yield); mp 78-80 °C;   
! 
"[ ]D
20 0.0 (c 0.3, CHCl3); Chiral HPLC analysis Chiralcel OJ-H (5% IPA:hexane, flow 
rate 1.0 mL min-1, 220 nm: tR: 10.6 min, tR: 12.3 min, <5% ee; νmax (KBr)/cm-1 2958, 
1819 (C=O), 1613, 1582, 1521, 1448, 1341, 1243, 1118, 974, 904, 788, 842, 706, 642 
and 534; 1H NMR (300 MHz, CDCl3) δH 0.82 (3H, d, J 6.7, i-BuCH3), 1.06 (3H, d, J 
6.7, i-BuCH3), 1.82-1.98 (1H, m, i-BuH) 2.44 (1H, dd, J 14.6, 6.4, i-BuCH2), 2.64 
(1H, dd, J 14.6, 6.4, i-BuCH2), 6.19 (1H, s, CH(Ar)), 7.01-7.07 (5H, m, ArH), 7.26-
7.33 (1H, m, ArHNO2-4), 7.43 (2H, d, J 3.9, ArHNO2-5,6) and 7.97 (1H, d, J 8.1, 
ArHNO2-3); 13C NMR (100 MHz, CDCl3) δc 23.9 (CH3), 23.9 (CH3), 25.5 (CH), 
45.3(CH2), 72.3 (C(Ph)i-Bu), 80.2 (CHAr), 124.7 (CAr-NO2-3), 126.8 (PhCH), 127.8 
(CPhH-4), 128.3 (CArNO2-6), 128.6 (PhCH), 129.1 (CArNO2-4), 132.7 (CArNO2-1), 
134.0 (CArNO2-5), 134.4 (PhC-1), 146.9 (CArNO2-2) and 172.1 (C=O); m/z: (ASAP) 
HRMS [M+] C19H20O4N1+: found 326.1382; calcd 3326.1387 (−) 1.5 ppm 
 
(246)-(3S,4R)-3-Ethyl-3-(4-fluorophenyl)-4-(2-nitrophenyl)oxetan-2-one  
OH
O
NO2
F
(246)-syn  
Scheme 65. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethyl-4-
flourophenylketene 422 (211 mg, 1.20 mmol, 1.2 equiv) and 2-nitrobenzaldehyde 
(151 mg, 1.00 mmol, 1.0 equiv) in toluene (10 mL) at −50 °C for 3 h gave crude 
product (dr 93:7 syn:anti) that was purified by flash silica chromatography (5% Et2O 
:petrol) to give 246 syn as a colourless solid (216 mg, 69% yield); mp 102-104 
°C; 
! 
"[ ]D
20
−19 (c 0.85, CHCl3); Chiral HPLC analysis Chiralpak AS-H (5% 
IPA:hexane, flow rate 1.0 mL min-1, 220 nm) tR minor (R,S): 11.1 min, tR major (S,R): 
12.3 min, 85% ee; νmax (KBr)/cm-1 2971, 1831 (C=O), 1614, 1605, 1522, 1319, 1353, 
1310, 1299, 1225, 1167, 1144, 1118, 1017, 949, 894, 859, 816, 787, 745, 682, 654, 
609, 536 and 506; 1H NMR (400 MHz, CDCl3) δH 1.14 (3H, t, J 7.4, CH2CH3), 2.52-
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2.67 (2H, m, CH2CH3),  6.22 (1H, s, CH(Ar)), 6.74-7.78 (2H, m, ArHF-3,5), 7.00-
7.04 (2H, m, ArHF-2,6), 7.33-7.37 (1H, m, ArHNO2-4), 7.52 (2H, dd, J 1.0, 4.9, 
ArHNO2-5,6) and 7.99 (1H, d, J 8.1, ArHNO2-3); 19F{1H} NMR (376 MHz, CDCl3) 
δF −114; 13C NMR (100 MHz, CDCl3) δc 9.3 (CH3), 29.5 (CH2), 72.3 (C(Ar)Et), 79.4 
(CHAr), 115.5 (d, J 21.4 CPhF-3,5), 124.8 (CAr-NO2-3), 128.1 (CArNO2-6), 128.6 
(d, J 8.2 CPhF-2,6), 129.2 (CArNO2-4), 129.6 (d J 3.1 CPhF-1) 132.6 (CArNO2-1), 
134.2 (CArNO2-5), 146.5 (CArNO2-2), 162.1 (d, J, 248 CPhF-4) and 171.9 (C=O); 
m/z: (ASAP) HRMS [M+] C17H15F1O4N1+: found 316.0974; calcd 316.0980 (−) 1.8 
ppm. 
 
(247)-(3S,4R)-3-(4-Chlorophenyl)-3-ethyl-4-(2-nitrophenyl)oxetan-2-one  
OH
O
NO2
Cl
(247)-syn  
Scheme 65. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethyl-4-
chlorophenylketene 423 (181 mg, 1.00 mmol, 1.0 equiv) and 2-nitrobenzaldehyde 
(181 mg, 1.20 mmol, 1.2 equiv) in toluene (10 mL) at −50 °C for 3 h h gave the crude 
product (dr 93:7 syn:anti) that was purified by flash silica chromatography (5% Et2O 
:petrol) to give 247 Syn as an off white solid (262mg, 79% yield); mp 78-80 °C; 
 
! 
"[ ]D
20
−15 (c 0.5, CHCl3); Chiral HPLC analysis Chiralpak AS-H (5% IPA:hexane, 
flow rate 0.5 mL min-1, 220 nm) tR minor (R,S): 22.5 min, tR major (S,R): 24.9 min, 
86% ee; νmax (KBr)/cm-1 2975, 1822 (C=O), 1614, 1525, 1497, 1343, 1250, 1130, 
1014,  939, 900, 860, 840, 792, 745, and 685; 1H NMR (300 MHz, CDCl3) δH 1.14 
(3H, t, J 7.4, CH2CH3), 2.50-2.69 (2H, m, CH2CH3), 6.23 (1H, s, CH(Ar)), 6.97-7.08 
(4H, m, ArClH), 7.34-7.40 (1H, m, ArHNO2-4), 7.51-7.54 (2H, m, ArHNO2-5,6) and 
8.00-8.03 (1H, m, ArHNO2-3); 13C NMR (100 MHz, CDCl3) δc 9.3 (CH3), 29.5 (CH2), 
72.3 (C(Ar)Et), 79.2 (CHAr), 124.9 (CAr-NO2-3), 128.1 (CArNO2-6), 128.2 (PhCH), 
128.8 (PhCH), 129.4 (CArNO2-4), 132.4 (2×C; (CArNO2-1) and (CPhCl-4)), 133.9 
(PhC-1),  134.3 (CArNO2-5), 146.5 (CArNO2-2)  and 171.6 (C=O); m/z: (ASAP) 
HRMS [M+] C17H1535Cl1O4N1+: found 332.0681; calcd 332.0684 (−) 0.9 ppm. 
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(249)-(3S,4R)-3-(4-Bromophenyl)-3-ethyl-4-(2-nitrophenyl)oxetan-2-one  
OH
O
NO2
Br
(249)-syn  
Scheme 65. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethyl-4-
bromophenylketene 424 (225 mg, 1.00 mmol, 1.0 equiv) and 2-nitrobenzaldehyde 
(181 mg, 1.20 mmol, 1.2 equiv) in toluene (10 mL) at −50 °C for 3 h gave crude 
product (dr 94:6 syn:anti) that was purified by flash silica chromatography (5% Et2O 
:petrol) to give 249 syn as a pale brown solid (257mg, 68% yield); mp 102-104 °C; 
! 
"[ ]D
20
−14 (c 0.5, CHCl3); Chiral HPLC analysis Chiralpak AS-H (5% IPA:hexane, 
flow rate 0.2 mL min-1, 220 nm) tR minor (R,S): 56.8 min, tR major (S,R): 61.7 min, 
92% ee; νmax (KBr)/cm-1 2974, 1821 (C=O), 1613, 1526, 1494, 1342, 1249, 1129, 
1077, 1011, 957, 938, 899, 860, 839, 791, 744, 721, 652 and 517; 1H NMR (300 
MHz, CDCl3) δH 1.13 (3H, t, J 7.4, CH2CH3), 2.49-2.68 (2H, m, CH2CH3),  6.21 (1H, 
s, CH(Ar)), 6.79-6.95 (2H, m, ArBrH-2,6), 7.18-7.22  (2H, m, ArBrH-3,5), 7.34-7.40 
(1H, m, ArHNO2-4), 7.50-7.56 (2H, m, ArHNO2-5,6) and 7.99-8.03 (1H, m, 
ArHNO2-3);  13C NMR (100 MHz, CDCl3) δc 9.3 (CH3), 29.5 (CH2), 72.4 (C(Ar)Et), 
79.2 (CHAr), 122.1 (CPhBr-4), 124.9 (CAr-NO2-3), 128.1 (CArNO2-6), 128.5 
(CPhBrH), 129.4 (CArNO2-4), 131.7 (CPhBrH), 132.4 (ArC-1),  132.9 (CArNO2-1), 
134.3 (CArNO2-5), 146.6 (CArNO2-2) and 171.6 (C=O); m/z: (ASAP) HRMS [M+] 
C17H15Br1O4N1+: found 376.0176; calcd 376.0279 (−) 0.8 ppm. 
 
(250)-(3S,4R)-3-Ethyl-4-(2-nitrophenyl)-3-(4-tolyl)oxetan-2-one  
OH
O
NO2
(250)-syn  
Scheme 65. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethyl-4-tolylketene 
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421 (167 mg, 1.00 mmol, 1.0 equiv) and 2-nitrobenzaldehyde (181 mg, 1.20 mmol, 
1.2 equiv) in toluene (10 mL) at −50 °C for 3 h gave the crude product (dr 90:10 
syn:anti) that was purified by flash silica chromatography (5% Et2O :petrol) to give 
250 syn as an off white solid (162 mg, 52% yield); mp 100-102 °C; 
! 
"[ ]D
20 −39 (c 0.25, 
CHCl3); Chiral HPLC analysis analysis  Chiralpak AD-H (5% IPA:hexane, flow rate 
1.0 mL min-1, 220 nm) tR minor (R,S): 9.6 min, tR major (S,R): 10.5 min, 83% ee; νmax 
(KBr)/cm-1 2975, 1825 (C=O), 1612, 1526, 1341, 1236, 1134, 1104, 951, 937, 890, 
858, 837, 742, 722, 697 and 520; 1H NMR (300 MHz, CDCl3) δH 1.07 (3H, t, J 7.4, 
CH2CH3), 2.07 (3H, s, ArCH3), 2.43-2.61 (2H, m, CH2CH3),  6.16 (1H, s, CH(Ar)), 
6.77-6.85 (4H, m, ArH), 7.24 (1H, ddd, J 8.3, 6.8, 1.7, ArHNO2-4), 7.40-7.48 (2H, m, 
ArHNO2-5,6) and 7.91 (1H, dd, J 8.3, 0.9, ArHNO2-3); 13C NMR (75 MHz, CDCl3) 
δc 9.4 (CH3), 21.0 (ArCH3, 29.4 (CH2), 72.7 (C(Ar)Et), 79.5 (CHAr), 124.7 (CArNO2-
3), 126.6, (ArCH), 128.2 (CArNO2-6), 129.0 (CArNO2-4), 129.2 (ArCH), 130.6 
(CAr-1), 132.9 (CArNO2-1), 134.1 (CArNO2-5), 137.5 (CPhH-4), 146.5 (CArNO2-2)  
and 172.3 (C=O); m/z: (ASAP) HRMS [M+] C18H18O4N1+: found 312.1226; calcd 
312.1230 (−) 1.4 ppm. 
 
(251)-(3S,4R)-3-Ethyl-3-(4-methoxyphenyl)-4-(2-nitrophenyl)oxetan-2-one  
OH
O
NO2
MeO
(251)-syn  
Scheme 65. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), ethyl-4-
methoxyphenylketene 425 (211 mg, 1.20 mmol, 1.0 equiv) [1.2 equiv of ketene used 
to aid purification] and 2-nitrobenzaldehyde (151 mg, 1.00 mmol, 1.2 equiv) in 
toluene (10 mL) at −50 °C for 3 h gave crude product (dr 86:14 syn:anti) that was 
purified by flash silica chromatography (10% Et2O :petrol) to give 251 as an off white 
solid and as a partially separable mixture of diastereoisomers (247 mg, 75% yield); 
data for major syn diastereoisomer; mp 58-64 °C; 
! 
"[ ]D
20 −57 (c 0.25, CHCl3); Chiral 
HPLC analysis Chiralpak AS-H (10% IPA:hexane, flow rate 0.8 mL min-1, 220 nm) 
tR major (S, R): 18.5 min, tR minor (R,S): 20.4 min, 86% ee; νmax (KBr)/cm-1 2974, 
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1828 (C=O), 1612, 1578, 1527, 1465, 1300, 1254, 1185, 1109, 945, 895, 837, 791, 
742, 699 and 686 1H NMR (300 MHz, CDCl3) δH 1.15 (3H, t, J 7.4, CH2CH3), 2.52-
2.66 (2H, m, CH2CH3), 3.66 (3H, s, ArOCH3), 6.22 (1H, s, CH(Ar)), 6.57-6.60 (2H, 
m, ArMeHO-3,5), 6.94 (2H, d, J 8.9, ArHMeO-2,6), 7.31-7.35 (1H, m, ArHNO2-4), 
7.49-7.56 (2H, m, ArHNO2-5,6) and 7.98 (1H, dd, J 8.3, 0.9 ArHNO2-3); 13C NMR 
(75 MHz, CDCl3) δc 9.4 (CH3), 29.4 (CH2), 55.1 (ArOCH3), 72.3 (C(Ar)Et), 79.6 
(CH(Ar)), 113.8 (CArMeO-2,6), 124.8 (CArNO2-3), 125.7 (CAr-1), 128.0 
(CArMeO-3,5), 128.2 (CArNO2-6), 129.0 (CArNO2-4), 132.9 (CArNO2-1), 134.1 
(CArNO2-5), 146.4 (CArNO2-2), 158.9 (CArMeO-2,6)  and 172.4 (C=O); m/z: 
(ASAP) HRMS [M+] C18H18O5N1+: found 328.1175; calcd 328.1179 (−) 1.8 ppm. 
 
(252)-3-Isopropyl-4-(2-nitrophenyl)-3-(thiophen-3-yl)oxetan-2-one  
OH
O
NO2
S OH
O
NO2
S
(252)-anti(252)-syn  
Scheme 252. Following general procedure 2: NHC precatalyst 66 (57.0 mg, 0.10 
mmol, 0.10 equiv), KHMDS (0.18 mL, 0.09 mmol, 0.09 equiv), isopropyl-3-
thionylketene 213 (180 mg, 1.00 mmol, 1.0 equiv) and 2-nitrobenzaldehyde (181 mg, 
1.20 mmol, 1.2 equiv) in toluene (10 mL) at 0 °C to rt over 12 h gave crude product 
(dr 45:55 syn:anti) that was purified by flash silica chromatography (3% Et2O :petrol) 
to give 252 as a predominately separable mixture of diastereoisomers; (147 mg, 46% 
yield);  
minor Syn as a pale brown solid (73 mg, 23% yield); mp 114 °C; 
! 
"[ ]D
20 −24 (c 0.15, 
CHCl3); Chiral HPLC analysis Chiralcel OJ-H (2% IPA:hexane, flow rate 0.5 mL 
min-1, 220 nm) tR major (S,R): 44.0 min, tR minor (R,S): 49.8 min, 58% ee; νmax 
(KBr)/cm-1 2978, 1825 (C=O), 1613, 1577, 1522, 1342, 1244, 953, 896, 857, 784,  
744, 705, 688 and 622; 1H NMR (300 MHz, CDCl3) δH 0.95 (3H, d, J 6.8, i-prCH3), 
1.45 (3H, d, J 6.8, i-prCH3), 2.87 (1H, sep, J 6.8, i-prH) 6.37 (1H, s, CH(Ar)), 6.55 
(1H, dd, J 4.9, 1.5, ArH), 6.97-7.01 (2H, m, ArH), 6.97-7.01 (1H, m, ArHNO2-4), 
7.50 (2H, d, J 3.9, ArHNO2-5,6) and 8.01 (1H, d, J 8.1, ArHNO2-3); 13C NMR (100 
MHz, CDCl3) δc 18.3 (CH3), 18.9 (CH3), 32.7 (CH), 74.4 (C(Ar)i-Pr), 76.8 (CH(Ar)), 
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122.9 (ArCH), 124.6 (CArNO2-3), 125.1 (CArNO2-4), 126.6 (ArCH), 128.2 
(CArNO2-6), 129.0 (ArCH), 133.1 (CArNO2-1), 134.1 (CArNO2-5), 134.9 (CAr-1), 
146.5 (CArNO2-2) and 171.1 (C=O); m/z: (ASAP) HRMS [M+] C16H16O4N1S1+: 
found 318.0791; calcd 318.0795 (−) 1.1 ppm. 
Major Anti as an off white solid (38 mg, 12% yield) mp 138-142 °C; 
! 
"[ ]D
20+40 (c 0.1, 
CHCl3); Chiral HPLC analysis Chiralcel OJ-H (2% IPA:hexane, flow rate 1.0 mL 
min-1, 220 nm) tR major (S,S): 28.8 min, tR minor (R,R): 43.2 min, 92% ee; νmax 
(KBr)/cm-1 2974, 1818 (C=O), 1613, 1535, 1469, 1389, 1344, 1261, 1227, 1192, 
1143, 1121, 995, 955, 902, 883, 863, 831, 790, 744, 710, 686 and 638; 1H NMR (300 
MHz, CDCl3) δH 0.40 (3H, d, J 6.7, i-prCH3), 0.92 (3H, d, J 6.8, i-prCH3), 2.18 (1H, 
sep, J 6.7, i-prH) 6.31 (1H, s, CH(Ar)), 7.39 (1H, dd, J 5.1, 3.0, ArH), 7.45 (1H, dd, J 
5.1, 1.3, ArH), 7.63 (1H, app td, J 7.8, 1.3, ArH), 7.66 (1H, dd, J 3.0, 1.3, ArHNO2) 
7.79-7.83 (1H, m, ArHNO2), 7.93 (1H, dd, J 8.3 1.3, ArHNO2) and 8.21 (1H, dd, J 
8.2, 1.3, ArHNO2-3); 13C NMR (100 MHz, CDCl3) δc 16.7 (CH3), 18.1 (CH3), 29.2 
(CH), 71.8 (C(Ar)i-Pr), 78.9 (CH(Ar)), 124.3 (ArCH), 125.4 (CArNO2-3), 125.5 
(CArNO2-4), 128.4 (ArCH), 129.7 (CArNO2-6), 130.0 (ArCH), 131.7 (CArNO2-1), 
133.7 (CAr-1), 134.1 (CArNO2-5), 148.2 (CArNO2-2) and 171.7 (C=O); m/z: (ASAP) 
HRMS [M+] C16H16O4N1S1+: found 318.0788; calcd 318.0795 (−) 2.1 ppm. 
 
(238)-(3S,4R)-3-Ethyl-4-(2-nitrophenyl)-3-phenyloxetan-2-one: Preparative scale  
OH
O
NO2
(238)-syn  
Scheme 68. Following general procedure 2: NHC precatalyst 66 (114 mg, 0.2 mmol, 
0.02 equiv), KHMDS (0.36 mL, 0.18 mmol, 0.018 equiv), ethylphenylketene 146 
(1.47 g, 10.0 mmol, 1.0 equiv) and 2-nitrobenzaldehyde (1.81 g, 12.0 mmol, 1.2 
equiv) in toluene (100 mL) at −50 °C for 1 h gave crude product (dr 93:7 syn:anti) 
that was purified by flash silica chromatography (5% Et2O :petrol) to give 238 syn 
(2.47 g, 83% yield); mp 58-60 °C; 
! 
"[ ]D
20
−46 (c 1.0, CHCl3); Chiral HPLC analysis 
Chiralcel OJ-H (5% IPA:hexane, flow rate 0.5 mL min-1, 220 nm) tR major (S, R): 
44.4 min, tR minor (R,S): 52.7 min, 95% ee; 1H NMR (300 MHz, CDCl3) δH 1.16 (3H, 
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t, J 7.4, CH2CH3), 2.54-2.72 (2H, m, CH2CH3), 6.26 (1H, s, CH(Ar)), 7.00-7.09 (5H, 
m, ArH), 7.28-7.34 (1H, m, ArHNO2-4), 7.46-7.55 (2H, m, ArHNO2-5,6) and 7.97 
(1H, dd, J 8.2 0.9, ArHNO2-3). 
Recrystallisation of 238 (95% ee) 
238 (73.0 mg, 0.25 mmol, 95% ee) was recrystallised from petrol and the minimum 
quantity of EtOAc to facilitate dissolution, cooled slowly to rt and the liquers 
removed to give 238 syn (65.0 mg, 89% yield) mp 56-58 °C; 
! 
"[ ]D
20
−48 (c 0.5, CHCl3); 
Chiral HPLC analysis Chiralcel OJ-H (5% IPA:hexane, flow rate 0.5 mL min-1, 220 
nm) tR major (S, R): 44.0 min, tR minor (R,S): 52.5 min, >99% ee;  
 
(263)-(S)-2-((S)-Amino(2-nitrophenyl)methyl)-2-phenylbutanoic acid  
HO
O NH2 NO2
(263)  
Scheme 70. To a solution of 238 (100 mg, 0.29 mmol, 1.00 equiv) in THF (4 mL) and 
H2O (1 mL) in a screw top vial was added PPh3 (84 mg, 0.31 mmol, 1.08 equiv) and 
the mixture vigorously stirred for 6 h. The mixture was then concentrated in vacuo, 
diluted with methanol and cooled to 0 °C in a screw cap vial. SOCl2 (0.06 mL, 0.30 
mmol, 1.0 equiv) was added dropwise then the vial heated to 65 °C for 12 h before 
concentration in vacuo. The resulting solid was then triturated with cold CHCl3 to 
give 263 as an off white solid; (75 mg, 81% yield); mp 188-194 °C (decomp); 
! 
"[ ]D
20+213 (c 0.15 MeOH); νmax (KBr)/cm-1 3417, 2800, 1684 (C=O), 1602, 1531, 
1496, 1352, 1220, 1195, 857, 713 and 603; 1H NMR (300 MHz, MeOD3) δH 0.55 
(3H, t, J 7.1, CH2CH3), 1.45 (1H, dq, J 13.9, 7.0, CH2CH3), 1.63 (1H, dq, J 13.9, 7.0, 
CH2CH3), 5.53 (1H, s, CHNH2), 7.32 (1H, dd, J 8.5, 4.1, ArH), 7.37 (4H, m, ArH), 
7.66 (1H, t, J 7.7, ArHNO2) 7.78 (1H, t, J 7.7, ArHNO2) 7.97 (1H, d, J 8.1, ArHNO2),  
and 8.04 (1H, d, J  8.1, ArHNO2); 13C NMR (75 MHz, MeOD) δc 10.0 (CH3), 28.3 
(CH2), 55.0 (CH(Ar)), 60.0 (C(Ar)Et), 126.6 (CArNO2), 129.1 (PhC-1),  129.2 
(PhCH), 129.7 (CArNO2), 130.2 (PhCH), 130.4 (CArNO2), 131.9 (CArNO2), 134.5 
(CArNO2), 137.5 (CArNO2-1), 151.8 (CArNO2-2) and 176.3 (C=O); m/z: (EI) HRMS 
[M+] C17H17O4N2+: found 313.1186; calcd 313.1194 (−) 2.5 ppm. 
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(266)-(S)-Benzyl 2-((S)-(benzylamino)(2-nitrophenyl)methyl)-2-phenylbutanoate 
BnO
O NH NO2
(266)
Bn
 
263 derivitised to the di-benzyl compound 266 for chiral HPLC analysis. Following 
general procedure 3; 263 (30 mg, 0.10 mmol, 1.0 equiv), benzylbromide (25 µL, 
0.21mmol, 2.2 equiv), i-Pr2NEt  (0.37 µL, 0.19 mmol, 2.2 equiv) in DMF (2 mLs) for 
12 h gave after flash silica chromatography (10% Et2O :petrol); 266 as a pale yellow 
oil (16 mg, 34% yield); 
! 
"[ ]D
20+269 (c 0.1, CHCl3); Chiral HPLC Chiralcel OD-H (1% 
IPA:hexane, flow rate 1.0 mL min-1, 220 nm) tR minor (R,R): 15.7 min, tR major (S,S): 
19.2 min, >99% ee; νmax (KBr)/cm-13031, 1730 (C=O), 1646, 1603, 1529, 1496, 1454, 
1357, 1218, 1108, 1029, 856, 739 and 698; 1H NMR (400 MHz, CDCl3) δH 0.64 (3H, 
t, J 7.3, CH2CH3), 1.82 (1H, dq, J 7.1, 13.8, CH2CH3), 2.37 (1H, dq, J 13.8, 7.1, 
CH2CH3), 3.45 (1H, d, J 13.4, BnCHAHB), 3.60 (1H, d, J 13.4, BnCHAHB), 5.01 (1H, 
d, J 12.3, BnCHAHB), 5.07 (1H, d, J, 12.3, BnCHAHB), 5.30 (1H, s, CHNHBn), 6.74-
6.76 (1H, m, ArHNO2), 6.91 (2H, dd, J 8.1, 1.4 ArHNO2), 7.12-7.24 (15H, m, ArH) 
and 7.64 (1H, dd, J 8.1, 1.4, ArHNO2); 13C NMR (100 MHz, CDCl3) δc 9.6 (CH3), 
28.6 (CH2), 51.7 (CH2Bn), 58.5 (CH(Ar)), 61.5 (C(Ar)Et), 66.6 (CH2Bn), 123.9 
(ArCH), 126.9 (ArCH), 127.2 (ArCH), 127.7 (ArCH), 127.9 (ArCH), 128.1 (ArCH), 
128.2 (ArCH), 128.4 (ArCH), 128.5 (ArCH), 128.6 (ArC), 130.0 (CArNO2), 131.2 
(CArNO2), 135.4 (ArC), 135.5 (ArC), 138.9 (ArC), 140.4 (ArC), 152.5 (CArNO2-2) 
and 173.7 (C=O); (1 ArC could not be resolved); m/z: (EI) HRMS [M+] C31H31O4N2+: 
found 495.2271; calcd 495.2278 (−) 1.5 ppm. 
 
(267)-(S)-2-((R)-Hydroxy(2-nitrophenyl)methyl)-2-phenylbutanoic acid  
HO
O OH NO2
(267)  
Scheme 71.To a solution of 238 (200 mg, 0.67 mmol, 1.0 equiv) in THF (4 mL) in a 
screw cap vial was added 1 M KOH (1.35 mL, 1.35 mmol, 2.0 equiv) and heated to 
65 °C for 5 h. The solution was cooled to rt, diluted with NaHCO3 and extracted with 
Et2O . The aqueous was slowly acidified with 2 M HCl and extracted with EtOAc 
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(×3). The EtOAc portions were combined, dried Na2SO4 and concentrated in vacuo to 
give 267 as an off white solid; (116 mg, 55% yield); mp 140-148 °C; 
! 
"[ ]D
20 −406 (c 
0.05 MeOH); νmax (KBr)/cm-1 3438, 1705 (C=O), 1528, 1355, 1223, 1037, 943 and 
857; 1H NMR (300 MHz, Me3OD) δH 0.84 (3H, t, J 7.4, CH2CH3), 1.74-1.83 (2H, m, 
CH2CH3), 6.14 (1H, s, CHOH), 6.38 (1H, dd, J 1.2, 8.0, ArHNO2), 7.05-7.13 (3H, m, 
ArH), 7.16-7.26 (3H, m, ArH), 7.27-7.34 (1H, m, ArH) and 7.65 (1H, dd, J 1.1, 8.1, 
ArHNO2); 13C NMR (75 MHz, CDCl3) δc 9.6 (CH3), 26.7 (CH2), 63.2 C(Ar)Et), 72.1 
(CH(Ar)), 123.1 (CArNO2), 127.5 (PhCH), 127.7 (ArCH), 128.5 (ArCH), 129.7 
(ArCH), 130.9 (ArCH), 131.3 (ArCH), 132.5 (ArCH), 135.4 (CArNO2), 149.7 
(CArNO2-2) and 177.7 (C=O); m/z: (EI) HRMS [M+] C17H16O5N+: found 314.1029; 
calcd 314.1034 (−) 1.6 ppm. 
267 Derivatised to the benzylester 268 for chiral HPLC analysis. Following general 
procedure 3; 267 (98 mg, 0.31 mmol, 1.0 equiv), benzylbromide (0.05 mL, 0.37 
mmol, 1.2 equiv), i-Pr2NEt  (0.08 mL, 0.37 mmol, 1.2 equiv) in DMF (2 mL) for 12 h 
gave after silica chromatography (20% Et2O :petrol); 268 as a orange oil (79 mg, 63% 
yield); 
! 
"[ ]D
20
−807 (c 0.3, CHCl3); Chiral HPLC analysis Chiralpak AD-H (5% 
IPA:hexane, flow rate 1.0 mL min-1, 220 nm) tR minor (S, R): 22.8 min, tR major (S,R): 
34.1 min, 96% ee; νmax (KBr)/cm-1 3527, 2975, 1714 (C=O), 1607, 1527, 1447, 1355, 
1216, 1125, 1039, 990, 912, 856, 785, 738 and 699; 1H NMR (400 MHz, CDCl3) δH 
0.74 (3H, t, J 7.3, CH2CH3), 1.61 (1H, dq, J 14.3, 7.2, CH2CH3), 1.86 (1H, dq, J 14.5, 
7.3, CH2CH3), 3.81 (1H, d, J 4.0, CHOH), 5.14 (2H, app d, J 0.9, BnCH2) 6.12 (1H, 
d, J 4.0, CHOH), 6.28 (1H, dd, J 8.3, 1.1 ArHNO2), 6.78-6.80 (2H, m, ArHNO2), 
6.95-6.99 (1H, m, ArH) 7.06-7.10 (2H, m, ArH), 7.14-7.25 (7H, m, ArH) and 7.53 
(1H, dd, J 1.1, 8.3, ArHNO2); 13C NMR (75 MHz, CDCl3) δc; 9.2 (CH3), 26.3 (CH2), 
61.3 (C(Ar)Et), 67.2 (CH2Bn), 69.7(CH(Ar)OH), 122.9 (ArCH), 127.3 (ArCH), 127.4 
(ArCH), 128.3 (ArCH), 128.4(ArCH), 128.5 (ArCH), 128.5 (ArCH), 129.3 (ArCH), 
131.0 (ArCH), 131.0 (ArCH), 132.5 (ArC), 135.2 (ArC), 136.5 (ArC), 149.8 
(CArNO2-2) and 175.7 (C=O); m/z: (EI) HRMS [M+H] C24H24O5N1+: found 
406.1650; calcd 406.1649 (+) 0.2 ppm.  
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(262)-(S)-2-((S)-Azido(2-nitrophenyl)methyl)-2-phenylbutanoic acid  
HO
O N3 NO2
(262)  
Scheme 70. To a solution of 238 (500 mg, 1.68 mmol, 1.0 equiv) in DMSO (5 mL) in 
a screw top vial was added sodium azide (219 mg, 3.36 mmol, 2.0 equiv) and the 
mixture heated to 65 ºC for 42 h. The solution was cooled to rt diluted with NaHCO3 
(20mL) and extracted with EtOAc (20 mL). The aqueous portion was re-acidified 
with 2 M HCl (50mL) and extracted with EtOAc (3 × 20 mL). The 3 organic portions 
were combined, washed with brine (20 mL) and H2O (20 mL), dried with Na2SO4 
then concentrated in vacuo to give 262 as a light brown solid; (564 mg, 99% yield); 
mp 156-160 °C; 
! 
"[ ]D
20+386 (c 0.25, CHCl3); νmax (KBr)/cm-1 2975, 2104 (N3), 1707 
(C=O), 1613, 1528, 1360, 1253, 1227, 1141, 1143, 1121, 857, 783, 831, 698, 744 and 
677; 1H NMR (300 MHz, CDCl3) δH 1.10 (3H, t, J 7.4, CH2CH3), 2.10-2.22 (1H, m, 
CH2CH3) 2.55-2.67 (1H, m, CH2CH3) 6.32 (1H, s, CHN3), 6.42 (1H, dd, J 7.9, 1.2, 
ArHNO2), 6.92-6.96 (2H, m, ArHNO2), 7.17-7.24 (2H, m, ArH), 7.25-7.28 (1H, m, 
ArH) 7.30-7.37 (2H, m, ArH) and  7.72 (1H, dd, J 8.1, 1.4, ArHNO2); 13C NMR (125 
MHz, CDCl3) δc 9.4 (CH3), 27.5 (CH2), 60.5 (C(Ar)Et), 60.5 (CH(Ar)N3), 123.8 
(CArNO2), 127.9 (PhCH), 128.1 (CPhH-4), 128.7 (CArNO2), 129.0 (PhCH), 130.4 
(ArC), 131.0 (CArNO2), 131.5 (CArNO2), 136.4 (ArC), 151.1 (CArNO2-2)  and 178.8 
(C=O); m/z: (EI) HRMS [M+] C17H15O4N4+: found 339.1093; calcd 339.1099 (−) 1.7 
ppm. 
262 was derivatised to the benzylester 265 to allow chiral HPLC analysis. Following 
general procedure 3: 262 (100 mg, 0.30 mmol, 1.0 equiv), DMF (5 mL), 
benzylbromide (0.04 mL, 0.36 mmol, 1.2 equiv) and i-Pr2NEt  (0.06 mL, 0.36 mmol, 
1.2 equiv) for 18 h give the crude product that was purified by flash silica 
chromatography (40% Et2O :petrol) to give 265 as a colorless crystalline solid; (53 
mg, 41% yield); mp 128 °C; 
! 
"[ ]D
20+376 (c 0.25, CHCl3); Chiral HPLC analysis 
Chiralcel OD-H (5% IPA:hexane, flow rate 1.0 mL min-1, 220 nm) tR minor (S,R): 8.3 
min, tR major (S,S): 9.9 min, 95% ee; νmax (KBr)/cm-1 3457, 2103 (N3), 1725 (C=O), 
1636, 1529, 1357, 1230, 1125, 970, 960, 788, 740 and 700; 1H NMR (300 MHz, 
CDCl3) δH 0.89 (3H, t, J 7.4, CH2CH3), 1.99-2.11 (1H, m, CH2CH3) 2.52 (1H, dq, J 
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14.2, 7.1, CH2CH3), 5.04 (2H, app q, J 14.5, BnCH2), 6.21 (1H, m, ArHNO2), 6.30 
(1H, s, CHN3), 6.75 (2H, d, J  7.4, ArHNO2), 7.04-7.27 (10H, m, ArH) and 7.67 (1H, 
dd, J 1.2, 8.1, ArHNO2); 13C NMR (125 MHz, CDCl3) δc 9.3 (CH3), 27.8 (CH2), 60.3 
(CH(Ar)N3), 60.5(C(Ar)Et), 67.0 (CH2Bn), 123.8 (CArNO2-3), 127.7 (ArCH), 127.9 
(ArCH), 128.4 (ArCH), 128.5 (ArCH), 128.6 (ArCH), 128.6 (ArCH), 129.1 (ArCH), 
130.9 (CArNO2-1), 130.9 (ArCH), 131.6 (ArCH), 135.2 (ArBnC), 137.3 (PhC), 151.1 
(CArNO2-2) and 173.2 (C=O); m/z: (EI) HRMS [M+NH4] C24H22O4N4NH4+: found 
448.1979; calcd 448.1979 (−) 0.1 ppm. 
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Experimental information for chapter 5 
 
General experimental procedures 
 
 
General procedure (1): Halogenation procedure at rt. 
To a flame dried Schlenk flask under an argon atmosphere was added NHC 
precatalyst (0.050 mmol), base (0.045 mmol) and toluene (3 mL) and the mixture 
stirred for 20 minutes. A solution of the requisite ketene (0.50 mmol) in toluene (6 
mL) was added, immediately followed by the requisite chlorinating reagent  (0.50 
mmol). Toluene (1mL) was added to wash residual solid into solution and the reaction 
was stirred for 3 h at rt before concentration in vacuo. The resulting crude residue was 
purified by flash silica chromatography to provide the title compound. 
 
General procedure (2): Halogenation procedure at −40 °C. 
To a flame dried Schlenk flask under an argon atmosphere was added NHC 
precatalyst (0.050 mmol), base (0.045 mmol) and toluene (3 mL) and the mixture 
stirred for 20 minutes. The mixture was then cooled to −40 °C before addition of a 
−40 °C solution of the requsite ketene (0.50 mmol) in toluene (6 mL), immediately 
followed by the requisite chlorinating agent (0.50 mmol). Toluene (1mL) was added 
to wash residual solid into solution and the reaction was stirred for 3 h at −40 °C 
before opening the flask to the air for 0.5 h and concentration in vacuo. The resulting 
crude residue was purified by flash silica chromatography to provide the title 
compound. 
 
General procedure (3): Derivatisation to the methyl ester. 
Following the procedure of Fu:20  the requisite α-chloroester (1.0 equiv) was 
dissolved in methanol (5 mL) and DMAP (3.0 equiv) was added. The resulting 
solution was stirred at rt for 16h before concentration in vacuo. The resulting solid 
was purified by flash silica chromatography to provide the title compound. 
Enantioselectivites were determined by chiral gas chromatography as outlined above. 
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General procedure (4): Dervatisation to (S,S) and (S,R)−α-methylbenzylamides 
To a solution of the requisite pentachlorophenyl α-chloroester (1.0 equiv) in THF (2 
mL) was added  (S)-(−)-α-methlybenzylamine (10-20 equiv) and the mixture stirred 
at rt for 16 h. The mixture was diluted with EtOAc (2 mL), washed with 2M aq. HCl 
(2 × 2mL), dried (Na2SO4) and concentrated in vacuo to give a mixture of the desired 
(S,S) and (S,R)−α-methylbenzylamides and pentachlorophenol.21 Diastereomeric 
ratios were determined by integration of the relevant peaks in the crude 1H NMR 
spectra.  
 
(291)-2,2,4-Trichloronaphthalen-1-(2H)-one 
N
O
Cl
Cl
Cl
(291)  
Scheme 82. 291 was prepared from via the literature method of Bartoli et al.22 To a 
solution of 8-hydroxyquinoline (3.63 g, 25.0 mmol, 1.0 equiv) in CH2Cl2 (125 mL) 
was slowly added t-butylhypochlorite (11.5 mL, 90.0 mmol, 3.6 equiv) at 0°C. The 
reaction was stirred at room temperature for 3 hours. The solvent was removed in 
vacuo, 20 mL of Et2O was added to the crude residue to precipatate a solid. The solid 
was collected by vacuum filtration and washed with cold hexane to afford 291 as a 
pale solid (3.42 g, 55% yield); 1H NMR (300 MHz, CDCl3) δH 6.87 (1H, s, C=CH), 
7.69 (1H, dd, J 4.7, 8.1, ArH), 8.13 (1H, dd, J 1.5, 8.1, ArH) and 8.89 (1H, dd, J 1.5, 
4.7, ArH). 
 
(311)-2,4,4-Tribromonaphthalen-1(4H)-one 
N
O
Br Br
Br
(311)  
Scheme 87. 311 was prepared from via the literature method of Bartoli et al.22 A 9/1 
glacial acetic acid/distilled H2O solution (400 mL) was added to 8-hydroxyquinoline 
(2.90 g, 20.0 mmol, 1.0 equiv). The yellow solution was cooled to 0°C in an ice bath 
and bromine (3.40 mL, 66.0 mmol, 3.3 equiv) was added dropwise over 20 minutes. 
After 1 hour stirring a precipitate had formed. Ice was added causing further 
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precipitatation. The solution was carefully extracted with CH2Cl2 (3 x 30mL) and the 
organic layer was washed with a saturated solution of NaHCO3 (3 x 100 mL), H2O 
(100 mL) and brine (1 x 100 mL), dried over MgSO4, filtered and trituated with cold 
CH2Cl2 to give 311 as a pale yellow solid (5.11 g, 67% yield); 1H NMR (300 MHz, 
CDCl3) δH 7.69 (1H, dd, J 8.2, 4.5, ArH), 7.99 (1H, s, C=CH), 8.49 (1H, dd, J 8.2, 
1.6, ArH) and 8.88 (1H, dd, J 4.5, 1.6, ArH). 
 
(312)-2,4,4,6-Tetrabromo-2,5-cyclohexadien-1-one 
O
Br Br
Br Br
(312)  
Scheme 88. 312 was prepared from via slight modification to the literature method of 
Lectka et al.23 To a glacial acetic acid/sodium acetate (13.5 g) solution (250 mL) was 
added to 2,4,6-tribromophenol (33.1 g, 0.1 mol, 1.0 equiv). The solution was heated 
to dissolve the 2,4,6-tribromophenol, then cooled to rt. Bromine (5.15 mL, 0.1 mol, 
1.0 equiv) in glacial acetic acid (100 mL) was added dropwise over 0.5 h. The 
reaction was stirred at rt for 0.5 h. The reaction was poured onto ice forming a light 
yellow precipitate, which was filltered and washed with distilled water. The solid was 
dissolved in CH2Cl2, dried with MgSO4, filtered and concentrated to give (45.6 g, 
quant). Additional drying was performed on 10 gramm scale as needed using a freeze 
dryer for 12 h; 1H NMR (300 MHz, C6D6) δH 7.41 (1H, s, C=CH). 
 
(283)-2,6,6-Trichlorocyclohex-1-en-1-yl 2-chloro-2-phenylbutanoate  
Cl
O
O
Cl
Cl
Cl
(283)  
Table 7, Entry 5. Following general procedure 1: NHC precatalyst 66 (28.5 mg, 0.05 
mmol, 0.1 equiv), Cs2CO3 (14.7 mg, 0.045 mmol, 0.09 equiv), ethylphenylketene 146  
(73.1 mg, 0.5 mmol, 1.0 equiv) in (6 mL) and 9 (118 mg, 0.05 mmol, 1.0 equiv) in 
toluene (10 mL) for 16 hours gave a crude product which was purified by flash silica 
chromatography (alumina, 25% EtOAc/petrol) to give 283 as a colourless oil; (90 mg, 
47%) with spectroscopic data in accordance with the literature.20 
! 
"[ ]D
200.0 (c 0.4, 
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CH2Cl2); dH  (400 MHz, CDCl3) 1.10 (3H, t, J 7.2, CH2CH3), 1.94-2.01 (2H, m, CH2), 
2.57 (2H, t, J 6.2, CH2) overlapping 2.47-2.59 (1H, m, CH2), 2.63-2.75 (3H, m, CH2), 
7.32-7.41 (3H, m, PhH-3,4,5) and 7.64-7.69 (2H, m, PhH-2,6).  
To a stirred solution of 238 (58 mg, 0.15 mmol, 1.0 equiv) in CH2Cl2 (2 mL) at 0 °C 
was added bromine (8 µL, 0.15 mmol, 1.0 equiv). The resulting solution was stirred at 
0 °C for 2 hours then concentrated in vacuo and, following general procedure 3, 
treatment with DMAP (55 mg, 0.45 mmol, 3.0 equiv) in MeOH (5 mL) gave a crude 
product which was purified by flash silica chromatography (silica, 5% EtOAc/petrol) 
to give 285 as a colourless oil; (23 mg, 72% yield) with spectroscopic data in 
accordance with the literature:20 
! 
"[ ]D
20
+0.0 (c 0.20, CH2Cl2); δH (300 MHz, CDCl3) 
0.98 (3H, t, J 7.2, CH2CH3), 2.36 (1H, dq, J 14.4, 7.2, CHAHBCH3), 2.51 (1H, dq, J 
14.4, 7.2, CHAHBCH3), 3.76 (3H, s, OCH3), 7.30-7.39 (3H, m, PhH-3,4,5), 7.47-7.50 
(2H, m, PhH-2,6); GC Analysis: CP-Chirasil-Dex CB column; 100 °C (60 min) 
1.0 °C/min to 120 °C; 11.6 psi H2; tR major (R); 45.2 min, tR minor (S) 46.3 min  <5 
% ee. 
 
(285)-Methyl 2-chloro-2-phenylbutanoate  
Cl
O
OMe
(285)  
Table 8, Entry 3. Following general procedure 2: NHC precatalyst 126 (17.4 mg, 
0.050 mmol, 0.1 equiv), KHMDS (0.5 M in toluene, 0.09 mL, 0.045 mmol, 0.09 
equiv), ethylphenylketene 146 (73.1 mg, 0.5 mmol, 1.0 equiv) and NCS (66.8 mg, 
0.050 mmol, 1.0 equiv) in toluene (10 mL) for 3 hours at −40 °C before warming to rt 
gave a crude product. Treatment of the crude mixture with DMAP (183 mg, 1.50 
mmol, 3.0 equiv) in MeOH (5 mL) at rt for 16 h gave a crude product which was 
purified by flash silica chromatography (5% EtOAc/petrol) to give 285 as a colourless 
oil; (47 mg, 39% yield, with respect to ketene) with spectroscopic data identical to 
that reported above; 
! 
"[ ]D
20 −2.6 (c 0.2, CH2Cl2); GC Analysis CP-Chirasil-Dex CB 
column; 100 °C (60 min) 1.0 °C/min to 120 °C; 11.6 psi H2; tR minor (R); 41.3 min, tR  
major (S) 43.7 min 11% ee. 
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(289)-Perchloroprop-1-en-2-yl 2-chloro-2-phenylbutanoate  
Cl
O
(289)
O
CCl3
Cl
Cl
 
Table 9, Entry 1. Following general procedure 2: NHC precatalyst 284 (54.6 mg, 
0.20 mmol, 0.1 equiv), KHMDS (0.5 M in toluene, 0.36 mL, 0.18 mmol, 0.09 equiv), 
ethylphenylketene 146 (292 mg, 2.0 mmol, 1.0 equiv), hexachloroacetone (0.30 mL, 
2.00 mmol, 1.0 equiv) and toluene (40 mL) for 3 hours at −40 °C gave a crude 
product which was purified by flash silica chromatography (2.5% EtOAc/petrol) to 
give 289 as a colourless oil; (358 mg, 44% yield); νmax (thin film)/cm-1: 2940, 1773 
(C=O), 1600 (C=C), 1447, 1162, 1064, 997 and 762; δH (400 MHz, CDCl3) 1.03 (3H, 
t, J 7.2, CH2CH3), 2.51-2.66 (2H, m, CH2CH3), 7.32-7.42 (3H, m, ArH-3,4,5) and 
7.60-7.65 (m, 2H, ArH-2,6); δC (75 MHz, CDCl3) 8.7 (CH3), 34.0 (CH2), 74.4 
(C(Ph)Et), 90.4 (CCl3), 124.6 (CCl2), 127.0 (CPhH), 128.3 (CPhH), 128.7 (CPhH), 
136.3 (CPh-1), 142.4 (C(Cl3)CCl2) and 166.2 (C=O); m/z HRMS (CI+), [M+NH4]+, 
C13H10O235Cl6NH4+ requires 425.9155, found 425.9150 (+1.1 ppm): Following 
general procedure 3: 289 (50 mg, 012 mmol, 1.0 equiv) and DMAP (45 mg, 0.37 
mmol, 3.0 equiv) in MeOH (5 mL) gave a crude product which was purified by flash 
silica chromatography (silica, 5% EtOAc/petrol) to give 285 as a colourless oil; (26 
mg, 89% yield) with spectroscopic data identical to that reported above. 
 
Table 9, Entry 2. Following general procedure 2: NHC precatalyst 70 (18.9 mg, 
0.050 mmol, 0.1 equiv), KHMDS (0.5 M in toluene, 0.090 mL, 0.045 mmol, 0.09 
equiv), ethylphenylketene 146 (73.1 mg, 0.50 mmol, 1.0 equiv) in (6 mL) and 
hexachloroacetone (0.050 mL, 0.050 mmol, 1.0 equiv) in toluene (10 mL) for 3 hours 
at −40 °C gave a crude product which was purified by flash silica chromatography 
(2.5% EtOAc/petrol) to give 289 as a colourless oil; (96 mg, 47% yield) with 
spectroscopic data identical to that reported above; 
! 
"[ ]D
20
−6.5 (c 0.53, CH3Cl). 
Following general procedure 3: 289 (48 mg, 0.12 mmol, 1.0 equiv) and DMAP (43 
mg, 0.35 mmol, 3.0 equiv) in MeOH (5 mL) gave a crude product which was purified 
by flash silica chromatography (silica, 5% EtOAc/petrol) to give 285 as a colourless 
oil; (25 mg, quantitative yield) with spectroscopic data identical to that reported 
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above; 
! 
"[ ]D
20 +3.0 (c 0.2, CH2Cl2); GC Analysis CP-Chirasil-Dex CB column; 100 °C 
(60 min) 1.0 °C/min to 120 °C; 11.6 psi H2; tR minor (R); 44.4 min, tR major (S) 46.0 
min 29% ee. 
 
(290)-Perchlorophenyl 2-chloro-2-phenylbutanoate. 
Cl
O
O
(290)
Cl
Cl
Cl
Cl
Cl
 
Table 10, Entry 1. Following general procedure 1: NHC precatalyst 284 (13.7 mg, 
0.050 mmol, 0.1 equiv), KHMDS (0.5 M in toluene, 0.09 mL, 0.045 mmol, 0.09 
equiv), ethylphenylketene 146 (80 mg, 0.55 mmol, 1.1 equiv) and 275 (150 mg, 0.50 
mmol, 1.0 equiv) in toluene (10 mL) gave a crude product which was purified by 
flash silica chromatography (petrol) to give 290 as a colourless solid;  (146 mg 65% 
yield); mp 80-84 °C; νmax (KBr disk)/cm-1: 2976, 1773 (C=O), 1386, 1362, 1190, 
1183, 1082, 990, 912, 863, 827, 767, 745, 722 and 698; δH (400 MHz, CDCl3) 7.67-
7.70 (2H, m, ArH), 7.35-7.46 (3H, m, ArH), 2.69 (1H, dq, J 14.5, 7.2, CHAHBCH3), 
2.56 (1H, dq, J 14.5 7.3, CHAHBCH3) and 1.09 (3H, t, J 7.2, CH2CH3); δC (75 MHz, 
CDCl3) 9.1 (CH3), 34.3 (CH2), 74.9 (C(Ph)Et), 127.1 (CPhH), 127.7 (CC6Cl5), 128.6 
(CPhH), 128.9 (CPh), 132.0 (CC6Cl5), 132.2 (CC6Cl5), 137.3 (CPh-1), 143.9 (CC6Cl5) 
and 166.7 (C=O); m/z HRMS (CI+), [M+NH4]+, C16H10O235Cl6NH4+ requires 
461.9154, found 461.9150 (+0.8 ppm). 
  
Table 10, Entry 7. Following general procedure 1: NHC precatalyst 66 (28.5 mg, 
0.050 mmol, 0.1 equiv), Cs2CO3 (14.6 mg, 0.045 mmol, 0.09 equiv), 
ethylphenylketene 146 (80.0 mg, 0.55 mmol, 1.1 equiv) and 275 (150 mg, 0.50 mmol, 
1.0 equiv) in toluene (10 mL) for 3 hours at −40 °C gave a crude product which was 
purified by flash silica chromatography (petrol) to give 290 as a colourless solid; (201 
mg 90% yield) with spectroscopic data identical to that reported above; mp 80-86°C; 
! 
"[ ]D
20
+14.8 (c 0.50, CHCl3). 
Following general procedure 3: 290 (36 mg, 0.08 mmol, 1.0 equiv) and DMAP (30 
mg, 0.24 mmol, 3.0 equiv) in MeOH (5 mL) gave a crude product which was purified 
by flash silica chromatography (silica, 5% EtOAc/petrol) to give 285 as a colourless 
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oil; (8.0 mg, 47% yield) with spectroscopic data identical to that reported above: 
! 
"[ ]D
20 −3.0 (c 0.1, CH2Cl2) {literature −23.0 (c 0.0005, CH2Cl2, 93% ee R)}; GC 
Analysis CP-Chirasil-Dex CB column; 100 °C (60 min) 1.0 °C/min to 120 °C; 11.6 
psi H2; tR major (R); 44.5 min, tR minor (S) 46.1 min (minor) 61 % ee {literature CP-
Chirasil-Dex CB column; 100 °C (2 min), 1.0 °C/min to 120 °C; 11.6 psi H2; tR major 
(R); 20.2 min, tR minor (S) 20.5 min 93% ee}.  
 
(294)-(R)-Perchlorophenyl 2-chloro-2-phenylhexanoate 
Cl n-Bu
O
O
Cl
Cl
Cl
Cl
Cl
(294)  
Scheme 83. Following general procedure 2: NHC precatalyst 66 (28.5 mg, 0.05 
mmol, 0.1 equiv), Cs2CO3 (14.6 mg, 0.045 mmol, 0.09 equiv), butylphenylketene 419 
(95.8 mg, 0.55 mmol, 1.1 equiv) and 275 (150 mg, 0.50 mmol, 1.0 equiv) in toluene 
(10 mL) for 3 hours at −40 °C gave a crude product which was purified by flash silica 
chromatography (petrol) to give 294 as a colourless solid;  (158 mg, 67% yield); mp 
66-72 °C; 
! 
"[ ]D
20 +5.9; νmax (KBr disk)/cm-1: 2959, 2933, 1773 (C=O) 1494, 1445, 
1385, 1360, 1178, 1133, 1052, 981, 914, 825, 769, 721 and 702; δH (400 MHz, 
CDCl3) 0.93 (3H, t, J 7.2, n-BuCH3), 1.34-1.46 (3H, m, n-BuCH2), 1.52-1.62 (1H, m, 
n-BuCH2), 2.50 (1H, ddd, J 14.6, 11.7, 4.1, n-BuCHACHB), 2.61 (1H, ddd, J 14.6, 
10.9, 4.1,  n-BuCHACHB), 7.34-7.44 (3H, m, PhH-3,4,5) and 7.66-7.69 (2H, m, ArH-
2,6); δC (75 MHz, CDCl3) 14.0 (CH3), 22.7 (CH2), 26.7 (CH2), 40.8 (CH2), 74.3 
(C(Ph)Et) 127.0 (CPhH), 127.8 (CC6Cl5), 128.6 (CPhH), 129.0 (CPhH-4), 132.0 
(CC6Cl5), 132.2 (CC6Cl5), 137.6 (CPhH-1), 143.9 (CC6Cl5) and 166.7 (C=O); m/z 
HRMS (ESI+) [M+NH4]+, C18H14O235Cl6NH4+ requires 489.9459, found 489.9463 
(−0.9 ppm).  
Following general procedure 4: 294 (12 mg, 0.03 mmol, 1.0 equiv), (S)-α-
methylbenzylamine (0.03 mL, 0.30 mmol, 10 equiv), and THF (2 mL) for 16 hours at 
room temperature gave the crude product as a brown oil. The diastereomeric ratio was 
determined as 67:33 by integration of the appropriate signals in the 1H NMR of the 
crude product; δH (300 MHz, CDCl3, characteristic signals only) 0.85 (3H, t, J 7.1, 
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diastereomeric n-BuCH3), 0.92 (3H, t, J 7.1, diastereomeric n-BuCH3), 1.48 (3H, d, J 
6.9, diastereomeric C(Ph)HCH3), 1.53 (3H, d, J 6.9, diastereomeric C(Ph)HCH3), 
2.32-2.25 (1H, m,  n-BuCH2), 2.57-2.48 (1H, m, n-BuCH2) and 5.01 (1H, app quintet, 
J 7.2, PhCH(CH3)N),  
 
(299)-(R)-Perchlorophenyl 2-chloro-2-(4-tolyl)butanoate  
Cl
O
O
(299)
Cl
Cl
Cl
Cl
Cl
 
Scheme 86. Following general procedure 2: NHC precatalyst 66 (71.3 mg, 0.13 
mmol, 0.25 equiv), Cs2CO3 (39.1 mg, 0.120 mmol, 0.24 equiv), ethyl-4-tolylketene 
421 (160 mg, 0.75 mmol, 1.5 equiv) and 275 (150 mg, 0.05 mmol, 1.0 equiv) in 
toluene (10 mL) for 3 hours at −40 °C before warming to rt gave a crude product 
which was purified by flash silica chromatography (petrol) to give 299 as a colourless 
solid;  (202 mg, 88% yield); mp 66-72 °C; 
! 
"[ ]D
20 +7.4 (c 0.50, CHCl3); νmax (KBr 
disk)/cm-1: 2921, 1784 (C=O), 1511, 1452, 1386, 1362, 1205, 1130, 1067, 1020, 886, 
791, 715 and 519; δH (400 MHz, CDCl3) 1.09 (3H, t,  J 7.3, CH2CH3), 2.38 (3H, s, 
ArCH3), 2.53 (1H, dq, J 14.5, 7.3, CHAHBCH3), 2.67 (1H, dq, J 14.5, 7.3, 
CHAHBCH3), 7.22 (2H, d, J 8.0 PhH-2,6) and 7.53-7.57 (m, 2H, PhH-3,5); δC 
(75 MHz, CDCl3) 9.1 (CH3), 21.2 (CH2), 34.3 (ArCH3), 74.9 (C(Ph)Et), 127.0 
(CArH), 127.8 (CC6Cl5), 129.3 (CArH), 132.0 (CC6Cl5), 132.2 (CC6Cl5), 134.4 (CAr-
4), 138.2 (CAr-1), 144.0 (CC6Cl5) and 166.8 (C=O); m/z HRMS (ESI+) [M+NH4]+, 
C17H12O235Cl6NH4+ requires 475.9302, found 476.9307 (−1.0 ppm).  
Following general procedure 4: 299 (45 mg, 0.10 mmol, 1.0 equiv), (S)-α-
methylbenzylamine (0.1 mL, 1.0 mmol, 10 equiv) and THF (2 mL) for 16 hours at 
room temperature gave the crude product as a brown oil. The diastereomeric ratio was 
determined as 74:26 by integration of the appropriate signals in the 1H NMR of the 
crude product; δH (300 MHz, CDCl3, characteristic signals only) 0.97 (3H, t, J 7.2, 
diastereomeric CH2CH3), 1.05 (3H, t, J 7.2, diastereomeric CH2CH3), 1.49 (3H, d, J 
6.9, diastereomeric C(Ph)HCH3), 1.54 (3H, d, J 6.9, diastereomeric C(Ph)HCH3), 
2.23 (3H, s, ArCH3), 2.17-2.23 (2H, m, CHACHBCH3), 2.44-2.59 (2H, m, 
CHACHBCH3) and 4.99-5.09 (1H, m, PhCH(CH3)N), 
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(300)-(R)-Perchlorophenyl 2-chloro-2-p-tolylpropanoate  
Cl
O
O
(300)
Cl
Cl
Cl
Cl
Cl
 
Scheme 86. Following general procedure 2: NHC precatalyst 66 (28.5 mg, 0.05 
mmol, 0.1 equiv), Cs2CO3 (14.6 mg, 0.045 mmol, 0.09 equiv), methyl-4-tolylketene 
420 (80.4 mg, 0.55 mmol, 1.1 equiv) and 275 (150 mg, 0.50 mmol, 1.0 equiv) in 
toluene (10 mL) for 3 hours at −40 °C gave a crude product which was purified by 
flash silica chromatography (petrol) to give 300 as a colourless solid;  (169 mg, 76% 
yield); mp 66-68 °C; 
! 
"[ ]D
20 +12.8 (c 0.53, CHCl3); νmax (KBr disk)/cm-1: 2922, 1762 
(C=O), 1512, 1444, 1382, 1360, 1202, 1185, 1084, 1053, 887, 815, 794, 721 and 518; 
δH (400 MHz, CDCl3) 2.34 (3H, s, CH3), 2.39 (3H, s, ArCH3), 7.22-7.25 (2H, m, 
ArH),) and 7.57-7.66 (2H, m, ArH), δC (100 MHz, CDCl3) 21.3 (CH3), 29.6 (ArCH3), 
69.2 (C(Ph)Et), 126.7 (CArH), 127.8 (CC6Cl5), 129.4 (CArH), 132.1 (CC6Cl5), 132.3 
(CC6Cl5), 136.0 (CAr-4), 139.2 (CAr-1), 144.0 (CC6Cl5) and 166.8 (C=O); m/z 
HRMS (ESI+), [M+NH4]+, C16H14O235Cl6NH4+ requires 461.9148, found 461.9150 
(−0.5 ppm). Following general procedure 4: 300 (10 mg, 0.02 mmol, 1.0 equiv), (S)-
α-methylbenzylamine (0.02 mL, 0.20 mmol, 10 equiv) and THF (2 mL) for 16 hours 
at room temperature gave the crude product as a brown oil. The diastereomeric ratio 
was determined as 72:28 by integration of the appropriate signals in the 1H NMR of 
the crude product; δH (300 MHz, CDCl3, characteristic signals only) 1.50 (3H, d, J 
6.9, diastereomeric CH(Ph)CH3), 1.54 (3H, d, J 6.9, diastereomeric, CH(Ph)CH3), 
2.12 (3H, s, diastereomeric, ArCH3),  2.14 (3H, diastereomeric, s, ArCH3), 2.32 (3H, 
s, diastereomeric C(Ar)(Cl)CH3), 2.36 (3H, s, diastereomeric C(Ar)(Cl)CH3) and 
5.08-5.14 (m, 1H, PhCH(CH3)N).  
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(302)-(R)-Perchlorophenyl 2-chloro-2-(2-chlorophenyl)butanoate 
Cl
O
O
(302)
Cl
Cl
Cl
Cl
Cl
Cl
 
Scheme 86. Following general procedure 2: NHC precatalyst 66 (28.5 mg, 0.05 
mmol, 0.1 equiv), Cs2CO3 (14.6 mg, 0.045 mmol, 0.09 equiv), ethyl-2-
chlorophenylketene 179 (99.3 mg, 0.55 mmol, 1.1 equiv) and 275 (150 mg, 0.50 
mmol, 1.0 equiv) in toluene (10 mL) for 3 hours at −40 °C gave a crude product 
which was purified by flash silica chromatography (petrol) to give 302 as a colourless 
solid;  (233 mg, 97% yield); mp 83-85 °C; 
! 
"[ ]D
20
 +3.6 (c 0.44, CHCl3); νmax (KBr 
disk)/cm-1: 2982, 2940, 1781 (C=O), 1465, 1431, 1382, 1359, 1166, 1130, 1066, 988, 
910, 822, 764, 754, 718, 726 and 674. δH (400 MHz, CDCl3) 0.89 (3H, t, J 7.4, 
CH2CH3), 2.65 (1H, dq, J 14.8, 7.4, CHAHBCH3), 3.11 (3H, dq, J 14.8, 7.4, 
CHAHBCH3), 7.32-7.45 (3H, m, ArH) and 7.98-8.01 (1H, m, ArH); δC (75 MHz, 
CDCl3) 8.6 (CH3), 31.4 (CH2), 75.1 (C(Ph)Et), 127.1 (CArH), 128.0 (CC6Cl5), 130.3 
(CArH), 130.8 (CArH), 131.0 (CArH), 132.0 (CAr-2), 132.0 (CC6Cl5), 132.3 
(CC6Cl5), 134.1 (CAr-1), 143.7 (CC6Cl5) and 166.8 (C=O); m/z HRMS (ESI+), 
[M+NH4]+, C16H9O235Cl7NH4+ requires 495.8755, found 495.8760 (−1.1 ppm).  
Following general procedure 4: 302 (20 mg, 0.04 mmol, 1.0 equiv), (S)-α-
methylbenzylamine (0.02 mL, 0.12 mmol, 20 equiv) and THF (2 mL) for 72 hours at 
reflux gave the crude product as a brown oil. The diastereomeric ratio was determined 
as 63:37 by integration of the appropriate signals in the 1H NMR of the crude product; 
δH (300 MHz, CDCl3, characteristic signals only) 0.95 (3H, t, J 7.2, diastereomeric 
CH2CH3) 1.10 (3H, t, J 7.2, diastereomeric CH2CH3), 1.55 (3H, d, J 4.4, 
diastereomeric PhCH(CH3)N), 1.57 (3H, d, J 4.4, diastereomeric PhCH(CH3)N) and 
5.21-4.12 (1H, m, PhCH(CH3)N)  
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(301)-(R)-Perchlorophenyl 2-chloro-2-(4-chlorophenyl)butanoate  
Cl
O
O
(301)
Cl
Cl
Cl
Cl
Cl
Cl
 
Scheme 86. Following general procedure 2: NHC precatalyst 66 (28.5 mg, 0.05 
mmol, 0.1 equiv), Cs2CO3 (14.6 mg, 0.045 mmol, 0.09 equiv), ethyl-
4chlorophenylketene  423 (99.3 mg, 0.55 mmol, 1.1 equiv) and 275 (150 mg, 0.50 
mmol, 1.0 equiv) in toluene (10 mL) for 3 hours at −40 °C gave a crude product 
which was purified by flash silica chromatography (petrol) to give 301 as a colourless 
solid; (218 mg, 91% yield); mp 88-92 °C;
! 
"[ ]D
20 +6.2 (c 0.53, CHCl3); νmax (KBr 
disk)/cm-1: 2983, 2942, 1791 (C=O), 1595, 1491, 1390, 1362, 1172, 1099, 1081, 
1018, 874, 820, 728, 717 and 517; δH (400 MHz, CDCl3) 1.08 (3H, t, J 7.2, CH2CH3) 
2.55 (1H, dq, J 14.5, 7.2, CHAHBCH3), 2.68 (1H, dq, J 14.5, 7.2, CHAHBCH3), 7.38-
7.43 (2H, m, ArH), and 7.60-7.65 (m, 2H, ArH); δC (75 MHz, CDCl3)  8.9 (CH3), 34.4 
(CH2), 74.3 (C(Ph)Et), 127.6 (CC6Cl5), 128.6 (CArH), 128.7 (CArH), 132.1 (CC6Cl5), 
132.3 (CC6Cl5), 135.1 (CAr), 136.0 (CAr), 143.8 (CC6Cl5) and 166.2 (C=O); m/z 
HRMS (ESI+) [M]+, C16H9O235Cl7+ requires 477.8417, found 477.8417 (+0.1 ppm); 
Following general procedure 4: 301 (8 mg, 0.02 mmol, 1.0 eq), (S)-α-
methylbenzylamine (0.20 mL, 0.20 mmol, 10 eq) and THF (2 mL) for 16 hours at 
room temperature gave crude product as a brown oil. The diastereomeric ratio was 
determined as 72:28 by integration of the appropriate signals in the 1H NMR of the 
crude product; δH (300 MHz, CDCl3, characteristic signals only) 0.88 (3H, t, J 7.2, 
diastereomeric CH2CH3), 0.99 (3H, t, J 7.2, diastereomeric CH2CH3), 1.41 (2H, d, J 
6.9, diastereomeric PhCH(CH3)N), 1.47 (3H, d, J 6.9, diastereomeric PhCH(CH3)N), 
2.14-2.28 (1H, m, CHAHBCH3), 2.42-2.56 (1H, m, CHAHBCH3) and 5.07-4.97 (1H, 
m, PhCH(CH3)N),  
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(313)-2,4,6-tribromophenyl 2-bromo-2-phenylbutanoate  
Br
O
O
(313)
Br
Br Br
 
Table 11, Entry 5. To a flame dried Schlenk flask under an argon atmosphere was 
added NHC precatalyst 66 (28.5 mg, 0.050 mmol, 0.1 equiv), Cs2CO3 (14.6 mg, 0.045 
mmol, 0.09 equiv) and toluene (3 mL) and the mixture stirred for 20 minutes. The 
mixture was then cooled to −40 °C in a cryostatic bath before addition of a solution of 
ethylphenylketene 146 (73.1 mg, 0.55 mmol, 1.1 equiv) in toluene (6 mL) at −40 °C, 
immediately followed by 2,4,4,6-tetrabromocyclohexa-2,5-dienone 312 (205 mg, 0.50 
mmol, 1.0 equiv). Toluene (1mL) was added to wash residual solid into solution and 
the solution stirred for 3 hours at −40 °C. The solution was allowed to warmed to 
room temperature over 16 h then concentrated in vacuo to give a crude product which 
was purified by flash silica chromatography (2% EtOAc/petrol) to give 313 as a 
colourless oil; (257 mg, 92% yield); 
! 
"[ ]D
20 +11.0 (c 0.7, CHCl3); Chiral HPLC 
analysis; Chiralcel OJ-H (30% ethanol: i-hexane, flow rate 1 mL min-1, 254 nm) tR 2.5 
min, tR 6.5 min, 44% ee; νmax (KBr disk)/cm-1: 3071, 2976, 1762 (C=O), 1560, 1494, 
1437, 1373, 1178, 1066, 953, 910, 857, 806, 743 and 694; δH  (300 MHz, CDCl3) 
1.07 (3H, t, J 7.2, CH2CH3) 2.61-2.78 (2H, m, CH2CH3), 7.31-7.41 (3H, m, 3, PhH-
3,4,5), and 7.71-7.74 (2H, m, PhH-2,6) and 7.66 (2H, br s,  C6H2Br3);  δC (75 MHz, 
CDCl3) 10.7 (CH3), 35.3 (CH2), 69.3 (C(Ph)Et), 118.6 (CC6Br3), 120.5 (CC6Br3), 
128.6 (CPhH), 128.7 (CPhH), 129.0 (CPh-4) 135.4 (CHC6Br3), 137.6 (CPh-1), 145.8 
(CC6Br3-1) and 167.1 (C=O); m/z HRMS (ESI+) [M+NH4]+, C16H16O2N179Br4+ 
requires 569.7906, found 569.7909 (−0.5 ppm). 
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Experimental information for chapter 6 
 
General experimental procedures 
 
General procedure (1): Synthesis of aroyloxy aldehydes via Grignard addition 
and ozonolysis. 
To a stirred solution of the requisite aldehyde (1.0 equiv) in THF (0.5M) at −78 °C 
was added vinylmagnesium bromide (0.7 M in THF, 1.1 equiv) dropwise and the 
resulting solution stirred at −78 °C for 0.5 h. Lithium chloride (1.2 equiv) was added 
followed by 4-nitrobenzoyl chloride (1.2 equiv) portion wise over 5 mins and the 
mixture stirred at rt for 2 h (until tlc shows complete consumption of the vinyl 
alcohol). Purification by flash silica chromatography afforded the O-4-nitrobenzoyl 
vinyl alcohol.  
A solution of the requisite O-4-nitrobenzoyl vinyl alcohol (1.0 equiv) in CH2Cl2 
(0.025M) at −78 °C was subjected to ozonolysis, followed by addition of dimethyl 
sulfide (2.0 equiv). The solution was warmed to rt over 2 h then concentrated in vacuo 
and the crude product purified by flash silica chromatography using the solvent 
system stated. 
 
General procedure (2): Synthesis of dihydropyran-2-ones 
To an oven dried vial containing molecular sieves, under an argon atmosphere, was 
added precatalyst 112 or 335, the requisite aroyloxy aldehyde (1.5 equiv)  (typically 
as a solution in anhydrous THF), ketoester 381 (1.0 equiv) and anhydrous THF. 
Triethylamine was added (1.5 equiv) and the reaction stirred at the given temperature 
for the required period of time. The reaction was then diluted with EtOAc, washed 
successively with 1 M aq. HCl and saturated NaHCO3, dried with Na2SO4 and 
concentrated in vacuo to provide the crude product with the given dr that was purified 
by flash silica chromatography.  
 
 
 
 
 
Chapter 8: Experimental Information 
 213 
(381)-(E)-Methyl 2-oxo-4-phenylbut-3-enoate 
Ph
O
CO2Me
(381)  
Scheme 100. A stirred slurry of potassium (E)-2-oxo-4-phenylbut-3-enoate24 (20 g, 
93.3 mmol, 1.0 equiv), 18-crown-6 (493 mg, 1.90 mmol, 0.02 equiv) and 
methlyiodide (8.72 mL, 140 mmol, 1.5 equiv) in DMF (100 mL) was stirred overnight 
at rt. An additional 50 mL of DMF was added and the slurry heated to 50 °C for 6 h. 
The slurry was cooled to rt, diluted with H2O and extracted twice with EtOAc. The 
combined organic portions were washed twice with H2O, twice with NaHCO3 , dried 
with Na2SO4 and concentrated in vacuo to provide crude 381 as a bright yellow solid. 
This solid was recrystallised from methanol to provide 2.76 g of 381. A further 0.95 g 
of 381 was obtained via flash silica chromatography (10% EtOAc:petrol) of the 
filtrate to provide 381 as a bright yellow solid; combined (3.71 g, 21% yield); mp 56-
62 °C, {literature 69-70 °C};25 1H NMR (400 MHz, CDCl3) δH 3.94 (3H, s, OCH3), 
7.38 (1H, d, J 16.1, C=CH(C(O)CO2Me)), 7.47 (3H, m, PhH-3,4,5), 7.63-7.65 (2H, 
m, PhH-2,6) and 7.88 (1H, d, J 16.1, C=CH(Ph)), in accordance with the literature.23  
 
(397)-N-methyl-O-(4-nitrobenzoyl)hydroxylamine hydrochloride 
O
H
N
O2N
O
Me
•HCl
(397)  
Scheme 109. Following the procedure of Tomkinson:26 potassium carbonate (41.4 g, 
0.30 mol, 0.5 equiv) was added to a 0 °C solution of N-methylhydroxylamine 
hydrochloride (50 g, 0.60 mol, 1.0 equiv) in a 1:1 mixture of THF and H2O (200 ml). 
A solution of di-tert-butyl dicarbonate (144 g, 0.66 mol, 1.1 equiv) in THF (100 ml) 
was then added dropwise to the mixture and stirred for 2 h at 0 °C and then warmed to 
rt for 3 h. The solution was partially concentrated in vacuo and extracted (top phase) 
with CH2Cl2 (100 ml) before washing with brine (3 × 50 ml) H2O and (50 ml). The 
organic fraction was dried (MgSO4) and concentrated in vacuo to yield an pale orange 
oil that was used without further purification. The crude solution of N-Boc-N-methyl 
hydroxylamine, DMAP (2 mol %) and triethylamine (89.0 mL, 0.60 mol, 1.0 equiv) 
in CH2Cl2 (800 ml) was cooled to 0 °C prior to slow addition of 
4-nitrobenzoylchloride (72.3 g, 0.60 mol, 1.0 equiv). The reaction mixture was 
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allowed to warm to rt and stirred for 16 h before washing with brine, NaHCO3 and 
brine again. The organics were dried with Na2SO4 and concentrated in vacuo to give a 
orange solid that was used without further purification. 
The crude orange solid was broken up and partially dissolved in 4M HCl in dioxane 
(300 mL) with the reaction exotherm controlled by an ice/H2O bath. Immediately 
upon dissolution a colourless solid precipitated from the reaction mixture, additional 
anhydrous dioxane was added (200 mL) and the slurry was stirred for 1 h until a thick 
white slurry had formed. The slurry was filtered and washed with Et2O  to provide 
N-methyl-O-(4-nitrobenzoyl)hydroxylamine hydrochloride; (71.0 g, 50% yield); mp 
135-137 °C decomp; νmax (ATR)/cm-1 2340, 1765 (C=O) 1694, 1609, 1537, 1325, 
1244, 1059, 1015, 881 and 783 1H NMR (400 MHz, DMSO) δH 2.84 (3H, s, NCH3), 
8.15 (2H, d, J 8.9, ArH-2,6), 8.34 (2H, d, J 8.9, ArH-3,5) and 11.48 (1H, br s, NH). 
 
(374)-1-Oxo-3-phenylpropan-2-yl 4-nitrobenzoate 
O
O
H
O
Ph
NO2
(374)  
Following general procedure 1: phenylacetaldehyde (2.92 mL, 25.0 mmol, 1.0 equiv), 
vinylmagnesium bromide (0.7 M in THF, 39.3 mL, 27.5 mmol, 1.1 equiv), lithium 
chloride (1.27 g, 30.0 mmol, 1.2 equiv) and 4-nitrobenzoyl chloride (5.60 g, 30.0 
mmol, 1.2 equiv) in THF (50 mL) gave, after purification by flash silica 
chromatography (5% EtOAc:petrol), the title compound as a yellow oil (2.74 g, 37% 
yield). Ozonolysis of 1-phenylbut-3-en-2-yl 4-nitrobenzoate was carried out on 2 × 
(765 mg, 2.57 mmol, 1.0 equiv) in CH2Cl2 (300 mL) at −78 °C, followed by addition 
of dimethylsulfide (0.38 mL, 5.1 mmol, 2.0 equiv) gave, after combination and 
purification by flash silica chromatography (10% EtOAc:petrol), 374 as a sticky white 
gum; (1.09 g, 71% yield); 1H NMR (400 MHz, CDCl3) δH 3.25 (1H, dd, J 14.5, 8.4, 
CHAHBPh), 3.38 (1H, dd, J 14.5, 5.0, CHAHBPh), 5.55 (1H, dd, J 8.4, 5.0, CH(Bn)), 
7.29-7.34 (5H, m, PhH), 8.21 (2H, d, J 9.0, ArHNO2-2,6), 8.33 (2H, d, J 9.0, 
ArHNO2-3,5) and 9.71 (1H, s, C(H)=O). In accordance with the literature.27 
 
Chapter 8: Experimental Information 
 215 
(390)-1-Oxohexan-2-yl 4-nitrobenzoate 
n-Bu
O
O
H
O
NO2
(390)  
Following general procedure 1: valeraldehyde (1.60 mL, 15.0 mmol, 1.0 equiv), 
vinylmagnesium bromide (0.7 M in THF, 23.6 mL, 16.5 mmol, 1.1 equiv) lithium 
chloride (763 mg, 18.0 mmol, 1.2 equiv) and 4-nitrobenzoyl chloride (3.34 g, 18.0 
mmol, 1.2 equiv) in THF (50 mL) gave, after purification by flash silica 
chromatography (5% EtOAc:petrol), the title compound as a yellow oil (2.4 g, 65% 
yield). Ozonolysis of hept-1-en-3-yl 4-nitrobenzoate was carried out on 2 × (1.00 g, 
3.80 mmol, 1.0 eqiuv) in CH2Cl2 (400 mL) at −78 °C, followed by addition of 
dimethylsulfide (0.56 mL, 7.60 mmol, 2.0 equiv) gave, after combination and 
purification by flash silica chromatography (10% EtOAc:petrol), 390 as pale yellow 
oil; (1.46 g, 72% yield); 1H NMR (400 MHz, CDCl3) δH 0.98 (3H, t, J 7.2, n-BuCH3), 
1.40-1.56 (4H, m, n-BuCH2), 1.91-2.06 (2H, m, n-BuCH2), 5.34 (1H, dd, J 8.3, 4.8, 
CH(Bu)), 8.28-8.31 (2H, m, ArHNO2-2,6), 8.34-8.38 (2H, m, ArHNO2-3,5) and 9.67 
(1H, s, C(H)=O). In accordance with the literature.27 
 
Following the procedure outlined by Tomkinson:24 to a stirred solution of hexanal 
(3.08 mL, 25.0 mmol, 1.0 equiv) in DMSO (50 mL) at rt was added N-methyl-O-(4-
nitrobenzoyl)hydroxylamine hydrochloride (6.4 g, 27.5 mmol, 1.1 equiv) in one 
portion, and the mixture stirred at rt for 24 h. The mixture was then diluted with 
EtOAc and washed with brine, then dried, filtered and concentrated in vacuo to give a 
crude product which was purified by slica flash chromatography (5% to 20% 
EtOAc:petrol) to give 390; (2.38g, 36% yield) spectroscopic data in accordance with 
the above described. 
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(391)-4-Methyl-1-oxopentan-2-yl 4-nitrobenzoate 
i-Bu
O
O
H
O
NO2
(391)  
Following general procedure 1: i-valeraldehyde (1.60 mL, 15.0 mmol, 1.0 equiv), 
vinylmagnesium bromide (0.7 M in THF, 23.6 mL, 16.5 mmol, 1.1 equiv) lithium 
chloride (763 mg, 18.0 mmol, 1.2 equiv) and 4-nitrobenzoyl chloride (3.34 g, 18.0 
mmol, 1.2 equiv) in THF (50 mL) gave, after purification by flash silica 
chromatography (5% EtOAc/petrol) gave crude 5-methylhex-1-en-3-yl 4-
nitrobenzoate that was taken onto the next step without further purification. 
Ozonolysis of 5-methylhex-1-en-3-yl 4-nitrobenzoate in CH2Cl2 (400 mL) at −78 °C, 
followed by addition of dimethylsulfide gave, after purification by flash silica 
chromatography (10% to 20% EtOAc:petrol), 391 as pale yellow oil; (940 mg, 24% 
yield over two steps); νmax (ATR)/cm-1 2959, 1724 (C=O) 1609, 1525, 1346, 1238, 
1101, 1015, 872, 842 and 783; (1H NMR (400 MHz, CDCl3) δH 1.01 (3H, d, J 6.4, i-
BuCH3), 1.03 (3H, d, J 6.4, i-BuCH3), 1.80-1.90 (3H, m, i-BuCH/CH2), 5.37 (1H, dd, 
J 9.0, 4.6, CH(i-Bu)), 8.25-8.28 (2H, m, ArHNO2-2,6), 8.31-8.34 (2H, m, ArHNO2-
3,5) and 9.63 (1H, s, C(H)=O); 13C NMR (100 MHz, CDCl3) 21.7 (i-BuCH3), 23.2 
(i-BuCH3), 24.8 (i-BuCH), 37.0 (i-BuCH2), 78.4 (CH(i-Bu)), 123.7 (CArHNO2-2,6), 
131.0 (CArHNO2-3,5), 134.6 (CAr-1), 150.9 (CAr-4), 164.3 (C=O ester) and 197.1 
(C=O aldehyde); m/z: (ASAP) HRMS [M+H]+ C13H16O5N+: found 266.1024; calcd 
266.1023 (+) 0.4 ppm. 
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(392)-Methyl-1-oxobutan-2-yl 4-nitrobenzoate 
O
O
H
O
NO2
(392)  
Following general procedure 2: i-butyraldehyde (1.37 mL, 15.0 mmol, 1.0 equiv), 
vinylmagnesium bromide (0.7 M in THF, 23.6 mL, 16.5 mmol, 1.1 equiv), lithium 
chloride (763 mg, 18.0 mmol, 1.2 equiv) and 4-nitrobenzoyl chloride (3.34 g, 18.0 
mmol, 1.2 equiv) in THF (50 mL) gave a crude oil. Addition of Et2O  precipitated a 
colourless solid that was filtered leaving the filtrate that solidified on standing and 
was taken on to the next step without further purification. Ozonolysis of 
4-methylpent-1-en-3-yl 4-nitrobenzoate was carried out with 2 × (1.00 g, 4.01 mmol, 
1.0 equiv) in CH2Cl2 (400 mL) at −78 °C, followed by addition of dimethylsulfide 
(0.59 mL, 8.02 mmol, 2.0 equiv) gave, after combination and purification by flash 
silica chromatography; (10% EtOAc:petrol), 392 as a colourless solid (922 mg, 46% 
yield); mp 46-48 °C {literature 50-52 °C};27 1H NMR (300 MHz, CDCl3) δH 1.17 
(3H, d, J 6.9, CH(CH3)2), 1.20 (3H, d, J 6.9, CH(CH3)2), 2.44-2.57 (1H, m, 
CH(CH3)2), 5.22 (1H, dd, J 4.5, 0.5, CH), 8.32-8.33 (2H, m, ArHNO2-2,6), 8.35-8.39 
(2H, m, ArHNO2-3,5) and 9.70 (1H, d, J 0.5, C(H)=O). In accordance with the 
literature.27 
 
(382)-Syn-(±)-Methyl3-benzyl-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate  
O
O
CO2EtPh
(382)
Ph
 
Table 12, Entry 1. Following general procedure 2: NHC precatalyst 335 (7.0 mg, 
0.02 mmol, 0.2 equiv), 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate (50 mg, 0.17 
mmol, 1.5 equiv), (E)-methyl 2-oxo-4-phenylbut-3-enoate (21.0 mg, 0.11 mmol, 1.0 
equiv), triethylamine (23 µL, 0.17 mmol, 1.5 equiv) and THF (3 mL) for 24 h at rt 
gave a crude mixture with (dr 84:16, syn:anti). This was purified by flash silica 
chromatography (10% EtOAc:petrol) to give 382 Syn as a colourless solid; (13 mg, 
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37% yield); mp 105-110 °C; Chiral HPLC analysis Chiralpak AD-H (10% 
IPA:hexane, flow rate 1.0 mL min-1, 254 nm, 30 °C) tR 18.0 min, tR 27.8 min; νmax 
(KBr)/cm-1 2956, 2925, 1765 (lactone C=O), 1628 (ester C=O), 1664, 1602, 1495, 
143, 1316, 1100, 1088, 756, 743, 697 and 539; 1H NMR (400 MHz, CDCl3) δH 2.33 
(1H, dd, J 15.8, 10.6, BnCHAHB), 3.16-3.23 (2H, m, BnCHAHB and CH(Bn)), 3.55 
(1H, t, J 6.8, CH(Ph)), 3.77 (3H, OCH3), 6.58 (1H, d, J 6.7, C=CH), 6.93-7.00 (4H, 
m, PhH), and 7.15-7.26 (6H, m, 1 × PhH and 5 × BnArH); 13C NMR (75 MHz, 
CDCl3) δC 32.1(CH2Bn), 40.6 (CH(Bn)), 44.8 (CH(Ph)), 52.7 (OCH3), 118.8 (C=CH), 
126.8 (CHArBn-4), 128.4 (CHPh-4), 128.4 (CArH), 128.7 (CArH), 128.9 (CArH), 
129.2 (CArH), 135.8 (CPh-1), 138.1 (CArBn-1), 141.9 (C=CH), 161.0 (C=O ester) 
and 168.5 (C=O lactone); m/z: (ESI+) HRMS [M+NH4]+ C20H22O4N+: found 
340.1544; calcd 340.1543 (+) 0.2 ppm. 
 
Syn-(S,S)-Methyl 3-benzyl-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate  
Table 12, Entry 2. Following general procedure 2: NHC precatalyst 112 (3.3 mg, 
0.01 mmol, 0.2 equiv), 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate (40 mg, 0.13 
mmol, 1.5 equiv), (E)-methyl 2-oxo-4-phenylbut-3-enoate (17.0 mg, 0.09 mmol, 1.0 
equiv), triethylamine (19 µL, 0.13 mmol, 1.5 equiv) and THF (2 mL) for 24 h at 0 °C 
to rt gave a crude mixture with (dr 98:2, syn:anti). This was purified by flash silica 
chromatography (10% EtOAc:petrol) to give  syn as a colourless solid; (27 mg, 50% 
yield); mp 106-107 °C; 
! 
"[ ]D
20
 +398 (c 0.23, CHCl3); Chiral HPLC analysis Chiralpak 
AD-H (10% IPA:hexane, flow rate 1.0 mL min-1, 254 nm, 30 °C) tR minor (R,R) 17.9 
min, tR major (S,S) 27.8 min >99% ee; spectroscopic data in accordance with above.  
 
(382)-Anti-(3S,4R)-methyl-3-benzyl-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
O
O
CO2EtPh
(382)-anti
Ph
 
Scheme 104. Following general procedure 1: NHC precatalyst 112 (1.1 mg, 0.003 
mmol, 0.01 equiv), 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate (135 mg, 0.43 mmol, 
1.5 equiv), (E)-methyl 2-oxo-4-phenylbut-3-enoate (57.0 mg, 0.30 mmol, 1.0 equiv), 
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triethylamine (63 µL, 0.43 mmol, 1.5 equiv) and THF (4 mL) for 48 h at rt gave a 
crude mixture with (dr 76:24, syn:anti). This was purified by flash silica 
chromatography (10% EtOAc:petrol) to give 382 syn as a colourless solid; (27 mg, 
50% yield, >99% ee) spectroscopic data in accordance with above;  
382-Anti as a colourless solid; (18 mg, 19% yield); 
! 
"[ ]D
20
  +163 (c 0.04, CHCl3); mp 
116-118 °C; νmax (ATR)/cm-1 1769 (C=O lactone), 1734 (C=O ester), 1655, 1437, 
1283, 1219, 1103 and 991; 1H NMR (400 MHz, CDCl3); 2.79-2.88 (1H, m, CH2(Bn)). 
2.97-3.07 (2H, m, CH2(Bn) and CH(Bn)), 3.51-3.58 (1H, m, CH(Ph)), 3.81 (3H, m, s 
OCH3), 6.46 (1H, d, J 5.0, C=CH), 6.93-6.98 (2H, m, PhH), 7.07-7.10 (2H, m, PhH) 
and 7.21-7.28 (6H, m, PhH); 13C NMR (100 MHz, CDCl3) δC 35.7 (CH2Bn), 41.4 
(CH(Bn)), 47.7 (CH(Ph), 52.8 (OCH3), 116.5 (C=CH), 127.1 (CHArBn-4), 127.3 
(CArH), 128.0 (CHPh-4), 128.8 (CArH), 129.2 (CArH), 129.3 (CArH), 137.3 (CPh-
1), 139.2 (CArBn-1), 141.7 (C=CH), 160.8 (C=O ester) and 168.0 (C=O lactone); 
m/z: (ESI+) HRMS [M+NH4]+ C20H22O4N+: found 340.1549; calcd 340.1543 (+) 1.7 
ppm. 
 
(389)-Methyl 5-benzyl-6-oxo-4-phenyl-3,6-dihydro-2H-pyran-2-carboxylate 
O
O
CO2EtPh
(389)
Ph
 
Scheme 107. To a solution of 382 syn (10 mg, 0.03 mmol, 1.0 equiv, >20:1 dr and 
>99% ee) in CH2Cl2 (2 mL) was added pyrrolidine (3 µL, 0.04 mL, 1.2 equiv) and the 
reaction stirred for 16 h. The solution was washed with 1 M HCl, dried (Na2SO4) 
concentrated in vacuo and purified by flash silica chromatography (10% 
EtOAc:petrol) to give 389 as a colourless oil; (5 mg, 50% yield); νmax (ATR)/cm-1; 
1656 (C=O), 1495, 1437, 1361, 1200, 1110 and 1016; 1H NMR (400 MHz, CDCl3); 
3.07 (2H, t, J 3.7, CH2), 3.49 (3H, s, OCH3), 3.62 (1H, d, J 14.3, BnCHAHB), 3.70 
(1H, d, J 14.4, BnCHAHB), 4.98 (1H, t, J 4.9, CH(CO2Et)), 6.91-6.94 (2H, m, PhH), 
7.06-7.19 (5H, m, PhH) and 7.32-7.40 (3H, m, PhH); 13C NMR (75 MHz, CDCl3) 
33.0 (CH2Bn), 33.4 (CH2), 52.8 (OCH3), 73.6 (CH(CO2Me)), 126.2 (CPhH-4), 127.4 
(CPhH), 128.1 (C=C(Bn)), 128.3 (CPhH), 128.5 (CPhH), 128.9 (CPhH), 129.0 
(CPhH-4), 138.0 (CPh-1), 139.3 (CPh-1), 149.7 (C=C(Ph)), 163.8 (C=O lactone) and 
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170.1 (C=O ester); m/z: (ESI+) HRMS [M+H]+ C20H19O4+: found 323.1283; calcd 
323.1278 (+) 0.2 ppm. 
(393) syn-(±)-methyl-3-butyl-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate 
O
O
CO2EtPh
n-Bu
(393)  
Table 15, Entry 1. Following general procedure 1: NHC precatalyst 335 (4.2 mg, 
0.01 mmol, 0.1 equiv), 1-oxohexan-2-yl 4-nitrobenzoate (50 mg, 0.19 mmol, 1.5 
equiv), (E)-methyl 2-oxo-4-phenylbut-3-enoate (25.2 mg, 0.13 mmol, 1.0 equiv), 
triethylamine (28 µL, 0.19 mmol, 1.5 equiv) and THF (3 mL) for 18 h at rt gave a 
crude mixture with (dr 92:8, syn:anti). This was purified by flash silica 
chromatography (5% EtOAc:petrol) to give 393 syn as a colourless oil; (15 mg, 40% 
yield); Chiral HPLC analysis Chiralpak AD-H (5% IPA:hexane, flow rate 1.0 mL 
min-1, 220 nm) tR 16.0 min, tR 17.4 min; νmax (ATR)/cm-1 2954, 1773 (C=O lactone), 
1734 (C=O ester), 1661, 1454, 1437, 1323, 1259, 1045 and 989; 1H NMR (300 MHz, 
CDCl3) δH 0.81 (3H, t, J 7.1, n-BuCH3), 1.08-1.40 (5H, m, n-BuCH2), 1.60-1.70 (1H, 
m, n-BuCH2), 2.79 (1H, d, J 6.9, CH(n-Bu)), 3.79 (1H, t, J 6.7, CH(Ph)), 3.83 (3H, s, 
OCH3), 6.68 (1H, d, J 6.4, C=CH), 7.06 (2H, dt, J 5.8, 1.8, PhH-2,6) and 7.23-7.29 
(3H, m, PhH-3,4,5); 13C NMR (100 MHz, CDCl3) 13.9 (n-BuCH3), 22.5 (n-BuCH2), 
26.0 (n-BuCH2), 29.4 (n-BuCH2), 41.5 (CH(Ph)), 43.4 (CH(n-Bu)), 52.7 (OCH3), 
118.4 (C=CH), 128.1 (CPhH-2,6), 128.1 (CPh-4), 129.1 (CPhH-3,5), 136.0 (CPh-1), 
142.1 (C=CH), 161.1 (C=O ester) and 168.8 (C=O lactone); m/z: (ESI+) HRMS 
[M+NH4]+ C17H24O4N+: found 306.1702; calcd 306.1700 (+) 0.7 ppm. 
 
(393)-(S,S)-methyl-3-butyl-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate  
Table 16, Entry 1. Following general procedure 2: NHC precatalyst 112 (1.2 mg, 
0.03 mmol, 0.01 equiv), 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate (133 mg, 0.50 
mmol, 1.5 equiv), (E)-methyl 2-oxo-4-phenylbut-3-enoate (63.0 mg, 0.33 mmol, 1.0 
equiv), triethylamine (70 µL, 0.50 mmol, 1.5 equiv) and THF (5 mL) for 3 h at rt gave 
a crude mixture with (dr >20:1, syn:anti). This was purified by flash silica 
chromatography (5% EtOAc:petrol) to give 393 syn as a colourless oil; (66 mg, 69% 
yield); 
! 
"[ ]D
20
+156 (c 0.15, CHCl3); Chiral HPLC analysis Chiralpak AD-H (5% 
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IPA:hexane, flow rate 1.0 mL min-1, 220 nm) tR minor (R,R) 14.7 min, tR major (S,S) 
16.5 min >99% ee; spectroscopic data in accordance with above.  
 
(393)-(S,S)-methyl-3-butyl-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate 
Scheme 112. Following general procedure 2: NHC precatalyst 112 (22.0 mg, 0.06 
mmol, 0.01 equiv), 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate (2.38 g, 8.97 mmol, 
1.5 equiv), (E)-methyl 2-oxo-4-phenylbut-3-enoate (1.14 g, 5.98 mmol, 1.0 equiv), 
(1.25 mL, 8.97 mmol, 1.5 equiv) and THF (100 mL) for 3 h at rt gave a crude mixture 
with (dr >20:1, syn:anti). This was purified by flash silica chromatography (5% 
EtOAc:petrol) to give 393 syn as a pale yellow oil (700 mg, 41% yield); 
! 
"[ ]D
20
 +298 (c 
0.28, CHCl3); Chiral HPLC analysis Chiralpak AD-H (5% IPA:hexane, flow rate 1.0 
mL min-1, 220 nm) tR minor (R,R) 15.5 min, tR major (S,S) 17.4 min >99% ee; 
spectroscopic data in accordance with above.  
 
(394)-Syn-(±)-methyl-3-isobutyl-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate  
O
O
CO2EtPh
i-Bu
(394)  
Table 17, Entry 1. Following general procedure 2: NHC precatalyst 335 (16.0 mg, 
0.05 mmol, 0.2 equiv), 4-methyl-1-oxopentan-2-yl 4-nitrobenzoate (100 mg, 0.38 
mmol, 1.5 equiv), (E)-methyl 2-oxo-4-phenylbut-3-enoate (48.0 mg, 0.25 mmol, 1.0 
equiv), triethylamine (52 µL, 0.38 mmol, 1.5 equiv) and THF (4 mL) for 12 h at rt 
gave a crude mixture with (dr >20:1, syn:anti). This was purified by flash silica 
chromatography (2.5 to 5% EtOAc:petrol) to give 394 syn as a colourless solid; (24 
mg, 33% yield); mp 84-88 °C; Chiral HPLC analysis Chiralpak AD-H (5% 
IPA:hexane, flow rate 1.0 mL min-1, 220 nm) tR 11.9 min, tR 13.6 min; νmax (KBr)/cm-
1; 2959, 1769 (C=O lactone), 1708 (C=O ester), 1661, 1317, 1265, 1094, 1082 and 
991; 1H NMR (300 MHz, CDCl3) δH 0.83 (3H, d, J 6.6, i-BuCH3), 0.88 (3H, d, J 6.6, 
i-BuCH3), 1.04 (1H, app dt, J 7.0, 14.0, i-BuCH), 1.56 (2H, dt, J 13.9, 7.0, i-
BuCHAHB), 1.72 (1H, dd, J 14.0, 7.0, i-BuCHAHB), 2.93 (1H, app q, J 6.9, CH(i-Bu)), 
3.77 (1H, t, J 6.7, CH(Ph)), 3.87 (3H, s, OCH3), 6.72 (1H, d, J 6.4, C=CH), 7.07-7.10 
(2H, dt, J 1.8, 5.8, PhH-2,6) and 7.27-7.34 (3H, m, PhH-3,4,5); 13C NMR (100 MHz, 
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CDCl3) δC 22.2 (i-BuCH3), 22.5 (i-BuCH3), 25.2 (i-BuCH), 35.2 (i-BuCH2), 41.2 
(CH(i-Bu), 41.7 (CH(Ph), 52.7 (OCH3), 118.4 (C=CH), 128.1 (CPhH-2,6), 128.1 
(CPh-4), 129.1 (CPhH-3,5), 136.0 (CPh-1), 142.1 (C=CH), 161.1 (C=O ester) and 
168.9 (C=O lactone); m/z: (ESI+) HRMS [M+NH4]+ C17H24O4N+: found 306.1704; 
calcd 306.1700 (+) 1.4 ppm. 
 
(394)-(S,S)- methyl 3-isobutyl-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate  
Table 17, Entry 2. Following general procedure 2: NHC precatalyst 112 (12.0 mg, 
0.03 mmol, 0.10 equiv), 4-methyl-1-oxopentan-2-yl 4-nitrobenzoate (133 mg, 0.50 
mmol, 1.5 equiv), (E)-methyl 2-oxo-4-phenylbut-3-enoate (63.0 mg, 0.33 mmol, 1.0 
equiv), triethylamine (70 µL, 0.50 mmol, 1.5 equiv) and THF (5 mL) for 16 h at rt 
gave a crude mixture with (dr >20:1, syn:anti). This was purified by flash silica 
chromatography (2.5 to 5% EtOAc:petrol) to give 394 syn as a colourless oil; (45 mg, 
47% yield); 
! 
"[ ]D
20 +279 (c 0.14, CHCl3); Chiral HPLC analysis Chiralpak AD-H (5% 
IPA:hexane, flow rate 1.0 mL min-1, 220 nm) tR minor (R,R) 10.6 min, tR major (S,S) 
13.0 min >99% ee; spectroscopic data in accordance with above.  
 
(395)-(5S)-methyl 5-isobutyl-6-oxo-4-phenyl-5,6-dihydro-2H-pyran-2-carboxylate 
O
O
CO2EtPh
i-Bu
(395)  
Scheme 113. Isolated as an inseparable mixture of diastereoisomers (70:30 dr); 
colourless oil; characteristic 1H NMR (300 MHz, CDCl3) δH 0.82 (3H, d, J 6.4, minor-
i-BuCH3), 0.84 (3H, d, J 6.6, major-i-BuCH3), 0.96 (3H, d, J 6.4, minor-i-BuCH3), 
0.96-0.98 (3H, m, major-i-BuCH3), 1.32-1.42 (1H, m, i-BuCHX), 1.61-1.80 (1H, m, i-
BuCHX), 1.82-1.96 (1H, m, i-BuCHX), 3.70-3.75 (1H, m, CH(i-Bu)), 3.84 (4 H, s, 
minor-OCH3), 3.85 (3H, s, major-OCH3), 5.52 (3H, app dd, J 1.7, 5.1, major-
CH(CO2Me)), 5.65 (1H, app t, J 2.1, minor-CH(CO2Me)), 6.20 (1H, app t, J 4.1, 
C=CH) and 7.37-7.40 (5H, m, PhH), 
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(396)-(3S,4S)-methyl-3-isopropyl-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
O
O
CO2EtPh
(396)  
Table 18, Entry 2. Following general procedure 2: NHC precatalyst 112 (4.9 mg, 
0.013 mmol, 0.10 equiv), 3-methyl-1-oxobutan-2-yl 4-nitrobenzoate (50.0 mg, 0.20 
mmol, 1.5 equiv), (E)-methyl 2-oxo-4-phenylbut-3-enoate (25.2 mg, 0.13 mmol, 1.0 
equiv), triethylamine (28 µL, 0.20 mmol, 1.5 equiv) and THF (3 mL) for 18 h at rt 
gave a crude mixture with (53:47) ratio of 397 to 396. 396 isolated in (>95:5 dr) as an 
inseparable mixture with 3-methyl-1-oxobutan-2-yl 4-nitrobenzoate. Characteristic 
signals 1H NMR (300 MHz, CDCl3) δH 0.82 (3H, d, J 6.8, CH(CH3)2), 1.01 (3H, d, J 
6.8, CH(CH3)2), 1.76-1.88 (1H, m, CH(CH3)2), 2.54 (1H, dd, J 8.7, 6.8, CH(i-Pr)), 
3.78 (3H, s, OMe), 3.85 (1H, t, J 6.7, CH(Ph)), 6.62 (1H, d, J 6.6, C=CH), 7.08-7.11 
(2H, m, PhH) and 7.23-7.27 (3H, m, PhH). 
 
(387)-(3S,4S)-ethyl 3-benzyl-2-oxo-6-phenyl-3,4-dihydro-2H-pyran-4-carboxylate 
O
O
EtO2C Ph
(387)
Ph
 
Scheme 104. Following general procedure 2; NHC precatalyst 112 (19.5 mg, 0.053 
mmol, 0.10 equiv), 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate (238 mg, 0.80 mmol, 
1.5 equiv), (E)-ethyl 4-oxo-4-phenylbut-2-enoate28 (108 mg, 0.53 mmol, 1.0 equiv), 
triethylamine (0.11 mL, 0.80 mmol, 1.5 equiv) and THF (5 mL) for 2 h at rt gave a 
crude mixture (dr 98:2, syn:anti). This was purified by flash silica chromatography (5 
to 10% EtOAc:petrol) to give 387 syn as a colourless oil; (140 mg, 79% yield); 
! 
"[ ]D
20
+173 (c 1.05, CH3Cl), {literature29 +107 (c 1.05, CH3Cl, (3S, 4S))}; 1H 
spectroscopic data in accordance with the literature27 (300 MHz, CDCl3) δH 1.29 (4 H, 
t, J 7.1, OCH2CH3) 2.77 (1 H, dd, J 14.2, 10.2, BnCHAHB), 2.98-3.01 (1H, m, 
CH(Bn)), 3.25 (1H, dd, J 6.9, 5.9, CH(CO2Et)) 3.55 (1H, dd, J 14.2, 4.6, BnCHAHB), 
4.22 (2H, q, J 7.1, OCH2CH3), 5.80 (1H, d, J 7.0, C=CH), 7.16-7.19 (2H, m, ArH), 
7.35-7.38 (6H, m, ArH) and 7.60-7.63 (2H, m, ArH). 
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